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Summary.
Bunyamwera (BUN) virus is the prototype type virus of the family Bunyaviridae. The virus 
has a genome composed of three single stranded RNA segments of negative polarity termed 
large (L), medium (M), and small (S). Described in this thesis, is the development of a 
reverse genetics reporter system to study the synthesis of BUN viral RNA and the proteins 
involved. The system utilises a recombinant RNA template, BUNSCAT, which comprises 
an antisense CAT gene flanked by the authentic BUN S 5’ and 3’ untranslated regions 
(UTRs). Transfection of in vitro transcribed BUNSCAT RNA into cells transiently 
expressing recombinant BUN viral proteins resulted in CAT activity only when both the L 
segment and the S segment proteins were expressed, indicating that the negative sense 
template had been transcribed into a positive sense, translatable RNA. Further analysis 
revealed that just BUN N and L proteins were sufficient for the transcription of BUNSCAT 
RNA. It was also demonstrated that the BUN L protein was able to transcribe BUNSCAT 
RNA in concert with the N proteins of certain heterologous bunyavirus S segments. 
Modifications to the BUNSCAT UTRs indicated that these terminal regions play an 
important role in transcription of BUNSCAT RNA. The addition of nucleotides to both the 
3’ and 5’ termini were tolerated to an extent. While deletion of one nucleotide at the 3’ 
terminus gave near wildtype CAT activity, any further deletions resulted in a significant drop 
in CAT activity, as did any deletion of the 5’ terminus. Analysis of a series of single point 
and complimentary base-pair mutations to the 5’ and 3’ termini determined that sequence 
specificity for nucleotides 2-12 of the termini was essential while maintenance of base- 
pairing between nucleotides 13-15 of the termini was also important. Construction and 
comparison of BUNLCAT and BUNMCAT RNAs with the BUNSCAT reporter determined 
that the L UTRs gave a higher CAT activity than M UTRs which in turn were higher than S 
UTRs. Construction and analysis of a series of chimeric BUN segment UTR reporters (e.g. 
BUNL 3’-CAT-BUNM 5’) showed that none of the chimeric RNAs were transcribed. A 
significant level of CAT activity was restored, however, to the BUNL/M-CAT reporter when 
the BUN L 5’ UTR terminus was mutated to recreate partly M 5’ UTR sequence, thereby 
restoring complementarity between the 18 terminal nucleotides.
Collectively, these results demonstrate that the reporter assay is a useful, reliable and 
convenient tool to study the molecular processes of Bunyamwera virus. Using this system, it 
is expected that further mutational analysis of the BUN RNA segments and replication 
proteins will provide insight into transcription and replication processes, and the ds-acting 
signals which control and orchestrate .these important events.
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UUK Uukuniemi virus (uukuvirus)
VSV Vesicular Stomatitis virus
vTF7-3 recombinant T7 pol expressing vaccinia virus
Amino acids.
Alanine Ala A
Arginine Arg R
Asparagine Asn N
Aspartic acid Asp D
Cysteine Cys C
Glutamine Gin Q
Glutamic acid Glu E
Glycine Gly G
Histidine His H
Isoleucine He I
Leucine Leu L
Lysine Lys K
Methionine Met M
Phenylalanine Phe F
Proline Pro P
Serine Ser S
Threonine Thr T
Tryptophan Trp W
Tyrosine Tyr Y
Valine Val V
xvn
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Chapter 1. 
Introduction.
1.0.0 The Bunyaviridae.
1.0.1 Characteristics and taxonomy of the B unyavir idae .
Members of the Bunyaviridae share characteristics such as molecular composition, particle 
morphology, mode of transmission, genome structure, and coding strategies (negative-sense 
and ambi sense).
All viruses in the family are enveloped, spherical particles of approximately 100 nm in 
diameter (in the range of 80-120 nm). The envelope is composed of host derived lipid, and is 
approximately 4 to 5 nm thick (Bishop, 1996). The virus particles are composed of four viral 
encoded structural proteins, two glycoproteins termed G1 and G2 and two nucleocapsid 
associated proteins, termed the L protein (RNA-dependent RNA polymerase) and the N 
protein (nucleocapsid protein). The viral glycoproteins are embedded in the lipid envelope 
and project 5 to 10 nm from the virion surface. The glycoproteins possess type-specific 
antigenic determinants and these variations contribute unique external features to 
representatives of different genera (Martin et al., 1985; Schmaljohn and Patterson, 1990: 
Schmaljohn, 1996b). Based on the structure and its components, the overall chemical 
composition is calculated to be 1-2% RNA, 58% protein, 33% lipid, and 7% carbohydrate 
(Objeski and Murphy, 1977). The envelope surrounds the virus genome which consists of 
three single stranded RNAs termed the small (S), medium (M), and large (L) segments, 
respectively. The three viral RNAs are present in the virions as nucleocapsids (RNPs). Each 
RNP consists of a single genomic RNA encapsidated by the viral N and L proteins. RNPs 
have a buoyant density of 1.31 g/ml (Kolakofsky et al., 1991). The length of the genomic 
segments vary among the genera, ranging from 6.3 to 13 kb for the L segment, 3.5 to 5 kb 
for the M segment, and 0.8 to 2.9 kb for the S segment (Figures 1.0). The pattern of 
genome segment sizes is conserved within a genera. Each RNA species has conserved 
complementary 3’ and 5’ ends which are genus specific (see Figure 1.1). The 3’ and 5’ ends 
of the RNAs are thought to be hydrogen bonded to form closed circular structures as seen by 
electron microscopy (EM) (Hewlett et al., 1977).
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At present, the International Catalogue of Arboviruses lists more than 525 viruses, 
(Karabatsos, 1985). Of these, 313 have been placed in the family Bunyaviridae. These again 
have been subdivided into five genera on the basis of serological, biochemical and genotypic 
characteristics: 172 viruses in the Bunyavirus genus, 10 in the Hantavirus genus, 34 in the 
Nairovirus genus, 51 in the Phlebovirus genus (Table 1.1). In addition the Tospovirus 
genus consists of 4 viruses (Table 1.1) (Schmajohn et al., 1985), another 19 viruses have 
characteristics of viruses of the family Bunyaviridae and have been placed in serogroups but 
unassigned to a genus, and another 23 are both ungrouped and unassigned within the family. 
Members of the same genera are also referred to by their vernacular term; bunyaviruses, 
hantaviruses, nairoviruses, phleboviruses and tospoviruses.
1.0.2 Host range, transmission and importance o f B unyaviridae  
diseases.
Four of the genera of the Bunyaviridae, Bunyavirus, Hantavirus, Nairovirus and 
Phlebovirus, contain vertebrate-infecting viruses while members of the Tospovirus genus 
infect plants. Most of the viruses are transmitted by arthropod vectors (and hence are known 
as arboviruses). In general, bunyaviruses are transmitted by mosquitoes or midges; 
nairoviruses by ticks, and phleboviruses by sandflys or ticks. Tospoviruses are transmitted 
(spread) by thrips. Hantaviruses do not have an arthropod vector but are maintained in nature 
as a persistent infection of rodents and are transmitted to humans and other rodents via 
aerosolised infectious rodent secretions.
A number of viruses belonging to the Bunyaviridae are serious human and veterinary 
pathogens (Elliott, 1997), for example Crimean-Congo haemorrhagic fever virus 
(nairovirus), Rift Valley fever virus (phlebovirus), La Crosse virus (bunyavirus) and a 
number of hantaviruses. Several hantaviruses including Hantaan (HTN), Seoul (SEO), 
Dobrava (DOB, and Puumala (PUU) viruses, are associated with haemorrhagic fever with 
renal syndrome of varying severity, ranging from HTN infection with 5 to 15% mortality to 
PUU virus infections with less than 1% mortality. These forms of the disease are currently 
recognised throughout Asia, the former Soviet Union, and northern Europe (McKee et al., 
1991). Recently, however, another hantavirus, Sin Nombre (SN) virus was recognised as a 
major etiological agent associated with the severest form of hantavirus pulmonary syndrome 
(HPS) occurring in the United States, with a mortality rate of approximately 60% (Nichol et 
al., 1996). Crimean-Congo haemorrhagic fever virus is the etiologic agent of another 
haemorrhagic fever which results in 10 to 20% mortality over a wide geographical area 
including Africa, Eastern Europe, the Middle East, and Asia through the western provinces
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Genus Serogroups Representative Viruses
Bunyavirus
19 groups containing 172 viruses. 
Example groups:
Bunyamwera group (32) 
California group (14)
Simbu group (25)
Germiston and Bunyamwera viruses (human pathogens), and 
Cache valley virus (pathogen of cattle and sheep).
California encephalitis, La Crosse and Snowshoe hare viruses 
(human pathogens).
Aino and Simbu viruses and Oropouche virus (human pathogen)
Hantavirus
One group containing 10 viruses. 
Hantaan group Hantaan, Puumala, Seoul and Sin Nombre viruses (human 
pathogens).
Nairovirus
7 groups containing 34 viruses, 
example groups:
CCHF group (3)
Nairobi sheep disease group (2)
Crimean-Congo haemorrhage fever virus (human pathogen).
Dugbi and Nairobi sheep disease viruses (pathogens o f humans 
and sheep).
Phlebovirus
3 groups containing 51 viruses 
example groups:
Sandfly fever group (23) 
Uukuniemi (12)
Sandfly fever Naples, Punta Toro and Rift valley fever viruses 
(human pathogens).
Uukuniemi virus
Tospovirus
2 groups containing 4 viruses. 
Tomato spotted wilt (3) 
Impatiens necrotic spot (1)
Tomato spotted wilt virus (plant pathogen). 
Impatiens necrotic spot virus (plant pathogen).
Table 1.1 Classification of the Bunyaviridae
Table adapted from Calisher, 1996.
Introduction: Chapter 1
of China (Gonzalez-Scarano et al., 1991, Gonzalez-Scarano and Nathanson, 1996). Rift 
Valley fever virus (RFV) causes an acute disease in humans with a convalescence period 
which may be prolonged (Eddy and Peters, 1980). RVF virus causes a more serious disease 
in domestic animals, and sheep are more susceptible than cattle; pregnant ewes normally 
abort and over 90% mortality amongst infected lambs has been reported (Meegan and Shope, 
1981). La Crosse virus is responsible for the majority of paediatric viral encephalitis cases in 
the US. Infections are generally located around the Midwestern United states and are 
responsible for around 100 cases annually (Kappus et al., 1983; Gonzalez-Scarano et al., 
1996).
Tospoviruses infect more than 800 species of plants from about 82 botanical families and 
result in great economic losses in many agricultural, horticultural, and ornamental crops 
(Prins and Goldbach, 1998).
1.0.3 Stages of virus replication.
The principle stages of the replication process for viruses in the family Bunyaviridae can be 
summarised simplisticaly as follows (Bishop, 1996; Shmaljohn, 1996a):
• Attachment of virus: this is mediated by an interaction of viral proteins and target host cell 
receptors.
• Entry and uncoating virions: this process is thought to occur via the endocytosis of 
virions and the subsequent fusion of the viral membrane with the endosomal membrane.
• Primary transcription: this step involves the synthesis of viral mRNA species from the 
genome templates by the virion associated polymerase using host cell derived primers.
• Primary translation: the L and S segment mRNAs are translated in the cytosol by free 
ribosomes, and the M segment mRNAs by membrane bound ribosomes on the rough 
endoplasmic reticulum. Processing, folding and primary glycosylation of the viral 
glycoproteins (G1 and G2) also occurs at the ER.
• Synthesis and encapsidation of antigenomes, also known as cRNA, to act as template for 
genomic RNA synthesis or, in some cases, as a template for subgenomic mRNA 
synthesis (i.e. a virus with an ambisense coding strategy).
• Genome replication and subsequent amplification.
• Secondary transcription: the amplified synthesis of the mRNA species and ambisense 
transcription.
• Continued translation and RNA replication.
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• Morphogenesis: newly formed nucleocapsids accumulate under Golgi membranes into 
which glycosylated G1 and G2 have been inserted. By an undefined process, virus 
particles are formed by budding into the Golgi cistemae.
• Virus release: newly assembled virions are transported out of the Golgi lumen in exocytic 
transport vesicles. Fusion of these vesicles with the plasma membrane releases mature 
virions.
A number of the principle stages will be discussed further within this section.
1.0.4 Attachment and entry.
In common with other enveloped viruses, it is the viral glycoproteins which mediate the 
attachment of Bunyaviridae virions to host cell receptors. As yet the cellular receptor 
involved in attachment has not been identified for any member of the Bunyaviridae but (33 
integrin is suspected to be involved with the attachment of several hantavirus.
Obijeski etal. (1976) demonstrated a five log reduction in infectivity of mammalian cells by 
La Crosse virus (LAC), when viral particles were rendered “spikeless” by proteolytic 
enzyme treatment. The viral proteins involved in attachment to vertebrate cells have been 
examined indirectly in experiments using monoclonal and polyclonal antibodies to block 
infection or haemagglutination activity. They have suggested that G1 is more actively 
involved in binding to vertebrate host cells than G2 (Kingsford and Hill, 1983; Grady et a l., 
1983a and b; Kingsford et al., 1983). In addition, treatment of La Crosse virions (LAC) 
with proteases, such as bromelain or pronase, which degrade portions of G1 but leave G2 
unchanged, rendered the virus completely non-infectious to vertebrate cells (Kingsford and 
Hill, 1983).
There is some evidence which indicates that viruses within the California serogroup share a 
common receptor on vertebrate cells, and that this receptor may differ from the receptor used 
by other members of the Bunyaviridae. Pekosz et al. (1995), have shown that a truncated 
soluble form of La Crosse (LAC) virus G1 expressed from baculovirus was able to bind to 
cells permissive for LAC virus infection but not to nonpermissive cells. The truncated G1 
was also able to block the entry and infection of LAC virus and other members of the 
California serogroup but not the infection of two other bunyaviruses. From this study the 
authors suggest that G1 is the viral attachment protein and that tropism for cultured cells 
occurs at the level of cell entry, as determined by RNA dot blots and virus binding assays 
(Pekosz et al., 1995).
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Efficient transmission and amplification of arboviruses requires replication in both vertebrate 
and invertebrate hosts. As a result virions are exposed to significantly different 
environments. Treatment of LAC virus with proteolytic enzymes such as those found in the 
mosquito midgut, e.g. trypsin and pronase, in line with earlier work by Kingsford and Hill 
(1983), cleave the G1 glycoprotein leaving the G2 glycoprotein intact; the treated virus was 
found to have an increased affinity for mosquito cells (Ludwig et al., 1989). The same 
enzyme treatment was shown to concurrently cause a significant decrease in viral attachment 
to Vero cells (Ludwig et al., 1989). Therefore the glycoprotein requirement for attachment to 
invertebrate and vertebrate cells maybe different.
With regard to the hantaviruses, which do not infect invertebrate hosts, it has recently been 
demonstrated by Gavrilovskaya et al. that p3-integrins facilitate the cellular entry of 
pathogenic HPS-associated hantaviruses New York-1 (NY-1) and Sin Nombre (SN) viruses 
(Gavrilovskaya et al., 1998). This study has shown that the treatment of permissive cells 
with a p3-integrin ligand, vitronectin, or with antibodies to (33 integrins, inhibited virus 
infection by 63-74%. Although virus infection was not completely inhibited by treatment 
with antibodies, the percentage of inhibition was within the range described for icosahedral 
viruses, which have previously been shown to enter cells via integrins. To further 
demonstrate that (33 integrins were indeed responsible for aiding cellular entry, the authors 
transfected a cell line (CHO), nonpermissive to SN and NY-1 infection with recombinant p3 
integrins, and found that infectivity was increased by 19 to 39 fold. The authors also noted 
that since p3-integrins regulate vascular permeability and platelet function these findings may 
also correlate the use of p3-integrin with common elements of hantavirus pathogenesis 
(Gavrilovskaya et al., 1998).
1.2.0 Genomes and coding strategies of the Bunyaviridae.
The genome of Bunyamwera virus was the first of the Bunyaviridae to be completely 
sequenced (Lees et al., 1986, Elliott, 1989a, Elliott, 1989b). The total size of the 
Bunyamwera virus genome is 12.33 kb, of which 95.33% encodes polypeptides. Similar 
efficient utilisation of coding potential is observed for all other characterised members of the 
Bunyaviridae and for other negative strand RNA viruses.
The complete genomic RNA sequence for at least one representative of each genus has since 
been determined, allowing the coding strategies of each segment to be deduced (Figure 1.0).
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1.2.1 L segment.
Bunyaviridae L segments range in size from 6.8 kb for Bunyamwera (BUN) virus, to 12.2 
kb for Dugbe (DUG) virus; the coding capacity of this one genome segment is approximately 
equivalent to the entire BUN virus genome (12.3 kb). All the L segments encode the L 
protein (RNA dependent RNA polymerase) in a negative-sense manner (Figure 1.0(A)), and 
there is no evidence that other minor predicted ORFs within the segment encode additional 
polypeptides.
1.2.2 M segment.
All viruses of the Bunyaviridae possess two glycoproteins denoted G1 and G2, and these are 
always expressed by the M segment which ranges in size from 3.2 to 4.9 kb (Figure 
1.0(B)). The M segment of all Bunyaviridae members encode a polyprotein precursor of G1 
and G2 in a negative-sense manner. Bunyaviruses, tospoviruses and some members of the 
Phlebovirus genus encode a non structural protein, NSm. No function has been attributed to 
this protein, with the exception of tospovirus NSm. Tospoviruses are also the only members 
which have been shown to utilise an ambisense coding strategy for their M segment. Figure 
1.0(B) shows the various M segment coding strategies of the Bunyaviridae.
1.2.3 S segment.
The length of virus genomic S segments range in size from 0.9 to 2.9 kb (Figure 1.0(C)), 
however a pattern of size is conserved within a genera. S segments for bunyavirus, 
nairovirus and hantaviruses code for proteins in a negative-sense manner, but unlike 
nairovirus and hantaviruses which encode only one protein (N), bunyaviruses encode two, 
N and NSs. The S segment of phleboviruses and tospoviruses, like bunyaviruses code for 
two proteins, one in the viral RNA complementary sense (N) and the other in the genomic 
RNA sense (NSs), a coding strategy referred to as ambisense. The two coding regions do 
not overlap, but are separated by an intergenic region (Figure 1.2(B)) extending between the 
two stop codons of the ORFs which varies in length (60 to 360 nucleotides) between 
different viruses.
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B unya virus 
BUN
Hantavirus
HTN
Nairovirus
L segment
3' 6875nt 5’
259kDa
3' 6530nt 5'
247kDa
3' 12225nt 5'
DUG I......................■..............■___ ■
459kDa
Phlebovirus
RVF
3' 6423nt 5'
238kDa
Tospo virus 
TSW
3' 8897nt 5'
332kDa
Figure 1.0 (A) The coding strategies for Bunyaviridae  genome segm ents
Genomic RNAs are represented by thin lines (length in nucleotides is shown above) and 
mRNA are shown as arrows (■ indicates host derived primer sequences at 5’ end, arrow 
head indicates 3 ’ end). Gene products with their size in kilodaltons, are represented by 
coloured rectangles. Two examples of phelebovirus M segments are given which differ 
with respect to the presence of NSm. Virus abbreviations: BUN, Bunyamwera; HTN, 
Hantaan; DUG, Dugbe; RVF, Rift Valley fever; UUK, Uukuniemi; TSW, tomato spotted 
wilt. Figures adapted from Elliott, (1996b). Figure (A), L segments; (B), M segments; 
(C), S segments.
Bunyavirus
BUN
Hantavirus
HTN
Nairovirus
DUG
Phlebovirus
RVF
Phlebovirus
UUK
Tospovirus
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M segment
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C
NSm G2 ' G1 
14kDa 55kDa 62kDa
3' 323 lnt 5'
G1 1 G1
72kDa 67kDa
3 ’ 482lnt 5 ’
G2 G1 .----------1
46kDa 75kDa NSm
37kDa
Figure 1.0 (B)
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S segment
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Bunyavirus
BUN
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Hantavirus Wt
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Bunyavirus 3’ U C A U CA C A U -—
Hantavirus 3’ A U C A U C A U C U G -
Nairovirus 3’ A G A G U U U CU -—
Phlebovirus 3’ U G U G  UUUCUG—
Tospovirus 3’ U C U C GUUAG-—
Figure 1.1 3 ’ Terminal consensus sequences of the five genera within the 
Bunyaviridae
The 3’ terminal sequence conserved within each of the five genera is shown above. The 
di- or tri-nucleotide repeats within each terminus are highlighted (bold, underlined and 
spaced apart). The same complimentary terminal sequences are found at the 5’ terminus 
of each genomic segment. Figure adapted from Elliott, (1996b).
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Figure 1.2 Transcription and replication strategies o f the Bunyaviridae 
genome segm ents
Figure (A) describes a scheme for negative strand expression and (B) describes an 
ambisense strategy. (A) In the negative strand scheme the viral RNA (vRNA) is 
transcribed (1° transcription) to give a complimentary sense mRNA which expresses the 
viral protein. The vRNA is then replicated to give a full length complimentary RNA 
(cRNA) or antigenome, which in turn acts as a template for further replication. (B) For 
the ambisense coding strategy the vRNA is transcribed (1° transcription) to give a 
subgenomic viral complimentary mRNA which expresses the first protein. The vRNA is 
then replicated to give a full length cRNA. The cRNA is then transcribed (2° 
transcription) to give a viral sense subgenomic mRNA which expresses the second 
protein or replicated to give a vRNA. The mRNA in (A) and the two mRNAs in (B) each 
possess nontemplated sequences at their 5’ end (black boxes; ■). The white boxes (B) in 
the vRNA and cRNA represents the intergenic region (IGR) between the two ORFs.
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1.2.4 L segment protein.
The L proteins described for bunyaviruses, phleboviruses, and hantaviruses are predicted to 
be similar in length, approximately 240 to 260 kDa in size. In contrast, the tospovirus TSW 
L protein is somewhat larger at approximately 331 kDa. Studies utilising antibodies raised to 
the N- and C-terminal portions of the TSW L protein from cDNA, have established that the 
protein does not undergo any proteolytic cleavages, is found at the predicted size, and is 
present at 10 to 20 copies per mature virion (van Poelwijk et a l., 1993). Additionally, the L 
segment of the nairovirus, DUG, is predicted to encode a polypeptide of 460 kDa (Marriott 
and Nuttall, 1996a). The reason for the dramatic size differences in L protein size between 
the different genera is unclear, but may represent additional properties related to the different 
hosts and vectors utilised by the virus.
The function of the L protein as the viral polymerase was confirmed by using L protein 
expressed from vaccinia virus recombinants to transcribe BUN virus nucleocapsids (Jin and 
Elliott, 1991). Endonuclease activity was also demonstrated with the BUN L expressed 
protein, thus providing evidence that the L protein was also responsible for generating the 
capped primers needed for viral mRNA transcription (Jin and Elliott, 1993a).
Previous analysis of all available RNA polymerase sequences has identified four conserved 
amino acid motifs (termed A, B, C, and D) which lie in close proximity to each other, and 
have been coined the polymerase module. The conservation of this module throughout RNA 
polymerases from disparate sources provides evidence for a common ancestral protein (Poch 
et al., 1989). Motif A is an acidic motif; motif B is the core motif for nucleotide binding; 
motif C is the core motif for catalytic function; and motif D is a basic motif (Poch et al., 
1990; Ishihama and Barbier, 1994). When these motifs are aligned for Bunyaviridae L 
proteins, in motif C an SDD triplet is strictly conserved, this motif is also strictly conserved 
for all segmented RNA virus genomes (Elliott, 1996b), as opposed to the GDD or GDN 
triplet found in motif C for other viral RNA polymerases (Poch et al., 1989).
With the availability of more L segments sequences for the family Bunyaviridae, further 
comparisons were achievable. Muller et al. (1994), described a further two conserved 
motifs, premotif A, found just upstream of motif A, and motif E found just down stream of 
D, which is strongly conserved only in segmented negative stranded virus polymerases.
The critical role of some of these residues conserved in the motifs initially described by Poch 
et al. (1989), Motifs A to D, has been tested by site directed mutagenesis of the Bunyamwera 
virus L protein (Jin and Elliott, 1992). It was shown that substitution of amino acids strictly
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conserved among the L proteins of the Bunyaviridae family abolished the RNA synthesis 
activity of the L protein (Jin and Elliott, 1992), thus suggesting that the conserved regions 
may indeed represent the catalytic sites of the L protein. The results of this work will be 
discussed in further detail along with a diagram demonstrating the sites of mutagenesis in the 
four conserved polymerase motifs, results section Chapter 3.
1.2.5 M segment proteins.
The gene order of the BUN M segment is NH2-G2-NSm-Gl-COOH as shown in Figure 
1.0(B). The first encoded glycoprotein, G2, is predicted to be 41 kDa in size, and the second 
encoded glycoprotein, G l, between 108 and 125 kDa. The short sequence between these 
two ORFs codes for, NSm, a short 174 amino acid peptide of unknown function. The exact 
cleavage sites between G2 and NSm (position 299) NSm and Gl (position 473) have only 
been determined for Snowshoe hare bunyavirus (SSH) (Fazakereley et a l , 1998).
1.2.6 Glycoprotein biogenesis.
Cotranslational cleavage of the M segment polyprotein is thought to be the general 
mechanism of glycoprotein biogenesis and that processing of bunyavirus glycoproteins 
occurs cotranslationally is inferred from the fact that no precursor has been found in pulse- 
chase experiments (Fazakerley et al., 1988). Which trypsin-like proteases cleave the 
poly protein precursor are unknown, but it is most likely that all cleavages are carried out by 
the ER luminal signal peptidases. None of the processing events involved in BUN 
glycoprotein biogenesis require the concomitant expression of any other viral proteins 
(Nakitare and Elliott, 1993).
Following synthesis, primary glycosylation and folding in the ER, it is presumed that Gl 
and G2 dimerise. This dimerisation allows transport to the Golgi, where the proteins are 
further processed. Transport is arrested at the Golgi, due to a retention signal in the G2 
glycoprotein (Lapin et a l, 1994). All bunyavirus envelope proteins examined possess N- 
linked oligosaccharides. Two such potential sites are conserved in the G2 sequences of 
SSH, LAC, GER and BUN viruses, and either one or two in G l, depending on the virus, 
and none in NSm (Eshita and Bishop, 1984; Lees et a l , 1986; Grady et al., 1987; Pardigon 
et a l , 1988). It has not been determined for all of the viruses which sites are actually 
utilised, but one study of SSH virus suggests that all of the sites on G2 are utilised, and at 
least one of the potential sites on Gl (Cash et a l, 1980; Eshita and Bishop, 1984; Fazakerley 
et a l, 1988).
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All M segment gene products are predicted by nucleotide sequence analysis to have a high 
cysteine content, and the positioning of cysteine residues is highly maintained within 
individual genera (Eshita and Bishop, 1984; Grady et a l., 1987; Elliott, 1990). It has been 
suggested that these cysteine residues may give rise to extensive disulphide bridging between 
glycoproteins, which might be necessary for folding and adoption of correct structural 
conformation.
1.2.7 The NSm protein of tospoviruses.
The NSm protein of tospovirus TSWV is the only nonstructural protein for which there is 
convincing experimental evidence to attribute a function, that of a "movement" protein.
Immunogold EM analysis of TSWV infected plant tissues has demonstrated that the NSm 
protein associates with nonenveloped nucleocapsids, and the plasmodesmata (channel link 
between cells), where the protein assembles into tubular structures, estimated to be 40 to 50 
nm in width (Storms et al., 1995). These tubular structures extend from the cell wall into the 
cytoplasm at one side, providing firm evidence that they are involved in cell to cell 
translocation. Since intact viral particles have a diameter of between 90 and 110 nm, and 
would be therefore too large to cross the plasmodesmata normally, the intriguing possibility 
has been raised that TSWV is able to move from cell to cell along the tubule as free, 
nonenveloped nucleocapsids (Storms etal., 1995).
1.2.8 S segment proteins.
The S RNA segment of bunyaviruses, phleboviruses and tospoviruses encode two proteins, 
the nucleocapsid protein (N) and a non-structural protein (NSs), while those of hantaviruses 
and nairoviruses encode only an N protein. Bunyavirus S segment proteins are translated 
from a single bicistronic mRNA species (Elliott et al., 1989), while phleboviruses and 
nairoviruses translate their S segment proteins from two monocistronic mRNAs as a result of 
an ambisense coding strategy (Figure 1.0(C) and Figure 1.2). The S RNA segment of 
hantaviruses and nairoviruses possesses a single ORF in the viral complementary sense 
which encodes an N protein approximately twice the size of the other genera N proteins 
(Figure 1.0(C)). It is tempting to speculate that these larger N proteins may contain extra 
domains which would negate the need for a NSs protein. Additional small ORFs have been 
detected in the cDNA of hantaviruses, however, protein products from these ORFs have 
never been detected in infected cells (Parrington and Kang, 1990).
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The N protein is the most abundant viral protein found both in the virion, and in infected 
cells. However, although the antigenic characteristics of N proteins of various members of 
the Bunyaviridae have been studied extensively (discussed in Elliott, 1996a), little is known 
of their basic functional properties.
Comparison of amino acid sequences of N proteins from viruses in different genera reveals a 
lack of homology between N proteins, suggesting that these proteins are highly divergent 
and may not share conserved functional motifs, such as RNA or polymerase binding motifs. 
Such amino acid homology, however, is evident in N proteins of viruses from within a 
specific genera. For bunyaviruses, there is 62% identity within the Bunyamwera serogroup, 
and >40% between the Bunyamwera and California serogroups (Dunn et a l., 1994; Elliott, 
1995). Identical residues between amino acid sequences are not distributed randomly 
throughout the proteins, but are clustered, which may indicate maintenance of functional 
domains specific to viruses in a genus.
Gott et al. (1993) published a study on the RNA binding properties of the Puumala 
hantavirus N protein, in which it was shown that the N protein could bind co-operatively to a 
partially double-stranded substrate consisting of the exact 5’ and 3’ HTN S RNA 
complementary termini. The N protein bound noncooperatively to single-stranded (ss) RNA, 
and this noncooperative binding was shown to be inhibited by double-stranded competitor. 
From other experiments published in this study, it was also suggested that the carboxy- 
terminal portion of the N protein is involved in RNA binding (Gott et al., 1993). However, 
in this study a large amount of non-specific binding was also observed which may 
compromise the interpretation of results from the binding experiments. Similarly, it was 
found that when HTN N protein was expressed by recombinant baculovirus in the absence 
of the correct RNA substrate, the HTN N protein was found to form nucleocapsid-like 
structures, possibly by binding with cellular or baculovirus nucleic acids, suggesting that the 
protein will bind non-specifically to available RNA (Betenbaugh et al., 1995).
Recently, Richmond etal. (1998), have reported results which conflict with those found for 
HTN N protein. In this study it was shown that TSWV N protein did not bind to double 
stranded RNA but did bind to TSWV like-RNA and did so in a co-operative manner, and 
that this binding was stable at high ionic concentrations (< 0.3 M NaCl), suggesting that 
binding is not solely due to electrostatic interactions. The binding to TSWV ssRNA was not 
sequence specific since complex formation was seen with non-specific ssRNAs, yeast tRNA 
and CCMV RNA3, and even Ml 3 ssDNA. However, if a nucleic acid competitor was added 
after complexes were allowed to form with TSWV ssRNA, then no competition was seen. In 
this study it was also demonstrated that both amino- and carboxy- regions of the N protein 
were capable of binding RNA, and they both did so in a co-operative manner. This was the
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first demonstration of multiple RNA binding domains in a segmented negative strand virus 
nucleocapsid protein.
However, one important caveat that the authors of both these studies point out is that there 
may be a difference between the binding of N protein to its target RNA in vitro as opposed to 
in vivo, where other viral or host proteins may influence the process.
As both the HTN N and the TSWV N proteins have been shown experimentally to bind non- 
specifically to RNAs, it is possible that the N proteins of the Bunyaviridae may not be 
sequence specific in their binding to RNA in vitro, a feature which is common to other 
negative strand RNA virus nucleocapsid proteins (Richmond et al., 1998) e.g. Sendai virus 
(Buchholz et al., 1993); influenza virus (Kingsbury et al., 1987); and VSV (Masters and 
Banerjee, 1988). The N protein of TSWV is predicted to have a charge of between +8 and 
+10 (Richmond et al., 1998). Therefore, the interaction between the N protein and the RNA 
might simply be the result of a positively charged N protein binding to negatively charged 
RNA, and co-operative binding may be a function of the N protein itself. It might be 
speculated that the specificity with which the N protein recognises and binds with viral RNA 
in the cell, may be attributed to the presence or orchestration of another viral protein, 
specifically that of the L protein.
1.3.0 The nucleocapsid assembly process.
The processes involved in bunyavirus nucleocapsid assembly have not yet been fully 
elucidated. However, it is thought that control is exerted at the level of initiation of N protein 
interaction either with a specific sequence on the target RNA molecule, or with the 
polymerase/RNA complex. It is proposed that following such an initiation event, the 
encapsidation process would proceed by addition of further N protein molecules to newly 
formed RNA-N complex by (N-N) protein interactions. As the genome and antigenome are 
always found encapsidated (in contrast to the mRNAs which are not encapsidated) the 
sequence required for nucleoprotein assembly must be present at the 3’ end of both the 
genome and antigenome. Therefore, it is likely that these sequences are contained in the 
conserved regions found at termini of each viral genomic segment (Kolakofsky and Hacker,
1991). It is conceivable that the polymerase binds to both termini to allow N protein binding, 
and its this binding of the L protein that orchestrates the addition of N proteins, possibly 
initially as a L-N binding, and continuing in a co-operative manner with further N-N 
bindings. If the polymerase does in fact need the presence of both termini to bind and 
subsequently initiate N protein binding, then this same hypothesis might also explain why 
viral mRNA is unencapsidated.
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1.3.1 Packaging.
Equal numbers of genome segments (nucleocapsids) may not always be packaged into 
mature virions, as evidenced by varying, nonequimolar ratios of L, M, and S molecules 
extracted from purified virions (Bishop and Shope, 1979). Talmon et al. (1987) have 
speculated that the size differences of virion particles observed by electron microscopy may 
be directly related to the number of nucleocapsids incorporated into individual virions.
Interestingly, the phlebovirus, UUK, was found to package virus genome complementary 
(cRNA) as well as vRNA of the S segment (but not of the M segment) in a ratio of 
approximately 1:10 (Simons et al., 1990). Similarly, both the S and M segment cRNA of 
TSW virus, a tospovirus, were found to be packaged (Kormelink et al., 1992a), suggesting 
that encapsidation of cRNAs might relate to the ambisense coding strategies of these RNAs 
(i.e. that the genome packaging signal may be linked to a 3’ UTR capable of promoting both 
transcription and replication, which for an ambisense coding strategy is both genome 
segments, vRNA and cRNA).
For LAC bunyavirus, S segment cRNA was detected in virions synthesised in insect cells, 
but not in mammalian cells (Raju and Kolakofsky, 1989). The significance of this finding is 
not clear.
1.3.2 Assembly, budding and release.
All members of the Bunyaviridae genera, with the possible exception of the tospoviruses, 
mature by budding through membranes of the Golgi complex (Pettersson, 1991; Hobman, 
1993). The precise reason why this membrane is chosen over the more commonly used 
plasma membrane as the site for exit is not understood. However, the observation that the 
ionophore monensin inhibits the release of LAC virus has led to the idea that the lower pH of 
the Golgi compartment is necessary for at least one of the processes of assembly (Cash, 
1982).
Bunyamwera virus, like other members of the Bunyaviridae, buds into Golgi membranes. 
BUN glycoproteins localise to Golgi membranes in infected cells. Additionally, 
accumulation of BUN glycoproteins at Golgi membranes has been shown to occur in HeLa 
cells expressing Gl and G2 from a full length BUN M cDNA (Nakitare and Elliott, 1993; 
Lappin e ta l,  1994). In the presence of brefeldin A, the glycoproteins were redistributed to 
the ER. Results by Lappin et al. (1994) indicate that all three products of the M segment,
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Gl, G2 and NSm, are localised to the Golgi complex when expressed from full length 
cDNA. G2 and NSm when expressed independently also localised to the Golgi, while Gl 
expressed alone remained in the ER. It was shown that G l localised to the Golgi if 
coexpressed with G2 but not with NSm, indicating that G2 facilitates the cotransport of Gl 
from the ER to the Golgi. Similar results have been reported for La Crosse bunyavirus 
glycoproteins (Bupp eta l., 1996). These results show that Gl requires coexpression of G2 
to be transport competent, suggesting heterodimeric interactions between the two proteins. 
This study also indicates that at least G2 contains a Golgi retention signal (Pettersson and 
Melin, 1996). The function of the BUN NSm protein is unknown, but its Golgi localisation 
in BUN infected cells suggests a role in virus maturation (Lappin etal., 1994).
The processes involved in assembly and release of bunyavirus particles are very poorly 
studied. Electron microscopic studies have visualised the maturation of the phleboviruses 
UUK (Kuismanen et al., 1982), PT and Karimabad (Smith and Pifat, 1982), RVF 
(Anderson and Smith, 1987) and the nairovirus DUG (Booth et al., 1991) at perinuclear 
membranes presumed to be Golgi cistemae. In other negative strand viruses such as 
members of the Rhabdoviridae, Orthmyxoviridae, and Paramyxoviridae, a viral matrix (M) 
protein bridges the gap between envelope viral glycoproteins and the nucleocapsids during 
virus assembly. Members of the Bunyaviridae lack a functional equivalent of the M protein. 
It has been shown that nucleocapsids accumulate under Golgi membranes in which 
glycoprotein projections are evident (Smith and Pifat, 1982; Parker et al., 1984). 
Furthermore no nucleocapsid accumulation was observed to occur under membranes bearing 
no glycoprotein spikes. These observations may indicate a direct interaction of the 
nucleocapsids with the carboxy- tails of the glycoproteins, but there is no experimental 
evidence as yet to support this idea. However, if such a direct interaction does occur, then in 
the case of BUN virus, it is possible that the carboxy tail of G2, being longer than that of 
Gl, would participate in the interaction.
It is thought that following viral budding into the Golgi, the particles are transported out of 
the cell in Golgi derived transport vesicles in a manner analogous to normal cellular 
exocytosis (Smith and Pifat, 1982).
1.4.0 Untranslated regions.
Each viral genomic segment can be described simply as consisting of two regions, a coding 
region (each of which have been discussed previously) and an untranslated region (UTR) 
which again can be subdivided into two regions, the conserved complementary termini and
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the rest of the 3’ and 5’ UTRs flanking the ORFs which share no obvious complementarity 
between segments.
1.4.1 Bunyamwera virus genome termini.
Figure 1.3 shows the complementary sequences between the termini of Bunyamwera virus. 
This diagram also illustrates how the terminal eleven nucleotides at 5’ and 3’ termini of the 
three genomic RNAs are conserved both between all three segments and between all 
members of the Bunyavirus genus (Figure 1.1). A further three or four adjacent nucleotides 
are conserved for each viral segment within a BUN serogroup, but not between segment 
types (Elliott, 1990; Elliott e/ al., 1991). These conserved regions between the 5’ and 3’ 
termini of the RNA molecule are also complementary. Further complementarity exists 
between 5’ and 3’ sequence adjacent to these 11 terminal nucleotides, although this 
complementarity occurs through sequence which is not conserved either between different 
viruses or between gene segments of the same virus. This additional complementary 
sequence results in a fairly long region at both ends of each gene segment with potential to 
form a double-stranded panhandle structure (see Figure 1.3), although whether this 
proposed panhandle structure is of significance to the structure and replication of the virus 
genome is unknown.
1.4.2 Possible function of genome segment UTRs.
It is believed that the 3’ and 5’ untranslated regions (UTRs) of the Bunyaviridae viral 
genome segments, also referred to as noncoding regions, contain signals which control the 
replication processes of the virus. These signals may include the viral recognition and 
promoter sequence, as well as packaging and cis-acting signals that may influence the level 
of transcription and replication of individual RNA segments. However, as discussed above, 
comparison of UTRs of bunyavirus genomes reveals very little conservation of sequence 
besides the terminal sequences. It is possible that this lack of conservation outwith the 11 
terminal nucleotides might indicate evolutionary divergence in the controlling mechanisms of 
transcription and replication between the segments.
In Table 1.2, the length of the UTRs for a representative virus from each genus are shown. 
When the lengths of the different UTRs are compared two general striking features are 
apparent: the vRNA 5’ UTR is at least twice the size of the 3’ UTR, and the L segment 
UTRs are generally shorter than the M UTRs which in turn are shorter than the S UTRs.
14
Introduction: Chapter 1
cRNA 5’ UTR cRNA 3 ’ UTR
L 50 108
BUN M 56 103
S 85 174
L 40 104
DUG M 47 185
S 49 337
L 37 40
HTN M 40 168
S 36 337
L 18 138
RVF M 20 271
*S 38 34
L 33 36
TSWV *M 84 100
*S 153 88
Table 1.2 The untranslated regions of the Bunyaviridae
A representative member from each genus, for which the complete genome sequence is 
known, was analysed to calculate the lengths of the untranslated regions (UTRs). The 
genome sequence accession numbers for each virus genome shown are referenced in 
Elliott (1996a). Those segments which have an ambisense coding strategy are indicated 
(*). The genera and example viruses were, Bunyavirus', Bunyamwera (BUN); 
Nairovirus, Dugbe (DUG); Hantavirus', Hantaan (HTN); Phlebovirus', Rift Valley fever 
(RVF); Tospovirus', Tomato spotted wilt (TSWV).
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5 '
5 '
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C - A -
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G - U -
C - A
G - U
C - A -
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U - G - C -
A - U - G -
U - G - C -
U G C - G - A
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-G G - A - U  U - U - U - G - A - A  U - A
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A- G U 1
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- G - U - A - U  -  G - U U - G - U - U  G - G - A - A
■ G- A - U - A  C - A
\  /  \  /  
A A - A
A - C - A - G C - C - U - U
G-
A A - U  U- U-
/  \  /  \  /  
- U - G - U - A - U  U - C - U - U - U - U - A - A  U
- A - C - A - U - A  -  A - G - A - A - A - A - U - U  A
\  /  \
G - U C- U-
H gure 1.3 Com plim entary sequences and possible base-pairing between 
the 3 ’ and 5’ term ini of the Bunyamwera virus genome segments
The first eleven bases (left of dotted line) are conserved for all segments of all members 
of the Bunyavirus genus. The next three or four bases (shaded box) are conserved for 
each viral segment within the BUN serogroup. The remainder of the sequence is BUN 
segment specific but such regions of segment complementarity exist for all bunyaviruses. 
The G/U base pair (double dots, position 9) becomes a mis-matched A/C pair in cRNA 
which could result in disruption of the helical duplex possibly enabling discrimination of 
vRNA from cRNA for packaging purposes. Figure adapted from Elliott, (1990).
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Those segments that do not hold true to these generalisations are those segments with an 
ambisense coding strategy (marked with an asterisk (*), Table 1.2).
The longer length of the 5’ vRNA UTR may indicate the presence of a mRNA termination 
signal. Although there are no obvious conserved mRNA termination sequences maintained 
between the three segments, clearly mRNA termination does occur within this region and 
must be controlled by some un-apparent mechanism. The difference in length of the 5’ 
vRNA UTR between the segments may also suggest the presence of further cA-acting 
signals which could regulate other aspects of segment expression.
1.4.3 Bunyavirus mRNA.
The mRNA transcripts of bunyaviruses contain non-templated heterologous capped leader 
sequences at their 5' ends (Figure 1.4) which have been obtained from the cytoplasmic pool 
of host cell mRNA by the viral polymerase (Bishop et al., 1983; Patterson and Kolakofsky, 
1984). Another defining feature of these viral mRNAs is that they are truncated at the 3’ end 
by approximately 50-110 nucleotides compared to the full length cRNA (Patterson and 
Kolakofsky, 1984; Bouloy etal., 1990; Jin and Elliott, 1993a). These features are shared 
with influenza virus mRNAs, however, unlike influenza virus, bunyavirus mRNA does not 
appear to be polyadenylated.
In vitro transcription studies using RNPs purified from La Crosse virus (Patterson et al., 
1984), demonstrated that transcription could be stimulated by dinucleotide ApG, A(n)G 
oligonucleotides and Alfalfa mosaic virus mRNA. This study also showed a methylated cap- 
dependent endonuclease activity which cleaved the plant virus mRNA 13 or 14 nucleotides 
from its 5' end. Direct evidence for the presence of capped structures at the terminus of the 
extensions in BUN viral mRNA was obtained by using anti-cap antibodies to immuno-select 
mRNAs (Hacker etal., 1990; Vialat and Bouloy, 1992).
1.4.4 Leader primed bunyavirus mRNA synthesis.
The mechanism by which bunyaviruses initiate transcription of their mRNA is not well 
defined, but similarities do exist with the mRNA transcription process of the influenza virus, 
where capped and methylated oligonucleotides are cleaved from host cell mRNA by 
influenza virus proteins and are used to prime transcription from the viral genome. However, 
unlike influenza virus, the transcription of bunyavirus mRNA occurs in the cytoplasm 
(Rossier et al., 1986).
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Figure 1.4 Infected cell viral RNA
The viral genomic (vRNA) and antigenomic (cRNA) viral RNAs are not found naked 
within the cell but encapsidated in N and L proteins. These RNAs are exactly 
complementary. The viral mRNA contains additional 5' sequences derived from host cell 
capped mRNA and is truncated at the 3 ’ end compared to the template. Sequences just 
upstream of the 3' terminus of the mRNA (within the untranslated region) have the 
potential to form a stem-loop structure which may serve to stabilise the message 
(Kolakofsky and Hacker, 1991). The blue box at 5 ’ of mRNA represents host derived 
leader sequence.
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Although heterogeneous in sequence, the 5' terminal extensions described for various 
viruses in the family display preferences for specific mono, di, or tri-nucleotides at the -1 to - 
3 positions with respect to the 5’ terminus of the mRNA (Figure 1.5).
The leader sequences of Bunyamwera virus S mRNA have been cloned and several 
independent 5' sequences determined (Jin and Elliott, 1993a). Of twenty one clones 
sequenced, all were found to have heterologous 5' leader sequences. The length ranged from 
12 to 17 nucleotides (average 14 nucleotides) and they had a combined base composition of 
62% G/C. The striking feature of the non viral sequences was the occurrence, in all but one 
of the clones, of a U residue at position -1 relative to the viral terminus. Ninety percent of the 
clones had G at position -2 and half had an A residue at -3. There appeared to be no marked 
base preference for sequences further upstream (Figure 1.5). These findings were similar to 
those reported for snow shoehare (SSH) bunyavirus (Eshita et al., 1985) and Germiston 
bunyavirus (GER) (Bouloy et al., 1990). Some evidence exists that these conserved 
nucleotides (A<G<U) are not present in the messages from which the leaders were cleaved 
(Jin and Elliott, 1993a). It seems an unlikely coincidence that the three conserved nucleotides 
are the same as the first three nucleotides of viral RNA.
A similar arrangement exists for the phlebovirus Uukuniemi (UUK). Instead of the double 
triplet 5'-AGU AGU— found at the termini of bunyavirus segments, UUK termini have 
repeated 5'-AC AC—. For eight out of eleven NSs mRNAs which had all the viral terminal 
sequence intact, it was shown that all had C at -1 and six of these also had A at -2, and five 
had C again at -3 (Simons and Pettersson, 1991). No information is available as to whether 
these repeated bases were present in the cellular mRNA (and were somehow specifically 
selected for priming), or whether the bases were added by the viral polymerase, perhaps by a 
slippage mechanism using the 3' end of the vRNA as template. It is interesting to note that all 
sequenced UUK mRNAs which had the C as the last leader base, had intact 5'-AC AC-- 
starts to the viral sequence, whereas 9 out of 10 clones with the viral A (at nucleotide +1) 
missing had a G residue, with potential to hydrogen bond to the template 3' terminal U 
residue, as the last base of the leader.
Alternatively, similarities between the 3’-most nucleotides of the stolen host sequences and 
the 5’ terminal viral sequences might result from a backward slippage of the viral polymerase 
on the template after the first two or three nucleotides are transcribed, resulting in a partial 
reiteration of the 5’ terminal sequence (Jin and Elliott, 1993a & b) or as the result of a 
“prime-and-realign” mechanism (Garcin et al., 1995a. This proposal will be discussed 
further in Chapter 7).
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Bunyavirus  (BUN)
(mRNA capped leader)
-1 +1
M7GpppXXXXXXXXAGU AGU AGUGUA............. 3 ’
/ I \
50% 90% 95%
N airovirus  (DUG)
-1 +1
M7GpppXXXXXXXXCUC U £  UCAAAGA 3 ’
/ I \
46% 58% 96%
Hantavirus (HTN)
-1 +1
M7GpppXXXXXXXXUAG UAG UAGUAG UG  3*
/ I \
50% 90% 95%
Phlebovirus  (UUK)
-1 +1
M7GpppXXXXXXXXAC AC ACAAACUG.............. 3 ’
/ I 
55% 95%
Figure 1.5 Host derived sequences on viral mRNA
Shown is a schematic summary of four studies characterising the nontemplated sequences 
found upstream of the templated sequences of viral mRNA (i.e. host derived cap- 
snatched primer sequence). The genomic templated sequence is shown in bold and the 
terminal nucleotide is marked as +1. The nucleotide repeats within the termini are 
underlined. Those nucleotides found commonly at positions -1,-2 and -3 are shown 
(blue) along with the percentage of occasion, X means any nucleotide. The nucleotides 
most commonly found at positions -1 to -3 are identical to the genomic template terminal 
repeats. Results summarised from: (BUN) Jin and Elliott, 1993a; (DUG) Jin and Elliott, 
1993b; (UUK) Simons and Pettersson, 1991; (HTN) Garcin etal., 1995.
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In Figure 1.5, the results of four individual studies are summarised, each of which examines 
one virus representative from four genera of the Bunyaviridae. No base preference at 
positions -1 to -3 were found in the nontemplated leader sequences of TSWV (tospovirus 
genus) N protein mRNA (van Poelwijk et al., 1996).
Clearly more data will be needed, particularly concerning the downstream sequences of the 
cleaved cellular mRNA, before meaningful hypotheses concerning the mechanism of leader 
selection and priming can be made.
1.4.5 Translational requirement for mRNA transcription.
An unusual aspect of bunyavirus mRNA transcription is the requirement for ongoing 
translation (Abraham and Pattnaik, 1983; Pattnaik and Abraham, 1983; Raju and 
Kolakofsky, 1986; Gerbaud et al., 1987). Studies of La Crosse virus have shown that the 
incorporation of radiolabelled NTP in in vitro transcription reactions was unaffected by 
cyclohexamide treatment, but that the in vitro transcripts formed terminated after only 
extending 175 nucleotides. If a reticulocyte lysate translation mix was added to the in vitro 
transcription reaction, normal length mRNA transcripts could be made (Bellocq etal., 1987). 
Addition of cycloheximide to the in vitro transcription/translation mix resulted in the 
reappearance of the prematurely terminated transcripts. Messenger RNA transcripts which 
had terminated at nucleotide 175 could also be detected in vivo if cycloheximide was present 
(Raju and Kolakofsky, 1987).
The sequence around nucleotide 175, where the truncated transcripts end, was shown to 
have homology to the region near the normal termination site for mRNA transcription at 
nucleotide 886 (Bellocq et al., 1987). Incorporation of inosine in place of guanosine in in- 
vitro transcription reactions, which would weaken any secondary structure involving G-C 
hydrogen bonds, allowed read through of the nucleotides 175 termination site and revealed 
other termination sites before the genuine one at nucleotide 886 (Bellocq and Kolakofsky, 
1987). Conversely replacement of uridine by bromo-uridine, to create stronger hydrogen 
bonds, resulted in more pronounced termination. These results together suggest that in the 
absence of translation the nascent RNA forms secondary structure, probably with the 
template RNA, which causes premature termination of mRNA synthesis. For cRNA 
synthesis, co-transcriptional encapsidation with N protein would attenuate all premature 
termination sites and the genuine site at nucleotide 886, allowing transcription of full length 
replicative intermediates to nucleotide 983 (Kolakofsky etal., 1987).
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1.4.6 mRNA termination.
The termination sites for several bunyavirus segments have been mapped by nuclease 
protection assays. Bunyamwera virus S mRNA is predicted to terminate in or near a site 100 
nucleotides in from the 5' end of template at 3'-UUGGGUGUUUU-5' (Jin and Elliott, 
1992). For Germiston (GER) virus S mRNA (Bouloy et a l., 1990), 3'-GUUUGU-5' is 
present whereas for the S and L segments of La Crosse (LAC) virus (Patterson and 
Kolakofsky, 1984; Hacker et al., 1990), and Germiston (GER) M (Bouloy et al., 1990) 
mRNAs, 3'-GUUUUU-5' is present (reviewed in Kolakofsky and Hacker, 1991). This last 
sequence is similar to viral transcription termination signal employed by influenza virus. For 
influenza virus however, this site is also a polyadenylation signal. Polyadenylation is a result 
of polymerase slippage which is thought to result from steric hindrance to the polymerase by 
the double stranded pan handle which is immediately adjacent to the U-rich termination site 
(Luo etal., 1991).
For bunyaviruses a possible pan handle structure lies much further downstream of the 
termination signal than for influenza virus so polyadenylation would not be expected to occur 
via a slippage mechanism. However the mRNAs of bunyaviruses are probably not 
polyadenylated, as evidenced by their low affinity for oligo (dT) columns (Cash et al., 1979; 
Pattnaik and Abraham, 1983).
Located immediately after the predicted G-U rich termination site on the BUN genomic 
template lies a CA-rich sequence (3’-CCCACCCACCA/UA/UCCC-5’). This CA-rich 
sequence can be aligned and is conserved in all sequenced Bunyamwera (8) and California 
(10) serogroup S segments. It is conceivable that this purine rich sequence may play a role in 
transcription termination of bunyavirus S segment mRNA due to its proximity to the 
characterised termini, possibly by weakening the interaction of the polymerase with its 
template (Bishop e ta l,  1982; Dunn e ta l, 1994; Bowen e ta l,  1995).
Another U rich stretch in the influenza virus vRNA promoter has been suggested to result in 
weak interaction of the polymerase to its template and can be mutated to result in premature 
termination (Seong and Brownlee, 1992b). In bunyaviruses the occurrence of U residues 
may therefore facilitate termination by weakening the contacts of the polymerase to its 
template which may be supplemented by the formation of secondary structures either with 
the nascent chain interacting with the template (Kolakofsky et a l,  1987) or within the new 
chain at sequences with potential to form a stem-1 oop structure just upstream of the 3' ends 
of mRNA (Kolakofsky and Hacker 1991). This picture is somewhat complicated by the 
occurrence in SSH and RVF phlebovirus M mRNAs of a C rich termination signal (3’-
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ACCCC 5’), (Iharaefa/., 1985; Collett, 1986). The termination consensus may thus depend 
on a short homopolymeric region, not necessarily on a run of U residues to signal mRNA 
termination.
To complicate matters further a recent paper by Hutchinson et al. (1996), characterising 
mRNA transcripts of the Sin Nombre hantavirus (SN), suggests a different mechanism for 
the termination of each of the three viral mRNAs. In this study it was shown that the S and 
M segment mRNAs 3’ termini were both truncated as described previously for mRNA 
termini, but that the M mRNA was found to be polyadenylated, and the L mRNA was 
untruncated. The truncated 3’ end of the SN S mRNA mapped to a C rich region (ACCC) on 
the template RNA sequence, which is also situated just down stream of a CCCACCC motif. 
The authors were able to map this C-rich motif to 21 other hantavirus S segment sequences 
(Hutchinson e ta l,  1996).
This motif is identical to a portion of the purine rich sequence down stream of the mRNA 
termination site in Bunyamwera and California serogroup viruses described above (shown 
underlined, 3’-CCCACCCACCA/UA/UCCC-5’Y It is possible therefore, that these motifs 
are similar and function as a signal for mRNA termination, the purine rich sequence could 
cause the polymerase to pause which signals the polymerase to cleave the mRNA transcript 
via its endonuclease activity within this region (Kolakofsky and Hacker, 1991).
The finding that the L mRNA 3’ end was a full length complement of the 5’ end of the 
genomic RNA template was very surprising, however, the authors were confident that there 
was no contamination of L anti genome segments as no such contamination was found when 
studying the other two mRNAs. The other unexpected finding was that the 3’ truncated end 
of the M mRNA was polyadenylated. The viral sequence at the 3’ end mapped to a U8 
sequence on the template, and this sequence was highly conserved among the other 
hantavirus M segment sequences (25 in all). To characterise the M mRNA 3’ end, the 
authors used a reverse transcription/PCR approach with an oligonucleotide d(T) primer and a 
internal M segment specific primer. It is possible, though the authors rule out this reasoning, 
that during the RT reaction in the absence of polyadenylated mRNA, the oligonucleotide d(T) 
could in theory prime the stretch of 8A residues as opposed to a poly A tail which is then 
amplified during PCR.
Interestingly, when the polymerase protein of BUN virus, expressed with a recombinant 
vaccinia virus, was able to transcribe virion-derived nucleocapsids, it was found that some 
of the S mRNA transcripts terminated at the authentic transcription termination site, but a 
significant proportion did not and were presumably untruncated (Jin and Elliott, 1993a).
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This however, may have been a side-afFect of the expression system used, rather than an 
inherent property of the BUN mRNA termination mechanism.
1.4.7 Ambisense transcription.
For the S segment of phleboviruses and S and M segments of tospoviruses, transcription is 
complicated by their ambisense coding strategy (Figures 1.0(B and C) and 1.3(B)). As 
described above, both the N and NSs subgenomic mRNAs have the same sort of 
heterogeneous, nonviral, 5’ terminal extensions like other Bunyaviridae mRNAs (Ihara et 
al., 1985; Kromelink et al., 1992b). Hybridisation studies on total cellular RNA from 
phleboviruses Punta Toro (PT) and UUK infected cells, confirmed earlier predictions based 
on sequence analysis that the NSs message was the same polarity as vRNA and the N 
message was complementary to vRNA (Ihara et al., 1984; Simons et al., 1990). Similarly 
for tospoviruses, both subgenomic NSs and NSm messages are the same polarity as vRNA 
(de Haan et al., 1990; Law et al., 1992). In the presence of cycloheximide, PT virus N 
mRNA was still detected, but NSs mRNA was not (Ihara et al., 1985). These results are 
consistent with a model in which replication of full length, encapsidated cRNA must occur 
before synthesis of the NSs mRNA. This suggests that the phlebovirus or tospovirus NSs 
protein is not involved in the early stages of replication.
Transcription termination for the ambisense genomes may involve RNA secondary structure. 
The transcription termination sites for both N and NSs mRNAs of PT virus were mapped by 
hybridisation with a series of oligonucleotides corresponding to vRNA or cRNA messages. 
The results indicated that the 3’ termini of both mRNAs were within 40 nucleotides of one 
another (Emery, 1987). Computer analysis of the intergenic region and the sequences 
encoding the 3 ’ termini of the messages showed a long inverted complementary sequence 
that could potentially form a hairpin structure. Similar stable hairpin structures are predicted 
to occur in the intergenic regions of the S and M segments of tospoviruses (de Haan et al., 
1990; Law e ta l,  1992).
1.5.0 Viral genome replication.
As the termini of all Bunyaviridae genomes described to date are exactly complementary for 
8 or 9 nucleotides (Figure 1.1) (and mostly complementary for about 20 nucleotides (Figure 
1.3), the 3’ ends of genome and antigenome RNAs (the latter being the presumptive 
promoters for genome replication), are very similar. Genome and antigenome synthesis is
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thus believed to initiate in the same manner on essentially the same sequence (Kolakofsky 
and Hacker, 1991).
In negative-strand viruses the change from primary transcription to replication requires a 
switch from mRNA synthesis to the synthesis of full length viral-complementary RNA 
templates and then viral RNA synthesis (Figure 1.4). The processes involved in these 
switches have not been defined for any member of the Bunyaviridae family. Genome RNA 
replication and subsequent secondary transcription can be prevented by translational 
inhibitors such as cycloheximide (Vezza et al., 1979; Eshita et al., 1985), indicating that 
continuous viral protein synthesis is required for replication of the genome. While it is not 
known which protein(s) are responsible or required for the switch, they are likely to of viral 
origin, including N and L, and possibly the NSs protein.
The onset of genome replication requires that the viral polymerase does not attempt to cleave 
host derived capped primers to initiate mRNA transcription, but initiates RNA replication at 
the extreme 3’ termini and that the recognition or action of mRNA transcription termination 
signals are suppressed, which may indeed be a result of not initiating transcription with a 
capped primer (Figure 1.4).
For the rhabdovirus vesicular stomatitis virus (VSV), the switch from RNA transcription to 
antigenome synthesis appears to be controlled by the availability of VSV N protein. 
Encapsidation by the VSV N also seems to serve as an antitermination signal, thus allowing 
full-length genome synthesis. It has been suggested that the VSV NS (or P protein) proteins 
are also involved and act to control the availability and delivery of N to the RNA species 
(Conzelmann, 1998; Wagner and Rose, 1996). A similar mechanism is plausible for the 
Bunyaviridae, whereby the bunyavirus N protein functions to regulate transcription and 
replication, possibly involving the NSs protein. The factors dictating how replicative RNAs 
react with N to form nucleocapsid structures, while mRNAs do not, are unknown. It has 
been suggested that the added (presumably capped) host cell sequences on the 5 ends of viral 
messages may somehow prevent encapsidation (Raju and Kolakofsky, 1986), or it could be 
the 3’ truncation that inhibits active nucleocapsid formation.
Recently a BUN-like virus defective in the expression of NSs protein, BUN(-NSs), was 
rescued from the BUN virus in vivo rescue system (Bridgen and Elliott, 1996; Bridgen and 
Elliott, 1997; 1.8.5). This was achieved by mutating the NSs initiation codons to stop 
codons and number of amino acids within the NSs reading frame without affecting the N 
ORF of the S segment genome rescue plasmid cDNA. The resulting BUN(-NSs) virus was 
capable of infecting cells and producing infectious viral progeny, indicating that the BUN 
NSs protein is not essential for replication in tissue culture.
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1.5.1 Persistent infections and defective RNAs.
Like all arboviruses, bunyaviruses and phleboviruses can replicate both in permissive 
vertebrate cells and in insect cells. The infection of cultured vertebrate cells is highly 
cytopathic and leads to cell death, whereas in cultured mosquito cells the infection is non- 
cytopathic and becomes persistent. This situation may be related to the inapparent infection 
of mosquitoes in vivo (Giorgi, 1996).
Mosquito cells (C6/36) infected with BUN virus have been shown to develop a persistent 
infection (Elliott and Wilkie, 1986). Upon analysis of total cell RNA from such cells, it was 
found that there was an over expression of S mRNA compared to L and M mRNAs. 
Additionally, the presence of subgenomic transcripts for the L segment but not for M and S 
was reported. Further investigation of the course of persistent infection of C6/36 cells by 
BUN virus by Scallan and Elliott (1992), confirmed the over-expression of S RNA. Initially 
in this study, no evidence of defective RNAs in the early phase of the infection was found, 
however, after prolonged propagation of the infected cultured cells several subgenomic L 
RNAs were identified. These subgenomic L RNAs were shown not to be defective 
interfering (DI) RNAs as they were not packaged into virions and their appearance did not 
correlate with infectious virus release titres (Scallan and Elliott, 1992).
Defective interfering particles, which are associated with autointerference in other negative- 
strand viruses, have been characterised for BUN virus (Patel and Elliott, 1992). Novel 
peptides and subgenomic RNAs were detected during the passaging of undiluted virus in 
mouse cells, but not in BHK cells. PCR cloning and sequencing of these RNAs determined 
that they comprised of only L segment sequences, and notM  or S segment sequences. These 
L segment RNAs had intact 3' and 5' untranslated regions with a single internal deletion in 
the ORF, which accounted for 72% to 77% of the L RNA (Patel and Elliott, 1992).
DI RNAs have also been characterised for tospoviruses, TSW and groundnut ringspot virus 
(GRSV) (Resende et al., 1991), and in this study, again, only L segment-like transcripts 
were found. Characterisation of the DI RNAs determined that all possessed the original 3' 
and 5' termini and a single internal deletion in the ORF which corresponded to 60% to 80% 
of the L RNA. Maintenance of an ORF suggests that these defective RNAs might encode 
protein. The comparison ofDI sequences to published viral L segment sequence determined 
that the deletions in the ORF occurred between short sequence repeats (of up to five 
nucleotides), one of which is lost during the generation of the DI RNA (Resende et al.,
1992). On the basis of this, the authors of this study suggest that DI genomes may arise via a
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"jumping" of the polymerase either internally on the template or even from one template to 
another.
1.5.2 Effects on host cell metabolism.
With the exception of viruses in the Hantavirus genus all members of the Bunyaviridae are 
capable of alternate replication in vertebrate and invertebrate hosts. Generally the 
Bunyaviridae are cytolytic for their vertebrate host but cause little or no pathological effect in 
their invertebrate host (James and Millican, 1986).
In vertebrate cells, bunyaviruses and phleboviruses have been shown to cause a progressive 
decrease in host cell protein synthesis. In Bunyamwera (BUN) infected BSC-1 cells, a 
decline in host protein synthesis was seen at 5 hours postinfection, by 7 hours, host protein 
synthesis was almost completely abolished (shutoff) (Pennington et al., 1977). In the 
absence of host protein synthesis these cells continued to support virus replication. The 
synthesis of viral proteins was detected up to 22 hour postinfection and infectious virus 
production continued up to 30 hours postinfection (Pennington et al., 1977). Similar results 
were obtained in La Crosse (LAC) virus infected BHK cells (Madoff and Lenard, 1982).
Hantavirus infections do not cause a detectable reduction in host cell macromolecular protein 
synthesis (Elliott et al., 1984; Schmaljohn and Dalrymple, 1984), but routinely establish 
persistent, noncytolytic infections in susceptible mammalian host cells, a finding consistent 
with their nonpathogenic persistence in their natural rodent host (Lee et al., 1981a).
1.5.3 Replication in vectors.
For several of the animal infecting members of the Bunyaviridae replication of the virus 
within the vector has been demonstrated (Calisher, 1991) but with no associated cytopathic 
effects (Beaty and Calisher, 1991), although evidence now exists that tospoviruses also 
replicate within their vectors and do cause some cytopathological effects and even mortality 
(Wijkamp e ta l,  1993).
Hantaviruses, unlike the other members of the Bunyaviridae, are not transmitted by 
arthropod vectors as mentioned earlier. Instead, they are maintained through the persistent 
infection of rodents and small mammals: these are termed reservoirs. The reservoirs of 
hantaviruses do not show clinical signs of illness but excrete the virus in the urine and saliva 
for a long period of time (Lee, 1996; and references there in).
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1.5.4 Evolution of the B u n yav ir idae .
Evolution of members of the Bunyaviridae is believed to occur by two major mechanisms: 
by genetic drift which occurs via the acquisition of genomic changes through point 
mutations, deletions, duplications, inversions etc., and by genetic shift, which occurs via the 
reassortment of viral RNA segments as an outcome of a mixed infection.
Until recently, evidence was weighted towards the view that the Bunyaviridae exhibited the 
genomic plasticity characteristic of other RNA genomes (Domingo and Holland, 1988). Viral 
RNA-dependent RNA polymerases lack a proof-reading ability and thus have a high error 
rate. The result of a virus polymerase replicating its genome without an editing ability is a 
high inherent error rate and an accumulation of mutations. On the basis of this, Bishop and 
Shope (1979) calculated the spontaneous mutation rate of snowshoe hare bunyavirus to be 1 
to 2 %. However, oligonucleotide fingerprinting studies carried out by Bilsel et al. (1988) 
and Baldridge et al. (1989), suggest that the frequency of such events in persistently infected 
arthropods may be very low. In support of this, Bilsel et al. have reported that Toscana 
phlebovirus underwent no detectable genomic change upon serial transovarial transmissions 
through 12 generations of experimentally infected laboratory colony of its natural sandfly 
host, Phlebotomusperniciou (Bilsel et al., 1988).
It might be considered, however, that if intra cellular viral RNA had been examined in the 
above studies, as opposed to the RNA from infectious viral particles which have been 
subjected to the selective pressures exerted by the host (replication and infection within the 
host), then the level of errors found may have been closer to that predicted by Bishop and 
Shope (1979). Perhaps genomic plasticity is only evident in the genomic sequence of 
infectious viral particles when the virus adapts to changes in host.
The role of other genetic drift mechanisms such as deletions, duplications and inversions, is 
less well documented. One possible duplication (approximately 28 nucleotides) of sequence, 
reported by Dunn et al. (1994) and confirmed by Bowen et al. (1995), exists within the 3’ 
untranslated region of the Lumbo bunyavirus S segment. The possible benefit or significance 
of this duplication is not known.
It is becoming clearer that the evolutionary potential of the Bunyaviridae is enhanced by 
genetic shift. The RNA segment reassortment possibilities for a virus with three genomic 
segments is equal to 23 - 2 = 6 (i.e. the number of reassortant genotypes in progeny, less 
parental types). This has been documented experimentally both in cell culture and in 
mosquitoes (Bishop and Beaty, 1988; Beaty et al., 1985). These genetic studies also
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provided the first data on the coding assignments of the bunyavirus RNAs and proteins, and 
their biological role. It was determined that the M RNA segment is a major determinant of 
virulence and infectivity. Distinct sites within the M RNA segment code for different genetic 
determinants of biological markers, including subcutaneous and intercranial mouse virulence 
and oral and interthoratic infection of mosquitoes (Beaty et al., 1982; Gonzalez-Scarano et 
al., 1988). For the L segment, evidence was obtained which showed an association of the 
polymerase with mouse neurovirulence and neurovasiveness (Endres etal., 1991).
Interestingly, it has been shown through reassortment experiments that only bunyaviruses 
from a single serogroup are able to reassort with each other (Pringle et al., 1984). It is 
thought therefore, that individual serogroups may potentially constitute divergent evolving 
virus pools.
1.6.0 Reverse genetics of negative strand RNA viruses.
Negative single strand RNA viruses can be divided into two groups, those with segmented 
genomes, the family Orthomyxoviridae consisting of influenza A and B viruses (eight 
segments) and influenza C viruses (seven segments), the genus Thogoto-like viruses (six 
segments), the Bunyaviridae (three segments), and the Arenaviridae (two segments; e.g. 
Lassa fever virus) and those with non segmented genomes, the order Mononegavirales. The 
order Mononegavirales is subdivided into four families; Bornaviridae (Boma disease virus); 
Rhabdoviridae (e.g. vesicular stomatitis virus (VSV) and rabies); Filoviridae (e.g. Marburg 
and Ebola viruses); and the Paramyxoviridae which is again split into two subfamilies: 
Pneumovirinae (e.g. respiratory syncytial virus (RSV); and Paramxyxovirinae (e.g. Sendai 
virus (SeV) and measles virus (MeV)), (Francki etal., 1991).
In the case of positive-strand RNA viruses, the naked RNA genome functions as a template 
to initiate translation and the infectious cycle. Therefore, either the introduction into cells of 
in vitro transcribed RNA from a cDNA clone or the intracellular expression of RNA 
following cDNA transfection, results in the production of infectious progeny. These 
approaches have established reverse technology for positive-sense viruses with relative ease 
(reviewed in Boyer et al., 1994).
In contrast, the naked RNA genomes of negative strand viruses are non infectious, and they 
cannot initiate the production of infectious viruses. Neither the genomic (vRNA) or the 
antigenomic complementary RNA (cRNA) can serve as a mRNA template for the translation
25
Introduction: Chapter 1
of viral proteins. To direct viral protein synthesis, the positive sense genome must be 
transcribed into a positive-sense mRNA, a process which can only be achieved by the 
specific viral RNA polymerase (RNA dependent RNA polymerase, RdRp), since animal 
cells do not possess such an enzyme. Furthermore, to function as a template for transcription 
and replication, the viral genome must also be encapsidated with the viral nucleocapsid 
protein. Therefore the minimum replication unit of a negative strand virus is the genome 
complexed with nucleocapsid protein and the viral polymerase (complex) to form a 
ribonucleocapsid (RNP) (Szewczyk e ta l, 1988; reviewed in Lamb and Krug, 1996).
Reverse genetic systems have now been successfully applied to all but two of the above 
mentioned families {Arenaviridae and Bornaviridae), and within the scope of this section I 
will not attempt to review all the current literature on the subject but highlight those reverse 
genetic systems and research that have allowed for the successful manipulation and rescue of 
negative strand genomes. Specifically the focus will be on that of influenza A virus research, 
as reverse genetic systems were established for this virus before other negative strand RNA 
viruses and have since helped propel their research. For fiither information on the application 
and use of reverse genetic systems to study negative strand viruses the reader is directed to 
reviews by Conzelmann (1996), Palese etal. (1996), Garcia-Sastre (1998), and Conzelmann 
(1998).
1.6.1 Influenza A virus.
Influenza A virus is a negative strand RNA virus belonging to the Orthomyxoviridae. It has a 
segmented genome consisting of eight single stranded RNA molecules which collectively 
encode a total of ten genes (Krug et al., 1989).
Following fusion of the viral and endosome membranes, the RNP complexes are released 
into the cytoplasm and migrate to the cell nucleus where transcription and replication of the 
viral genomes occur. The incoming RNPs are first transcribed into monocistronic mRNAs 
that are translated to yield viral proteins that are required for replication of the viral genome. 
Replication of the viral genome involves copying of the vRNA molecules into 
complementary RNA templates (cRNA) which in turn are used for synthesis of new vRNAs. 
Newly synthesised vRNAs are finally exported from the cell nucleus to the cytoplasm, and 
associate with other structural viral proteins to form virus particles that are budded at the 
plasma membrane and released into the cell medium (reviewed in Lamb and Krug, 1996).
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1.6.2 Influenza A virus reverse genetic systems.
1.6.3 RNP reconstitution system.
The first successful attempt to reconstitute transcriptionally active influenza virus RNPs in 
vitro, used purified virus RNA mixed with purified viral proteins (Szewczyk et a l., 1988). 
This study utilised a method developed to allow renaturing of the NP and polymerase 
proteins (PB1, PB2 and PA) after isolation from intact virus particles by denaturing gel 
electrophoresis. After blotting onto membranes, the proteins were refolded by the bacterial 
protein thioredoxin. When genomic RNA purified from virions was mixed with the purified 
renatured proteins to reconstitute RNPs, transcription was detected. This study demonstrated 
for the first time that for transcription to occur all three proteins of the polymerase complex 
and NP were necessary. However this system was not developed further for the 
reconstitution of RNPs using synthetic RNAs derived from plasmid cDNA.
1.6.4 Reverse genetics of influenza viruses.
Influenza virus became amenable to the expression of foreign proteins when Luytjes et al. 
(1989) established the first reverse genetics system for negative strand RNA viruses (Figure 
1.6(A)). A plasmid was engineered containing the chloramphenicol acetyl transferase (CAT) 
gene in negative polarity. The reporter gene was flanked by the 3’ (26 nucleotides) and 5’ 
(22 nucleotides) untranslated regions (UTRs) of the NS gene of influenza A/WSN/33 virus, 
and was under the transcriptional control of a T7 promoter. From this plasmid it was 
possible to generate in vitro an influenza virus-like RNA molecule with precise viral 3’ and 
5’ termini, due to the presence of an appropriate restriction site at the 3’ terminus and a 
truncated T7 promoter that starts transcription at the 5’ terminus. The CAT-RNA molecules 
were then mixed with purified NP protein and viral polymerases, depleted of endogenous 
RNA by CsCl centrifugation. This would reconstitute active RNPs, which were then 
transfected into cells that were previously infected with an influenza helper virus. The helper 
virus was able to replicate, transcribe, and package the foreign CAT gene, and CAT 
expression was detected in infected cells. When either naked recombinant RNA alone in the 
presence of infecting helper virus or recombinant RNP complex in the absence of infecting 
helper virus were transfected into cells, no CAT activity was detected. Thus the helper viral 
proteins in this system were not able to elicit reporter activity from a naked RNA, nor were 
reconstituted RNPs alone able to initiate transcription (Luytjes etal., 1989).
The role of the helper virus in this system (and in other systems that will be described later) 
is to provide in trans the viral proteins required for expression and amplification of the
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Figure 1.6(A ) Synthetic RNP transfection, expression and packaging into 
virion like particles
Shown above is a diagram of the reporter construct pIVACATl (Luytjes et al., 1989), 
and a schematic for RNP transfection. The in vitro transcribed RNA transcript from 
pIVACATl is essentially an antisense CAT ORF flanked by the authentic full length 5 ’ 
and 3’ UTRs of influenza virus segment 8 (see text for further details 1.6.4). The 
synthetic RNA is complexed with purified viral nucleocapside proteins to form RNPs 
before being transfected into influenza A virus infected cells. The helper viral proteins act 
in-trans to allow expression of the CAT gene, amplification, and packaging of the 
synthetic RNA into a viral-like particle.
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synthetic RNP complex. An alternative procedure for RNP reconstitution was reported by 
Seong and Brownlee (1992a). In this procedure, the isolated viral RNPs of disrupted virion 
cores were freed from endogenous RNA molecules by digestion with micrococcal nuclease. 
The subsequent addition of EGTA to the preparation inactivated the calcium-dependent 
micrococcal nuclease enzyme. Reconstituted RNPs obtained after incubation of the nuclease 
treated cores with a synthetic viral RNA (Luytjes et al., 1989) was shown to support 
transcription in vitro as well as in vivo and the subsequent rescue by a helper virus. CAT 
expression was also detected, although at low levels, when the RNP transfection was done 
in the absence of helper virus, a result differing from Luytjes et al., suggesting that the 
reconstituted RNPs alone could initiate transcription of the synthetic RNA in vivo. This 
result may simply reflect the different methods used for preparing the viral cores for RNP 
reconstitution (Seong and Brownlee, 1992a). This system also allowed for the first time the 
use of short model templates. These short templates consist only of the 3’ and 5’ 
untranslated regions consensus sequences. When these short templates were reconstituted 
with the nuclease treated cores, all three influenza virus transcription activities were detected 
in vitro, i.e. capped primer dependent mRNA synthesis, primer-independent cRNA 
synthesis, and ApG-primed vRNA synthesis (Seong et al., 1992). The use of the short 
template in vitro system has provided a wealth information on the functions and structure of 
the viral UTRs, some of which will be discussed in the context of other studies in future 
sections.
The systems described have been successfully used for the characterisation of cA-acting 
elements involved in replication and transcription of the influenza virus RNAs (reviewed in 
Garcia-Sastre and Palese, 1993). They all share one common problem, however, and that is 
that the foreign gene (segment) behaves like a defective RNA segment, and it is rapidly lost 
after a few passages of the virus. The generation of stable influenza virus vectors expressing 
foreign sequences was made possible with the establishment of methods to replace an 
influenza virus RNA segment with a synthetic RNA. In order to replace an influenza virus 
gene segment with a synthetic RNA, a negative selection method against the helper virus 
gene or a positive selection method for the transfected gene must be available.
1.6.5 Genetic manipulation of influenza virus genomes.
Enami et al. (1990) first described the rescue of a synthetic neuraminidase (NA) gene in 
which specific mutations had been introduced into infectious influenza viruses (Figure 
1.6(B)). This was achieved by using a helper virus with a strong counter-selectable 
phenotype which was well characterised. Influenza virus A/WSN-HK is a reassortant 
containing seven segments from influenza A/WSN/33 and the neuraminidase gene segment
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NA segment (A/WSN/33) In vitro transcribed RNA
Transfect 
naked RNA
Infect cells 
with helper virus 
A/WSN-HK after 
trypsin treatment
Synthetic RNPs are reconstituted 
by incubating RNA transcripts 
with proteins dissociated from 
native RNPs
f Output viruses plaqued onto cells without trypsin treatment
Virus particle containing 
all eight A/WSN/33 
segments
Figure 1 .6(B ) Rescue o f a synthetic NA RNA segment by influenza virus
The schematic describes a method to allow substitution of one of the eight genomic RNA 
segments of the helper virus by a synthetic RNA. The synthetic NA RNA segment 
(A/WSN/33) transcribed in vitro from a cDNA is complexed with viral proteins to form 
RNPs. The RNPs are then transfected into cells infected with an influenza helper virus 
(trypsin treated). The RNP is amplified by the helper virus proteins and packaged into 
infectious progeny viruses. Appropriate selection conditions, in this case a lack of trypsin 
treatment, allows the rescue of an transfectant influenza virus containing an RNA derived 
from cDNA (Enami et al., 1990).
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from influenza virus A/HK/8/86. This reassortant virus can only form plaques in MDBK 
cells when the cell culture media is supplemented with a protease (Schulman and Palese, 
1977), whereas the parent WSN/33 strain replicates and forms large plaques without the 
requirement for exogenous protease. The strategy was to provide WSN NA segment (and 
therefore protease-independence) in the form of a synthetic RNP. Any virus replicating and 
packaging the synthetic WSN/NA segment could easily be selected from the helper virus by 
omitting protease from the cell culture media. Using this procedure it was possible to obtain 
2.5 x 102 pfu/ 35mm transfection dish formed by virus in which the neuraminidase segment 
was derived from the transfected synthetic RNP. To verify the plasmid origin of the WSN 
segment, further constructs were made into which five silent point mutations were 
introduced in the NA coding sequence. All the viruses recovered in the absence of protease 
contained the mutations, demonstrating that synthetic RNP had indeed been stably 
incorporated into an influenza virus (Figure 1.6(B)). Alternatively, a helper virus which only 
forms plaques in MDBK cells due to a deletion in the stalk region of its NA protein can be 
used to rescue synthetic NA genes after RNP transfection and passage in MDCK cells (again 
nonpermissive for the helper virus) (Li et a l, 1993b).
The efficiency of the system was considerably improved by performing the plasmid 
transcription reaction in the presence of purified influenza virus proteins (Enami and Palese, 
1991) rather than mixing pre-transcribed RNA with the protein as had originally been done 
to effect reconstitution (Luytjes et al., 1989). Using the optimised protocol, the rescue of 
synthetic WSN/NA segment into WSN/HK reassortant virus could be achieved at a much 
greater efficiency with at least 100-fold more virus being isolated (0.5-1 x 105 
pfu/transfection compared with 2.5 x 102 observed earlier).
The improved efficiency enabled the exchange of the haemagglutinin (HA) and NS genes of 
influenza virus by cDNA derived RNAs. Selection of viruses containing the transfected HA 
gene was achieved by using neutralising antibodies that were directed against the HA protein 
of the helper virus and therefore suppress its infection and further replication. NS gene 
transfections have been performed using a temperature sensitive influenza virus strain with a 
defect in the NS gene, which meant transfections were performed at the permissive 
temperature (33°C), and selection of recombinant viruses was achieved by plaquing at the 
non-permissive temperature (38°C) (Enami and Palese, 1991).
The combination of improved RNP transfection technology and the use of appropriate 
selection methods has also allowed the introduction of specific mutations to the PB2 
(Subbarao etal., 1993), M (Castrucci and Kawaoka, 1995), and NP genes (Li e ta l,  1995).
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1.6.7 Plasmid based reverse genetics system: RNA polymerase I.
A method was recently developed to reconstitute a biologically active influenza virus RNP 
complex within the cell rather than in vitro (Neumann et al., 1994). This approach 
circumvents the need for viral protein purification, in vitro transcription, and in vitro RNP 
reconstitution by taking advantage of the characteristics of RNA polymerase I (Pol-I) 
transcription. RNA Pol-I catalyses the synthesis of ribosomal RNA (rRNA) within the 
nucleus which lack a 5’ cap and a 3’ polyA tail, thereby resembling influenza virus RNA. An 
RNA Pol-I based reverse genetics system for influenza virus was therefore established by 
cloning a reporter cassette (Luytjes et al., 1989) containing an antisense CAT gene flanked 
by the heamagglutinin (HA) UTRs between a mouse RNA Pol-I promoter and terminator 
sequences. Transcription by RNA Pol-I transcribes an RNA transcript that initiates and 
terminates with the authentic 5’ and 3’ termini, and this occurs within the nucleus, the site of 
influenza replication. Detectable CAT activity was found in mouse cells (NIH3T3) initially 
infected with a helper virus then transfected with the Pol-I construct (I-HA-CAT). Moreover, 
the HA-CAT vRNA was also shown to be packaged into progeny virions (Neumann et al.,
1994).
A similar system was also developed by Pleschka et al. (1996), but differed in using the 
human RNA Pol-I promoter to initiate transcription and the hepatitis delta ribozyme to 
generate the correct 3’ end of the viral like RNA transcript. When the Pol-I driven synthetic 
NA cDNA plasmid is transfected into human cells infected with helper virus, transcription of 
reporter activity was detected, and packaging of the viral like transcript into virions was also 
reported. Pleschka et al. found that the efficiency of their system was enhanced by the 
cotransfection of plasmids that express the three polymerase proteins and the NP. These 
expression constructs were also specialised in their design, in that RNA transcription of each 
was driven by the RNA Pol-II promoter, thus producing mRNA like transcripts that are 5’ 
capped and 3’ polyA tailed to allow export from the nucleus and subsequent translation. 
These two systems provided the basis for a helper virus free system for the rescue of 
recombinant viral particles with segmented genomes (1.8.6).
1.6.8 Helper virus-free systems.
One consequence of using reverse genetic systems that rely on the use of helper virus to 
supply the viral proteins necessary for replication is that functional analyses of these 
replicative proteins is clearly precluded. Therefore, attempts have been made to develop a 
helper virus-free system. In one system the influenza virus proteins were expressed in vivo 
from recombinant vaccinia virus constructs (Huang et al., 1990). When cells infected with
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four recombinant vaccinia viruses expressing the polymerase subunits, (PB1, PB2 and PA) 
and the NP protein, were transfected with a synthetic RNP, CAT expression was detected 
when all four viral components were present. In a similar approach the polymerase subunits 
(PB1, PB2 and PA) and NP proteins were expressed from recombinant simian virus 40 
(SV40) constructs (de la Luna et al., 1993). As in the previous study it was demonstrated 
that only when COS-1 cells were infected with all four SV40 expression viruses and then 
transfected with PB2-CAT RNA transcripts reconstituted into RNPs, that CAT activity could 
be detected. However, unlike in the system described by Huang et al. (1990), naked RNA 
templates were expressed efficiently upon transfection into cells, and to a greater extent 
compared to when the RNA template was reconstituted into RNPs (de la Luna et al., 1993).
Mena et a l , (1994), have also described a reverse genetics system based on the recombinant 
vaccinia virus (vTF7-3) T7-expression system (Fuerst et al., 1986). In this system, four 
pGEM recombinant plasmids expressing the four influenza core proteins, allowed the 
expression of a synthetic influenza like CAT RNA (PB2CAT9). This was the first system to 
transiently express the viral proteins necessary to transcribe a synthetic RNA entirely from 
plasmids. Moreover, as in the SV40 system (de la Luna etal., 1993 ), naked RNA could be 
transcribed and consistently yielded higher CAT activity levels compared to encapsidated 
RNA.
Both the SV40 and the vTF7-3 driven systems obviate the need to encapsidate template 
RNA, and the added advantage of the vTF7-3 system is the ease in which mutagenesis of the 
genes encoded by the expression plasmid cDNAs can be performed to allow functional 
studies of the individual viral proteins involved in transcription. The vTF7-3 system has 
since been further developed (Mena et al., 1996), and it has been demonstrated that by 
supplying the vTF7-3 infected cell with plasmids containing cDNAs of all ten influenza 
encoded viral proteins, not only could the CAT RNA template be expressed but rescued into 
virus-like particles (VLPs). These VLPs budded into the supemate and resembled authentic 
influenza virions in EM studies. It was demonstrated that NS1 protein was dispensable for 
the detection of VLPs, which agrees with the fact that NS1 has never been detected in virus 
particles (Menae ta l,  1996). This system can be used to analyse the viral proteins involved 
in replication and virion particle formation.
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1.6.9 Influenza virus as a vector for foreign epitopes and 
protein expression.
From the development of the systems described above to rescue synthetic viral genes into 
influenza A viruses, it has since become possible to generate chimeric viruses either 
containing foreign epitopes within a viral protein, or expressing a foreign protein.
Most of the antibodies generated during a influenza virus infection have been shown to be 
directed mainly against specific domains of the HA protein. These domains are hypervariable 
regions within the HA protein termed A, B, C, D and E (reviewed in Garcia-Sastre and 
Palese, 1995). The hypervariability of these regions allows them to be amenable as an 
insertion site for short protein sequences representing foreign B-cell epitopes. The B domain 
has been most successfully utilised.
Li et al. (1993 a), constructed a chimeric influenza A virus by inserting a 12 amino acid 
sequence (IHIGPGRAFYTT) which was derived from the V3 loop of gpl20 of HTV-l/MN 
into the antigenic site B of the HA protein of influenza virus A/WSN/33. They demonstrated 
that BALB/c mice immunised with the chimeric virus were able to elicit antibodies against the 
HTV peptide. The induced antibodies were able to neutralise the corresponding HIV-1 strain 
virus in tissue culture. Furthermore, the chimeric virus was able to induce production of HIV 
specific cytotoxic T cells. These results were the first to show that a influenza A virus can be 
used as a viral vector to induce B and T cell responses against other infectious agents. The 
highly conserved epitope (ELDKWAS) from the ectodomain of HIV-1 gp41 has been 
introduced into the antigenic B site of HA protein. The chimeric virus was also shown to 
induce neutralising antibodies which were also effective against different HIV-1 strains as 
well as inducing a mucosal immune response: high levels of HTV specific IgAs could be 
detected in mucosal excretions of immunised mice (Muster et al., 1994).
Various other groups have successfully grafted foreign epitopes not only into other antigenic 
domains of the HA protein (site E; Castrucci et al., 1992), but into the stalk region of the NA 
protein (Castrucci etal., 1994; reviewed in Garcia-Sastre and Palese, 1995).
Transfectant influenza viruses can also protect animals from diseases caused by protozoa and 
bacteria. It has been demonstrated that a recombinant virus containing the B cell epitope of a 
human malaria {Plasmodium falciparum) antigen in the HA protein elicited a protective 
immunity in mice (Miyahira et al., 1998). Also, Gilleland et a l., (1997) and Staczec et al.,
(1998), have shown that immunisation of mice with recombinant influenza viruses 
expressing epitopes of the Pseudomonus aeruginosa protein F in the antigenic B site of HA, 
afforded protection against challenge. This work is potentially important for cystic fibrosis
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(CF) sufferers as P. aeruginosa, an opportunistic pathogen, is a major cause of morbidity for 
CF sufferers (Gilleland e ta l,  1997).
The success of foreign epitope grafting into a viral protein depends on the ability of the viral 
protein to accommodate the foreign sequence without compromising the viability of the 
chimeric virus. One approach to avoid this problem has been to engineer a virus segment to 
encode two proteins, an essential viral protein and a foreign protein, thus allowing the 
expression of long protein sequences without compromising the viability of the vector. Two 
such strategies are depicted in figure (1.7 A and B).
Percy et al. (1994) (Figure 1.7 A) engineered an NA segment encoding a polyprotein 
comprising the 2A self cleaving protease (17 amino acids) inserted in-frame between the 
coding regions of a CAT gene and the NA gene. Upon transcription and translation, this 
construct results in a CAT/2A/NA polyprotein which self-cleaves to release both the CAT-2A 
and NA proteins. It was shown that this recombinant NA segment could be rescued and 
CAT activity detected; notably the CAT activity was not lost after several passages of the 
virus.
Using a different approach (Figure 1.7.B), Garcia-Sastre et al. (1994a) constructed and 
rescued a recombinant NA segment which transcribed a bicistronic mRNA. This was 
achieved by positioning an internal ribosomal entry site (IRES) between the foreign ORF, in 
this case the gp41 gene of HIV, and the NA gene. After transcription of the bicistronic 
mRNA, expression of the gp41 ORF was effected by cap-dependent translation initiation 
while the NA gene was expressed by cap-independent translation initiation via the IRES 
element.
1.7.0 Transcription and replication of influenza virus.
During the replication cycle of influenza virus in infected cells, the genomic viral RNA 
(vRNA) segments serve as templates for the synthesis of subgenomic mRNAs as well as for 
full length complement RNA (cRNA), which in turn acts as a template for vRNA synthesis.
The initial in vivo study by Luytjes et al. (1989) showed that the conserved 5’ and 3’ 
untranslated regions sequences were sufficient for the expression, replication, and packaging 
of genome like segments into influenza virus particles (Luytjes et al., 1989). The 
development of RNP reconstitution systems and transfection systems has allowed detailed 
characterisation of the RNA signals involved in the regulation of transcription, initiation, 
termination, polyadenylation, and replication. All of these signals are known to reside in the
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Figure 1.7 Strategies for the expression o f fu ll length foreign proteins 
from influenza virus vectors
(A) The foreign protein is expressed as part of a self cleaving polyprotein. The coding 
sequence for a self cleaving protease (shown in italics), 2A, of foot-and-mouth disease 
virus, is positioned in frame between the coding regions of CAT and NA. The resulting 
polyprotein CAT/ 2A / NA is autocatalyticaly cleaved by the protease in trans to release a 
CAT/2A fusion and the NA protein with an extra amino-terminal proline. The site of 
proteolytic cleavage is indicated by the arrow. Figure adapted from Percy et al. (1994).
(B) The foreign protein is expressed from a bicistronic mRNA. The IRES element of the 
human immunoglobulin heavy chain binding protein (BiP) was inserted between the 
foreign protein gp41 and the NA gene, allowing gp41 to be expressed via cap-dependent 
translation while the NA is expressed via internal ribosomal initiation of translation. 
Figure adapted from Garcia-Sastre et al. (1994b).
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terminal sequences of the vRNA segments (Luytjes et al., 1989; Enami et a l,  1990). 
Specifically the vRNA 3’ end is believed to be responsible for mRNA transcription and 
cRNA replication, while the signals for vRNA replication and mRNA termination/poly 
adenylation are thought to reside in the 5’ end. Thus these regions have been major targets 
for mutational analysis using the reverse genetics systems.
1.7.1 Poly A signal.
Viral mRNAs are incomplete copies of the vRNA, whereas cRNAs are complete copies. 
Viral mRNA synthesis initiates at the 3’ end on the vRNA template with a capped primer 
(derived from host mRNA) and terminates at a stretch of U residues 16 nucleotides (in the 
case of the NS gene) from the 5’ end of the vRNA. Since the stretch of U residues is 
adjacent to the panhandle structure made by the termini it has been postulated that this 
sequence is responsible for polyadenylation, and that this process occurs by stuttering of the 
viral polymerase at the RNA duplex with repeated copying of the U sequence.
Both Luo et al. (1991) and Li and Palese (1994), have shown that for polyadenylation to 
occur an uninterrupted stretch of five to seven uridines must be located near the 5’ end of the 
vRNA: a deletion of two uridines (from 6 to 4) decreased CAT expression to 4% of wild- 
type RNA. It has also been shown that the distance between the U stretch and the 5’ end of 
the vRNA is crucial: 16 nucleotides optimal, and an increase of just one nucleotide reduced 
CAT expression to less than 1%. In addition, the base-paired region adjacent to the polyA 
signal (region II) was found to be crucial for its function, although a specific sequence in this 
region was not (Li and Palese, 1994).
Recent findings by Pritlove et al. (1998) and Poon et al. (1998) also indicate that a functional 
polymerase binding site at the 5’ of the vRNA is essential for polyadenylation. Thus, for 
polyadenylation to occur, three elements are required: a uridine stretch near the 5’ end of the 
vRNA, a base paired region at region II, and specific nucleotides in region I 5’ end (Figure 
1 . 8 ).
1.7.2 Noncoding regions.
The noncoding regions lie between the terminal partly double stranded promoter (conserved 
between genome segments) and the start and stop codon, respectively. The lengths and 
nucleotide composition of these regions vary among gene segments. Whereas the basic 
information for transcription and replication is located in the terminal promoter element, the 
noncoding regions are thought to contain c/s-acting signals involved in the regulation of
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these processes. Deletion of either, but not both, the 3’ and 5’ noncoding regions of the 
influenza NA gene did not effect the amount of NA RNAs (Zheng et al., 1996). Also, 
transfectant viruses containing mutations in the noncoding regions showed a reduction in the 
corresponding vRNA (Bergmann and Muster, 1996). Together these data may indicate that 
the noncoding regions are not crucial for replication and transcription, but that they contain 
signals that regulate these processes.
1.7.3 Influenza virus promoter regions.
Whether it is essential that the viral promoter is situated at the extreme 3’ end of the RNA 
template is unclear and seems dependent upon the assay system used. Parvin et al. (1989) 
reported that an RNA template containing 5 extra nucleotides at the 3’ end was only 
transcribed in vitro at 33% the efficiency of authentic sequence. Similarly, templates with 1, 
5, and 13 extra nucleotides at the 3’ end of a cRNA CAT reporter retained only 55, 26 and 
6% respectively of the promoter activity in vitro (Li and Palese, 1992). However, when 
these CAT cRNAs were tested in an in vivo system, only the template with one additional 
nucleotide was functional showing 20% wild type activity (Li and Palese, 1992). Piccone et 
al. (1993) reported that RNA templates containing 13 or 30 extra nucleotides or a deletion of 
one nucleotide at the 3’ vRNA terminus showed a drastic reduction in either in vitro or in 
vivo systems. Taken together these results strongly suggest that optimal promoter activity in 
vivo and in vitro requires the precise 3’ terminal sequence, without additional or deletion of 
terminal nucleotides. These results also suggest that in vivo assays are more sensitive to 
modifications at the 3’ end.
The two main research groups who have undertaken extensive mutagenesis of the influenza 
promoters have used different systems. Brownlee’s group have utilised an in vitro 
transcription system (Seong and Brownlee, 1992a, b; Fodor et a l., 1994, 1995, 1998; 
Pritlove etal., 1995), while Hobom’s group have used the Pol-I in vivo system (Neumann 
and Hobom, 1995; Flick et al., 1996).
These extensive mutational studies have determined nucleotides crucial for promoter activity, 
however, which particular nucleotides were found to be critical depended on the assay 
system used in the investigation. In general, mutations in the vRNA or cRNA promoter 
affect in vivo expression of a CAT reporter gene more extensively than in vitro transcription. 
This maybe because in vitro systems measure a single step (e.g. the synthesis of cRNA from 
vRNA), whereas in vivo systems could involve multiple steps (i.e. transcription and 
replication of the vRNA template, as well as translation of the CAT mRNA). In fact, the 
discrepancies between results from the two systems suggest that nucleotides within the
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promoter region are involved in additional functions required for CAT expression (e.g. 
stability, polyadenylation, transport, and or translation of the mRNA). Results of promoter 
studies obtained using various systems are therefore not strictly comparable, however, they 
do share general features.
The promoter sequence has been mapped to the first 12-14 nucleotides at the 3’ end of the 
vRNAs, and to the first 11-13 nucleotides at the 3’ end of the cRNAs, which correspond 
approximately to the conserved terminal nucleotides, although initially results from in vitro 
systems suggested that the promoter for polymerase binding and transcription initiation 
resided entirely in the 3’ conserved sequence (Parvin et al., 1989; Seong and Brownlee, 
1992a). More recent studies using the vaccinia virus-T7 system suggest that the binding of 
the 5’ ends of the vRNAs are a prerequisite for both endonuclease activity and transcription 
initiation of influenza virus polymerase (Hagen etal., 1994; Tiley et al., 1994; Cianci et al.,
1995). In fact the promoter activity of a construct containing a mutation within the 3’ end of 
the vRNA could be restored by introducing a complementary mutation at the 5’ end of the 
vRNA, or vice versa. Studies of the cRNA promoter produced similar results. Therefore, the 
vRNA and the cRNA promoters consist of both the 3’ and 5’ ends of the vRNA and the 
cRNA, respectively. Mutational analysis revealed that the vRNA and cRNA promoter can be 
divided into two elements: region I (nucleotides 1-9 at the 3’ end and nucleotides 1-9 at the 
5’ end) and region II (nucleotides 10-15 and 11-16 at the 3’ and 5’ ends respectively; Fodor 
et al., 1994; Fodor et al., 1995; Flick et al., 1996. These two regions may be connected by a 
flexible joint, formed by the unpaired A at position 10 at the 5’ end of the vRNA (Flick et 
al., 1996). Within region II base-pairing is crucial: mutations that result in the loss of base- 
pairing abolish promoter activity completely (Fodor et al., 1994; Flick et al., 1996; Kim et 
al., 1997). Promoter activity can, however, be restored by introducing complementary 
mutations that restore base-pairing (Fodor et al., 1994; Kim et al., 1997; Flick et al., 1996). 
By contrast, specific nucleotides are crucial for promoter activity in region I.
1.7.4 Structural models for the influenza promoter.
The panhandle was the first structural model to be proposed for influenza vRNA 
(Desselberger et al., 1980; Hsu etal., 1987) (Figure 1.8(A)). It is based on nuclease SI 
protection assay and electron microscopy studies. The sequence shown in figure 1.8(A), is 
that of the influenza virus terminal consensus sequence. Initial attempts to characterise the 
interaction of the 3’ and 5’ ends by mutational analysis (Li and Palese, 1992; Piccone et al., 
1993) and by biochemical analysis (Baudin et al., 1994) supported the notion of a panhandle 
structure. It was Fodor et al. (1994) who first proposed a new terminal structure, the fork 
model (Figure 1.8(B)), which predicts a single stranded conformation for region I and a
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Figure 1.8 Proposed secondary structures for influenza A virus 3’ and 5 ’ 
ends
(A) The influenza A virus proposed panhandle secondary structure based on the 
consensus sequence. (B) and (C), secondary structures as proposed by patterns of single 
substitutions, and supported by complimentary double substitutions, (B) the fork model 
(Fodor et al., 1994), and (C) the corkscrew model (Flick et al., 1996). Watson and Crick 
base pairs are indicated by vertical lines. Figures (A) and (C) adapted from Flick et al. 
(1996), and Figure (B) is adapted from Fodor et al. (1994).
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double stranded element in promoter region n. This fork model is based on findings that 
base pairing is crucial within region II (nucleotides 12-14, 3’ and 11-13, 5’), but not at 
positions 1-8 (Fodor et al., 1994; Fodor et al., 1995; Kim et al., 1997). Flick et al. (1996) 
proposed the corkscrew model (Figure 1.8(C)), which agrees that region II is base-paired, 
but differs from the other models in that it also predicts intra-strand base pairing within the 3 ’ 
and 5’ ends, rather than between them. The intra-strand base pairs are formed between the 
nucleotides at positions 2 and 9, and 3 and 8 at both ends of the viral RNA. These short base 
paired regions stabilise exposed single stranded RNA tetra-loop structures (positions 4 to 7). 
The strength of the cork screw model is supported by the finding that mutations that destroy 
base pairing within the short stem regions (positions 2:9, 3:8) reduce CAT activity, while if 
intra-strand base-pairing is maintained with a complementary mutation, reporter activity is 
restored (Flick et al., 1996). The authors also suggest a two step model for the interaction of 
the polymerase complex with the vRNA terminal promoter sequence, where, initially the 
polymerase interacts with closed structure, as shown in figure 1.8(A), with the termini based 
paired together. Once protein has bound, it is proposed that the terminal structure then 
converts to an open complex interaction (corkscrew structure, Figure 1.8(C)) with the viral 
polymerase (Flick et al., 1996).
1.8.0 Negative strand virus rescue systems.
1.8.1 Reverse genetics of nonsegmented viruses.
Following on from the successful rescue of influenza A virus genome segments by 
reconstituting synthetic RNPs in vitro, the same approach was tried in an attempt to rescue 
nonsegmented viruses. However, as yet, all attempts to encapsidate synthetic RNAs of 
nonsegmented viruses in vitro have failed (Garcin et al., 1995(b); reviewed in Conzelmann,
1996). This maybe because these viruses have a tighter RNP structure or due to the length of 
RNAs involved (11-15 kb).
In previous attempts to rescue influenza A virus by transfecting naked influenza virus RNAs 
into virus infected cells, it was found that these RNAs were not recognised by the viral 
proteins (Luytjes et al., 1989). In contrast, for some nonsegmented viruses it has been 
shown that in vitro transcribed synthetic RNAs when transfected into cells previously 
infected with the homologous helper virus were recognised by the viral nucleocapsid 
proteins, and were subsequently replicated, transcribed and rescued. However, the success 
of this method has been limited, achieving the rescue only of subgenomic RNAs for a small
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number of nonsegmented viruses, e.g., Sendai virus (SeV) (Park et al., 1991), RSV 
(Collins etal., 1991), andMeV (Sidhu etal., 1995).
1.8.2 Ribozymes allow in vivo transcription of template RNAs.
Another major breakthrough in optimising reverse genetic systems exploited the use of the 
hepatitis delta virus (HDV) ribozyme. This ribozyme has autocatalytic activity which is 
indiscriminate with regard to sequences 5’ of its cleavage site, and was therefore useful in 
developing plasmid vectors designed to allow intracellular generation of RNAs with defined 
3’ termini (Ball, 1992).
Initially, this system was applied to produce VSV interfering particles which originated 
entirely from cDNA clones (Pattnaik et al., 1992). It had previously been shown that VSV 
DI particles could be replicated when infected into cells expressing the L, N, and NS 
proteins from plasmids via the vTF7-3 T7-system. If the M and G proteins were also 
expressed within the cell, the replicated DI genomes could be packaged into DI particles 
which budded from the cells (Pattnaik and Wertz, 1991). This system, as it stood, allowed 
structural and functional analysis of the interaction between the VSV proteins and DI 
template to be undertaken.
Pattnaik et al. (1992) placed a HDV ribozyme downstream of a cDNA corresponding to a DI 
genome under control of a T7 promoter, so that the resulting transcript was initiated at the 
first DI specific nucleotide, and when the ribozyme cleaved itself from the T7 transcript, it 
generated the authentic DI 3’ nucleotide. As described previously, when all the VSV gene 
products were present in the cell, the in vivo transcribed DI RNA could be packaged into 
VSVDI particles (Pattnaik et al., 1992). This work was a major achievement, and was the 
first report of a DI particle formed entirely from cDNA in vivo. The system also allowed for 
the mutational analysis of the VSV DI promoters and cis-acting sequences and formed the 
basis for the rescue of a full VSV genome (Pattnaik et a l, 1995).
The basis of this helper free system has been successfully utilised by nearly all other 
nonsegmented negative strand (NNS) virus reverse genetic systems (e.g., human 
parainfluenza virus 3 (hPIV-3), De and Banerjee, 1993, Dimock and Collins, 1993; Rabies 
virus (RV), Conzelmann and Schnell, 1994; Sendai virus (SeV), Harty and Palese, 1995). 
However, at this point, all attempts to rescue a full length genomic RNA transcript were 
unsuccessful, and in fact, Conzelmann and Schnell (1994), had found that DI rescue 
efficiency decreased as the length of the transcripts increased, by approximately 10 fold with 
each additional kb.
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1.8.3 Rescue of a negative strand virus from cDNA.
In 1994, Schnell et al., reported the first successful recovery of a recombinant infectious 
rabies virus (RV), produced entirely from cDNAs. The authors used a similar system to that 
described by Pattnaik et al., (1992), whereby cells infected with vaccinia virus vTF7-3, were 
transfected with T7-plasmids encoding the viral replication proteins N, P and L along with a 
T7-plasmid encoding the full length RV antigenomic viral RNA under the control of a T7 
promoter placed at the 5’ end, and with the HDV ribozyme placed at the 3’ end. In this initial 
study only 1 to 3 plaque forming units were rescued from ~2 x 107 cells. The rescued 
viruses were separated from the high number of vTF7-3 particles by a filtration step after 
freezing and thawing. The key to the recovery of infectious RV was to express a full length 
antigenome transcript rather than previous attempts with genome templates.
Using the same experimental approach, the successful rescue of VSV was subsequently 
reported (Lawson et al., 1995; Whelan et al., 1995), and also in the same year, MeV 
(Radecke et al., 1995), SeV (Garcin et al., 1995b), and RSV (Collins et al., 1995) (See 
Table 1.3). Although variations within the recovery systems were employed, each group 
found that successful recovery of recombinant viruses depended upon expression of the viral 
antigenomic RNAs.
The advantage of using antigenome transcripts to initiate encapsidation may be obvious. If 
naked genome sense transcripts were produced in the cytoplasm of cells that were also 
expressing mRNAs encoding viral proteins, the two could hybridise and prevent the critical 
assembly of the genome into an RNP structure. While starting with antigenomes templates, 
the mRNAs will not interfere in the encapsidation process. However, this has since been 
demonstrated not to be an absolute requirement for virus rescue (Table 1.3), as SeV and 
hPIV-3 viruses have both been rescued from genomic as well as antigenomic cDNA clones, 
albeit at a 10-100 fold lower level (SeV, Kato et al., 1996; hPIV-3, Durbin et al., 1997).
As can be seen from Table 1.3, vaccinia virus vTF7-3 was generally used in the earlier 
studies to drive the transient expression of viral proteins. One obstacle that was encountered 
in each of these studies was the requirement to separate the rescued virus from the vaccinia 
virus. This separation was accomplished either by a filtration step (Schnell et al., 1994; 
Lawson et al., 1995), by inhibiting vaccinia DNA replication with cytosine arabinoside 
(AraC) and rifampicin (Whelan et al., 1995; Kato et al., 1996; He et al., 1997), or by 
passage in cells that were nonpermissive for vaccinia virus e.g. hens eggs (Garcin et al., 
1995(b) and Kato etal., 1996) or mosquito cells (Bridgen and Elliott, 1996). An alternative
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N onsegm ented
V iruses Rescue genome Expression system Reference
Rabies virus (+) vTF7-3 Schnell et al., 1994
VSV (+) vTF7-3 Lawson et al., 1995
VSV (+) vTF7-3 Whelan etal., 1995
Measles virus (+) Cell line expressing T7 RNA pol, viral NP and P proteins Radecke etal., 1995
Sendai virus (+) VTF7-3 Garcin etal., 1995
RSV (+) MVA-T7 Collins et al., 1995
Sendai virus (+) + (-) vTF7-3 Kato et al., 1996
RPV (+) MVA-T7 Baron and Barrett, 1997
hPIV-3 (+) vTF7-3 Hoffman and Banerjee, 1997
hPIV-3 (+) + (-) MVA-T7 Durbin et al., 1997
SV5 (+) MVA-T7 He etal., 1997
RSV (+) MVA-T7 Jin et al., 1998
Segmented Virus
Bunyamwera virus 
influenza A virus 
influenza A virus
(+)
(-)
(-)
vTF7-3 
Pol I and Pol II 
Pol I and Pol II
Bridgen and Elliott, 1996 
Neumann et al., 1999 
Fodor etal., 1999
Table 1.3 The recovery of negative strand viruses from cDNA
The table lists in order the successful rescue of nonsegmented and segmented negative 
stranded RNA viruses entirely from cDNA. Polarity of the rescued RNA genome 
templates are indicated by (+) and (-) symbols. Recombinant vaccinia viruses expressing 
bacteriophage T7 RNA polymerase were, vTF7-3 (Fuerst et al., 1986) and MVA-T7 
(Wyatt etal., 1995).
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approach was to use a host-range restricted vaccinia virus (MVA-T7) that expresses T7 
polymerase by early gene transcription (Wyatt et al., 1995), and being deficient in late gene 
expression did not replicate in many mammalian cells (Collins et al., 1995; Baron and 
Barrett, 1997).
Finally, a vaccinia virus-independent system has been developed by generating a 293 cell 
line constiitutively expressing T7 RNA polymerase along with viral helper proteins (Radecke 
e ta l ., 1995).
1.8.4 The rescue of segmented virus genomes.
1.8.5 Bunyamwera virus, the first segmented negative strand virus to be 
rescued.
The first segmented negative strand virus to be rescued from cDNA was Bunyamwera virus 
and was reported by Bridgen and Elliott (1996). This result marked a considerable 
achievement as each of three individual genomic segments had to be rescued. In this study, a 
similar approach was taken to that used by Schnell et al. (1994), but in this case six different 
plasmids had to be delivered to a single cell: three of these plasmids expressed the virus 
genomic segments and the other three included for the transient expression all of the viral 
proteins. The rescued BUN viruses were separated from the high number of vaccinia virus 
particles by infecting mosquito cells (C6/36) with transfectant supernates. These cells are 
permissive for BUN replication but nonpermissive to vaccinia virus replication, and so this 
step served to enrich for rescued BUN virus. As might be predicted from such a complex 
system, rescue levels were low at 10 pfu from 107 cells.
1.8.6 Influenza A virus rescued entirely from cDNAs.
Neumann et al. (1999) recently described the efficient rescue of influenza A virus entirely 
from cDNA clones. This was soon followed, independently, by another group describing a 
similar plasmid based rescue system for influenza A virus (Fodor et al., 1999). Both groups 
describe a technique similar to that of Pleschka et al. (1996) who demonstrated the rescue of 
an artificial NA Pol-I transcript. In the Influenza virus A studies, both systems involved 
transfection of 293 cells with eight plasmids encoding the individual vRNA segments of 
influenza virus under the control of a truncated human RNA Pol-I promoter and mouse Pol-I 
transcription terminator. Cotransfection of four plasmids encoding the viral replication 
proteins under the control of an RNA Pol-II promoter (Figure 1.9) allowed vRNA
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Figure 1.9 The rescue of influenza A virus entirely from cDNAs
This schematic describes a helper vims free plasmid based reverse genetics rescue system 
for influenza A virus. All eight viral genome segments (vRNAs) are expressed within the 
cell nucleus from Pol-I expression plasmids. The replication, amplification and 
expression of recombinant vRNAs is achieved by cotransfection of four Pol-11 plasmids 
expressing the viral replication proteins (PA, PB1, PB2, and NP). Although recombinant 
influenza virus particles can be detected when only transfecting the Pol-II PA, PB1, PB2, 
and NP expression plasmids (Neumann et al. 1999; Fodor et al. 1999), expression of all 
remaining viral proteins (shown in brackets) increases the efficiency of virus rescue 100- 
fold (Neumann et al. 1999). Figure adapted from Neumann et al. (1999) and Fodor et al.
(1999).
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replication, amplification and subsequent RNP packaging and virion particle release. 
Neumann et al. (1999) described the efficient rescue of 103-107 pfu/ 106 cells (the highest 
reported level ofNSV rescue) while Fodor et al. (1999) repeatedly obtained 10-20 pfu/ 107 
cells. The marked differences in the rescue levels maybe due the protocol used by Neumann 
et al., which utilised the mouse Pol-I terminator to terminate vRNA transcription with the 
correct 3’ termini. Remarkably Neumann et a l, found that cotransfection of plasmids 
expressing all nine viraly encoded proteins {i.e. a 17 plasmid transfection) resulted in 
improved rescue levels of 100-fold. In contrast, Fodor et al., used the HDV ribozyme to 
achieve the correct 3’ termini and expressed only four of the viral proteins essential for 
replication.
In both influenza rescue systems vRNA templates were successful as opposed to the initial 
rescue attempts of NNS viruses and the rescue of BUN virus. It maybe that in the NNS and 
BUN virus rescue systems the (-) vRNA anneals to the vast amounts of (+) mRNA in the 
cytoplasm, and that this problem is overcome in the influenza system because it is host cell 
factors {i.e. RNA Pol-I and RNA Pol-II) that are responsible for the transcription of are 
vRNAs and recombinant mRNAs.
This plasmid based rescue system of influenza virus marks an important step which now 
allows investigation of all aspects of the influenza virus life cycle. It is expected that the 
system will permit the generation of transfectants with mutations in multiple gene segments 
or with severe growth defects (Neumann et a l, 1999).
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A im s o f  the project.
The general aim of this project was to develop a reverse genetics system to investigate the 
molecular biology of the Bunyamwera virus. At the onset of this study no other reverse 
genetic systems had been developed for any member of the Bunyaviridae, nor had a plasmid 
based reverse genetics system been developed for the influenza A virus. For this reason 
some aspects of the work presented here should be regarded within the context of both 
scientific and technical advances that had been achieved in the field at the time.
To study the molecular processes of Bunyamwera virus it was decided to develop a reporter 
system that would be characterised by, and would benefit from, several key features. The 
reporter assay would be plasmid based, with the virus-like reporter RNA originating from an 
in vitro transcription reaction and the virus replication proteins being supplied by transfected 
cDNA containing plasmids. Such a system would allow all components of the assay to be 
manipulated with ease, allowing the study of signals within the viral RNA as well as the 
proteins involved in the transcription and replication processes.
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Chapter 2.
2.0.0 Materials and Methods.
2.1.0 Materials.
2.1.1 Enzymes.
Most restriction enzymes, calf intestinal alkaline phosphatase (CIP) and Taq DNA 
polymerase were purchased from Boehringer Mannheim. The restriction enzymes Bbsl and 
Hgal, T4 DNA polymerase, T4 polynucleotide kinase and T4 RNA ligase were purchased 
from New England Biolabs. T7 RNA polymerase, SP6 RNA polymerase, RQ1 DNase, 
recombinant ribonuclease inhibitor RNasin®, M-MuLV and AMV reverse transcriptases were 
purchased from Promega. T7 DNA polymerase was purchased from Pharmacia. RNaseA 
and lysozyme were purchased from Sigma.
All enzymes reactions were performed in their appropriate reaction buffer, under the reaction 
conditions specified by the manufacture unless otherwise stated.
2.1.2 Radiochemicals.
With the exception of [14C] chloramphenicol, which was supplied by DuPont NEN®, all 
other radiochemicals (listed below), were supplied by Amersham.
[14C] chloramphenicol 
[35S] L-methionine 
[a-35S] dATP 
[<x-32P] UTP
(58.5 mCi/mmol, 0.1 piCi/pil) 
(>800 Ci/mmol)
(>1000 Ci/mmol)
(-3000 Ci/mmol)
2.1.3 Synthetic oligonucleotides.
The M13/pUC sequencing primer (-40) 17-mer and the M13/pUC reverse sequencing primer 
(-48) 24-mer were obtained from New England Biolabs. Other oligonucleotides used as 
primers in this study were synthesized on a Cruachem PS250 automated synthesizer.
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2.1.4 Expression vectors and plasmids.
The construction of T7 promoter-containing plasmids which express Bunyamwera virus 
proteins used in this study were described previously: pTF7-5BUNS, expressing N and 
NSs proteins (Jin and Elliott, 1991) and pTF7-5BUNL, expressing the L protein (Jin and 
Elliott, 1991).
Cloning vectors pUC118/119 and expression vectors pTZ18/19 were supplied by Prof. R. 
M. Elliott.
2.1.5 Bacterial strains.
The E. coli strain DH5a™ (f80d/tfcZAM15, recAl, endAl, gyrA96, thi- \ , hsdK ll (rK', 
mK+), supE44, relAl, deoK, A(lacZYA-argF)\J 169) was the main host for maintenance and 
propagation of recombinant plasmids.
For plasmids carrying the bla resistance gene, maintenance and growth media were 
supplemented with 100 pg/ml ampicillin.
2.1.6 Viruses.
Bunyamwera and Maguari bunyaviruses were obtained from Prof. R M. Elliott, and vTF7-3 
(Fuerst etal., 1986), a recombinant vaccinia virus that expresses T7 RNA polymerase, was 
originally supplied by Dr. B. Moss.
2.1.7 Eucaryotic cells and tissue culture growth media.
Generally, unless otherwise stated, all reagents used in tissue culture were supplied by 
Gibco BRL.
BHK-21 Clone 13, a baby hamster kidney cell line, was used for growing stocks of 
Bunyamwera and Maguari viruses. The cells were maintained in Glasgow modified Eagle’s 
medium supplemented with 10% new bom calf semm and 5 mM L-glutamine, 10% tryptose 
phosphate broth and 14 ml MOO ml of 7.5% sodium bicarbonate.
CV-1, an African Green monkey kidney cell line, was used to grow vTF7-3. The cells were 
maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% foetal
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calf serum. The two human cell lines, 293, and HeLa(T4) were grown in DMEM 
supplemented 10% foetal calf serum and 5 mM L-glutamine.
All cell media were supplemented with 100 units/ml penicillin and 100 units/ml 
streptomycin. Cells were grown at 37°C under 5% C 02 in a humidified incubator.
2.1.8 Reagents.
Acrylamide/bis-acrylamide 30% stock solution: 30% (w/v) acrylamide, 0.8% (w/v) 
bis-acrylamide, final ratio 37.5: 1.
Agarose gel loading buffer: 0.25% (w/v) bromophenol blue, 0.25% (w/v) xylene 
cyanol, 30% (v/v) glycerol.
AMV Reverse Transcriptase buffer (5x): 250 mM Tris-HCl (pH 8.3), 250 mM KC1, 
50 mM MgCl2, 50 mM DTT, 2.5 mM spermidine, (Promega).
B al 31 reaction buffer (lOx): 200 mM Tris-HCl (pH 8.1), 125 mM M gS04, 125 mM 
CaCl2, 6 M NaCl, 10 mM EDTA.
Carrier DNA: 10 mg/ml salmon sperm DNA in water, autoclaved, and stored at -20°C.
Denhart’s solution 50x: 1% polyvinylpyrrolidone, 1% (w/v) BSA (Fraction V), 1% 
(w/v) Ficoll® (type 400).
Gel fix: 50% (v/v) methanol, 10% (v/v) acetic acid, 40% (v/v) water.
Giemsa stain: 1.5% (w/v) Giemsa in glycerol, heated to 50°C for 2 hours and diluted with 
an equal volume of methanol.
Glyoxal gel loading buffer: 50% (v/v) glycerol, 10 mM Na-phosphate (pH 7.0), 
0.25% (w/v) bromophenol blue, 0.25% (w/v) xylene cyanol.
GSCN solution: 4.2M guanidinium thiocyanate, 0.5% (w/v) N-lauroyl sarcosine, 100 
mM, |3-mercaptoethanol, 0.33% (v/v) antifoam-A emulsion, 50 mM Tris-HCl (pH 7.5) and 
2 mM EDTA.
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L-broth: lOg NaCl, lOg Bactopeptone and 5g yeast extract per litre.
LB agar: L-broth plus 1.5% (w/v) agar.
Pfu PCR buffer (lOx): 200 mM Tris-HCl (pH 8.8), 20 mM M gS04, 100 mM KC1, 100 
mM (NH4)2S04, 1% Triton X-100, 1 mg/ml nuclease-free BSA.
Phenol: chloroform: isoamyl alcohol (25:24:1): 1 part TE-buffer saturated phenol 
mixed with 1 part chloroform: isoamyl alcohol (24:1).
Prehydridization/ Hybridization solution: 0.1% SDS, 50% Formamide, 5x SSC, 5x 
Denharts solution, 0.1% Sodium Pyrophosphate, 50 jag/ml carrier DNA.
Protein dissociation mix: 100 mM Tris-HCl (pH 6.8), 4% (w/v) SDS, 200 mM J3- 
mercaptoethanol, 20% (v/v) glycerol, 0.2% (w/v) bromophenol blue.
RNaseA solution: 10 mg/ml pancreatic RNaseA in 10 mM Tris-HCl (pH 7.5), 15 mM 
NaCl, heated at 100°C for 15 minutes to inactivate DNases, cooled and stored at -20°C.
SSC 20x: 3M NaCl, 3M trisodium citrate, adjust to pH 7.0 with 1M HC1.
SSPE 20x: 3M NaCl, 0.18M NaH2P 0 4, 20 mM EDTA, adjust to pH 7.4 with 1M HC1.
Sequencing gel mix: 6-12% (w/v) acrylamide / bisacrylamide (57:3), 8M urea, 1 x TBE.
Solution 1 (Soli): 50 mM glucose, 250 mM Tris-HCl (pH 8.0), 12 mM EDTA, 5 pg/ml 
Lysozyme.
Solution 2 (SoI2): 0.2N NaOH, 1% (w/v) SDS, freshly made.
Solution 3 (Sol3): 5M potassium acetate, adjust to pH 4.8 with 1M NaOH.
STET solution: 8% (w/v) sucrose, 50 mM Tris-HCl (pH 8.0), 50 mM EDTA (pH 8.0), 
5% (v/v) Triton® X-100, filter sterilized and stored at 4°C.
T4 DNA polymerase buffer (lOx): 500 mMNaCl, 100 mM Tris-HCl (pH 7.9), 100 
mM MgCl2, 10 mM DTT, (NEB).
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T4 polynucleotide kinase buffer (lOx): 700 mM Tris-HCl (pH 7.6), 100 mM MgCl2, 
50 mM DTT, (NEB).
T4 RNA Ligase NEBuffer (lOx): 500 mM Tris-HCl (pH 7.8), 100 mMMgCl2, 100 
mM DTT, and 10 mM ATP, (NEB).
T7 DNA polymerase enzyme dilution buffer: 20 mM Tris-HCl (pH 7.5), 5 mM 
DTT, 100 jig/ml BSA, 5% (v/v) glycerol, (Pharmacia).
T7 RNA polymerase optimised transcription buffer (5x): 200 mM Tris-HCl 
(pH7.5), 30 mM MgCl2, 10 mM spermidine, 50 mM NaCl, (Promega).
TAQ DNA polymerase buffer (lOx): 300 mM Tris-HCl (pH 9.0), 50 mM MgCl2, 300 
mM KC1, 0.5% (w/v) W-l® buffer.
TAE: 40 mM Tris-acetate (pH 8.0), 1 mM EDTA.
TBE: 90 mM Tris-HCl (pH 8.0), 90 mM boric acid, 1 mM EDTA (pH 8.0).
TE: 10 mM Tris-HCl (pH 8.0), 1 mM EDTA (pH 8.0).
TEN: 150 mM NaCl, 40 mM Tris-HCl (pH 7.5), 1 mM EDTA (pH 8.0).
Trypsin solution: 0.25% (w/v) Difco trypsin dissolved in Tris-saline solution plus 
0.005% (w/v) phenol red.
Versene solution: PBS supplemented with 0.6 mM EDTA and 0.0015% (w/v) phenol 
red.
2YT broth: 5g NaCl, 16g Bactopeptone and lOg yeast extract per litre.
2.1.10 Chemicals.
Unless specifically stated, all chemicals and reagents were obtained from BDH Chemicals 
Ltd or Sigma Chemicals Co. Ammonium persulfate was obtained from Bio-Rad. En3Hance 
was obtained from DuPont. Temed was obtained from Bio-Rad.
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2.1.11 Equipment and miscellaneous materials.
PerkinElmer Cetus DNA Thermal cycler 480 (Perkin-Elmer Corporation, Foster City, CA, 
USA), Blotting pads (11-14 cm) (BRL Life Technologies), GeneClean® II purification kit 
(Bio 101 Inc., La Jolla, CA, USA), X-Omat S film (Kodak Ltd), Tissue culture materials 
(Nunc), Hybond N+ nylon blotting membrane (Amersham), Light Mineral oil (Sigma), 
OptiMEM media (Gibco BRL), Nescofilm (Nipon, Bando Chemical Ind, Ltd), SDS-PAGE 
standards, low range (14.5-97.4 Kda) (BIO-RAD Laboratories Ltd), Spin-X® centifuge tube 
filter (Costar®), Polygram® SIL G (0.25 mm) TLC plates (Camlab), Sterile Acrodisc®, 
0.2pm (Gelman Sciences).
2.2.0 Methods.
2.2.1 Virus growth and propigation.
2.2.2 Harvesting cell lines.
Cell monolayers were harvested by first washing the cell monolayer once with versene 
solution, then with a 5:1 mix of versene and trypsin solutions. Cells were then incubated at 
37°C for 5 minutes before resuspension in 5 ml of media. Cells were routinely split 1:6 into 
flasks (Nunc, 80cm2 or 175cm2) or seeded at 4 xlO5 cell/ml of media in 35mm dishes and 
incubated at 37°C.
2.2.3 Growth and purification of recombinant vaccinia virus vTF7-3.
A confluent 175cm2 flask of CV-1 cells was inoculated with vTF7-3 stock virus at 0.05 pfu/ 
cell, in 10 ml DMEM-5% FCS and incubated at 37°C for 1 hour with gentle agitation every 
15 minutes. The medium was replaced with 30 ml DMEM-5% FCS and returned to 37°C for 
approximately 2 days or until cytopathic effects were visible. The infected cells were 
resuspended in their culture medium and centrifuged at 3,000 rpm before resuspension in 6 
ml 10 mM Tris-HCl pH 9.0 at 4°C. The cell associated virus was released by 3 cycles of 
freeze-thawing (5 minutes in dry ice, 5 minutes at 37°C) before the nuclei and cellular debris 
were pelleted by centrifuging at 1,000 rpm for 5 minutes at 4°C, and then the supernatant 
was removed to a sterile tube. The cellular debris pellet was resuspended in 6 ml 10 mM 
Tris-HCl pH 9.0, recentrifuged and the two supernatants combined. Six milliliters aliquots 
were then layered onto 6 ml 36% (w/v) sucrose in 10 mM Tris-HCl pH 9.0 on ice and
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centrifuged at 13,000 rpm in an TST41 rotor for 80 minutes at 4°C. The supernatant was 
discarded and the pellets resuspended in 1 ml 10 mM Tris-HCl pH 9.0, aliquotted and stored 
at -70°C.
2.2.4 Titration of vTF7-3 stock virus.
Thirty-five millimeter petri dishes containing 5 x 105 CV-1 cells were infected with ten-fold 
serial dilutions of vTF7-3 stock virus. Dilutions were carried out in a total volume of 1 ml 
PBS and duplicate 0.1 ml aliquots (for each dilution from 10'5 to 10'9) were used for 
titration. The cells were incubated at 37°C for 60 minutes with gentle agitation every 15 
minutes to allow the virus to adsorb. The inoculum was removed, 2 ml DMEM-5% FCS 
added and the cells incubated at 37°C for 2 days. Then the medium was removed and the 
cells gently covered with CIDEX (a commercial glutaraldehyde preparation, diluted 1:1 with 
PBS) for 3-4 hours to fix the cells. The CIDEX was removed and the cells stained with 
Giemsa for 10 minutes before washing with tap water. Virus plaques were clearly visible as 
clear regions within purple-stained cells.
2.2.5 Growth and purification of Bunyamwera virus.
Confluent 175cm2 flasks of BHK-21 cells were infected with Bunyamwera virus at a 
multiplicity of 0.01 pfu/ cell, in 10 ml GMEM-5% FCS and incubated at 37°C for 1 hour 
with agitation every 15 minutes. The medium was replaced with 30 ml GMEM-5% FCS and 
returned to 37°C for approximately 3 days until cytopathic effects were visible. The culture 
medium was harvested and clarified by centrifugation at 3,000 g for 15 minutes (Sorval GS3 
rotor). The clarified fluid was aliquotted and stored at -70°C, and used as virus stock without 
further purification.
2.2.6 Titration of Bunyamwera stock virus.
Virus was titrated by plaque assay (Iroegbu and Pringle, 1981). Ten-fold serial dilutions of 
virus stocks were made in a final volume of 1 ml PBS/2% NBC serum. The growth medium 
was removed from confluent BHK cell monolayers in 35mm dishes and 0.1 ml of diluted 
virus (for each dilution from 10'4 to 10'7 in duplicate) was added to each dish. The dishes 
were incubated at 31°C or 37°C for 1 hour to allow the virus to adsorb to the cells. The 
inoculum was removed and the cells overlaid with Eagle's medium supplemented with 2% 
NBC serum containing 0.6% agarose. The dishes were incubated at 31°C for 3-5 days. 
Then to each dish, 2 ml of CIDEX was added (see 2.2.3) for 3-4 hours to fix the cells. The
49
Materials and Methods: Chapter 2
CIDEX and agarose overlay was removed and the cells stained with Giemsa for 10 minutes 
before washing with tap water. Virus plaques were clearly visible as clear regions within 
purple-stained cells.
2.2.7 Bacterial glycerol stocks.
Duplicate glycerol stocks were made by mixing 800 pi of a fresh overnight culture with 200 
pi 80% (w/v) glycerol in two sterile vials, which were then stored at -20°C and -70°C.
2.2.8 Preparation of competent bacterial cells.
Ten milliliters of 2YT broth were inoculated with a single bacterial colony and incubated 
overnight at 37°C with shaking. One milliliter of the overnight culture was inoculated into 
100 ml of 2YT broth in a 250 ml flask and shaken at 37°C until the cells reached an A550 of 
0.4 (typically 2 hours). The cells were pelleted at 3,300 rpm for 5 minutes and then gently 
resuspended in 20 ml ice-cold 0.1M CaCl2, and placed on ice for 30 minutes. Following this 
the bacteria were repelleted and resuspended in 5 ml of ice cold 0.1M CaCl2 and stored at 
4°C.
2.3.0 DNA manipulation and cloning procedures.
2.3.1 Plasmid DNA minipreparation via the boil lysis method.
A 20 ml glass universal containing 3 ml of YT broth (supplemented with 100 pg/ml 
ampicillin) was inoculated with a single bacterial colony, and incubated at 37°C with 
vigorous shaking for 12-16 hours. A 1.5 ml volume of the overnight culture was transferred 
to an 1.5 ml eppendorf tube and centrifuged at 13,000 rpm for 20 seconds. The medium was 
removed by aspiration leaving a bacterial pellet which was then vortexed for 5 seconds to 
break up the pellet before the bacteria were resuspended in 450 pi of STET lysis solution 
containing 200 pg lysozyme. The resuspended pellet was then placed on ice for 10 minutes 
before transferring to a boiling waterbath for 40 seconds and then centrifuged at 13,000 rpm 
for 20 minutes. The pelleted lysed bacterial debris were then picked out from the tube with a 
sterile toothpick before mixing the supernatant with 400 pi of isopropanol and freezing at - 
20°C for 30 minutes. The tube was then centrifuged at 13,000 rpm for 10 minutes, the 
supernatant removed by aspiration and the DNA/RNA pellet dried under vacuum for 10 
minutes before the pellet was resuspended in 80 pi of dw and stored at -20°C.
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2.3.2 Large scale plasmid DNA preparation.
A single bacterial colony picked from an agar plate was inoculated into 5 ml of LB broth, 
containing 100 pg/ml ampicillin, and incubated overnight at 37°C in a shaking incubator. 
The 5 ml overnight culture was used to inoculate 300 ml of LB-broth (containing 100 pg/ml 
ampicillin) in a 21 flask and shaken overnight at 37°C. Following centrifugation of the culture 
at 3,000 rpm (Sorval GS3 rotor) for 10 minutes at 4°C, the bacterial pellet was resuspended 
in 20 ml TE buffer and then repelleted again in the SS34 rotor at 3,000 rpm for 10 minutes at 
4°C. This pellet was resuspended in 8 ml of Soli and incubated for 5 minutes at room 
temperature before the cells were lysed by the addition of 16 ml Sol2 and mixed by inverting 
the tube 10 times. The mixture was incubated for 10 minutes at room temperature followed 
by the addition of 12 ml of ice-cold Sol3 and a further 10 minute incubation on ice. 
Following centrifugation at 6,000 rpm (Sorval SS34 rotor) for 15 minutes at 4°C, the 
supernatant was transferred to Corex tubes and the plasmid DNA precipitated by the addition 
of 0.6 volumes of isopropanol for 15 minutes at room temperature followed by 
centrifugation at 10,000 rpm for 15 minutes at 15°C. The DNA pellet was washed with 70% 
ethanol, air-dried and resuspended in 10 ml TE buffer. Ten grams of cesium chloride (CsCl) 
and 1 ml of a 10 mg/ml ethidium bromide (EtBr) solution were added to the DNA solution 
giving a final density of 1.55 to 1.60 g/ml. The solution was then transferred to a heat- 
sealable centrifuge tube and centrifuged at 40,000 rpm (Beckman T1270 or Ti-50 rotor) for 
48 hours at 19°C. Supercoiled plasmid DNA appeared as a red band (due to the intercalated 
ethidium bromide) and was removed from the gradient using a syringe fitted with a wide- 
bore needle (18-G) through the side of the tube. EtBr was removed from the plasmid DNA 
solution by at least five extractions with an equal volume of isopropanol (equilibrated with 
5M NaCl). The CsCl was then removed by dialyzing the solution twice against 41 of 0.5% 
TBE buffer at 4°C after which the DNA was precipitated by the addition of one tenth of a 
volume 3M NaOAc and 3 volumes EtOH and stored at -20°C for 2-24 hours. The DNA was 
then pelleted, dried under vacuum, resuspended in a suitable volume of dw and stored at - 
20°C. The concentration of plasmid DNA was determined by measuring the absorbance at 
260 nm (A260) in a spectrophotometer, assuming that 1 A260= 50 pg/ml in water for dsDNA.
2.3.3 Restriction enzyme digestion of DNA.
For the analysis of plasmid DNA from minipreparations, restriction enzyme digests were set 
up in 10 pi volumes containing 2 pi miniprep DNA, 1 pi specific reaction buffer, 2 units 
restriction enzyme, 0.2 pi RNaseA (10 pg/ml) and made up to volume with dw and 
incubated at the appropriate temperature, depending on the enzyme for 2 hours. After
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incubation, 0.1 volume of loading dye was added and the DNA fragments were separated by 
electrophoresis on a non-denaturing 1% agarose TBE gel.
For the preparation of a vector backbone or DNA fragments for cloning and subcloning, 5- 
20 pg DNA were digested in 50-100 pi reaction volume in the presence of a specific 
restriction enzyme buffer, 2 units restriction enzyme/pg DNA and incubated for 2-4 hours 
before electrophoresis in a 1-1.2% agarose TAE gel.
2.3.4 Dephosphorylation of linearised plasmid DNA.
The terminal 5' phosphates of digested vector were removed by treatment with calf intestinal 
alkaline phosphatase (CEP). The reaction was as follows, DNA (typically 3-5 pg) was 
diluted to 43 pi with dw and mixed with 5 pi lOx CIP buffer, 2 pi CEP (1 U/pl) and then 
incubated at 37°C for 30-60 minutes. The dephosphorylated vector was then purified by the 
GeneClean® protocol (2.3.7), and recovered in a final volume of 30 pi.
2.3.5 Agarose gel electrophoresis of DNA.
Electrophoresis of DNA was performed in horizontal slab gels, either 14 x 11 x 0.5 cm 
(BRL gel electrophoresis apparatus Model EE5), or 5.7 x 8.3 x 0.3 cm (BRL gel 
electrophoresis EEorizon 58), containing 1-1.2% (w/v) agarose in lx TBE or lx TAE 
containing 0.5 pg/ml ethidium bromide. DNA samples were mixed with a tenth volume 
loading dye before loading an appropriate volume into the gel. Electrophoresis was carried 
out at 50-100 V in lx TBE or lx TAE containing 0.5 pg/ml ethidium bromide.
2.3.6 Transformation of competent bacterial cells.
Two hundred microlitres of competent bacterial cells were incubated with half of a ligation 
reaction (10 pi) for 60 minutes on ice, followed by a heat shock at 42°C for 2 minutes to 
allow uptake of the ligated DNA by the E. coli cells. The reaction tube was returned to the ice 
bath to cool before 0.5 ml of 2YT broth was added and the cells incubated for a further 60 
minutes at 37°C. The cells were then plated onto LB agar plates, containing 100 pg/ml 
ampicillin, and incubated for 16 hours at 37°C to allow single colonies to form. For vectors 
containing the lacZ gene, 45 pi of X-Gal (40 pg/ml) was added to the cells before plating out 
to allow blue/white colour selection of recombinants.
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2.3.7 DNA purification from agarose gels by silica matrix adsorption.
DNA fragments produced by restriction enzyme digestion or by PCR were first resolved by 
electrophoresis through a 1-1.2% agarose TAE gel containing 0.5 pg/ml ethidium bromide. 
DNA fragments were visualised by long-wave UV illumination, and a gel slice was removed 
and mixed with 3 volumes of Nal solution (GeneClean® kit) and incubated at 55°C until the 
agarose slice has completely dissolved (10-15 minutes). Glassmilk® (GeneClean® kit), a 
silica matrix solution, was added (5 pi for up to 5 pg of DNA) and the mixture incubated for 
10-20 minutes at room temperature and vortexed intermittently to allow the DNA to bind to 
the matrix. Following a 5 seconds spin at 13,000 rpm, the supernatant was removed and the 
pellet (containing DNA bound to silica particles) washed 3 times by repeated 
resuspension/centrifugation cycles using NEW Wash™ solution (a Tris-buffered mixture of 
NaCl, ethanol and water). The DNA was eluted from the silica matrix by resuspending the 
pellet in 20-80 pi water, incubating for 3 minutes at 55°C and pelleting the glass milk at
13,000 rpm for 2 minutes before removing the DNA solution and storing at -20°C.
The GeneClean® protocol was also used to purify DNA from enzyme reactions and 
oligonucleotides when electrophoresis was not required.
2.3.8 End repair of DNA fragments.
Linearised vectors and DNA fragments were blunt-ended by resuspending the DNA in T4 
DNA polymerase lx buffer (NEB) containing 150 pM of each dNTP, 0.1 mg/ml BSA and 5 
units T4 DNA polymerase (NEB)/pg of DNA in a final volume of 50 pi. The reaction was 
incubated at 37°C for 20 minutes before purifying the repaired DNA by the GeneClean® 
protocol (2.3.7).
For the end repair of PCR fragments, the DNA was resuspended in 100 pi of lx T4 
polynucleotide kinase buffer (NEB) which contained 150 pM of each dNTP, 0.1 mg/ml 
BSA, 2 mM ATP, 5 units T4 DNA polymerase (NEB)/pg DNA and 10 units T4 
polynucleotide kinase (NEB). The reaction was incubated at 37°C for 30 minutes then the 
repaired DNA was purified by the GeneClean® protocol (2.3.7).
2.3.9 DNA ligation.
Ligation reactions were set up at two ratios (1:1 and 1:5) of linerised vector DNA (100 ng/pl) 
to insert DNA (50 ng/pl) in a 20 pi reaction volume (DNA, 5 pi 5x Ligation buffer (Gibco- 
BRL), 1 unit T4 DNA Ligase (Gibco-BRL) made up to volume with dw) and incubated at 
16°C overnight, then stored at -20°C.
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2.3.10 Purification of synthetic oligonucleotides.
Synthetic oligonucleotides were removed from the column by pushing 1.5 ml ammonia 
through the column between two 2 ml syringes slowly over 1 hour. The solution was heat 
treated for 5-16 hours at 55°C to remove the base protecting groups and then the ammonia 
was removed by lyophylisation. The dried oligonucleotide pellet was dissolved in 200 pi of 
dw, mixed with 100 pi 95% formamide and electrophoresed on an 12% polyacrylamide gel 
containing 8M urea. The gel was then viewed under short wave UV light and oligonucleotide 
bands were visualized as dark shadows against an intensifying screen. Gel slices containing 
each full length oligonucleotide species were excised with a scalpel blade and the 
oligonucleotide was eluted in 1.5 ml of water at 42°C overnight with shaking. Supernatants 
were transferred to a Spin®-X centrifuge tube (Costar®) containing a 0.45 pm cellulose 
acetate filter and centrifuged for 2 minutes to remove the acrylamide gel pieces. The 
oligonucleotide in the filtrate was precipitated with 3 volumes of ethanol in the presence of 
0.2M NaCl overnight at -20°C. The oligonucleotide precipitate was pelleted, washed with 
70% ethanol, dried under vacuum and dissolved in 200 pi dw. Spectrophotometry was used 
to determine the concentration of the oligonucleotide in solution, assuming that 1 A2 6 O = 20 
pg/ml for ssDNA.
2.3.11 Polymerase chain reaction (PCR) amplification of DNA.
All PCR reactions were set up using the lOx PCR buffer and 50 mM MgCl2 stock solution 
supplied by the manufacturer of the Taq DNA polymerase used in the reactions.
Each reaction consisted of the following components which were added and mixed in the 
following order, on ice, in a thin-walled 0.5 ml reaction tube. (When working with multiple 
samples, a master mix containing all but the DNA template and primers was assembled.)
Nuclease free dH20
(to a final volume of 50 pi) xpl
lOx PCR buffer (Gibco-BRL) 5 pi
4dNTPs (10 mM) 1 pi
50 mM MgCl2 (Gibco-BRL) 2 pi
Taq DNA polymerase (5 U/pl) (Gibco-BRL) 1U
downstream primer 50 ng
upstream primer 50 ng
template DNA (10-50 ng/pl) 1 pi
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The reaction was overlaid with 1-2 drops nuclease-free light mineral oil (Sigma) (to overlay 
the top of the reaction mixture), centrifuged briefly, then placed in the heating block of the 
Perkin Elmer Cetus DNA Thermal cycler 480. The thermal cycling profile was 93°C for 30 
sec, 56°C for 20 sec, 72°C for 80 sec (80 sec/kb) and cycled 25-30 times unless otherwise 
stated. PCR reactions were run on a 1% TAE agarose gel and fragments of interest were 
purified as in protocol (2.3.7).
PCR was also carried out using the proofreading DNA polymerase Pfu . Reactions were set 
up using the lOx Pfii PCR buffer supplied with the enzyme (Stratagene) as illustrated below.
Nuclease free dT^O
(to a final volume of 50 pi) xp
lOx Pfu PCR buffer 5 pi
4 dNTPs (10 mM) 1 pi
upstream primer 100-250 ng
downstream primer 100-250 ng
Pfu DNA polymerase (5 U/pl) 1 pi
Template DNA (~ 100 ng/pl) 1 pi
The actual reaction was carried out in the same manner as for Taq PCR reactions but with a 
strand separation temperature of 94°C and a strand elongation temperature of 73°C (4 
minutes/Kb).
PCR reactions were electrophoresed through a 1% TAE gel (2.3.5) and purified using a 
silica matrix as in protocol (2.3.7).
2.3.12 PCR driven site-directed mutagenesis.
The QuikChange™ site-directed mutagenesis kit from Stratagene was utilised for PCR 
driven site-directed mutagenesis. All reactions were set up following the manufacturers 
protocol and with the supplied reagents (lOx Pfu reaction buffer, dNTP mix and Pfu DNA 
polymerase) as indicated below.
lOx Pfu reaction buffer 5 pi
dNTP mix 1 pi
dsDNA template (50 ng/pl) 1 pi
primer 1 (125 ng) 1 pi
primer 2 (125 ng) 1 pi
ddH20 41 pi
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Then add
Pfu DNA polymerase (2.5 U/pl) 1 pi
After the addition Pfu DNA polymerase, the reaction was overlaid with 30 pi nuclease-free 
light mineral oil (Sigma) centrifuged briefly, then placed in the heating block of the Perkin 
Elmer Cetus DNA Thermal cycler 480. The thermal cycling profile was 95°C 30 sec for one 
cycle followed by 12 cycles of 95°C 30 sec, 55°C 30 sec, and 68°C 16 minutes. After 
temperature cycling, the reaction was cooled on ice for 2 minutes before 1 pi of restriction 
enzyme Dpn I (10 U/pl) was added below the mineral oil layer with a fine pipette tip. The 
reaction was then incubated at 37°C for 1 hour to digest the parental DNA. After which, 1 pi 
of the Dpn I-treated DNA was mixed with 50 pi Epicurian Coli XL 1-Blue supercompetent 
cells and the transformation reaction incubated on ice for 30 minutes and then heat-shocked 
at 42°C for 45 seconds before cooling on ice for a further 2 minutes. 0.5 ml of NZY+ broth 
(see materials) preheated to 42°C was added to the transformation reaction and incubated at 
37°C for 1 hour before plating the entire transformation reaction onto an agar (amp) plate. 
The agar plate was then incubated at 37oC for approximately 16 hours.
2.3.13 Double stranded DNA Sequencing.
Sequencing of dsDNA by dideoxynucleotide chain termination (Sanger et al., 1977) was 
performed in accordance with the methods used by Tabor and Richardson (1987) utilising a 
modified T7 DNA polymerase (Pharmacia LKB) which lacks a 3’ to 5’ exonuclease. The 
method was as follows:-
Preparation of single strand template- In an 1.5 ml eppendorf tube, 10 pi of plasmid 
miniprep DNA (approx. 2-5 pg) were denatured by the addition of 2.5 pi 2M NaOH and 
incubated at 42°C for 10 minutes. The reaction was then neutralized and the ssDNA 
precipitated by adding 3.75 pi of 3M NaOAc (pH 4.5), 9 pi H20  and 65 pi absolute ethanol. 
The tube was then placed in dry ice for 15 minutes or at -20°C for 1 hour, centrifuged at
13,000 rpm for 10 minutes, the supernatant removed and the DNA pellet dried under 
vacuum for 15 minutes. The pellet was then resuspended in 10 pi water.
Annealing Reaction- To 10 pi denatured template were added 2 pi primer (5 ng/pl, -0.8 
pM), 2 pi of annealing buffer (280 mM Tris-HCl (pH 7.5) and 100 mM MgCl2, 350 mM 
NaCl2), and this was incubated at 42°C for 10 minutes, then at 4°C for a further 10 minutes, 
or frozen at -20°C.
Labeling Reaction- To the annealing reaction (14 pi) 6 pi of labeling mixture were added 
(2 pi of 3dNTPs (2 pM each dGTP, dTTP and dCTP), followed by 1 pi of 0.3M 
dithiothreitol (DTT), 0.5 pi a-35S-dATP, 2 units T7 DNA polymerase (Pharmacia) diluted in
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enzyme dilution buffer (Pharmacia) to give a final volume of 6 |nl) mixed and incubated at 
room temperature for 5 minutes.
Extension-Termination Reaction- Four separate dideoxy “termination” mixtures were 
prepared, each containing 150 pM 4dNTPs and 15 pM ddNTP where the ddNTP is ddGTP 
(G), ddATP (A), ddTTP (T) or ddCTP (C) in 40 mM Tris-HCl, 10 mM MgCl2, 50 mM 
NaCl. While the labeling reaction was incubating at room temperature the termination 
reactions were set up in a 96 well roundbottom micro-well plate by pipetting 2.5 pi of each 
termination mixture into individual wells, in the order G, A, T, C to which 4.5 pi of the 
incubated labeling reaction was aliquoted into each. The reactions were mixed by 
centrifuging the plate at 1000 rpm for 10 seconds, incubated at 37°C for 5 minutes, after 
which the reactions were stopped by the addition of 5 pi of stop mix (95% formamide, 20 
mM EDTA (pH7.5), 0.05% (w/v) bromophenol blue, 0.05% (w/v) xylene cyanol). The 
reactions were incubated at 85°C for 2 minutes prior to loading (3 pi) onto a 6% sequencing 
gel (assembled and poured as described in the manufacturer’s manual) in the order G, A, T, 
C. The samples were run at a constant power of 60 watts for 2-4 hours, the gel was 
transferred from the glass plates, onto 3MM paper and dried under vacuum for 2 hours. The 
dried sequencing gel was then exposed directly against a sheet of X-Omat S film for 16-24 
hours at room temperature.
2.3.14 Nuclease Bal 31 digestion of linearised DNA.
Approximately 10 pg of linearised DNA was digested with Bal 31 nuclease (0.1 units/pg) in 
lx Bal 31 buffer in a final volume of 100 pi, at 30°C. At various time points 20 pi aliquots 
were removed and the nuclease reaction stopped by the addition of EGTA to give a final 
concentration of 20 mM. Reactions were then run on a 1% TAE gel, and the DNA bands 
excised and purified by GeneClean (2.3.4), prior to DNA end repair with T4 DNA 
polymerase (2.3.8).
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2.4.0 RNA manipulations.
2.4.1 T7 RNA polymerase in vitro transcription reaction.
Transcription reactions were set up in the following in order at room temperature.
Nuclease free water
(to a final volume of 100 pi) 47.5 pi
5x Transcription buffer 20.0 pi
DTT, 100 mM 10.0 pi
10 mM rNTP mix 5.0 pi
RNasin®, 40 U/pl 2.5 pi
T7 RNA Polymerase (20 U/pl) 5.0 pi
linearised DNA template, 100 ng/pl 10.0 pi
The reaction mixture was incubated at 37°C for 2 hours after which 4 pi were removed and 
run on a 1% agarose TBE gel to check RNA quality. To the remainder of the reaction 4 pi of 
RQ1 DNase lU/pl (Promega) were added and this was then incubated at 37°C for 15 
minutes. The transcribed RNA was either utilised immediately or stored in liquid nitrogen.
2.4.2 Measuring radioactivity in RNA transcripts by acid precipitation.
When studying the pBUNSCAT single point mutants it was essential that equivalent 
amounts of RNA transcripts were transfected. To achieve this a trace amount of 32P-UTP 
(0.2 pi) was added to the transcription mix (2.4.1). Each template has approximately the 
same efficiency incorporating 32P-UTP and allowed comparable quantification of each RNA 
transcript by acid precipitation.
An aliquot (typically 4 pi) of the reaction mixture was mixed with 50 pi salmon sperm DNA 
(10 mg/ml) in a 1.5 ml eppendorf tube, 500 pi ice-cold 10% TCA solution were added, and 
the tube placed on ice for 10 minutes. The contents were mixed and the precipitate collected 
by filtering through a Whatman GF/C glass-fiber disc (2.4 mm diameter). The filter was 
washed 5 times with 4 ml ice-cold 10% TCA solution then once with 5 ml ethanol. It was 
then allowed to dry briefly before being transferred to a scintillation vial containing 5 ml of a 
toluene-based scintillation fluid. Radioactivity was measured in a scintillation counter set to 
count 32P for 30 seconds.
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2.4.3 Extraction of total cellular RNA.
RNA was extracted from cell monolayers by the method described by Chomczynski and 
Sacchi (1987). Cell monolayers in 35mm dishes were washed with PBS and lysed in 500 pi 
GSCN solution. The lysate was transferred to a 1.5 ml microfuge tube and 50 pi of 2M 
NaOAc pH 4.0, 500 pi of water-saturated phenol, and 100 pi chloroform/isoamylalcohol 
(49:1) were added. After vortexing for 10 seconds the tubes were incubated on ice for 15 
minutes before centrifuging for 10 minutes at 13,000 rpm in a microcentrifuge. The aqueous 
phase was mixed with an equal volume of isopropanol and the RNA precipitated at -20°C for 
1 hour followed by centrifugation for 10 minutes at room temperature. The RNA pellet was 
resuspended in 300 pi of GSCN solution, mixed with 300 pi isopropanol and reprecipitated. 
After centrifugation for 10 minutes, the pellet was dissolved in 200 pi of water by heating 
for 5 minutes at 60°C and extracted with an equal volume of a 4:1 mixture of chloroform: 
butanol. The RNA was precipitated with 3 volumes of ethanol in the presence of 0.3M 
NaOAc and pelleted by centrifugation for 10 minutes at 13,000 rpm in a microcentrifuge. 
The RNA pellet was washed once with 70% ethanol, partly vacuum dried and dissolved in 
water before use or storage at -70°C.
2.4.4 Purification of RNA transcripts by spin columns.
The RNeasy Mini spin column kit protocol for RNA clean up was essentially as described in 
the RNeasy Mini hand book (QIAGEN). Three hundred and fifty microlitres of RLT™ 
buffer (supplied in the kit) were added to the transcription reaction after DNase 1 treatment 
(methods 2.4.1) and mixed thoroughly. A further 250 pi of ethanol (100%) were added to 
the reaction mixture and vortexed before applying the sample, now 700 pi, to an RNeasy 
mini spin column and centrifuging at 10,000 rpm for 15 seconds. The RNeasy column was 
then transferred to a new 2 ml collection tube (supplied in the kit) and then washed three 
times by the addition of 500 pi RPE buffer (supplied in kit) to the column and centrifuged 
for 15 seconds at 10,000 rpm. After each wash, the flow-through was discarded before the 
next wash. After the final wash the RNeasy column was transferred to a new 1.5 ml 
collection tube and centrifuged at 13,000 rpm to remove any residual ethanol from the wash. 
The RNeasy column was then transferred to a new 1.5 ml collection tube (supplied by kit) 
and 100 pi of RNase free-water (supplied by kit) pipetted directly onto the RNeasy 
membrane and centrifuged at 10,000 rpm to elute the RNA transcripts. The eluted RNA 
transcripts were either utilised immediately or aliquoted and stored at -70°C.
The concentration of the RNA transcripts were determined by measuring the absorbance at 
260nm (A260) in a spectrophotometer, given that an absorbance of 1 unit at A260 corresponds 
to 40 pg of RNA/ ml in water (A ^  = 1 = 40 pg/ml).
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2.4.5 Northern blot hybridization of RNA denatured by glyoxal/DMSO  
treatment.
RNA was denatured by treating the RNA samples with glyoxal and DMSO prior to running 
in a phosphate buffer/ agarose gel. The RNA was denatured by mixing 11 pi of RNA 
solution with 4.5 pi 100 mM sodium phosphate (pH 7.0), 22.5 pi DMSO and 6.6 pi 6M de­
ionized glyoxal and incubating for 1 hour at 50°C. The sample was then cooled on ice and 12 
pi glyoxal loading buffer were added. Electrophoresis of the denatured RNA samples was 
carried out on a 1% agarose gel buffered with 10 mM sodium phosphate (pH 7.0) and run at 
4 V/cm with constant recirculation of buffer so to maintain a pH below pH8.0. Once the 
bromophenol blue dye had migrated two thirds of the length of the gel electrophoresis was 
halted and the gel blotted (Northern transfer) onto a nylon membrane (Hybond-N+, 
Amersham). The gel immersed for 30 minutes in a tray containing 20x SSC. Meanwhile all 
components of the blotting apparatus were also presoaked in 20x SSC. Two pieces of 
Whatman® 3MM paper were layered over a platform in a tray containing a reservoir of 20x 
SSC so that the paper was over the edge of the platform into the 20x SSC buffer to act as a 
wick. A presoaked blotting pad (the same size as the gel, BRL) w^ as placed on top of the 
3MM paper followed by the gel which was placed face down on top of the pad. A sheet of 
presoaked nylon membrane cut to the same size as the gel was then placed on top of the gel 
followed by another presoaked blotting pad. At all stages any air bubbles were removed by 
gently rolling a 10 ml pipette over the surface. A further ten blotting pads (dry) were placed 
on top followed by a glass plate and a weight (0.5kg). The setup is left overnight at room 
temperature to allow transfer to proceed.
Once transfer was complete the apparatus was dismantled carefully and the nylon membrane 
rinsed gently in 5x SSC for 5 minutes and allowed to air dry RNA side up. The RNA was 
immobilised to the nylon membrane (RNA side up) by UV crosslinking in a Stratalinker® 
UV Crosslinker set to irradiate at 120mJoules. The membrane was stored between two 
sheets of 3MM Whatman® paper prior to hybridization.
The components of the riboprode reaction mix were set up at room temperature as follows:-
Transcription 5x buffer 4.0 pi
DTT 100 mM 2.0 pi
Rnasin®(40 U/pl) 0.5 pi
ATP, CTP and GTP (2.5 mM each) 4.0 pi
100 pMUTP 2.5 pi
linearised DNA template (200 ng/pl) 1.0 pi
T7 RNA Polymerase (20 U/pl) 1.0 pi
[a-32P] UTP (-1000 Ci/mmol) 5.0 pi
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The reaction mixture was incubated at 37°C for 60 minutes then 80 pi dw, 50 pi 7.5M 
ammonium acetate and 250 pi of 100% ethanol were added and the mixture placed in dry-ice 
for 30 minutes. Centrifugation was carried out at 13,000 rpm for 5 minutes, the supemate 
was removed and RNA pellet dried under vacuum. The pellet was resuspended in 100 pi 
nuclease free dw and frozen at -70°C until required.
To allow hybridisation of the probe to the membrane, the membrane was first immersed 
briefly in 6xSSC, then placed (RNA side in) into a hybridization tube containing 15 ml 
prehybridisation solution and incubated for 3 hours at 42°C. The prehybridisation solution 
was removed, and 15 ml hybridisation solution (preheated to 60°C) were added, followed by 
the addition of 50 pi riboprobe. The incubation was continued at 60°C overnight.
The following day, hybridization solution was removed and the membrane washed with 30 
ml 2xSSC/0.1% SDS for 2x 10 minutes. A low-stringency (0.2xSSC, 0.1%SDS) wash was 
then carried out, and the incubation continued for 15 minutes at room temperature, the wash 
then changed and repeated. The blot was removed from the tube, rinsed once in 2xSSC and 
allowed to air dry for 5 minutes before being wrapped in cling film and exposed against X- 
Omat S film at -70°C for 2-24 hours. If there was a high background the blot was washed 
two more times with high-stringency wash solution at 68°C for 15 minutes.
2.4.6 T4 RNA Ligase reactions.
The ligation of single-stranded RNA transcripts was achieved by treatment with T4 RNA 
ligase (NEB). The reaction conditions were as follows.
ssRNA transcript 1.0 ng
lOx RNA Ligase NEBuffer 2.o ni
RNasin (40 U/pl) o,5 ni
T4 RNA Ligase (2,000 U/pl) 4.0 (4.1
Nuclease free water
to a final volume of 20.0 ni
Reactions were incubated at 17°C for 6 hours, and subsequently stored frozen at -70°C, or 
utilised immediately as a template for first strand cDNA synthesis (Methods 2.4.7).
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2.4.7 First strand cDNA synthesis.
First strand cDNA synthesis was achieved using AMV Reverse transcriptase under the 
reaction conditions described below. Initially 14 pi of a RNA Ligation reaction (Methods 
2.4.6) was mixed with 1 pi of first strand primer (0.5 pg/pl), and incubated at 70°C for 10 
minutes, then chilled on ice before the addition of further reaction components in the order 
shown.
(RNA template/ first strand primer 15.0 pi)
5x AMV buffer 5.0 pi
RNasin® (40 U/pl) 1.0 pi
4 dNTPs, 10 mM 0.5 pi
AMV-RT (20 U/pl) 1.0 pi
Nuclease free water 2.5 pi
The reaction was incubated at 42°C for 1 hour then chilled on ice before using 5 pi of the 
first strand synthesis reaction as a template for second strand synthesis with the appropriate 
primer and PCR amplification by TAQ DNA polymerase (methods 2.3.11).
2.5.0 Introduction of nucleic acids into eucaryotic cells.
2.5.1 Preparation of cationic liposomes.
This method is based on that described by Rose et a l . (1991).
Dimethyldioctadecyl ammonium bromide (DDAB) was diluted to 4 mg/ml in chloroform 
(stored at -20°C) and 1 ml was mixed with 1 ml of dioleoyl L-a-phosphatidyl ethanolamine 
(DOPE: 10 mg/ml in chloroform) in a glass universal. The chloroform was removed by 
evaporation with a gentle stream of nitrogen gas. Lyophilization was carried out for 4 hours 
to remove any further traces of chloroform and the dried lipids were resuspended in 10 ml 
sterile dw by sonication in a sonicating water bath. The lipids were further sonicated with a 
soniprobe (on ice) set at maximum power until the suspension cleared (~4 minutes.). The 
final suspension had a 1:2.5 ratio by weight of DDAB to DOPE and could be stored at 4°C 
for up to one month.
62
Materials and Methods: Chapter 2
2.5.2 Liposome mediated transfection of nucleic acids into mammalian 
ce lls .
Cationic liposomes were used for the transfection of plasmid DNA and in vz'/rotranscribed 
RNA transcripts into mammalian cells.
Thirty five millimetre dishes containing -80% confluent cell monolayers were infected with 
the recombinant vaccinia virus, vTF7-3, at 5-10 pfu/cell in 400 pi OptiMEM®(Gibco-BRL) 
for 1 hour at 37°C. The inoculum was removed and the monolayer washed once in 
OptiMEM® before the addition of 500 pi DNA-transfection mix. Transfection mixes were set 
up in 15 ml Falcon tubes and contained plasmid DNA (1-10 pg) which was diluted in 250 pi 
OptiMEM® before mixing with 250 pi diluted liposomes (15 pi cationic liposomes mixed 
with 235 pi OptiMEM®). The transfection mixture was allowed to stand for 10-15 minutes at 
room temperature before addition to cell monolayer. The monolayers were then incubated at 
37°C for 2.5 hours. Following this, RNA transfection mix (10 pi in vitro transcribed RNA 
and 15 pi liposomes were diluted to 500 pi OptiMEM®, vortexed and added immediately) 
was added, and incubation was continued for a further 3 hours at 37°C with periodic 
agitation. Five hundred microlitres of DMEM-10% FCS were subsequently added and 
incubation continued for a further 16-40 hours, after which cell lysates were then assayed for 
CAT activity (2.5.3).
2.5.3 Chloramphenicol acetyltransferase (CAT) assay.
The CAT enzyme assay system is an adaptation of that described by Gorman (1982) and 
Cullen (1987).
Cell extracts were prepared by first scraping cells into their medium before transferring to an
1.5 ml eppendorf and centrifuging at 6,500 rpm for 30 seconds. The supernatant was 
removed and cells washed once in 500 pi TEN buffer, repelleted at 13,000 rpm for 2 
minutes and the supernatant removed. The cell pellets were then resuspended in 75 pi of 250 
mM Tris-HCl (pH7.5) and subjected to 3 freeze/thaw cycles (dry ice 5 minutes / 37°C 5 
minutes). Nuclei and cell debris were removed by centrifuging samples at 13,000 rpm for 2 
minutes. Extracts were removed to another tube and assayed immediately or stored at -20°C. 
CAT assay reactions were set up by mixing 2-25 pi cell extract with 1 pi [14C] 
chloramphenicol (0.1 pCi/pl), lpl 50 mM acetyl CoA and 0.25M Tris-HCl (pH7.5) to a 
final volume of 50 pi. Incubations were carried out at 37°C for 2-16 hours (if incubating for 
16 hours, the cell extract was first heated to 60°C for 10 minutes to inactivate any 
endogenous deacetylase activity). After incubation chloramphenicol was extracted by first
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vortexing the reaction mixture for 20 seconds with 250 pi ethyl acetate, and centrifuging at
13.000 rpm for 5 minutes to achieve phase separation. The upper organic phase was 
removed to a new tube and dried under a vacuum. The dried residue of chloramphenicol was 
resuspended in 25 pi ethyl acetate and spotted 2cm from the base of a silica gel TLC plate 
and allowed to air dry. The TLC plate was then placed in a chromatography tank which had 
been pre-equilibrated for 30 minutes with chloroform: methanol (95:5), and the 
chromatography allowed to proceed until the solvent was 0.5cm from the top of the plate 
before removing the plate to air dry. Once dry, the TLC plate was then exposed direcdy 
against a sheet of Kodak X-omat S film for 16-24 hours, or a phosphor-imager plate (3-16 
hours) for phosphor-imager scanning.
2.6.0 Protein analysis.
2.6.1 Coupled in vitro transcription / translation reactions.
Cell-free protein synthesis was carried out using the TnT® Coupled Transcription/ 
Translation system (Promega). The TnT® reactions were set up on ice in accordance with the 
protocol supplied.
Nuclease free dH20
(to a final volume of 25 pi) 5.9 pi
TnT® Rabbit Reticulocyte Lysate 12.5 pi
TnT® Reaction buffer 2.0 pi
TnT® T7 RNA polymerase 0.5 pi
Amino acid mixture Minus methionine 0.5 pi
[35S] methionine (15pCi/pl) 2.0 pi
RNasin® (40 U/pl) 0.6 pi
DNA template (0.5 pg/pl) 1.0 pi
The reaction was incubated at 30°C for 60 minutes after which 50 pi protein dissociation mix 
was added. The reactions were stored at -20°C or immediately analysed by SDS-PAGE 
(Methods 2.6.4).
2.6.4 SDS polyacrylamide gel electrophoresis (SDS-PAGE) of proteins.
Protein samples were fractionated by electrophoresis through a polyacrylamide gel 
containing SDS using a discontinuous buffer system (Laemmli, 1970). The gel apparatus
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and glass plates were assembled following the manufacturer's instructions. The resolving gel 
mix 12% or 15% acrylamide solution (recipes as below, 10% APS and TEMED added prior 
to pouring gel) was poured between the assembled glass plates, with sufficient space left at 
the top for the stacking gel (1 cm of stacking gel is below the loading well) to be added later. 
The resolving gel was immediately overlaid with 2 ml isopropanol to leave a smooth 
interface after polymerisation.
Resolving gel mixes:
12% 15% 18%
acrylamide/bis stock solution (37.5:1) 14.4 ml 18.0 ml 21.6 ml
1M Tris-HCl (pH8.8) 16.8 ml 16.8 ml 16.8 ml
dH20 12.9 ml 9.3 ml 5.7 ml
10% SDS 0.45 ml 0.45 ml 0.45 ml
10% APS 0.45 ml 0.45 ml 0.45 ml
TEMED 50.0 pi 50.0 pi 50.0 pi
Once the gel had polymerised, the isopropanol was poured off and the surface was rinsed 
once with water, and once with unpolymerised stacking gel solution. The stacking gel (1.0 
ml acrylamide stock solution, 0.63 ml lMTris-HCl (pH6.8), 8.0 ml dH20 , 100 pi 10% 
SDS, 100 pi APS, 5.0 pi TEMED) was poured onto the resolving gel surface and a comb 
inserted to form the loading wells. Once the stacking gel had polymerised the comb was 
removed and the wells rinsed once with running buffer (25 mM Tris base, 192 mM glycine,
0.1% SDS). The gel was placed in the electrophoresis apparatus and the reservoirs filled 
with running buffer. Samples in protein dissociation mix were boiled for 10 minutes before 
being loaded into the loading wells along with mid-range protein molecular markers (14.5-
97.4 KDa, BIO-RAD) and the gel run at 45mA until the bromophenol blue reached the 
bottom of the resolving gel. The gel was removed from the glass plates after electrophoresis 
and immersed in gel fix solution for 30 minutes and then treated with gel En3Hance solution 
for 30 minutes. After treatment with En3Hance, the gel was washed in water with several 
changes for a further 30 minutes before being dried under vacuum for 2 hours and placed in 
contact with X-Omat S film over night at -70°C.
2.6.5 Protein concentration determination.
The protein concentration of cell lysates to be used in CAT assays were determined using the 
method described by Bradford (1976).
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The protocol for determining protein concentration was essentially as described in the manual 
supplied with the Bradford reagent (Bio-Rad). Four microlitres of cell extract and 4 pi 10 
mM Tris pH 7.5 were pipetted directly onto the bottom of a 96 flat bottom microtiter plate 
(Nunc), to which 192 pi of lx Bradford reagent (5x Bradford reagent (BioRad) diluted in 10 
mM Tris pH 7.5 to give a lx working solution, stored at 4°C) was added. The wells of the 
plate were sealed with a plate sealer and, to allow efficient mixing of the reaction, the plates 
were inverted several times before centrifuging at 300 rpm for 20 seconds.
Protein concentration standards were made by the dilution of BSA 100 mg/ml (NEB) 
between the range 0.1 to 1.5 mg/ml in 10 mM Tris pH 7.5. Eight microlitres of diluted 
protein standards were pipetted onto the bottom of a flat bottom well microtiter plate to which 
were then added, 192 pi of lx Bradford reagent. The Bradford reactions were incubated at 
room temperature for 10 minutes before the absorbance at A595 was read in a automated plate 
reader. The A595 values for the BSA standards were plotted against protein concentration to 
give a standard curve from which the absorbances of the test samples could be applied to 
determine their protein concentrations.
2.7 Quantification of CAT assays.
The calculation of CAT activity from cell extracts was done exactly as described in Current 
Protocols in Molecular Biology (9.7.4 supplement 29). The air dried TLC plate (methods 
2.5.3) was placed in direct contact with a Molecular Dynamics Phosphorlmager screen and 
placed at room temperature overnight. The screen was then loaded into a Molecular 
Dynamics Phosphorlmager and the image from the screen scanned. The ImageQuant 
software (version 3.2) was used to analyse the scanned image. Background volume values 
were taken before determining the volumes of the acetylated and unacetylated 
chloramphenicol forms. The background value boxed areas were equal to the boxes used to 
calculate the volume of the chloramphenicol forms. The background values were subtracted 
from the sample values before any calculations were carried out.
acetylated volume
% acetylated = -----------------------------------------------------
acetylated volume + non-acetylated volume
The acetylated forms were only read when the reaction was in the linear range.
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Lysate Ojil 0.5|il l.Opl 2.0(il 3.0|il 4 .0 |l i 1 5 .0 |l l 1 6 .0 j j .1 7.0pl 8.0pl
Figure 2.1 Calculation of CAT activity from cell extracts.
Increasing amounts of cell lysate were tested for CAT activity. Using ImageQuant software, 
the nonacetylated CAT signal (lower small box) and the monoacetylated CAT signal were 
measured. For subsequent experiments which required quantification, CAT activity was only 
measured in the linear range, where the monoacetylated species is between 20 to 40% of total 
counts.
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Chapter 3.
3.0 Establishment of a reporter assay to study transcription and 
replication of Bunyamwera virus.
3.0 Introduction.
This chapter describes the establishment and optimisation of a CAT reporter assay designed 
to investigate the transcription and replication processes of Bunyamwera virus. The intention 
was to develop a reporter assay which would allow the characterisation of the 
transcription/replication signals encoded within the S segment of the virus genome, and 
which would also facilitate investigation of the viral proteins involved in these processes.
In this system, it was planned that a recombinant bunyavirus-like RNA transcript carrying a 
reporter gene would be transfected into cells, and be recognised and transcribed by 
transiently expressed recombinant bunyavirus proteins. To provide an RNA template for this 
assay, a reporter construct based on the Bunyamwera virus (BUN) S segment was designed 
(Pritlove, 1993). The design of this construct was based on a reporter construct (pIVACAT), 
originally described by Luytjes etal. (1989) which was used in the investigation of influenza 
virus transcription. Luytjes etal. constructed a recombinant RNA molecule which consisted 
of an antisense CAT gene flanked by the authentic 3' and 5' noncoding regions of the NS 
gene RNA of influenza virus A/AR18/34. This RNA transcript was mixed with purified 
influenza virus nucleocapsid proteins and transfected into cells. When these cells were 
subsequently infected with influenza AAVSN/31 virus, CAT activity was detected. This 
indicated that the recombinant RNA transcript was recognised by influenza viral proteins to 
and transcribed at least, to give a functional CAT mRNA. These workers also demonstrated 
that the recombinant RNA was not only transcribed, but was replicated and packaged 
correctly.
Given the success of this reporter construct, it was decided to utilise a similar design to build 
the Bunyamwera virus (BUN) S segment reporter construct.
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3.1 Design of the reporter construct.
The reporter construct designed for this assay was named pBUNSCAT, and is shown 
diagramatically in Figure 3.1. The reporter plasmid contained an antisense sequence 
encoding the open reading frame (ORF) of the chloramphenicol acetyl transferase (CAT) 
gene (the reporter gene). The antisense CAT gene replaced the coding region in a negative 
sense BUN S segment cDNA. Essentially, therefore, the antisense CAT gene was flanked 
by the complete 3’ and 5’ BUN S segment untranslated regions (UTRs). Since the complete 
3’ and 5’ UTRs of the BUN S segment are thought to contain the signals for encapsidation, 
transcription and replication of the RNA transcript (Chapter 1), it was expected that 
transcripts from the reporter construct would behave as authentic viral RNAs.
It was thought to be important that the reporter RNA transcripts should have the exact 3’ and 
5’ termini of the BUN S segment since these sequences are strictly conserved among 
different bunyaviruses. To achieve the exact 5’ terminus, the reporter construct was cloned 
immediately downstream of a truncated T7 RNA promoter (Parvin et al., 1989) so that 
transcription would initiate at the 5’ A residue of the BUN S 5’ terminus. The rationale 
behind using the truncated T7 promoter to initiate transcription of the reporter construct was 
based on previous work by others (Luytjes et al., 1989; Seong and Brownlee, 1992a), in 
which it was demonstrated that the truncated T7 promoter initiates transcription on an A 
residue at nucleotide position +1. These studies also demonstrated that an influenza-like 
RNA transcript initiating on an A residue (+1 AGUAG—3’) was replicated by viral proteins, 
which suggested that this arrangement should also function to produce bunyavirus-like 
transcripts which initiate on the correct nucleotide.
To achieve the exact 3' end in the RNA transcript, a Bbsl restriction enzyme site was 
engineered downstream of the 3’ terminus. This enzyme was chosen as there are no Bbsl 
sites either in the CAT gene, or in the BUN UTRs. Additionally, Bbsl cuts away, i.e. 
upstream of its recognition site, and therefore, it was possible to position the recognition 
sequence of this enzyme, so that linearisation of the pBUNSCAT plasmid with this enzyme 
allowed run off transcripts to terminate exactly at the 3’ nucleotide of the BUN S 3’ 
terminus.
RNA transcripts derived from the pBUNSCAT plasmid, therefore, would have the authentic 
ends of the BUN S segment RNA, and would contain, in the 5’ to 3’ order, the 174 
nucleotides of the 5’ untranslated region of the BUN S segment, the entire CAT gene in a 
negative-sense polarity, and the 85 nucleotides BUN S segment 3’ untranslated region.
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(A)
174 nuc 660 nuc 85 nuc
T7 BUN S 5’UTR X V  D BUN S 3’UTR
vvi 01V
 ^ T7 promoter +1
■TAATACGACTCACTATA AGTAGTGTGCTCC- ■ GGAGTACAAACT G CGTCTTCTA- -
-  - ATTATGCTGAGTGATAT TCATCACACGAGG-  -------- CCTCATGTGATGA CGCAGAAGAT -  -
Bbsl
(B) 5’ AGUAGUGUGCUCC- - /-/ - -GGAGUACACUACU 3’
Figure 3.1 D iagram  of the reporter construct pBUNSCAT.
(A) The plasmid pBUNSCAT, contains a CAT gene in the antisense orientation (indicated on 
the diagram by “CAT” -written upside down and backwards), flanked by the complete 5' 
(174 nucleotides) and 3’ (85 nucleotides) non-coding regions (UTRs) of the Bunyamwera 
genomic S segment in a pUCl 18 backbone. The truncated T7 promoter initiates transcription 
on the first base (+1 A) of the BUN S 5’ UTR. Linearisation of the template prior to 
transcription with the restriction endonuclease Bbsl (recognition sequence underlined, and 
restriction sites marked by black triangles), allows run-off transcripts to terminate at the 
precise 3’ terminal nucleotide (nucleotide U) of the BUN S 3’ UTR.
(B) Run-off transcripts from pBUNSCAT will encode an antisense CAT gene flanked by the 
complete BUN S 5’ and 3’ UTRs with the authentic 5’ and 3’ termini.
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3.2 In vitro transcription of run-off BUNSCAT RNA transcripts.
To allow the production of RNA transcripts from pBUNSCAT, the plasmid DNA was 
initially linearised by digestion with the restriction enzyme Bbsl (Methods 2.3.3). The 
linearised DNA was isolated by agarose gel electrophoresis, and purified by silica matrix 
absorption (Methods 2.3.7). The purified linear DNA was used as a template in an in vitro 
transcription reaction, performed exactly as described in Methods 2.4.1. The quality of the 
RNA was assessed by agarose gel electrophoresis. The RNA was treated with DNase I, 
assessed again for integrity by agarose gel electrophoresis, and if suitable, was used for 
transfection. Quantitation of the RNA was performed according to Methods 2.4.2, Figure
3.2 shows aliquots of purified 2?6sl-digested template DNA, run off RNA transcripts prior 
to DNase I treatment, and the RNA transcripts after DNase I treatment (Lanes 2, 3, and 4 
respectively).
3.3 Expression of recombinant BUN virus proteins.
To allow in vivo transcription/translation of the reporter RNA, it was necessary to supply the 
cells with the BUN virus proteins which were presumed to be involved in virus replication,
i.e. the proteins encoded by the L and S segments. In setting up this reporter assay, two 
approaches were initially utilised to transiently express recombinant BUN virus proteins in 
cells: either by recombinant vaccinia virus, or by transfected plasmids which encoded BUN 
virus proteins, the expression of which was driven by the vaccinia virus-T7 system (vTF7- 
3) (Fuerst et al, 1986).
3.4 Expression of BUN virus proteins by recombinant vaccinia viruses.
The recombinant vaccinia viruses vSCllBUNL and vSCllBUNS were used to supply 
BUN virus replication proteins to the assay. Recombinant vaccinia virus vSCllBUNL has 
been described previously (Jin and Elliott, 1992), and contains the entire open reading frame 
of the BUN L segment therefore expressing the BUN L protein, the RNA-dependent RNA 
polymerase (RdRp). vSCllBUNS was also constructed previously (Elliott and Page, 
unpublished work), and contains the entire open reading frame of the BUN S segment, 
therefore expressing the BUN nucleocapsid (N) and non-structural (NSs) proteins. Both the 
L and the S genes were cloned, using the transfer vector pSCl 1 (Chakrabarti et a l, 1985), 
downstream of the vaccinia virus P I.5 promoter.
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Lane 1 2  3 4
Figure 3.2 In vitro transcription of B bsl linearised pBUNSCAT.
A 1% agarose TBE gel was loaded with the following samples: lOOng of Bbsl linearised 
pBUNSCAT DNA (Lane 2), 4pl of Bbsl linearised pBUNSCAT transcription reaction 
(methods 2.4.1) after 2 hours incubation at 37°C (Lane 3), 4pl of the same pBUNSCAT 
transcription reaction after a further incubation with 5 units DNasel for 20 minutes at 37°C 
(Lane 4). X ZTstEII markers (0.5pg) are shown in lane 1.
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3.5 Expression of BUN virus proteins by plasmids.
The plasmids used to allow transient expression of BUN virus proteins were pTFBUNL and 
pTFBUNS. The construction of pTFBUNL has been described previously (Jin and Elliott, 
1992). This plasmid contains the entire open reading frame of the BUN L segment under the 
control of the T7 promoter in pTF7-5 (Fuerst et al, 1986). pTFBUNS was also constructed 
previously (Elliott and McGregor, unpublished work), and contains nucleotides 8 6  to 961 of 
the BUN S segment cDNA, cloned downstream of a T7 promoter in pTF7-5, and therefore 
expresses both the BUN N and NSs proteins.
3.6 Introduction of plasmid DNA into cell cytoplasm by cationic-lipid 
transfection.
The chosen method of delivery of plasmid DNA into the cell cytoplasm was by a cationic 
liposome mediated DNA transfection procedure. This method was originally described by 
Feigner et a l (1987), and then later adapted by Rose e ta l  (1991). Both groups were able to 
demonstrate efficient transfection of plasmid DNA into a variety of eucaryotic cell types. 
Furthermore, Rose et a l also demonstrated the efficient cytoplasmic expression of a reporter 
construct, delivered by this transfection method, using the vaccinia virus-T7 expression 
system.
The method for the preparation of the cationic liposomes used in these experiments is 
described in Methods 2.5.1, and is adapted from Rose et a l (1991). The conditions of the 
transfection protocol used in these experiments are described below (see also methods
2.5.2). These conditions were adapted from those originally described by Feigner et a l 
(1987), and Rose etal. (1991).
3.7 Transfection of BUNSCAT RNA into 293 cells transiently expressing 
recombinant BUN virus proteins.
The following describes the protocol used for the transfection of cells used in the CAT 
reporter assay, as outlined in Figure 3.3. Subconfluent monolayers of 293 cells were 
infected with the recombinant vaccinia virus vTF7-3 in serum-free medium (OptiMEM), to 
allow expression of T7 RNA polymerase in the cytoplasm of infected cells. The cells were 
then transfected with the plasmids pTFBUNS and pTFBUNL, via liposome mediated 
transfection (methods 2.5.1). Incubation at 37°C for 3 hours allowed for expression and 
accumulation of recombinant BUN proteins. Following this, the cells, now transiently 
expressing recombinant Bunyamwera virus proteins, were transfected with in-vitro
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1 hr
VTF7-3
pTFBUNL Plasmid
DNA
3 hr
pTFBUNS
transfect
BUNSCAT (-)
3 hr
pTF-BUNL CD
pTF-BUNS
transfect
RNA
transcript
Add
growth
medium
16 hr
Cell lysate assayed for CAT activity
Figure 3.3 Schematic describing the transfection and detection of CAT 
activity from BUNSCAT RNA.
Subconfluent monolayers of 293 cells were infected with vTF7-3 at 10 pfu/cell, and 
incubated at 37°C for 1 hour. The monolayers were then washed once with 500pl of 
OptiMEM prior to the transfection of plasmid DNA in 500pl OptiMEM with 15pl liposomes. 
After a 3 hour incubation to allow expression and accumulation of recombinant bunyavirus 
proteins, 10pl of in-vitro transcribed BUNSCAT RNA was transfected into the cells in 
500pl OptiMEM with 15pl liposomes. The incubation was continued for a further 3.5 hours 
before the addition of 500|il of growth medium. The cells were incubated at 37°C for a 
further 16 hours before harvesting, and cell extracts assayed for CAT activity (Methods
2.5.3).
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transcribed BUNSCAT RNA (Figure 3.2), and the incubation continued for a further 3.5 
hours before the addition of growth medium. The experiment was incubated for a further 16 
hours, after which the cells were harvested, and cell extracts assayed for CAT activity by 
thin layer chromatography (Methods 2.5.3).
When Bunyamwera virus proteins were supplied by recombinant vaccinia viruses, the assay 
was performed as follows: subconfluent monolayers of 293 cells were infected with the 
recombinant vaccinia viruses vSCl 1BUNS and vSCl 1BUNL for 1 hour, prior to liposome 
mediated transfection of the cells with in-vitro transcribed BUNSCAT RNA. Following a
3.5 hour incubation, growth medium was added, and the incubation continued for a further 
20 hours. The cells were harvested and cell extracts assayed for CAT activity as described in 
Methods 2.5.3.
3.8 Demonstration that BUNSCAT RNA transcripts could act as a template 
for transcription by recombinant BUN virus proteins.
It was first necessary to determine whether the BUNSCAT RNA transcripts derived from the 
Bbsl linearised pBUNSCAT could act as a template for transcription by recombinant BUN 
virus proteins.
Figure 3.4 (A) shows the results of the reporter assay when the BUN virus proteins were 
supplied by recombinant vaccinia viruses. CAT activity could only be detected in cells 
expressing both the L and S segment gene products (Lanes 3 and 4). No CAT activity was 
detected in cells infected with only one of the recombinant viruses (Lanes 2 and 5).
To determine whether BUN virus proteins could be supplied by transfected plasmids, the 
vTF7-3 T7 expression system was employed. In this system, the recombinant vaccinia virus 
vTF7-3 expresses T7 RNA polymerase (Figure 3.3). Thus infection with this virus prior to 
plasmid transfection results in expression of T7 RNA polymerase in the cytoplasm of 
infected cells. The T7 RNA polymerase drives the transcription of mRNAs from plasmids 
encoding the BUN S and L segment ORFs, under the control of the T7 promoter (Figure
3.3). The results of the experiment shown in Figure 3.4 (B) show that the transcripts derived 
from BUNSCAT could act as templates for transcription by transiently expressed BUN virus 
proteins, when the proteins were supplied by transiently transfected plasmids. Measurable 
CAT activity could only be detected in cells which had been transfected with both plasmids, 
and were therefore expressing both the L and S segment gene products (Figure 3.4 B, Lane 
11). No CAT activity was detected in cells which were transfected with only one of the 
plasmids (Lanes 9 and 10), or in control cells which had been infected with vTF7-3, and
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(A)
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• m
BUNSCAT RNA + + + + +
vSCllBUNS - + + + -
vSCllBU N L - - + + +
Lane 1 2 3 4 5
(B)
mm
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BUNSCAT RNA - + + + + +
vTF7-3 - - + + + +
pTFBUNS - - _ + - +
pTFBUNL - - - - + +
Lane 6 i 8 9 10 l
Figure 3.4 Transcription of BUNSCAT RNA transcrip ts by transiently  
expressed bunyavirus proteins.
(A) Cells were infected with 10 pfu/cell of vSCl 1BUNL, vSCl 1BUNS, or both viruses, as 
indicated, and subsequently transfected with 10(il BUNSCAT RNA. Cell extracts were 
harvested 20 hours post infection, and assayed for CAT activity by thin layer 
chromatography (TLC) (methods 2.5.3). (B) Cells were infected with vTF7-3 at 10 pfu/cell, 
and then transfected with 5|ig pTFBUNL, 5p.g pTFBUNS, or 5pg of both plasmids, as 
indicated, then subsequently transfected with lOpl BUNSCAT RNA. Cell extracts were 
harvested 24 hours post infection and assayed for CAT activity by thin layer chromatography 
(TLC). As can be seen from lanes 3, 4 and 11, CAT activity was dependent on expression of 
both L and S segment gene products, regardless of whether these proteins were supplied by 
recombinant vaccinia viruses or by transfected plasmids using the vaccinia virus-T7 
expression system.
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mock transfected (Lanes 7 and 8). Comparison of figure 3.4 A and B, which represent 
similar cell equivalents suggest that CAT expression was greater when BUN proteins were 
supplied by recombinant vaccinia viruses compared to recombinant plasmids.
The results of these experiments indicated that proteins from both the BUN L and the S 
segments were required for successful transcription of the reporter BUNSCAT RNA. 
Furthermore, these proteins could be supplied either via recombinant vaccinia viruses, or via 
the transfection of plasmids using the vaccinia T7 expression system.
3.9 Optimisation of the expression of BUN virus proteins by plasmids.
The ultimate aim of the experiments in this section was to develop a reporter assay system 
which would not only allow us to study bunyavirus transcription, but also enable the 
analysis of the effects of specific mutations in the BUN viral proteins. Therefore, it was 
decided that, despite higher CAT levels obtained with the recombinant vaccinia virus system, 
the plasmid expression system would be more convenient. The main advantage this system 
has over recombinant vaccinia viruses is the relative ease with which mutated BUN proteins 
could be produced via specific mutagenesis of plasmid encoded cDNA.
Experiments were performed to optimise the expression of BUN viral proteins from 
plasmids. As shown in Figure 3.5, pTFBUNL and pTFBUNS were titrated against each 
other in order to optimise the ratio of each plasmid in the reporter assay. Different amounts 
of pTFBUNS DNA (0.5 to 20 fig) and 5pg transfected pTFBUNL DNA were used, thereby 
increasing the amount of S segment proteins expressed against a constant level of BUN L 
protein. By simple visual assessment of the CAT signal, it was judged that the optimal 
amount of pTFBUNS transfected was lfig (Figure 3.5 A). By varying the amounts of 
pTFBUNL transfected (0.5 to 15fig) with l|ig  pTFBUNS, thereby increasing the amount of 
BUN L protein expressed against a constant level of S segment proteins. , it was found that 
the optimal amount of this plasmid for transfection was 5jig (Figure 3.5 B). Therefore, the 
highest measurable CAT activity obtained (as judged by visual assessment) from the reporter 
RNA was achieved when 5fig pTFBUNL were transfected with lpg pTFBUNS. Hence, in 
all subsequent experiments these amounts of plasmid DNA were used (unless otherwise 
stated).
3.10 Optimisation of the incubation time before cell extract harvesting.
In an effort to determine the optimal time point at which harvesting the cells from the reporter 
assay would result in the highest and most consistent level of CAT activity, a time course
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«wml i i i
pTF-BUNS 0 0.5 1.0 2.5 5.0 7.5 10.0 15.0 20.0
pTF-BUNL 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0
pTF-BUNS 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
pTF-BUNL 0 0.5 1.0 2.5 5.0 7.5 10.0 15.0
Figure 3.5 Titration of the pTFBUNL and pTFBUNS plasmids in the CAT 
repo rter system.
(A) Cells infected with vTF7-3 were transfected with 5pg pTFBUNS and varying amounts 
of pTFBUNL as indicated (in pig). (B) Cells were transfected with 5|ig pTFBUNL, and 
varying amounts of pTFBUNS, as indicated (in pg). After transfection of plasmid DNA, 
cells were then transfected with an equal quantity of BUNSCAT RNA from the same 
transcription reaction. Cell extracts were harvested 24 hours post infection and assayed for 
CAT activity by thin layer chromatography.
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Lanes 1 2 3 4 5 6 7 8 9 10
0 hr 4 hr 16 hr 24 hr 36 hr
Figure 3.6 The effect of incubation time on CAT expression.
Duplicate dishes of cells transiently expressing the BUN L and S segment gene products 
were transfected with BUNSCAT RNA for 3.5 hours at 37°C, prior to the addition of 0.5 ml 
growth medium (DMEM/10% FCS). The cells were subsequently incubated at 37°C for 
varying times (as indicated) before extracts were harvested and assayed for CAT activity. 
The addition of growth medium was taken as time zero (0 hours). Low levels of CAT 
activity were detected at 0 hours and 4 hours incubation. A strong CAT signal was detected 
at 16 hours, and this increased to 36 hours.
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experiment was performed, the results of which are shown in Figure 3.6. A series of 
replicate BUNSCAT RNA transfections were set up as described previously, where cells 
transiently expressing recombinant BUN proteins were transfected with identical amounts of 
BUNSCAT RNA. The transfected cells were then incubated at 37°C after the addition of 
growth media (time 0 hours) for various time points (0, 4, 16, 24 and 36 hours post RNA 
transfection) when cell extracts were assayed for CAT activity.
As shown in figure 3.6, low levels of CAT activity could be detected at 0 and 4 hours 
incubation. These levels increased markedly to give a strong CAT signal at 16 hours, which 
was increased slightly at 36 hours incubation. The half life of CAT is relatively long 
(approximately 50 hours). Therefore, it was thought that the increase observed between 24 
hours and 36 hours post RNA transfection was due not to a continued linear increase in 
translation of the reporter RNA, but to a small amount of continued translation and a slow 
accumulation of CAT enzyme. On this basis, therefore, it was decided that the level of CAT 
activity obtained between 16 and 24 hours post RNA transfection, was both consistent and 
sufficiently high for accurate and meaningful quantitation. Hence, in all subsequent 
experiments the 20 hour time point was used (unless otherwise stated).
3.11 Optimisation of the amount of BUNSCAT RNA used in transfections.
To determine the optimal quantity of transfected BUNSCAT RNA to produce a consistent 
and quantifiable CAT signal, the following experiment was performed. Cells transiently 
expressing recombinant BUN proteins were transfected with various amounts of BUNSCAT 
RNA ranging between 0.5pg and 5pg. It can be seen in Figure 3.7, CAT activity increased 
with increasing amounts of BUNSCAT RNA transfected.
It was decided, that transfection of 3pg of BUNSCAT RNA gave a CAT signal that was 
both consistent and sufficiently high for the purposes both of detection and for accurate and 
meaningful quantitation, this amount was used in all subsequent experiments (unless 
otherwise stated).
3.12 The effect of using different cell lines in the reporter assay.
To determine if different levels of CAT activity would be produced in the reporter assay by 
using different cell lines, three other cell lines HeLa(T4), CV-1 and BHK-21, cells were 
tested and compared to 293 cells. Dishes of each of the four cell lines, transiently expressing 
the BUN viral proteins of the L and S segments, were transfected with identical amounts of 
BUNSCAT RNA and assayed for CAT activity as described previously. From the CAT
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0.5 1.0 2.0 3.0 4.0 5.0 0
Figure 3.7 CAT activity in cells transfected with varying amounts o f 
BUNSCAT RNA.
Cells transiently expressing the gene products of the BUN L and S segments were 
transfected with varying amounts of BUNSCAT RNA as indicated, (in |ig), in 0.5 ml 
OptiMEM containing 15pl liposomes. Cells were harvested 24 hours post infection, and cell 
extracts were assayed for CAT activity. CAT activity was detected in cells transfected with 
0.5 to 5.0 p.g BUNSCAT RNA. CAT activity increased in accordance with amount of RNA 
transfected.
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« ■ *
Cell type 293
Figure 3.8 The effect of using different cell lines on CAT expression.
Four different cell lines (as indicated above) transiently expressing the gene products of the 
BUN L and S segments were transfected with identical amounts of BUNSCAT RNA. Cell 
extracts were harvested 16 hours later and assayed for CAT activity. As judged by visual 
assessment all four cell lines gave similar CAT activities.
HeLa BHK CV-1
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results in figure 3.8, it can be seen that all four cell lines gave similar CAT activities. It was 
decided that because they were easier to maintain and grow, CV-1 cells would be used for all 
future reporter assays.
3.13 The effects of a specific point mutation in the 5’ UTR terminal 
sequence in pBUNSCAT.
During the course of constructing pBUNSCAT, a clone was isolated which had a single C to 
G mutation at position 12 in the BUN S 5' UTR terminal sequence. This was named 
pBUNSCATmut-12 (Figure 3.9). This mutation lies within the terminal 15 nucleotides 
which have been found to be conserved in all the available sequenced bunyavirus S segments 
(Dunn eta l., 1994). The effect of the mutation was predicted to result in a slight disruption 
in the potential base-paired structure between the 5’ and 3' sequences of the BUN S segment 
termini (Elliott, 1990), as indicated in Figure 3.9.
Transcripts derived from this mutant clone were tested in the reporter assay, and the results 
shown in Figure 3.10. It was demonstrated that transfection of the mutant RNA transcripts 
resulted in barely detectable CAT activity, when BUN virus proteins were supplied by either 
transfected plasmids (Lane 6) or recombinant vaccinia viruses (Lane 8). Equivalent amounts 
of wildtype (wt) BUNSCAT RNA (Lanes 7 and 9) gave a high CAT signal. No CAT 
activity was seen for either RNA when transfected into vTF7-3 infected cells (Lanes 4 and 
5). However, CAT activity could be measured following transfection of either plasmid DNA 
into vTF7-3 infected cells (Lane 4 and 5). This result illustrates the promiscuity of vaccinia 
virus RNA polymerase in utilizing the plasmid DNA as a template, and also demonstrates 
that the CAT gene in pBUNSCATmut-12 was functional. More importantly, the experiment 
shows that a mutation in the conserved terminal sequence drastically affects recognition of 
the template by the BUN virus proteins.
3.14 The effects of specific mutations in the BUN L protein using the 
BUNSCAT reporter assay.
In a previous paper from this laboratory, the construction of a series of specifically mutated 
BUNL proteins expressed from the plasmid pTF7.5 was described (Jin and Elliott, 1992). 
Using a nucleocapsid transfection assay it was demonstrated that certain mutations in the 
putative polymerase motifs, which are conserved among all RNA-dependent RNA 
polymerases (Chapter 1.2.4 and Figure 3.12), abolished the RNA synthesis capability of L 
protein, whereas mutations at unconserved sites still gave rise to functional L protein (Jin 
and Elliott, 1992). It was decided to investigate the effects of these mutated L proteins in the
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BUNSCAT | I I | | I | I : | [ | f | | [ [ |
3 ' U - C - A - U - C - A - C - A - U - G - A - G - G - U - G  G - A - U ,
U
G
5 ' A - G - U - A - G - U - G - U - G - C - U  C - A - C - C - U - A  
BUNSCAT m u t l 2  I I I I I I I I : I I I I I I I I
3 ' U - C - A - U - C - A - C - A - U - G - A  „  G - U - G  G - A - U
G U
Figure 3.9 Comparison of the predicted base pairing between the 3’ and 5 ’ 
termini of RNAs transcribed from pBUNSCAT and pBUNSCATmut-12.
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Figure 3.10 The effects of a specific mutation in the BUNSCAT 5’ UTR 
term inal RNA sequence.
BUN L and S segment proteins were expressed either by the vaccinia virus-T7 transient 
system (Lanes 6 & 7), or by infection with recombinant vaccinia viruses (Lanes 8 & 9) as 
indicated. Control cells were infected with vTF7-3 alone (Lanes 1-5) or were mock infected 
(Lane 10). The cells were then transfected with BUNSCAT RNA (Lanes 3, 7 & 9), 
BUNSCATmut-12 RNA (Lanes 2, 6 & 8), or the respective plasmid DNAs (Lanes 4 & 5). 
Cell extracts were assayed for CAT activity as described. CAT activity in cells transfected 
with BUNSCATmut-12 RNA was approximately 0.5% of that in cells transfected with 
BUNSCAT RNA (Lanes 6 vs. 7, 8 vs. 9), whereas similar levels of CAT activity were 
observed in vTF7-3 cells transfected with the respective plasmid DNAs (Lanes 4 vs. 5).
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Figure 3.11 Effects of specific amino acid substitutions in the Bunyam wera 
virus L protein.
Cells were infected with vTF7-3, then transfected with pTFBUNS and 5pg of either wild 
type (wt) pTFBUNL or derivative containing specific mutations as indicated. The mutations 
are designated by amino acid in wt L protein/ position/ amino acid in mutant. The cells were 
subsequently transfected with aliquots of the same preparation of BUNSCAT RNA, and cell 
extracts were prepared for CAT assay 16 hours later. Mutation of residues conserved 
between negative strand virus polymerases (Figure 3.12) resulted in nonfunctional L protein 
and hence no CAT detectable CAT activity, (Lanes 2, 3, 6, 7, 10, 11 and 13). Mutations to 
the nonconserved residues were found to still be positive for CAT activity, (Lanes 4, 5, 8, 9 
and 12) and summerised in Figure 3.12.
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Figure 3.12 Alignment of the putative polymerase domains of Bunyaviridae 
L proteins.
The above figure is an adapted from Jin and Elliott, (1992) and shows an alignment of the 
available Bunyaviridae L protein amino acid sequences using the programs PILEUP and 
PRETTY in the GCG Wisconsin package. Regions corresponding to the four motifs (A to 
D) identified by Poch et al, (1989) (1.2.4) are overlined. ‘Con’ shows the residues 
conserved in all sequenced L segments of the Bunyaviridae and the arrows indicate the 
position and the resulting change to the amino acid residues in the Bunyamwera virus L 
protein (BUN sequence, bold). The plus and minus signs indicate the ability of the mutant L 
proteins to function, both in the nucleocapsid assay (Jin and Elliott, 1992) and in the CAT 
reporter system discussed here (Figure 3.11).
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CAT reporter system by substituting plasmids which encoded specifically mutated L 
proteins, and to compare the results from these experiments to the previous results from the 
nucleocapsid transfection assay.
The results of the CAT assays shown in Figure 3.11, are entirely in accord with those 
obtained previously with the nucleocapsid transfection assay (Figure 3.12). Thus, mutation 
of the conserved Asp at position 1037 in motif A, Asn at position 1119 in motif B, or Asp at 
position 1165 in motif C gave L proteins that were inactive in transcribing BUNSCAT RNA 
(Figure 3.11, Lanes 2, 3, 6, 7, 10, and 11 respectively). Similarly, changing the SDD triplet 
(motif C, Figure 3.12) which is characteristic of the polymerases of negative strand viral 
polymerases, also resulted in nonfunctional L protein (Figure 3.11, Lane 13). In contrast, 
mutation of nonconserved residues, such as Gin at position 1044, Leu at position 1150, and 
Gin at position 1180, yielded L proteins which retained polymerase activity (Figure 3.11, 
Lanes 4, 5, 8, 9 and 12 respectively, and Figure 3.12).
At the time of conducting this study, it was decided that characterisation of the signals 
encoded in the RNA transcript was of primary importance, and that study of the interaction 
of the RNA transcript with the replication proteins should be pursued at a later date. The 
BUN L protein mutants, therefore, were not investigated further using the reporter assay. 
However, the importance of motif C in RNA-dependent RNA polymerases has since been 
verified by several other groups working on other negative strand RNA viruses such as VSV 
(Canter et al., 1993), and rabies virus (Schnell and Conzelmann, 1995).
In conclusion therefore, the observation that the results of testing the L protein mutants in the 
CAT reporter assay were entirely in accord with results from previous experiments using the 
nucleocapsid transfection assay substantiates the authenticity of this system.
3.15 The BUNSCAT transcript is transcribed, but is it also replicated?
The detection of CAT activity from cell extracts, shown in Figure 3.4, indicates that the 
BUNSCAT RNA transcript (which is of negative polarity) had been transcribed by the 
transiently expressed BUN virus proteins into a positive sense RNA transcript, and this 
positive sense transcript was subsequently translated to yield CAT protein. However, these 
experiments could not distinguish whether the positive-sense RNA was mRNA-like or 
antigenome-like, or whether BUNSCAT could act as a template for both authentic 
transcription (primer dependent mRNA production) and replication (primer independent 
production followed by further negative strand synthesis). To this end Northern blot analysis
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Figure 3.13 Construction of riboprobe constructs pTZCAT(-) and
pTZC A T(+).
(A) Primers were designed to amplify the CAT ORF of pBUNSCAT by PCR (methods 
2.3.11). The CAT.l primer sequence was homologous to nucleotides 1 to 27 of the CAT 
ORF : 5 ’ - ATGG AGAAAAAAATCACTGGAT AT ACC. The CAT.2 primer sequence was 
complementary to nucleotides 660 to 636 of the CAT ORF: 5’-
TTACGCCCCGCCCTGCCACTCATCGCA. The resulting PCR fragment was end- 
repaired, phosphorylated (Methods 2.3.8) and cloned into Smal cut pTZ18U to allow the 
cloning in both orientations. (B) The orientation of the CAT gene in the resulting constructs 
was characterised by restriction digestion with EcoRl. The CAT riboprobe constructs were 
called pTZCAT(+) and pTZCAT(-).
Results and Discussion: Chapter 3
was performed on total cellular RNA extracts from transfected cells, since mRNA and 
antigenome RNAs would have different mobilities on agarose gels.
Duplicate transfection reactions were performed as described in Figure 3.4. One set of 
transfected dishes was analysed for CAT activity, while total cellular RNA was extracted 
from the other using the acid-guanidinium method as described in Methods 2.4.3. The total 
cellular RNA was subjected to Northern blot analysis according to the method described in 
Methods 2.4.5.
To detect BUNSCAT negative and positive sense transcripts, two CAT gene containing 
plasmids were constructed (pTZCAT(+) and pTZCAT(-)) for the purpose of generating 
riboprobes. These are shown in Figure 3.13. CAT probes were used instead of BUN S 
segment probes to remove the possibility that a background signal would be detected from 
transcripts transcribed from the pTFBUNS support plasmid.
A 32P-UTP labeled riboprobe was transcribed from Xbal linearised pTZCAT(-) (Figure 
3.13). This probe directs transcription of a minus sense CAT transcript, and was therefore 
used to probe for positive sense transcripts transcribed from BUNSCAT, i.e. antigenomic 
and messenger RNA. A 32P-UTP labeled riboprobe was transcribed from Xbal linearised 
pTZCAT(+) (Figure 3.13). This probe transcribes a positive sense CAT transcript, and was 
therefore used to detect the negative sense, i.e. genomic sense, the BUNSCAT RNA 
transcript.
As is shown in Figure 3.14, when northern blots (A) and (B), were probed with the CAT(-) 
riboprobe, the positive sense CAT control marker CAT(+) RNA, could be detected in (A) 
lane 12 and (B) lane 10, however, no positive sense transcripts were detected (as hoped for) 
in (A) lanes 7 and 8 and in gel (B) lanes 5 and 6 which would have indicated transcription of 
a positive sense transcript. When the northern blots were probed with the CAT(+) riboprobe, 
BUNSCAT RNA could be detected in those dishes that had been transfected with RNA, (A) 
lanes 3 to 8 and (B) lanes 2 to 6, the BUNSCAT control marker (Lanes (A) 10 and (B) 8) 
and the CAT(-) control marker (Lanes (A) 11 and (B) 9). However, there was also no 
indication of an increase in the amount of BUNSCAT RNA detected. Had an increase in 
BUNSCAT RNA been detected in (A) lanes 7 and 8 and (B) lanes 5 and 6, this would have 
indicated that replication of the BUNSCAT template had occurred.
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Figure 3.14 (A and B) Northern blot analysis of total cellular RNA extracts.
Total cellular RNA was harvested by the acid guanidinium method (methods 2.4.3) from a 
series of transfection experiments (shown above) performed as described previously (Figure 
3.4). The purified total cellular RNA was denatured by glyoxal treatment, and then 
fractionated on duplicate 1.2% agarose gels and transferred to nylon membranes (methods 
2.4.5). The membranes were either hybridised with a negative sense (-) CAT riboprobe, 
transcribed from Xbal linearised pTZCAT(-) to detect positive sense CAT transcripts, or 
with a positive sense (+) CAT riboprobe, transcribed from Xbal linearised pTZCAT(+) 
(Figure 3.13) to detect negative sense CAT transcripts.
(A) The CAT (+) riboprobe detected transcripts only from cells which had been transfected 
with BUNSCAT (RNA) (Lanes 3 to 8) as well as detecting the BUNSCAT RNA template 
control in lane 10 and cold CAT(-) RNA in lane 11. The CAT(-) riboprobe was only able to 
detect a positive sense CAT transcript in the control lane 12, containing cold CAT(+) RNA. 
No positive sense transcripts were detected in lanes 7 and 8.
CAT (+) probe CAT(-) probe
It680 nt ' '919 nt m I680 nt
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Figure 3.14 (B).
(B) Similarly, the CAT(+) riboprobe detected transcripts only from cells which had been 
transfected with BUNSCAT (RNA) (Lanes 2 to 6) as well as detecting the BUNSCAT RNA 
template control in lane 8 and cold CAT(-) RNA in lane 9. No positive sense CAT transcripts 
again were detected (Lanes 5 and 6) except for the cold CAT(+) probe control (Lane 10) 
when probed with the CAT(-) riboprobe.
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3.16 Discussion.
In this chapter, I have described the establishment and characterisation of a convenient in 
vivo transient expression system which utilised a chimeric, Bunyamwera virus-like S 
segment RNA transcript carrying an antisense CAT reporter gene. Transfection of this 
reporter RNA into cells expressing recombinant BUN virus proteins resulted in the detection 
of CAT activity. This indicated that the negative sense BUNSCAT RNA transcript, which 
could not have acted as a template for translation, was recognised by, and had interacted 
with, the recombinant BUN virus proteins to form a functional bunyavirus ribonucleoprotein 
(RNP)-like complex. Formation of this complex allowed the subsequent transcription of a 
positive sense RNA transcript from the BUNSCAT reporter RNA transcript. This is shown 
schematically in (Figure 3.15).
It was also shown that detection of CAT activity from the reporter transcript was dependent 
upon expression of proteins from both the BUN L and S segments. These proteins could be 
supplied by transient expression, either from recombinant vaccinia viruses, or from 
transfected plasmids using the vaccinia virus-T7 system.
Titration of the amounts of pTFBUNL and pTFBUNS plasmids added to the system 
determined optimal conditions for the assay. This suggests CAT expression was dependent 
on the amounts and the ratio of the plasmids transfected into the cells. It could be argued that 
a “checkerboard” style titration may have offered a finer optimisation of the system. 
However, this was not considered necessary, in view of the sufficient level of CAT activity 
that was obtained.
A time course experiment was performed to determine the optimal time for cell extract 
harvesting. It was decided that collection of cell extracts between the time points of 16 and 
24 hours post RNA transfection, gave a suitably strong CAT signal. Although the CAT 
signal increased slightly after 24 hours, until 36 hours post RNA transfection, it must also be 
considered that the CAT enzyme has a relatively long half life of 50 hours. Therefore, the 
increase noted at 36 hours time point may have been due to accumulation of the protein, 
rather than continued optimal expression. All further assays were thereby harvested at 24 
hours post infection. It was also shown that transfection of 3pg of BUNSCAT RNA gave a 
CAT signal that was consistent and sufficient for efficient detection and quantitation.
In order to demonstrate directly that the BUNSCAT RNA was being replicated in the assay, 
detection of positive sense transcripts was attempted using Northern Blot analysis. This 
proved unsuccessful. The inability to detect BUNSCAT positive sense RNA transcripts (i.e. 
BUNSCAT mRNA and antigenome RNA) by Northern blotting, despite the fact that CAT
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BUNSCAT
RNP
BUNSCAT
RNP
BUNSCAT
replication
transcription
BUNSCAT mRNA
Figure 3.15 Proposed recognition and transcription of BUNSCAT RNA by 
recombinant BUN viral proteins.
The diagram above describes how naked RNA is encapsidated by N protein, with a possible 
association of L protein, to form the RNP complex. The RNP can act as the template either 
for subsequent transcription to produce mRNA, or it can act as a template for replication.
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activity, indicative of the presence of positive sense transcripts, was obtained, may be 
explained by the fact that the CAT assay, because it is an enzymatic reaction, is considerably 
more sensitive than direct RNA detection. The level of replication in transfected cells may 
have been low, which would have resulted in a low number of genomic RNA transcripts, 
undetectable by RNA detection methods. Additionally, it is possible that only a small 
proportion of the cells from the given population (i.e. from any one dish) actually became 
successfully transfected with the BUNSCAT RNA transcript. This would have resulted in a 
low copy number of mRNA transcripts within the whole cell population, again possibly 
rendering positive sense transcripts undetectable by the RNA detection methods employed.
Finally, experiments with the BUNSCATmut-12 transcript, and the mutated L proteins, 
demonstrated the versatility of the CAT reporter system to study the effects of mutations in 
both the input reporter RNA, and the interacting recombinant BUN viral proteins.
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Chapter 4.
4.0 Protein requirements for transcription of BUNSCAT RNA.
4.0 Introduction.
As described in Chapter 3, transcription of the reporter BUNSCAT RNA required the 
protein products of the Bunyamwera virus L and S segments. These proteins are presumed 
to be necessary for the formation of a replication competent RNP complex. The bunyavirus 
L segment codes for only one structural protein, the L protein, which has been demonstrated 
to be the viral RNA-dependent RNA polymerase (Jin and Elliott, 1992). The S segment, 
however, encodes two polypeptides, N and NSs, which are translated from overlapping 
reading frames in a single mRNA species (Bishop et a l,  1982). As discussed previously, 
the N protein is the nucleocapsid protein while the function of the non-structural NSs protein 
is unknown. Both of these proteins are synthesised in the reporter assay from expression of 
the S segment, and therefore it was not known if both proteins are required for transcription 
of the reporter RNA.
This chapter describes experiments to determine whether both BUN S segment gene 
products, N and NSs, are required for transcription of the reporter RNA.
4.1 Supplying the N and NSs proteins from individual plasmids.
In order to investigate whether both N and NSs proteins were required for transcription in 
the reporter assay, it was necessary to obtain plasmids which expressed these proteins 
individually.
Initially it was planned to use plasmids which were designed previously in our laboratory to 
produce only N protein or NSs protein from the S segments of Bunyamwera virus (BUN) 
and Maguari virus (MAG), another member of the Bunyamwera virus serogroup. The 
strategy used to produce these N-expressing clones was to mutate the tandem ATG initiation 
codon (ATGATG) of the NSs ORF to AAGACG (at nucleotides 105-110 of the BUN virus 
S segment cDNA, and at nucleotides 93-98 for the MAG S segment cDNA). This mutation 
however, also caused a change in the amino acid residue (His to Glu) at position 7 in the 
overlapping N ORF. The resulting cDNAs were cloned under the control of a T7 promoter
80
Results and Discussion: Chapter 4
resulting in the plasmids pGEMBUNN (Elliott and Page, unpublished work), and 
pTZMAGN (Elliott and McGregor, 1989).
Plasmids which express only NSs were constructed by subcloning appropriate portions of 
the cDNAs, omitting the N protein initiation codon, downstream of a T7 promoter, to give 
plasmids designated pTZBUNNSs and pTZMAGNSs (Elliott and McGregor, 1989).
4.2 Verifying previously constructed plasmids, pGEMBUNN, pTZMAGN, 
pTZBUNNSs, pTZMAGNSs, by in vitro transcription /translation reactions.
The TNT coupled transcription/ translation system (Promega) was used to confirm that these 
constructs expressed the expected proteins. Reticulocyte lysates were programmed with 
pGEMBUNN, pTZMAGN, pTFBUNS pTZMAGS, pTZBUNNSs and pTZMAGNSs 
plasmid DNAs. The products of these reactions were analysed by SDS-PAGE (Figure 
4.1(A) and (B)). It can be seen that N protein was translated in reactions programmed with 
pGEMBUNN (Figure 4.1(A), Lane 4), pTZMAGN (Figure 4.1(B), Lane 2), pTFBUNS 
(Figure 4.1(A), Lane 1), and pTZMAGS (Figure 4.1(B), Lane 4), as expected. The NSs 
expressing plasmids (pTZBUNNSs and pTZMAGNSs) also produced proteins which 
migrated at the same rate as the NSs proteins expressed from the intact S segment plasmids 
(pTFBUNS and pTZMAGS). However, in reactions programmed with both pGEMBUNN 
and pTZMAGN (Lanes 4 (Figure 4.1(A)) and 2 (Figure 4.1(B)) small amount of a protein 
corresponding in size to NSs was detected. It is possible that translation of NSs protein was 
initiated at a ACG codon, (the product of mutating the NSs ORF tandem ATG from 
ATGATGto AAGACGV this would explain the expression of the NSs-like protein. The use 
of ACG as a translation initiation codon is rare in eukaryotic systems, but has been reported 
for the initiation of a adeno-associated virus coat protein (Becerra et al., 1985) and the 
Sendai virus C’ protein (Curren and Kolakofsky, 1988; Gupta and Patwardhan, 1988). The 
possibility that even a small quantity of NSs protein could be translated from the mutated 
BUN and MAG virus N clones would have compromised the validity of the experiment. 
Similarly, the generation of the histidine to glutamine amino acid substitution at position 7 of 
the BUN N protein amino acid sequence was not ideal. Therefore, a different strategy for the 
production of N protein without NSs was adopted.
4.3 Construction of new BUN and MAG S segment plasmids expressing N 
but not NSs protein.
Instead of mutating the tandem initiation codon, the third codon of the NSs ORF was 
mutated to a stop codon (TAG, Amber), which results in the termination of NSs translation,
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without mutation of the N protein overlapping reading frame (Figure 4.3). S segments of 
both BUN and MAG viruses, expressing N protein without NSs, were constructed using 
this strategy. These plasmids were named pBUNS(-NSs) and pMAGS(-NSs), respectively. 
The details of the PCR used to introduce these mutations, and the cloning of the constructs 
into the pTZ18U plasmid vector, are shown in Figure 4.3, and are described below.
The template for amplification of BUNS(-NSs) was pTFBUNS, and for MAG(-NSs) the 
template was pT7MAGS-R-T(|) (Dunn and Elliott, unpublished work) which contains the 
complete MAG S segment cDNA under control of a T7 promoter. These cDNA were 
amplified with oligonocleotides designed to mutate the third codon of the NSs ORF to a stop 
codon (TAG, (amber)). For BUN the mutating oligonucleotide was ED. 13 
(5'CGCGGATCCACCATGATTGAGTTGGAATTTCATGATGTAGCTGCTAAC), which is 
complementary to bases 86 to 121 (bold) of BUN S cDNA and introduces a stop codon in 
the NSs ORF by a C to A change (underlined) at position 112. The mutating oligonucleotide 
for MAG was ED 14 (5'GCGGGATCCACCATGATTGAACTTGAATTCAATGATGTAGCT 
GCTAAC) which is complementary to bases 74 to 109 (bold) of MAG S cDNA and 
introduces a stop codon in the NSs ORF by a C to A change at position 100. Both mutating 
oligonucleotides also contain a BamHl restriction enzyme site upstream of the cDNA 
complementary sequence to facilitate subsequent cloning.
The cDNAs were amplified using appropriate 5’ oligonucleotide and the same 3’ 
oligonucleotide BUN-S4 (5’ AGTAGTGTGCTCCACCT) which comprises the conserved 
3’ terminal 17 nucleotides of BUN and MAG S segments. PCR involved 25 cycles of heating 
at 93°C for 15 seconds, 40°C for 20 seconds, and 72°C for 70 seconds. The cDNA 
fragments were resolved by electrophoresis through a 1% agarose TAE gel and the correct 
sized fragment removed as a gel slice for further purification by GeneClean. The purified 
DNA fragments were end-repaired and phosphorylated, then digested with BamHI before 
being cloned by directional ligation into BamHVHincll digested pTZ18U. Clones were 
characterized by restriction enzyme digestion, and then sequenced to confirm their mutations. 
Suitable plasmid clones were selected and designated as plasmids pTZBUNS(-NSs) and 
pTZMAGS(-NSs).
4.4 Verifying proteins expressed by pTZBUNS(-NSs) and pTZMAGS(- 
NSs), by in vitro transcription/translation reactions.
The new Bunyamwera and Maguari S segment constructs, pTZBUNS(-NSs) and 
pTZMAGS(-NSs), were used to program TNT reticulocyte lysates, and the results shown in 
Figures 4.1 (Lane 2), and 4.2 (Lane 3). As can be seen from the lane 2 (Figure 4.1) and lane
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Figure 4.1 (A) Protein expression from BUN S cDNA expression clones in 
TNT (Promega) coupled in vitro transcrip tion /translation  reactions.
DNA from Bunyamwera virus S cDNA clones were used to program coupled in vitro 
transcription-translation reactions. The radiolabeled translation products were analysed on a 
15% SDS-polyacrylamide gel. The positions of the N and NSs proteins are indicated. 
Reactions were programmed with pTFBUNS (Lane 1), pTZBUNS(-NSs) (Lane 2), 
pTZBUNNSs (Lane 3) and pGEMBUNN (Lane 4). A band produced from reaction lysates 
programmed with pGEMBUNN, migrating at the same rate as the BUN NSs, is indicated on 
the gel above with a cross. This possible BUN NSs-like protein may have been produced as 
a result of translation initiation on the mutated initiation site ACG. No such band is present in 
lysates from reactions programmed with pTZBUNS(-NSs) (Lane 2).
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Figure 4.1 (B) Protein expression from M aguari virus S segment expression 
clones.
DNA from Maguari S segment cDNA clones were used to used program coupled in-vitro 
transcription-translation reactions. The radiolabeled translation products were analysed on an 
18% SDS-polyacrylamide gel. The positions of the N and NSs proteins are indicated. 
Reactions were programmed with pTZMAGS (Lane 5), pTZMAGN (Lane 6), pTZMAGS(- 
NSs) (Lane 7), and pTZMAGNSs (Lane 8). A band produced from reaction lysates 
programmed pTZMAGN, migrating at the same rate as Maguari virus NSs, is indicated on 
the gel above with a cross. This possible Maguari NSs-like protein may have been produced 
as a result of translation initiation on the mutated initiation site ACG. No such band is 
present in lysates from reactions programmed with pTZMAGS(-NSs) (Lane 7).
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ED.13 (BUN)
BamHl 74
ED. 14 (MAG) QQCj3GAT0CfiCCATCATT^^
pTFBUNS . . . TITAATGAiriGAGTIQSAATITC .
N M I E L E F N D V A A ____
NSs M M  S L L.  .
pTZBUNS(-NSs) . . . TTAATGATTCAGTTCGAATTICATGATGTAGCTCCTA.
N M I E L E F N D V A A ____
(NSs) M M *
pTZMAGS • • . TCAATGATKWOTIGAATICAATGATGTCGCTGCrA. .
N M I E L E F N D V A A ..........
NSs M M S L L ____
pTZMAGS(-NSs) . . . TCAATGATTGZVOirGAATTCTVATGATGTZ^GCTGITA. .
N M I E L E F N D V A A ..........
(NSs)  M M *
Figure 4.2 Strategy employed to disrupt the NSs coding sequence o f  
Maguari and Bunyamwera virus S segments.
(A) Schematic of oligonucleotides ED.13(BUN) and ED.14(MAG). (B) Nucleotide and 
amino acid sequences of the wild type and NSs-minus mutants of Bunyamwera virus 
(nucleotides 93-119), and Maguari virus (nucleotides 91-107) S segments. The ATG 
initiation codons of N and NSs ORFs are underlined, and the C to A mutations, which 
results in the introduction of a stop codon in the NSs ORF of both proteins, are denoted in 
bold type and underlined twice. For the Bunyamwera virus S segment, the mutated 
nucleotide is at position 112 (A), and for the Maguari virus S segment, position 100 (A).
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3 (Figure 4.2), no NSs protein was produced from either of the new constructs pTZBUNS(- 
NSs) and pTZMAGS(-NSs). These plasmids were then used in conjunction with 
pTFBUNL, to determine the S segment protein requirements for transcription of the 
BUNSCAT reporter RNA.
4.5 Determination of the minimum protein requirements for CAT activity in 
the BUNSCAT reporter assay.
The N and NSs expressing plasmids were incorporated into the BUNSCAT reporter assay to 
determine which proteins were required for the production of CAT activity. The BUNSCAT 
reporter assay was performed as described previously (Chapter 3), with the exception that 
the S segment proteins were supplied by the new constructs. N and NSs expressing 
plasmids were transfected into vTF7-3 infected cells at two concentrations: 2.5pg and 5pg 
DNA. pGEMl 1 DNA was also added, as required, to maintain a consistent amount of total 
DNA transfected.
The results of this experiment are shown in Figure 4.4. CAT activity was detected when the 
BUN L protein was expressed in conjunction with just the BUN N protein i.e. in the 
absence of the BUN NSs (Lanes 2 and 5). No CAT activity was detectable when the BUN L 
protein was expressed with just the BUN NSs (Lanes 3 and 6). This result indicates that the 
L and the N proteins of Bunyamwera virus are both necessary and sufficient for the 
transcription of BUNSCAT RNA in the reporter assay. These results also indicate that there 
is no requirement, in the reporter assay, for the expression of NSs.
Similar results were obtained with Maguari virus S segment cDNAs : BUN L protein 
expression would only result in measurable CAT activity when co-expressed with MAG N 
protein (Lanes 8 and 11), and not with MAG NSs protein (Lanes 9 and 12). Interestingly, in 
addition to supporting the observation that NSs is not required for production of CAT 
activity from the reporter assay, this experiment also demonstrates that the BUNSCAT RNA 
could be transcribed by the BUN L protein in cooperation with a heterologous N protein, i.e. 
that of MAG virus S segment cDNA.
4.6 Discussion.
The findings from this study, that the L and the N proteins of bunyavirus are both necessary 
and sufficient for the transcription of BUNSCAT RNA in the reporter assay, can be 
extrapolated to suggest that the only L and N proteins are required, in conjunction with an
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pTZBUNS(-NSs) - 2.5 - 2.5 5.0 - 5.0
pTZBUNNSs - - 2.5 2.5 - 5.0 5.0
pG EM ll - 2.5 2.5 - 5.0 5.0 -
pTFBUNS 1.0 - - - - - -
Lane 1 2 3 4 5 6 7
m m | * *
pTZMAGS(-NSs) 2.5 2.5 5.0 5.0
pTZMAGNSs - 2.5 2.5 - 5.0 5.0
pG EM ll 2.5 2.5 - 5.0 5.0 -
Lane 8 9 10 11 12 13
Figure 4.3 Protein requirem ents for transcription of BUNSCAT RNA.
CV-1 cells were infected with vTF7-3, then transfected with 5pg pTFBUNL and varying 
amounts (indicated above, in pg), of Bunyamwera or Maguari virus S segment cDNA 
expressing plasmids (Lanes 1 to 7, and Lanes 8 to 13, respectively). pGEM ll DNA was 
added to some samples, as required, to maintain the overall amount of transfected DNA. The 
cells were subsequently transfected with the same preparation of BUNSCAT RNA, and the 
cell extracts were assayed for CAT activity 24 hours post infection. It can be seen from 
Lanes 2 and 5, that CAT activity was detected in cells expressing only BUN L and N 
proteins. No significant increase or decrease is noted when cells are supplied with BUN NSs 
protein, in addition to L and N proteins (Lanes 4 and 7). No CAT activity was detected in 
cells expressing BUN L and NSs proteins (Lanes 3 and 6). In Lanes 8 and 11, it can be seen 
that Maguari virus N protein can co-operate with Buyamwera virus L protein to produce 
detectable CAT activity from BUNSCAT RNA.
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appropriate RNA molecule, to reconstitute a transcriptase active RNP structure. This is in 
agreement with the observations of others. It has been shown previously that transcriptase 
activity can be detected in detergent disrupted bunyavirus preparations (BUN, Jin and Elliott, 
unpublished results; La Crosse virus (LAC), Patterson et al., 1984; GER, Gerbaud et al., 
1987). Given that NSs is a putative non-structural protein, and detergent disrupted 
preparations made from intact virus particles would presumably contain only structural 
proteins, the suggestion is that there is no requirement, at least in the stages of primary 
transcription, for the presence of NSs.
Recently, Lopez et al. (1995) described a similar CAT reporter system to study Rift Valley 
fever virus (RVF: Bunyaviridae\ Phlebovirus genus) RNA transcription. They used a 
reporter RNA construct, based on the RVF S segment designated CAT-RVF-Sg, which 
consisted of an anti sense CAT gene, flanked by the 5’ and 3’ terminal untranslated regions 
of the RVF S segment. Normally, the S segment of RVF encodes a nucleocapsid, N protein 
and a non-structural protein, NSs, but the reading frames for these proteins are in an 
ambisense arrangement. The reporter template however, was designed so that it contained 
only a single ORF, i.e. that of the antisense CAT gene, rather than two ambisense ORFs. 
Using this reporter system, Lopez et a l demonstrated that RVF L and N proteins were 
necessary and sufficient for transcription of the RNA template, and that co-expression with 
RVF NSs protein had neither an additive, nor an inhibitory effect on the level CAT activity 
obtained. This may have been expected as the biology of RVF virus dictates that NSs 
expression in a virus-infected cell does not result from primary transcription, but from 
secondary transcription from the viral complementary RNA (cRNA), i.e. after replication 
(Giorgi, 1996).
However, it should be noted that in replacing the ambisense coding regions with the CAT 
open reading frame, the intergenic region between the N and NSs ORFs was omitted (Figure 
1.2). Therefore, the RVF reporter transcript did not contain the authentic intergenic 
sequences of the RVF S segment. It has been suggested that both the sequence and structure 
of the intergenic region are thought to play some role in the transcription termination 
mechanism of mRNA in Punta Toro and Toscana Phleboviruses (Emery and Bishop, 1987; 
Gro et al., 1992; Giorgi, 1996; Qin et al., 1998), recently provided evidence that 
demonstrates the importance of this region. They showed that a mutant tomato spotted wilt 
virus (TSWV-10), with an S segment which contained a 33 nucleotide duplication in the 
intergenic region of this segment, suffered a selective disadvantage in forming genome 
reassortants i.e. in a mixed virus infection, this mutated S segment was not selected into 
reassortant viruses. Thus the authors concluded that the intergenic region correlated with the 
competitiveness of this genome segment in reassortment. If the intergenic region is important 
in this context, then the mRNA transcripts produced from the RVF reporter system would
84
Results and Discussion: Chapter 4
not have the correct 3’ terminus, and would possibly resemble a capped antigenome-like 
transcript.
Nevertheless, assuming NSs is truly a non-structural protein of RVF virus, the implication 
would be that it is not necessary for either primary transcription or replication events, 
although this does not rule out a regulatory role for the protein. It should be considered, 
however, there is no evidence as yet to suggest that NSs of RVF and NSs of BUN are 
functionally homologous.
The results presented in this chapter have also demonstrated that Bunyamwera virus L 
protein was able to transcribe BUNSCAT RNA in the presence of heterologous N protein, 
expressed from a Maguari virus S segment cDNA. This may not be altogether surprising in 
light of the observations made previously by Pringle et al. (1991) (Pringle, 1996), that 
Bunyamwera and Maguari viruses can form reassortments (for example BUN(L), BUN(M), 
MAG(S)), as a result of a mixed infection.
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Chapter 5.
5.0 The interaction of various heterologous S segment encoded 
proteins with Bunyamwera virus L protein.
5.0 Introduction.
Previously, we reported the cloning and sequencing of S segments from a number of 
bunyaviruses from the Bunyamwera serogroup (Batai (BAT), Cache Valley (CV), Guaroa 
(GRO), Kairi (KRI), Main Drain (MD) and Northway virus (NOR)), and also one virus 
from the California serogroup (Lumbo virus (LUM)) (Dunn et a l., 1994). It has been 
demonstrated previously that a number of these viruses could form reassortments by the 
exchange of genome segments as a result of mixed infections (reviewed in Pringle, (1991) 
and Elliott, (1996)).
The purpose of the experiments presented in this chapter was to investigate whether the 
Bunyamwera virus L segment protein could act in concert with heterologous S segments 
proteins to transcribe the BUNSCAT reporter RNA.
5.1 Construction of heterologous S-segment expression plasmids.
In order to use the BUNSCAT reporter assay to investigate the interaction of different 
heterologous N and NSs proteins with the Bunyamwera L protein, it was necessary to 
subclone the heterologous S segments described in Dunn et al. (1994) into an expression 
plasmid under the control of a T7 promoter. Therefore, the full length cDNAs of various 
heterologous S segments were excised as XbaVSacl fragments from their original pUCl 18 
plasmid, and subcloned into pTZ18U. The resulting clones were digested with appropriate 
restriction enzymes and sequenced to confirm the presence and orientation of the insert. 
These were denoted: pTZBATS (Batai); pTZCVS (Cache Valley); pTZGROS (Guaroa); 
pTZKRIS (Kairi); pTZLUMS (Lumbo); pTZMDS (Main Drain); and pTZNORS 
(North way).
Full length Bunyamwera and Maguari S segment cDNAs were also cloned into pTZ18U. To 
achieve this, full length cDNA fragments were amplified from pT7-BUNS-R-T<() and pT7- 
MAGS-R-T(|> (Dunn and Elliott, unpublished work) with the bunyavirus S segment specific
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5’ terminal primer BUN-S4 (5’ AGTAGTGTACTCCACAC), and the 3’ terminal primer 
BUN-S3 (5’ AGTAGTGTGCTCCACCT) by PCR. PCR fragments were purified and end 
repaired/ kinased, and cloned into Smal cut pTZ18U. Clones were digested with appropriate 
restriction enzymes and sequenced to confirm the presence and orientation of the insert. The 
resulting clones were named pTZBUNS and pTZMAGS.
5.2 In vitro expression of N and NSs proteins from various bunyavirus S 
segment clones.
The expression of N and NSs proteins from these plasmids was confirmed by in vitro 
transcription/translation reactions (Figure 5.1). Plasmid DNA from each clone was used to 
program a TNT coupled transcription/ translation reaction (Methods 2.6.1), the products of 
which were analysed by SDS-PAGE electrophoresis. As indicated in Figure 5.1, all 
constructs expressed both N and NSs proteins. The slight differences in electrophoretic 
mobility detected between the Bunyamwera serogroup virus N proteins, which all have 233 
amino acids, has been noted previously for proteins detected in infected cell extracts and is 
thought to be due to differences in amino acid composition (Elliott, 1985). LUM virus 
(which is from the California serogroup) encodes an N protein of 235 amino acids in length, 
which is the case for all California serogroup viruses thus explaining its slightly slower 
migration.
All S segment clones gave detectable NSs proteins. The NSs protein of GRO virus 
(indicated by the arrow shown in Lane 7) has a notably faster migration than the NSs 
proteins produced by other clones, as described previously (Dunn et al., 1994). The NSs 
protein of KRI virus is larger than the others (109 amino acids). This protein appears as a 
smear on the gel (as indicated by the arrow shown in Lane 8). This smearing is an artifact of 
the reticulocyte lysate reaction, and due to the protein co-migrating with globin, a constituent 
of reticulocyte lysate.
5.3 Transfection of heterologous S segment RNAs into the BUNSCAT 
reporter assay.
The protocol was essentially the same as that described in Figure 3.3. Following infection 
with vTF7-3, cells were transfected with pTFBUNL and varying amounts of the appropriate 
heterologous S segment plasmid. This was followed by transfection with equal amounts of 
BUNSCAT RNA, transcribed from the same transcription reaction.
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Figure 5.1 Expression of various bunyavirus S segment clones.
The DNA from the different S segment clones in T7-promoter plasmids, were used to 
program in vitro transcription/translation reactions. The radiolabeled translation products 
were analysed by electrophoresis on a 15% SDS-polyacrylamide gel. Samples were loaded 
on the gel as follows: pTFBUNS (Lane 1); pTZCVS (Lane 2); pTZNORS (Lane 3); 
pTZMAGS (Lane 4); pTZBATS (Lane 5); pTZMDS (Lane 6); pTZGROS (Lane 7); 
pTZKRIS (Lane 8) and pTZLUMS (Lane 9). The positions of the N and NSs proteins are 
indicated at the side of the gel (denoted by large arrows). The faster migrating NSs of GRO 
is indicated at the side of the gel (indicated by a small arrow, Lane 7). The NSs protein of the 
KRI S segment, migrates slower on the gel and appers as a smear (indicated by a small 
arrow, Lane 8). This is due to co-migration with the heavy globin protein band, a component 
of the in vitro transcription/translation reaction.
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Figure 5.2 CAT activity in cells expressing BUN L protein and 
heterologous S segment proteins.
Transfections were set up as described (Methods 2.5.2). vTF7-3 infected cells were 
transfected with 5 pg pTFBUNL and varying amounts, -either lpg, 2.5pg, 5pg, or lOpg 
heterologous S segment plasmid DNA (as indicated above). Cell extracts were harvested and 
assayed for CAT activity 16 hours post transfection with BUNSCAT RNA, as described 
previously. It was found that the maximum CAT activity (over the range of transfected 
DNA), for each heterologous S segment tested, was directly related to the percentage 
homology of each particular S segment to the BUN S sequence. Also shown in the figure are 
the CAT activities measured for each heterologous S segment, expressed as a percentage of 
the CAT activity measured for the “wt” control, the homologous BUN S : BUN L 
combination.
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Cells were transfected with varying amounts of DNA in order to optimise the ratio of 
heterologous S to BUN L segment gene products expressed. The maximum CAT activity 
obtained for each heterologous S : BUN L segment combination was compared to the 
activity gained from the BUN S : BUN L segment combination. The results of this are also 
shown in Figure 5.2. Only half of the amount of cell extract (protein), was assayed for the 
control samples (i.e. BUN S : BUN L assays) compaired to the herologous S segments. 
This was taken into consideration when the overall percentages of CAT activity were 
calculated for the heterologous S segment combinations.
It was found that the Bunyamwera virus L protein was able to transcribe the reporter 
BUNSCAT RNA, resulting in a significant level of CAT activity, when acting in concert 
with the S segment proteins from BAT, NOR, MAG and MD viruses, but not with the S 
segment proteins of KRI, GRO and LUM viruses.
With the exception of the MD virus, the S segment of which is able to interact in the reporter 
assay, but fails to produce reassortments, the observed compatibility of bunyavirus S 
segment proteins in the CAT reporter system, reflects the ability to form reassortments by 
genome segment exchange in the course of a mixed infection.
Figure 5.3 displays a dendrogram adapted from Dunn et al.(1994), showing the relationship 
between the N protein amino acid sequences of 15 bunyaviruses. The distance along the 
horizontal axis of the dendrogram is proportional to the similarity between sequences. The 
viruses whose S segments can successfully interact in the reporter assay, and can also form 
reassortments as a result of mixed infection, are also found closely grouped together on this 
diagram. Additionally, those unable to interact in the reporter assay are found outwith the 
close groupings. In other words, the degree of homology of the N proteins from these 
viruses correlate with their ability to interact with BUN polymerase in the reporter assay.
5.4 Discussion.
The results shown in this chapter demonstrate that the Bunyamwera virus L protein was able 
to transcribe the reporter BUNSCAT RNA, in concert with certain heterologous bunyavirus 
S segment proteins. Some of the heterologous S segments studied, were unable to mediate 
the transcription reaction. The heterologous S segments that produced significant levels of 
CAT activity, were those in which the N protein was most closely related to Bunyamwera 
virus N protein, at the amino acid level (Figure 5.3).
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Figure 5.3 Dendrogram showing the relationship between the bunyavirus N 
protein amino acid sequences.
The diagram above displays a dendrogram (adapted from Dunn et al., (1994)), showing the 
relationship between the N protein amino acid sequences of 15 bunyaviruses from three 
serogroups was generated by the PILEUP program in the GCG Wisconsin Package (Version 
9)™. The dendrogram represents the clustering order of similarity between the N proteins 
after pairwise comparisons by the program to create the alignment figure shown above. The 
distance along the horizontal axis of the dendrogram is proportional to the similarity between 
sequences. The figure also displayes the relative CAT activity detected from those S- 
segments above that were applied to the reporter system. Bunyaviruses not previously 
described in this chapter were Aino virus (AINO) and Tinaroo virus (TIN) of the Simbu 
serogroup, La Crosse virus (LAC), Inkoo virus (INK) and Trivittatus virus (TVT) of the 
California serogroup and Germiston virus (GER) another member of the Bunyamwera 
serogroup.
CAT
Simbu
serogroup
California
serogroup
Bunyamwera
serogroup
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With one exception, compatibility in the CAT reporter system, correlated with the ability of 
certain bunyaviruses to form reassortments by genome segment exchange in the course of a 
mixed infection (reviewed in Pringle, 1991). Therefore, as BUN has been shown to reassort 
with BAT, MAG, NOR, so have the BUN L segment gene products been shown here to 
cooperate with the S-segment gene products of these viruses to produce transcription of the 
BUNSCAT reporter RNA. Similarly, as BUN has been observed to be unable to produce 
reassortments with KRI, GRO, or LUM, so do the products of the BUN L segment fail to 
interact with the S-segment product of these viruses in the BUNSCAT reporter system. 
Furthermore, it was shown that this compatibility also correlated with a high percentage of 
sequence homology with the BUN N protein.
It is not clear at what level the KRI, GRO and LUM S segment proteins fail to interact with 
the BUN L protein to result in non-transcription of BUNSCAT RNA. The possibilities are 
as follows: either a failure of the heterologous N protein to encapsidate reporter RNA 
transcripts, or possibly a failure of the heterologous N protein to interact with the BUN L 
protein.
5.6 Future work.
To determine if the failure to form a functional nucleocapsid occurred at the level of RNA-N 
protein interaction, the following experiment could be performed. A radioactive BUNSCAT 
transcript could be transfected into cells expressing BUN L and one of the heterologous S 
segments. UV crosslinking, followed by SDS-PAGE analysis of cell lysates, could then be 
performed to determine if the N protein was associated with the BUNSCAT RNA. To 
determine if the failure occurred at the level of L protein-N protein interaction, the same 
transfection experiment could be performed, although with radiolabeled proteins, and the 
resulting lysates probed by chemical crosslinking.
In future work, the fact that some heterologous N proteins are not transcriptionally active in 
the reporter system {i.e. KRI, GRO and LUM), could be exploited to our advantage. It may 
be possible to map regions of importance in the BUN N protein, by creating chimeric N 
proteins between BUN N and the non-active heterologous N proteins. Figure 5.4 explains 
how one of these chimeras could be achieved. The S segments from both BUN and KRI 
share a unique restriction site within the N coding region, therefore BUN/KRI and 
KRI/BUN chimeras can be easily constructed. The use of the Kpnl site at nucleotides 3ST- 
392 in BUN S segment cDNA, and nucleotides 383-388 in KRI S segment cDNA, along 
with a site unique to the multiple cloning site will allow the construction of chimeras 
BUN/KRI N, and a KRI/BUN N protein, by the exchange of 102 amino acids between the
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pTZBUNS —|_T7
Kpnl Kpnl
Kpnl X Kpnl
pTZKRIS - pf7
pTZB UN/KRIS -jT7
Kpnl Kpnl
Kpnl Kpnl
pTZKRI/BUNS —pfT
Figure 5.4 Construction of the proposed N protein chimeras of BUN and 
KRI N proteins.
The initial construction of a chimeric BUN/KRI N protein, and a KRI/BUN N protein could 
be easily achieved by the subcloning of a Kpnl fragments from pTZKRIS and pTZBUNS. 
The orientation of the insert could be checked by restriction digestion, and fidelity of 
sequence and reading frames, by sequencing.
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cDNAs of each of these segments, without altering the reading frame of the N and NSs 
proteins (Figure 5.4).
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Chapter 6.
6.0 Construction and expression of an antigenomic BUNSCAT 
construct, pBUNSCAT(+).
6.0 Introduction.
As has been discussed previously, all bunyavirus S segment sequences are conserved for the 
first 15 nucleotides at the 3’ and 5’ termini, and with the exception of one mismatch at 
position 9, the 3’ and 5’ sequences are complementary. It is presumed that the promoters and 
c/A-acting signals required for replication and transcription reside in these regions. The 
genomic RNA promoter stimulates transcription with capped primers, whereas the 
antigenomic promoter does not (reviewed in Elliott, 1996), pointing to a mechanism 
whereby the BUN polymerase can distinguish between them.
In this chapter, an antigenome CAT reporter construct is described, which was designed to 
investigate the mechanism of differentiation between the two promoters.
6.1 Construction of pBUNSCAT(+).
Two oligonucleotides (ED. 17 and ED. 18), complementary to the 3’ and 5’ BUN S termini 
respectively, were designed to amplify the BUNSCAT reporter construct from pBUNSCAT 
(Figure 6.1). The resulting PCR fragment was digested with Xba\ and Sacl, and 
directionally cloned into appropriately cut pUC118. The resulting clones were sequenced 
into the CAT open reading frame to confirm the orientation and fidelity of the insert 
sequence. After sequencing, three suitable clones were selected which had the insert in the 
correct orientation, with the T7 promoter upstream of the coding sequence, and which had 
the Bbsl site intact, and had no spurious misincorporations. These constructs were denoted 
pBUNSCAT(+), and the clones numbered 11,12 and 13.
pBUNSCAT(+), therefore, contained the complementary sequence of pBUNSCAT under 
the control of the T7 promoter, such that transcripts from this construct would be of message 
sense (i.e. positive polarity). These message sense transcripts would essentially be the 
equivalent of BUN S antigenomic transcripts. Again, as in the case of pBUNSCAT, 
transcription of pBUNSCAT(+) would initiate from a truncated T7 promoter at the 5’ A
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Figure 6.1 Templates and primers used in the construction o f  
pBU N SC A T(+).
pBUNSCAT(+) was constructed by PCR using pBUNSCAT as the template, and the 
primers ED. 17 (5’ ATTCG AGCTCT AAT ACG ACTC ACT AT A AGT AGTGT ACTCC AC A 
CTACAAAO and ED. 18 (5’ AGACTCTAGAAGACGCAGTAGTGTGCTCCACCTA A ) . 
The region of sequence of primer ED. 17 which is underlined, corresponds to the 
complement of the last 24 nucleotides of the BUN S segment 3’ UTR. This sequence is 
immediately preceded by a T7 promoter, and a Sacl restriction site, included for cloning 
purposes. The region of sequence of primer ED. 18 which is underlined, corresponds to the 
first 26 nucleotides of the BUN S segment 5’ UTR. The remainder of the sequence an Xbal 
site, included for cloning purposes, and an inverted Bbsl site. This site allows run-off 
transcripts to terminate at the correct 3’ nucleotides. The PCR conditions were 93°C for 30 
seconds, 62°C for 30 seconds, and 72°C for 80 seconds, for 30 cycles. The resulting PCR 
fragment was purified from a 1% TAE gel by silica matrix absorption, digested with Xbal 
and Sacl, and ligated into Xbal/Sacl digested pUC118. Three clones were selected for 
screening. These were denoted pBUNSCAT(+) -11, -12, and -13.
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residue of the BUN S antigenome, and would terminate at the exact 3’ residue of the BUN S 
antigenome, due to linearisation of the plasmid by Bbs\. Thus T7 transcripts derived from 
pBUNSCAT(+) would have the authentic termini of the BUN S antigenome, and would 
contain a CAT ORF, flanked by the 5’ UTR (85 nucleotides) and 3’ UTR (174 nucleotides) 
of a BUN S antigenome.
6.2 Confirmation that the CAT gene in the pBUNSCAT(+) reporter 
construct was active.
To confirm that the CAT gene in the pBUNSCAT(+) gene was active, 1 pig of plasmid DNA 
was transfected into CV-1 cells which had been pre-infected with vTF7-3. At 20 hours post 
infection, cells were harvested and cell lysates assayed for CAT activity. The results are 
shown in Figure 6.2, and it can be seen from Lanes 2, 3 and 4, that all three pBUNSCAT(+) 
clones contained an active CAT gene.
6.3 Transfection of BUNSCAT(+) RNA transcripts.
Run-off RNA transcripts were transcribed from Bbsl linearised pBUNSCAT(+) constructs 
(Figure 6.3). The RNA transcripts from each reaction were quantified by TCA precipitation, 
and 32P counting (Methods 2.4.2).
The RNA transcripts from three independent clones of pBUNSCAT(+), along with RNA 
transcripts from pBUNSCAT included as a control, were used in the reporter assay. 
Equivalent amounts of each transcript were transfected into either mock infected cells, cells 
infected with vTF7-3, or cells transiently expressing the viral proteins of the BUN L and S 
segments. Cells were harvested, and extracts assayed for protein concentration as described 
previously, before equivalent amounts were assayed for CAT activity. Thus CAT activity per 
pg of protein was calculated for each transfection.
It was thought that the BUNSCAT(+) RNA transcripts, when transfected into cells, could in 
theory, act as a template for translation. However, as can be seen from Figure 6.4 (A) 
(Lanes 2, 3 and 4), no CAT activity was detected when BUNSCAT(+) RNA was transfected 
into mock infected cells, suggesting therefore, that translation did not occur. CAT activity 
was detected in cells which had been infected with vTF7-3, in the absence of BUN L and S 
segment proteins (Figure 6.4 (A), Lanes 10, 11 and 12). This observation suggests that a 
vaccinia virus encoded activity, such as mRNA capping by guanylyltransferase, enables 
translation of the BUNSCAT(+) RNA by host cell proteins. However, in cells which had 
been supplied with BUN L and S segment proteins, CAT activity was markedly increased,
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Figure 6.2 Confirm ation that the CAT gene in the pBUNSCAT(+) reporter 
construct is active.
CV-1 cells were infected with vTF7-3, and then transfected with lpg of plasmid DNA. 
Following a 3 hour incubation at 37°C, 1ml of growth medium was added, and the 
incubation continued overnight. At 20 hours post infection, cells were harvested and cell 
lysates assayed for CAT activity. In lanes 2, 3 and 4, cells have been transfected with DNA 
from pBUNSCAT(+) reporter construct, clones 11, 12 and 13 respectively. In lane 1, to 
provide a positive control, cells have been transfected with pBUNSCAT DNA. As can be 
seen in lanes 2, 3 and 4, all three pBUNSCAT(+) clones contained an active CAT gene.
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Figure 6.3 In vitro transcrip tion of reporter RNA from B b s I linearised 
pBUNSCAT(+) tem plates.
A 1% TBE agarose gel was loaded with 4fll of a transcription reaction which had been 
incubated for 20 minutes at 37°C with 5 units of RQ1 DNase. Lanes 3, 4 and 5 contain 
the RNA transcribed from Bbsl linearised pBUNSCAT(+) constructs, clones 11, 12 
and 13, respectively. Lane 2 contains RNA transcribed from pBUNSCAT (also 
DNasel treated). Lane 1 contains XBstEll markers (0.5 pg). The RNA transcribed in 
each reaction was quantified by TCA precipitation, and ?2P counting (Methods 2.4.2).
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Figure 6.4 Replication/Transcription of BUNSCAT(+) RNA by recom binant 
BUN viral proteins.
Equivalent amounts of three independent BUNSCAT(+) RNA transcripts, and a control 
BUNSCAT RNA transcript, were transfected into (A) mock infected cells (Lanes 1-4), 
vTF7-3 infected cells (Lanes 5-8), and vTF7-3 infected cells transiently expressing 
recombinant BUN L and S segment proteins (Lanes 9-12). Cell extracts were harvested 20 
hours post infection, and CAT protein concentration determined prior to assaying for CAT 
activity. No CAT activity was detected when the positive sense BUNSCAT(+) transcripts 
were transfected into mock infected CV-1 cells. In vTF7-3 infected cells, CAT activity was 
detected following transfection of BUNSCAT(+) RNA (Lanes 6, 7 and 8). Levels of CAT 
activity were markedly increased when BUN proteins were transiently expressed in vTF7-3 
infected cells (Lanes 10, 11 and 12). (B) To confirm that BUNSCAT(+) transfected cell 
extracts truly exhibited a higher CAT activity than vTF7-3 infected samples, cell extracts 
from lanes 5-12 shown above, were diluted 1 in 10, and re-assayed. Lanes 5-12 on this TLC 
plate highlight the increase in CAT activity in cells expressing BUN proteins.
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such that almost all the chloramphenicol was completely acetylated. The cell lysates from 
Lanes 5 to 12, were re-assayed, with just one tenth of the quantity of extract tested 
previously, to highlight the increase in CAT activity (Figure 6.4 (B)).
6.4 Attempted BUN virus rescue of BUNSCAT(+) (anti genome) and 
BUNSCAT (genome) transcripts.
It had been determined from previous experiments that both the BUNSCAT and the 
BUNSCAT(+) RNA transcripts can be recognised, encapsidated and expressed by 
recombinant BUN viral proteins (Chapter 3 and this chapter). Therefore, it might also be 
possible, during an ongoing infection of a cell by Bunyamwera virus, to introduce the BUN- 
like RNA transcripts into the cytoplasm of cells, so that these RNAs might be recognised by 
viral proteins, encapsidated, transcribed and possibly packaged into virus like particles. If so 
this would provide a means to study signals encoded by the reporter transcript for these 
events.
To investigate whether Bunyamwera virus dependent transcription of BUNSCAT and 
BUNSCAT(+) RNA was possible, CV-1 and C6/36 cells were either mock infected or 
infected with BUN virus at 10 pfu/cell for 3 hours before the inoculum was removed. 
Monolayers were washed once with OptiMEM before 3 pg of BUNSCAT or BUNSCAT(+) 
were transfected into the cell monolayers as described previously. Cells and supemates were 
harvested 24 hours later, and cell extracts assayed for CAT activity (Figure 6.5).
As shown in figure 6.5, no CAT activity was detected from mock infected or BUN infected 
CV-1 cell lysates when transfected with either transcript.
When C6/36 cells were either mock transfected or transfected with BUNSCAT, similarly, no 
CAT activity was detected. Transfection of BUN infected C6/36 cells with BUNSCAT(+) 
resulted in a small but detectable amount of CAT activity. This signal, however, was also 
present in C6/36 cells which had not been infected with helper virus although at a lower level 
(Figure 6.6A). Since the CAT signal from cells which had been infected with helper virus 
was slightly higher than cells which had no helper virus, it was decided to investigate 
whether the viral-like BUNSCAT(+) transcript might have been replicated and packaged into 
virus-like particles in the C6/36 cells. Therefore, the supernatant from the transfected cells 
the which had also been infected with helper virus, was used to infect fresh plates of C6/36 
cells. The lysates from these cells were subsequently assayed for CAT activity, but no signal 
was detected, indicating that replication and packaging was unlikely to have occurred (Figure 
6.6B).
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Figure 6.5 Expression of BUNSCAT and BUNSCAT(+) RNA during a BUN 
virus infection of CV-1 cells.
CV-1 cells were either mock infected or infected with BUN virus at 10 pfu/cell for 3 hours 
before the inoculum was removed. Monolayers were washed once with OptiMEM before 3 
pg of BUNSCAT (Lanes 3, 4, 9 and 10) or BUNSCAT(+) (Lanes 5, 6, 11 and 12) were 
transfected into the cell monolayers as described previously. Cells and supernates were 
harvested after 24 hours, and cell extracts assayed for CAT activity.
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Figure 6.6 Expression of BUNSCAT and BUNSCAT(+) RNA during a BUN 
virus infection of C6/36 cells.
(A) C6/36 cells were either mock infected or infected with BUN virus at 10 pfu/cell for 3 
hours before the inoculum was removed. Monolayers were washed once with OptiMEM 
before 3 pg of BUNSCAT (Lanes 3, 4, 9 and 10) or BUNSCAT(+) (Lanes 5, 6, 11 and 12) 
were transfected into the cell monolayers as described previously. Cells and supernates were 
harvested after 24 hours, and cell extracts assayed for CAT activity. (B) To determine if 
BUNSCAT(+) had been packaged into virion like particles, the media from dishes 5+6 as a 
control and the media from dishes 11 + 12 were used to infect fresh C6/36 cell, lanes 13 and 
14 respectively. Cell lysates were harvested 24 hours postinfection and assayed for CAT 
activity (Lanes 13 and 14). Lane 15 is a repeat of lane 12.
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That the BUNSCAT and BUNSCAT(+) transcripts were not recognised by the BUN helper 
virus proteins is perhaps not surprising, as similar results were found for other Bunyaviridae 
genus reporter systems (HTN virus, Schmaljohn (personal communication); RVF virus, 
Lopez and Bouloy, (personal communication); and PUU virus, (Shi and Elliott, personal 
communication). Luytjes et al. (1989), investigating influenza A virus, also reported that 
naked RNA transfected into cells which were subsequently infected with helper virus, failed 
to give rise to reporter activity.
However, the observation that transfection of the BUNSCAT(+) transcripts into C6/36 cells 
resulted in a small but detectable CAT signal, both in the presence and the absence of helper 
virus, is not easily explained. In theory, eukaryotic cells require a cap structure to be present 
at the 5’ end of the mRNA transcript to achieve efficient translation. One hypothetical 
explanation might be that C6/36 cells may not have such a strict requirement for a capped 
structure, and that cap-independent translation may be possible from the BUNSCAT(+) 
RNA transcript.
In conclusion therefore, it was found that the BUNSCAT and BUNSCAT(+) constructs 
proved were not useful as reporter constructs for helper virus rescue studies.
6.5 Discussion.
In this chapter, a pBUNSCAT(+) reporter construct was described which was designed to 
allow the generation of positive sense RNA transcripts. These transcripts would represent 
the antigenomic version of BUNSCAT RNA (Chapter 3).
It was found that when BUNSCAT(+) transcripts were transfected into cells expressing the 
gene products of the BUN L and S segments, a high level of CAT activity was obtained. 
This CAT activity was elevated above the background CAT activity obtained from 
transfection of BUNSCAT(+) RNA into vTF7-3 infected cells.
In an authentic bunyavirus infection, the antigenomic (cRNA) transcripts are not naked, but 
are encapsidated in viral proteins to form nucleocapsid structures within the cell. 
Antigenomic transcripts, incorporated within nucleocapsids, represent an intermediate step in 
the replication process of the virus genome. Therefore, the elevated CAT activity detected in 
cells transiently expressing BUNL and S segment proteins suggests that the BUNSCAT(+) 
transcripts were recognised by these proteins, and interacted with them to form functional 
nucleocapsids: these nucleocapsids then served as templates for the transcription of a
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negative sense BUNSCAT RNA transcript. The negative sense BUNSCAT RNA then acted 
as a template for transcription of BUNSCAT(+) mRNA, which was subsequently translated, 
giving rise to the observed elevated CAT activity. This series of events is described 
schematically in Figure 6.7.
A reporter system to study the replication events of Rift Valley fever (RVF) virus, first 
described by Lopez et a l (1995), was utilised by Prehaud et al. to try to demonstrate 
replication and expression of CAT activity from the reporter construct CAT-RVF-Sag(+) 
(Prehaud eta l., 1997). CAT-RVF-Sag(+) contained the antigenome of the RVF S segment, 
with a CAT gene in a positive sense orientation. This group were unable to demonstrate 
replication of the CAT-RVF-Sag(+) reporter construct (i.e. the positive sense reporter 
RNA), as CAT activity was not raised above background level when transfected into cells 
expressing RVF L and N proteins. They also noted that transfection of CAT-RVF-Sag(+) 
gave rise to detectable CAT activity in cells which had been previously infected with wild 
type vaccinia virus, but were not expressing the RVF proteins. This was interpreted to be a 
consequence of expression of vaccinia virus encoded proteins, which allowed translation of 
the transfected CAT-RVF-Sag(+) RNA transcripts.
The effect of vaccinia virus encoded proteins on positive sense reporter transcripts has also 
been noted previously by other groups, who have used recombinant vaccinia viruses both to 
drive expression of their reporter transcript (Stillman et a l ,  1995), and to express 
recombinant proteins (Prehaud et al., 1997). Stillman et a l have used the recombinant 
vaccinia virus-T7 (vTF7-3) in a reporter system to study synthetic VSV minigenomes. In 
this study, it was suggested that expression from antigenomic replicative intermediates (RI) 
may have occurred inadvertently as a consequence of vaccinia virus encoded proteins. An 
alternative explanation was also given for this expression: there may have been insufficient N 
protein in some cells to allow efficient encapsidation of the RI transcripts, thus enabling 
these transcripts to be translated.
Further experiments to study the antigenomic promoter of the BUN S segment were not 
pursued. This was largely due to the high level of background CAT activity detected in 
vTF7-3 infected cells. Thus, no attempt was made either to investigate the antigenomic 
promoter by mutational analysis, or to determine whether the bunyavirus NSs protein was 
necessary for the elevated CAT expression observed when transfected cells express L and S 
segment proteins.
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Figure 6.7 Proposed recognition and transcription of BUNSCAT(+) 
RNA.
The schematic describes the mechanism by which BUNSCAT(+) RNA may be recognised 
by recombinant BUN viral proteins, to give rise to a nucleocapsid structure, from which 
BUNSCAT (negative polarity) RNA can be transcribed. The resulting encapsidated negative 
sense RNA transcript then can act as a template for the transcription of a message sense 
transcript, to result in translation of the CAT gene.
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6.5 Future Work.
Due to the background CAT activity discussed previously, it would be difficult to use the 
reporter system as it stands to study the promoter and the viral proteins involved in the 
replication of the antigenomic BUNSCAT(+) transcript to genomic sense (BUNSCAT) 
transcripts. To circumvent this problem, expression of BUN viral proteins could be achieved 
via a vaccinia-independent system. It may be possible, for example, to establish a stably 
transformed cell line which constitutively expresses T7 RNA polymerase, or alternatively, a 
stably transformed cell line expressing the BUN L and S segment gene products would also 
remove the requirement for vTF7-3. Semliki Forest Virus vectors (Gibco), constructed to 
allow cytoplasmic expression, have also been successfully utilised by others to express 
recombinant viral proteins in trans (Rolls etal., 1994).
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Chapter 7.
7.0 Effect of modifications to the termini of BUNSCAT RNA.
7.0 Introduction.
It has been reviewed previously in this thesis that the terminal sequences of bunyavirus RNA 
segments are conserved and complementary, and that these sequences are important for 
recognition by the viral polymerase and encapsidation by N protein (Kolakofsky and 
Hacker, 1991). Presented in this chapter is a series of experiments designed to investigate 
the effect of deletion or addition of nucleotides at the extreme 3’ and 5’ termini of the 
BUNSCAT reporter RNA.
7.1 Production of BUNSCAT RNA transcripts with modified termini.
To produce BUNSCAT reporter RNA containing the desired deletions or extensions to the 
3’ terminus, pBUNSCAT plasmid DNA was digested with suitable restriction enzymes as 
described in Figure 7.1, and subsequently used in in-vitro transcription reactions. 
Linearisation of the pBUNSCAT template with Bbsl produced a transcript which had wild 
type 5’ and 3’ termini, i.e. termini in which the full complement of the eleven conserved 
nucleotides were present. Linearisation of the pBUNSCAT template with Xbal produced a 
BUNSCAT RNA in which the 3’ terminus had an additional 11 nucleotides at the extreme 
end. Similarly, digestion with HindUI produced an RNA with an additional 35 nucleotides 
whereas digestion with Hgal produced an RNA with 5 nucleotides deleted from the 3’ 
terminus.
The addition of nucleotides at the 5' end was achieved by transcribing the BUNSCAT RNA 
from the transcription template, pT7BUNSCAT-Ribo, instead of pBUNSCAT. RNA 
transcribed from this construct is identical to that from pBUNSCAT except that it contains 2 
additional G residues at the 5' end before the conserved terminal BUN sequence, and has a 
2',3' cyclic phosphate at the 3' terminus generated by ribozyme (Ribo) cleavage (Kuo et al., 
1988). Transcripts from this template were synthesised in-vitro under standard conditions, 
and the DNA template was removed by DNasel digestion. Agarose gel electrophoretic 
analysis showed that about 50% of the primary transcripts were processed by self cleavage 
by the ribozyme (Figure 7.2), however, it was not possible to purify, and thereby quantify,
97
Results and Discussion: Chapter 7
660 nuc 85 nuc174 nuc
BUN S 3’UTRBUN S 5’UTR
9 IVVV1
T7 promoter +1
- TAATACGACTCACTATA AGTAGTGTG-
Hgal Xbal H indlll
-  -AGTGTGGAGTACACTACT GCGTCTTCTAGAGTCGACCTGCAGGCATGCAAGCTTGG- -
-  - TCACACCTCATGT.GATGA. CGCAGAAGATCTCAGCTGGACGTCCGTACGTTCGAACC- -A A --------------
Bbsl
Figure 7.1 Restriction digestion of pBUNSCAT to result in transcripts with 
modified 3’ term ini.
pBUNSCAT plasmid DNA was digested with suitable restriction enzymes (these enzyme 
sites are indicate in the diagram above), and subsequently used in in-vitro transcription 
reactions to produce run-off BUNSCAT RNA transcripts with modified termini. 
Linearisation of the pBUNSCAT DNA template with Bbsl (shown as black triangles) 
produced a transcript which had the exact wild type 5’ and 3’ termini. Linearisation of the 
pBUNSCAT template with Hgal (shown as open triangles), Xbal or Hindlll, produced run­
off transcripts with deletions or additions at the 3’ termini of -5, +11 and +35 bases 
respectively.
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Figure 7.2 Mechanism of ribozyme cleavage to release BUNSCAT plus two 
extra 5’ G residues.
The above diagram describes the self cleavage event, mediated by the Hepatitis delta 
ribozyme (HepA) sequence present at the 3’ terminus of the primary transcript, which results 
in the release of a BUNSCAT RNA with two additional G residues at the 5’ terminus. One 
hundred basepair (bp) ladder markers are shown in lane 1. In lane 2 the primary transcript is 
evident, running between the 700 and the 800 bp markers, and the self cleaved BUNSCAT 
RNA is present as the lower band, which runs between the 600 and the 700 bp markers. The 
ribozyme fragment is also visible on the gel, running around the 200 bp marker.
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the fraction of correctly processed RNA. Therefore, the RNA transfected into cells contained 
a mixture of processed and unprocessed transcripts.
7.2 Effect of modified template RNAs in the reporter assay.
Run off BUNSCAT RNA transcripts with modified ends, generated as described above, 
were transfected into the reporter system using the same protocol as described earlier 
(Section 3.1). CV-1 cells, transiently expressing the viral proteins of the BUN S and L 
segments, were transfected with equal amounts of each transcript (as determined by 
incorporation, Methods 2.4.2). The cells were harvested 20 hours post transfection and the 
extracts collected as described previously (Section 3.1). The protein concentration in each 
cell extract was determined and equal amounts were used for determination of CAT activity. 
The results of which are shown in Figure 7.3.
It can be seen from Figure 7.3 that CAT activity was obtained from BUNSCAT RNAs 
which had additional nucleotides at either the 5’ terminus or the 3’ terminus. Lanes 1 and 2 
show the CAT signal obtained from BUNSCAT RNA with 2 additional nucleotides at the 5’ 
terminus, which was comparable to wild type BUNSCAT. It should be noted that since it 
was not possible to quantify the amount of processed RNA produced by the self cleavage 
reaction, it was also not possible to estimate the efficiency of CAT production from 
pT7riboBUNSCAT(-) RNA compared to BUNSCAT RNA. Essentially, however, this is 
irrelevant, and the fact that a high CAT signal was obtained from this construct, regardless of 
a possible difference in CAT production between this and the wild type BUNSCAT 
transcript, indicates that the addition of 2 G residues to the 5’ UTR produced no gross 
change in the ability of the polymerase to recognise and interact with this modified terminus.
Lanes 7 and 8 show the CAT signal obtained from BUNSCAT RNA with 11 additional 
nucleotides at the 3’ terminus, and Lanes 9 and 10 show the signal obtained from 
BUNSCAT RNA with 35 additional nucleotides at the 3’ terminus. The CAT signal obtained 
from RNAs with 11 and 35 additional nucleotides at the 3’ terminus, although lower than 
wild type BUNSCAT RNA was still detectable. However, deletion of 5 nucleotides from the 
3’ terminus effectively abolished CAT activity (Lanes 5 and 6).
That CAT activity was obtained from BUNSCAT RNA with 2 additional nucleotides at the 
5’ terminus indicates that the presence of 2 G residues 5' to the conserved terminal BUN 
sequence still allowed recognition by the transcriptase complex. Similarly, the results 
obtained from BUNSCAT RNAs with additional nucleotides at the 3’ terminus suggest that 
the RNA can still be recognised by the transcriptase complex and initiate transcription,
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Figure 7.3 The effect of a deletion and extensions to the BUNSCAT termini 
on CAT activity.
CV-1 cells transiently expressing BUN viral proteins were transfected in duplicate with equal 
quantities of the BUNSCAT RNAs with modified termini and BUNSCAT RNA with 
authentic (i.e. wild type) termini, included as a control (lanes 3 and 4). Cells were harvested 
20 hours post transfection and the cell extracts assayed for protein concentration. Equivalent 
amounts of protein from each cell extract were assayed for CAT activity. Lanes 1 and 2 
show the CAT signal obtained from transfection of BUNSCAT RNA which had an 
additional 2 nucleotides at the 5’ terminus. Lanes 5 and 6 show the CAT signal obtained 
from transfection of BUNSCAT RNA with 5 nucleotides deleted from the 3’ terminus, 
Lanes 7 and 8, BUNSCAT RNA with 11 nucleotides added at the 3’ terminus, and Lanes 9 
and 10, BUNSCAT RNA with 35 nucleotides added at the 3’ terminus. Lanes 3 and 4 
represent the CAT signal from BUNSCAT with authentic termini as a control.
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although the efficiency of the interaction may be reduced by the presence of the extra 
sequence. Therefore, it appears that the viral polymerase and the N protein can recognise and 
can interact, at least to some extent, with specific sequences present in the 5’ and 3’ termini, 
whether these signals are presented at the extreme termini, or whether they are internal to 
other sequence.
The deletion of 5 nucleotides at the 3’ terminus abolished CAT activity, suggesting that 
although it is possible to add extra nucleotides on to the 5’ and 3’ termini, it may not be 
possible to delete nucleotides from these regions, presumably as this would remove part of 
the sequences recognised by the viral proteins.
Further experiments, described below, were performed to determine if deletions of less than 
5 nucleotides from the 3’ terminus would result in a functional RNA template, and to 
investigate the effect of deletion of nucleotides from the 5’ terminus.
7.3 Construction of terminal deletion mutants.
The introduction of terminal deletions to the 3’ and 5’ termini of BUNSCAT transcripts was 
performed in a stepwise fashion by oligonucleotide directed PCR mutagenesis. A series of 
oligonucleotides were synthesised as primers to introduce deletions to the BUNSCAT 3’ and 
5’ termini by PCR mutagenesis (Figure 7.4).
The pBUNSCAT 3’ terminal deletions were constructed by PCR, using the 3’ deletion 
primers ED.37, 38, 39 (Figure 7.4 A) and an unmutated 5’ terminal primer (shown as M  
sequence, Figure 7.4 B) as the distal primer. The pBUNSCAT 5’ terminal deletion mutants 
were constructed using the 5’ terminal deletion primers ED.41, 42, 43 (Figure 7.4 B) and an 
unmutated 3’ terminal primer (shown as M  sequence, Figure 7.3 A) as the distal primer. A 
similar PCR reaction was performed, using primers ED.37 and ED.41, to construct a 
pBUNSCAT clone with a deletion of 1 nucleotide at both the 3’ and 5’ termini.
The resulting PCR fragments were digested with restriction enzymes Sacl and Xbal and then 
ligated into Sacl and Xbal digested pUC118. Clones positive for a insert were sequenced 
into the CAT open reading frame to confirm the sequences of the T7 promoter, Bbsl site, to 
check that no spurious mutations had occurred during PCR, and to confirm that the desired 
deletion to the 3’ or 5’ BUNSCAT termini was present.
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The terminal deletion clones were denoted pBUNSCAT(37)(3’-l), pBUNSCAT(38)(3’-2), 
pBUNSCAT(39)(3’-3), pBUNSCAT(41)(5’-l), pBUNSCAT(42)(5’-2), pBUNSCAT(43)- 
(5’-3’) and pBUNSCAT (3’-l,5 ’-l)
7.4 Use of BUNSCAT terminal deletion RNA transcripts in the reporter 
assay.
The RNAs transcribed from the pBUNSCAT terminal deletion clones were applied to the 
reporter system using the same protocol as described earlier (Section 3.1). CV-1 cells, 
transiently expressing the BUN viral proteins of the BUN S and L segments, were 
transfected with equal amounts of each transcript. The cells were harvested 20 hours post 
transfection and the extracts collected as described previously (Section 3.1). The amount of 
cell extract assayed was adjusted for protein concentration before assaying for CAT activity 
and quantification (Figure 7.5).
From the results shown in Figure 7.5 (Lanes 13 and 14), it can be seen that transfection of 
BUNSCAT RNA with 1 nucleotide deleted from the 3’ terminus, as in construct 3(-l), 
resulted in a level of CAT activity which was comparable to wild type BUNSCAT RNA. 
Quantification of this CAT signal (Figure 7.9) by phosphorimager analysis showed that it 
represented 98% of the activity obtained from transfection of BUNSCAT RNA. However, 
the CAT signal obtained from BUNSCAT RNA with 2 nucleotides deleted from the 3’ 
terminus, as in construct 3’(-2), was drastically reduced (Figure 7.5, Lanes 11 and 12), and 
when quantified (Figure 7.9), it was found to represent only 6% of the signal obtained from 
wild type BUNSCAT RNA. Similarly, deletion of 3 nucleotides from the 3’ terminus, as in 
construct 3’(-3), also drastically reduced the CAT signal (Figure 7.5, Lanes 9 and 10). This 
signal was found to represent less than 3% of that obtained from the wild type BUNSCAT 
RNA (Figure 7.9).
Deletion of nucleotides from the 5’ terminus was found to be less well tolerated than the 3’ 
deletions. Removal of 1 nucleotide, as in construct 5’(-l), resulted in a CAT signal which 
was only 8% of the wild type BUNSCAT signal (Figure 7.5, Lanes 3 and 4, and Figure 
7.5). Similarly, removal of 2 or 3 nucleotides (Figure 7.5, Lanes 5 and 6, and Lanes 7 and 
8, respectively), as in constructs 5’(-2) and 5’(-3), resulted in CAT activity which was less 
than 3% of wild type BUNSCAT RNA CAT activity.
The removal of 1 nucleotide from both the 3’ and the 5’ termini also resulted in a drastic loss 
of CAT activity (Figure 7.6), and the signal from this construct, construct 3’(-l)5’(-l), was 
quantified to represent 8% of the wild type BUNSCAT RNA signal (Figure 7.9). This is
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Figure 7.5 The effect of terminal deletions to the BUNSCAT termini on 
CAT activity.
CV-1 cells transiently expressing BUN viral proteins were transfected in duplicate with equal 
quantities of the BUNSCAT RNAs with modified termini and BUNSCAT RNA with 
authentic (i.e. wild type) termini included as a control (lanes 1 and 2 and 15 and 16). Cells 
were harvested 20 hours post transfection and the cell extracts assayed for protein 
concentration. Equivalent amounts of protein from each cell extract were assayed for CAT 
activity.
Lanes (1 and 2) and (15 and 16) show the CAT signal obtained from transfection of wild 
type BUNSCAT RNA, and Lanes 3 and 4 show the CAT signal obtained from BUNSCAT 
RNA with 1 nucleotide deleted from the 5’ terminus. Lanes 5 and 6 show the CAT signal 
from BUNSCAT RNA with 2 nucleotides deleted, and Lanes 7 and 8, BUNSCAT RNA 
with 3 nucleotides deleted at the 5’ terminus. Lanes 9 and 10, Lanes 11 and 12, and Lanes 
13 and 14 show the CAT signal from BUNSCAT RNA with deletions at the 3’ terminus of - 
3, -2 and -1, respectively. The resulting levels of CAT activity are summerised in Ligure 7.9
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Figure 7.6 Reporter gene expression from BUNSCAT with terminal 
de le tions.
CV-1 cells transiently expressing BUN viral proteins were transfected in duplicate with equal 
quantities of the BUNSCAT RNAs with modified termini and BUNSCAT RNA with 
authentic (i.e. wild type) termini, included as a control (lanes 1 and 2). Cells were harvested 
20 hours post transfection and the cell extracts assayed for protein concentration. Equivalent 
amounts of protein from each cell extract were assayed for CAT activity. Lanes 3 and 4 
show the CAT signal obtained from transfection of BUNSCAT RNA which possessed a 
deletion of 1 nucleotide at the 3’ terminus and also 1 nucleotide at the 5’ terminus. Lanes 5 
and 6 contain extracts from cells transfected with a different clone of this same construct. 
The CAT signals obtained from transfection of BUNSCAT RNAs which possessed wild 
type 3’ termini, and which had a deletion of 1 nucleotide at the 3’ terminus or the 5’ 
terminus, are shown in Lanes 1 and 2, Lanes 7 and 8, and Lanes 9 and 10, respectively.
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comparable to the removal of 1 nucleotide from only the 5’ terminus. Furthermore, as the 
complementarity of sequence, and flushness of the termini was restored in this construct, 
this result also demonstrates that the reduced CAT activity obtained from the BUNSCAT 
RNA with a deletion of 1 nucleotide from the 5’ terminus was not due to the inhibitory 
presence of a 3’ overhang, but was truly the effect of deletion of the 5’ nucleotide.
7.5 Can T7 RNA polymerase initiation transcription with a uridine?
In a previous study which characterised mRNA transcripts from a large number of viral 
RNA polymerases by direct mRNA sequencing, it was found that mRNA transcription 
initiation always occurred with a purine (G or A) and not with a pyrimidine (U or C), 
(Banerjee, 1980). This study suggests the possibility that all viral RNA polymerases initiate 
mRNA transcription with a purine.
After analysis of the pBUNSCAT 5’ terminal deletion clones CAT results (Figure 7.5), the 
question arose as to whether T7 RNA polymerase (a DNA dependent RNA polymerase) can 
initiate transcription at the +1 residue of BUNSCAT 5’(-2) transcript which initiates with a 
uridine (U) (Figure 7.7B). It has been shown previously that T7 RNA polymerase initiates 
transcription of its own viral genes with a purine, either a G or a A, as the first encoded 
nucleotide (Dunn and Studier, 1983). However, evidence that T7 RNA polymerase may be 
able initiate transcription with a pyrimidine was reported in a paper by Chapman and 
Burgess, (1987). In this study a series of constructs was built which contained single point 
mutations within the a full length T7 promoter. Of the mutants characterised, one contained a 
G to T substitution at nucleotide position +1, therefore transcription from this construct 
would theoretically initiate with a U +1. The authors found that this mutant gave 
approximately 80% transcription activity compared to the control sequence. However, this 
study examined only the quantity of transcripts produced, and no attempt was made to 
determine the quality or the terminal 5’ nucleotides of the mutant transcripts. It has 
previously been reported that T7 RNA polymerase run-off transcripts can demonstrate a 
degree of heterogeneity of the 5’ termini, depending on the sequence downstream of the T7 
promoter (Pleiss e ta l., 1998), suggesting that T7 RNA polymerase can initiate transcription 
at various nucleotides downstream of its promoter. Therefore, it is possible that transcription 
from the position +1 mutant in Chapman and Burgess’s study was actually initiated from the 
purine at position +2 (i.e. G).
Clearly from the literature, the question of whether T7 RNA polymerase can initiate 
transcription at position +1 with a pyrimidine has not yet fully been resolved, however, if the 
requirement is in fact for a purine, then this has implications for the pBUNSCAT 5’(-2)
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+1 = >
A G U  A G U  G U G -------3  ' RNA
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U A G U  G U G  3  ' RN A
ATTATGCTGAGTGATAT A TCA CAC 5 '  DNA
-l
Figure 7.7 T7 RNA polymerase transcription initiation.
The above figure demonstrates how T7 RNA polymerase may initiate transcription down 
stream of the T7 promoter sequence (underlined) at position +1 with respect to the promoter. 
In (A) BUNSCAT transcription initiates with a A residue at position +1, and in (B) deletion 
mutant BUNSCAT 5’(-2) transcripts may initiate with an A at position +2 rather than with a 
U residue at position +1.
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Figure 7 .8  Characterisation o f 5 ’ terminal nucleotides.
Figure (A) describes schematically the methods utilised to characterise the terminal 5’ 
nucleotides of BUNSCAT transcripts, where primer pl is nucleotides 646 to 660 of the CAT 
gene, and p2 is the compliment of nucleotides 15 to 29 of the CAT gene. (B) The ligation of 
the template RNA 3’ and 5’ termini may allow formation of a secondary structure due to the 
high degree of complimentarity of the sequence, which is deleted during first strand 
synthesis.
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BUNSCAT relative CAT
Clone Terminal sequences activity
w t 5 ' AGUAGUGUGCUCC------------/ / ---------------GGUGAUCACUACU 3 ' 100%
3 ' ( - 1 ) 5 ' AGUAGUGUGCUCC------------/ / ---------------GGUGAUCACUAC 3 ' 98%
u> 1 to 5 ' AGUAGUGUGCUCC------------/ / ---------------GGUGAUCACUA 3 ' 6%
3 ' ( - 3 ) 5 ' AGUAGUGUGCUCC------------/  / ---------------GGUGAUCACU 3 ' <3%
w t 5 ' AGUAGUGUGCUCC----- —  / /  — ----------GGUGAUCACUACU 3 ' 100%
5 ' l:-u 5 ' GUAGUGUGCUCC----- —  I I  — ----------GGUGAUCACUACU 3 ' 8%
5 ' l[-2) 5 ' UAGUGUGCUCC----- —  I I  — ----------GGUGAUCACUACU 3 ' <3%
5 ' l[ - 3 ) 5 ' AGUGUGCUCC----- —  / /  — ----------GGUGAUCACUACU 3 ' <3%
3 ' I; - u , 5 ' GUAGUGUGCUCC----- --------- GGUGAUCACUAC 3 ' 8%
5 ' ( - 1 )
Figure 7.9 Summary of the CAT activity results obtained from the 
BUNSCAT terminal deletion mutants.
The above diagram summarises the results obtained from the BUNSCAT terminal deletion 
mutants. The mutants are denoted as follows: clone 3’(-l), for example, possesses a 3’ 
terminus which has a deletion of 1 nucleotide, and has a wild type 5’ terminus, and clone 
5’(-l) possesses a 5’ terminus which has a deletion of 1 nucleotide, and has a wild type 3’ 
terminus. Clone 3’(-l) 5*(-l) has 1 nucleotide deleted at both the 5’ and the 3’ termini. The 
sequence of the termini of each mutant is also shown in the diagram. The % CAT activity 
from each of the modified BUNSCAT RNAs compared to wild type BUNSCAT RNA is 
listed to the right of the figure. The CAT activity from transcript BUNSCAT 5’(-2) is shown 
in bold and underlined as the validity of this result is discussed in section 7.5.
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clone used in the study presented here. It is possible that transcription from this clone may 
not initiate with a pyrimidine (U) at position +1 but with a purine (A) at positions +2 with 
respect to the T7 RNA promoter (Figure 7.7B), rendering it impossible under the present 
system to characterise the effect of a two nucleotide deletion at the 5’ terminus of BUNSCAT 
RNA.
In an attempt to determine the nature of the nucleotides at the 5’ terminus of transcripts from 
the pBUNSCAT 5’(-2) clone, RNA ligation of the resulting run-off transcripts was 
performed (methods 2.4.6), followed by reverse transcription (methods 2.4.7) and PCR 
with the appropriate primers. Figure 7.8A describes schematically the methods used in this 
protocol. As a control, BUNSCAT transcripts was also treated in this manner.
Various attempts were made to analyse these transcripts in this way, but without success, 
since sequencing of the resulting cDNAs showed that all contained deletions spanning the 
predicted region of ligation between the 3’ and 5’ termini of RNA transcripts of 
approximately 30 to 50 nucleotides. It is possible that deletion of these sequences was due to 
the reverse transcriptase transcribing over this region due to secondary structures, formed 
between the complementary ligated 3’ and 5’ termini (Figure 7.8 (B)). In an attempt to 
inhibit the formation of secondary structures, DMSO was included in the ligation reaction 
and subsequent reverse transcription reaction up to a final concentration of 20% v/v 
(Romaniuk and Uhlenbeck, 1983), but without improvement. No further attempts were 
performed to determine the 5’ nucleotide of BUNSCAT 5’(-2) RNA transcripts.
In other studies characterising the promoter regions of influenza virus segments, the problem 
of RNA transcription initiation was either not a consideration, as in the in-vivo RNA pol-I 
catalysed transcription system used by Flick et al. (1996), or circumvented by the chemical 
synthesis of short RNA oligonucleotides as templates as used in the study by Fador et al 
(1994).
As it was not possible to determine if the BUNSCAT 5’ (-2) transcript contained a U residue 
at its 5’ terminus, the results from the pBUNSCAT 5’(-2) clone are not valid at present until 
further characterisation of the 5’ terminal can be achieved. In future work, this could 
possibly be done using a synthesised short 32P-UTP labeled transcript containing only one 
uridine at position +1.
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7.6 Discussion.
The first 11 nucleotides of the 5’ and 3’ terminal sequences of bunyavirus RNA segments 
are conserved and complementary, both between genomic segments and between different 
bunyaviruses. The aim of the experiments presented in this chapter was to investigate the 
effect of adding or removing nucleotides from the extreme ends of these termini.
It was found that the addition of nucleotides at the end of either the 5’ or the 3’ termini of 
BUNSCAT reporter RNA resulted in a transcript which gave detectable CAT activity in the 
reporter assay. This result suggests that the signals encoded within the conserved terminal 
BUN sequence were recognised by the transcriptase complex, and that these additional 
nucleotides were tolerated because they did not completely abolish viral polymerase 
recognition and interaction. The viral polymerase, therefore, can probably recognise and 
interact, at least to some extent, with specific sequences which are present in the 5’ and 3’ 
termini, whether these signals are presented at the extreme termini, or whether they are 
internal to other sequence. This result is in accordance with evidence offered by Prehaud etal 
(1997), that addition of 4 nucleotides to the 3’ terminus of a reporter RNA based on the Rift 
Valley fever virus S segment, exhibited measurable CAT activity. This suggested that the 
polymerase could still recognise and interact with the promoter at the 3’ UTR, without it 
being presented at the extreme end of the terminus. However, this study also reported that an 
addition of 16 nucleotides to the 3’ terminus abolished CAT activity from the reporter RNA, 
a result which differs slightly from the finding here, that an additional 35 nucleotides could 
be added to the 3’ terminus of the BUNSCAT RNA without complete disruption of function.
The specific mechanism of how the polymerase recognises and interacts with the termini, 
and initiates transcription of the bunyavirus segments, is not understood. However, on the 
basis of recent work on influenza virus it has been proposed that the it is the 5’ terminus that 
is initially recognised by the polymerase complex, and then the 3’ terminus binds to initiate 
transcription. Li etal. (1998) have offered evidence in support of this model, the mechanics 
of which are described in Figure 7.10 (A). Binding of the 5’ vRNA terminus to the PB1 
component of the influenza virus transcriptase complex induces a conformational change in 
this protein which then allows the PB2 component to bind the capped 5’ end of host mRNA. 
Once the capped mRNA is bound, PB1 can then bind the 3’ terminus of the vRNA, and it is 
the binding of the 3’ terminus which activates enzymic activity of the complex to result in 
cleavage of the cap-group and 10-13 nucleotides from the host mRNA. This capped RNA 
fragment then serves as a primer for mRNA synthesis by the PB1 protein. Throughout chain 
elongation, the polymerase complex tethers the 5’-end vRNA sequence, and as a result it is 
unable to transcribe through the bound region at the extreme 5’ vRNA terminus because of
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Figure 7.10 Proposed models for the initiation of influenza virus and 
bunyavirus mRNA transcription.
(A) Model for the proposed mechanism for RNA transcription initiation in influenza virus. 
The 5’ terminus is initially recognised by the polymerase complex, and the 3’ terminus 
consequently binds to initiate transcription. Binding of the 5’ vRNA terminus to PB1 
induces a conformational change in this protein which allows PB2 to bind 5’-capped host 
mRNA. PB1 can then bind the 3’ terminus of the vRNA, which activates enzymic activity of 
the complex to result in cleavage of the cap-group and 10-13 nucleotides from the host 
derived mRNA. The capped RNA fragment serves as a primer for mRNA synthesis by the 
PB1 protein. Throughout chain elongation, the polymerase complex tethers the 5’-end 
vRNA sequence, and is unable to transcribe through this bound sequence region at the 
extreme 5’ terminus due to steric hindrance. This leads to reiterative copying of the poly-U 
tract, resulting in the addition of a poly(A) tail to the mRNA transcript.
(B) This describes a similar model for mRNA initiation by the BUN L protein where the 5’ 
terminus of the BUN genomic segment is tethered by the BUN L protein. This induces a 
conformational change in the polymerase which allows it to bind host derived capped 
mRNA. This facilitates an interaction of the polymerase with the 3’ terminus of the segment, 
thereby allowing the polymerase to cleave off a capped leader sequence from the host mRNA 
(via endonuclease activity), to prime transcription initiation via the prime-and-realign 
mechanism. As with the influenza virus model, the L protein transcribes along the template, 
whilst constantly tethering the 5’ terminus and is consequently unable to transcribe through 
the bound 5’ terminal sequence region due to steric hindrance. However, unlike the influenza 
virus polymerase, which stutters at the poly-U tract and results in the addition of a poly(A) 
tail, the bunyavirus L protein cleaves the nascent transcript, possibly via the same 
endonuclease activity used for cap-snatching, to result in termination of transcription.
Results and Discussion: Chapter 7
steric hindrance. This leads to reiterative copying of the poly-U tract, resulting in the addition 
of a poly(A) tail to the mRNA transcript.
A similar model can be imagined for mRNA initiation by the BUN L protein to which all 
viral encoded enzymic functions have been attributed (Figure 7.10 B). It is possible that the 
5’ terminus of the BUN genomic segment interacts with the BUN L protein, and in doing so 
induces a conformational change in the polymerase which allows it to bind host capped 
mRNA. This may facilitate an interaction of the polymerase with the 3’ terminus of the 
segment, thereby allowing the polymerase to cleave off a capped leader sequence from the 
host mRNA (via endonuclease activity), and use it to prime transcription initiation via the 
prime-and-realign mechanism proposed by Garcin et al. (1995a). In accordance with the 
influenza virus model, the L protein would transcribe the template, whilst constantly 
tethering the 5’ terminus. As a result, the L protein would be unable to transcribe through the 
5’ vRNA terminal sequence region to which it is bound because of steric hindrance. 
However, unlike the influenza virus polymerase, which stutters at the poly-U tract and 
results in the addition of a poly(A) tail, the bunyavirus L protein might cleave the nascent 
transcript, possibly via the same endonuclease activity used for cap-snatching at a 
transcription termination signal which is upstream of the 5’ end of the template, to result in 
termination of transcription.
The results of the experiments presented in this chapter would lend support to such a model 
for bunyavirus transcription, where the 5’ terminus is involved in recognition by the L 
protein, and the 3’ is involved in transcription initiation.
It was found that deletion of any number of nucleotides from the 5’ UTR was not tolerated, 
indicating that the terminal conserved nucleotides of the 5’ UTR are absolutely essential for 
interaction of some description with the polymerase. Deletion of one nucleotide from the 3 ’ 
terminus was better tolerated, resulting in CAT activity that was equivalent to “wild type” 
BUNSCAT RNA. However, a deletion of 2 nucleotides drastically reduced CAT activity. 
This is interesting, and can be explained if we consider that the 3’ UTR is involved in 
transcription initiation.
Analysis of Bunyaviridae mRNA 5’ leader sequences has indicated a preference for certain 
bases at positions -1 to -3. These nucleotides have been found to be a reiteration of the 
terminal nucleotides of the genomic template (Chapter 1.4.4). On the basis of this 
observation, a model has been proposed which describes a mechanism for Bunyaviridae 
transcription initiation. The mechanism, known as “prime-and-realign”, is shown in Figure 
7.11, and is based on the evidence offered by Garcin et al .(1995a). According to this 
model, the viral polymerase primes transcription with a cap-snatched primer ending in a G 
residue (the endonuclease activity has a bias for cleavage after a G), and initiates internally
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Figure 7.11 Initiation of mRNA transcription by the “prime-and-realign “ 
mechanism.
The above figures describe the possible mechanism for bunyavirus mRNA initiation as 
described by Garcin et al.{ 1995). (A) Predicted mRNA initiation and synthesis mechanism 
for authentic BUN termini and for a deletion of -1 nucleotide. (B) Possible initiation of 
mRNA synthesis with a -2 deletion.
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on the vRNA template at a C residue, possibly at position +2 (3’ U £A  UCA--5’). After 
incorporation of a few nucleotides, the newly transcribed strand slips back and realigns on 
the template, as shown, before further elongation of the mRNA transcript (Figure 7.11 A).
This model would account for the observation that a deletion of 1 nucleotide from the 3’ 
UTR was well tolerated. Deletion of 1 nucleotide would still allow the primer to anneal at the 
C at position 2, and to initiate with a G in the usual manner, and that the prime-and-realign 
mechanism could proceed without disruption. A deletion of 2 and 3 nucleotides was found to 
drastically reduce transcription from the BUNSCAT reporter RNA, but the low level of 
activity that was detected may have risen from transcription initiation further upstream of the 
deleted 3’ UTR, either on the U at position +4, or the C at position +5, as shown in Figure
7.11 B.
Results from studies conducted by Prehaud et al. (1997) lend support to this explanation of 
transcription from the bunyavirus 3’ deletion constructs. In their study, it was found that a 
deletion of 1 or 2 nucleotides from the RVF S segment reporter RNA was tolerated, whereas 
deletion of more than 2 nucleotides was not. Again, the prime-and-realign mechanism is 
thought to be used for transcription initiation in RVF, and the snatched CAP-primer which 
the virus uses to initiate transcription from the 3’ UTR initiates with an A at position 3 (3’ U 1 
G2 H 3 G4 U5 U6 U7- - 5’) of the vRNA template. This would explain how a deletion of 1 
and 2 nucleotides can be tolerated by the viral polymerase, which is still able to initiate 
transcription on the preferred nucleotide at position 3.
The models described above have largely discussed the transcription of mRNA. However, it 
is thought that the same mechanisms also operate for viral genomic replication of 
hantaviruses (Garcin et al., 1995a), although this process is thought not to employ the use of 
a host derived capped primer RNA. Instead, the polymerase initiates transcription internally 
without the use of a primer sequence, but primes with a single purine (GTP or ATP) and the 
prime-and-realign model continues as usual. To date, all RNA polymerases that initiate chain 
transcription with triphosphates, have a preference for purines (Banerjee, 1980; Garcin et 
al., 1995a).
Therefore, transcription of bunyavirus genomic RNA could initiate internally on the C at 
position +2, as shown in Figure 7.11. Initial chain elongation, slippage and realignment, 
would then produce a 2 nucleotide overhang in the newly transcribed RNA. This is thought 
to be excised by the same endonuclease activity responsible for cap-snatching, before the 
polymerase continues elongation.
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Figure 7.12 Initiation of genome replication by the “prime-and-realign“ 
m echanism.
The model shown in (A) describes the proposed mechanism for initiation of bunyavirus 
replication. This model is based on studies of hantavirus replication (Garcin et al., 1995). It 
is thought that the polymerase initiates transcription internally by priming the template with a 
single purine, in this case a GTP, and the “prime-and-realign” mechanism continues, as 
described previously. The L protein initiates transcription internally on the C at position +2, 
as shown. Initial chain elongation, slippage and realignment, would produce a 2 nucleotide 
overhang in the newly transcribed RNA. This could possibly be excised by the same 
endonuclease activity responsible for cap-snatching, thereby leaving apA at the 5’ terminus, 
before the polymerase proceeds with elongation. This mechanism also has a potential ability 
to repair damaged genome ends by restoring small terminal deletions or mutations in the 
resulting complementary segment, as shown in (B). The figure demonstrates a possible 
mechanism by which a single 3’ deletion could be repaired in the resulting complementary 
strand by the “prime-and-realign” mechanism. The polymerase would again prime at the C 
residue (now position +1) with GTP, by “prime-and-realign” as described previously, then 
cleave off the non-viral terminal sequence before continuing elongation, thus restoring a 5’ A 
residue (highlighted with star).
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Another feature of this mechanism is that it has a potential ability to repair damaged genome 
ends by restoring small terminal deletions or mutations. The reiteration of sequence at the 3’ 
terminus, in conjunction with the prime and realign mechanism, would mean that segments 
which lack a few nucleotides at the 3’ end could feasibly be repaired, as shown in Figure
7.11 B. This is achieved by a slipping back of the new transcript, primed from reiterated 
sequence found at the 3’ terminus, followed by further transcription through the template, 
which thereby restores the correct nucleotide sequence at the terminus.
This is also shown in Figure 7.12, and interestingly, this mechanism could possibly account 
for the results of the 3’ terminal deletion studies presented in this chapter, where it was 
shown that a deletion of 1 nucleotide from the 3’ terminus of the reporter RNA produced no 
significant reduction in function of this RNA. This being so, the polymerase would have to 
initiate transcription on the first nucleotide of the 3’ terminus, rather than initiating internally 
as in the model.
7.7 Future work.
It would be interesting to try and determine if transcripts made off deleted templates have had 
their ends repaired. This would support the idea of the “prime-and -realign” mechanism and 
help determine the function of the conserved reiterated terminal sequences.
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Chapter 8.
8.0 Internal deletions within the BUNSCAT RNA 5’ UTR 
sequence.
8.0 Introduction.
The 5’ UTR of the Bunyamwera S segment vRNA is 174 nucleotides in length: this is about 
twice as long as the 3’ UTR, which is 85 nucleotides. It is proposed that this difference in 
length is relevant in terms of encoded signals and cis acting sequences involved in 
transcription, specifically, signals involved in the termination of mRNA transcription 
(Kolakofsky and Hacker, 1991). A comparison of the S vRNA 5’ UTRs of nine different 
BUN serogroups and three different CAL serogroup viruses (Figure 8.1, Dunn et a l, 
1994), and twelve different CAL serogroups viruses (Bowen et a l, 1995), revealed a highly 
conserved purine (A-C) rich region stretching between nucleotide positions 74 and 89, with 
respect to the BUN S 5’ UTR. This motif is found in close proximity to the region of the 3’ 
termini of viral mRNA, which has been characterised for BUN, GER, LAC and SSH 
viruses (Jin and Elliott, 1993; Bouloy et a l,  1990; Patterson and Kolakofsky, 1984; Eshita 
et a l, 1985, respectively). This region, which stretches between nucleotides 100 to 112 with 
respect to the BUN S 5’ UTR, is a U-G rich region which can be aligned for all the viruses 
mentioned above (Dunn et a l, 1994)
To analyse the possible significance of these motifs, it was decided to produce a series of 
deletion mutants within the BUN S vRNA 5’ UTR. These deletions would be within the 5’ 
UTR, between the stop codon of the CAT ORF and the 5’ terminus. To achieve this, the 
exonuclease Bal 31 was used to degrade pBUNSCAT DNA, linearised previously with 
Nsil. The unique Nsil site is downstream of the CAT stop codon, and within the 5’ UTR 
(Figure 8.2).
8.1 Introduction of deletions within the BUN S 5’ UTR.
Construction of the deletions within the BUN S 5’ UTR is described below, and is also 
outlined schematically in Figure 8.2. Nsil linearised pBUNSCAT DNA was digested with 
Bal 31 endonuclease for varying time after which the DNA was separated on a 1% TAE
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Figure 8.2 Schematic describing the protocol for the generation 
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agarose gel (Figure 8.3) and then purified by silica matrix absorption before the ends of the 
DNA were repaired with T4 DNA polymerase.
As Bal 31 nuclease would digest the DNA bidirectionaly at the Nsil site, i.e. upstream, into 
the 5’ UTR (as intended), and also downstream, into the CAT ORF. Therefore, to ensure a 
complete CAT ORF would be present in the resulting construct, the entire CAT ORF and the 
BUN S 3’ UTR from the Bal 31 treated DNA was excised by digestion with Xbal, and 
replaced with an intact antisense CAT ORF and BUN S 3’ UTR. To produce the intact CAT 
ORF and BUN S 3’ UTR fragment, a portion of the Nsil digested pBUNSCAT DNA was 
end repaired by treatment with DNA polymerase I prior to digestion with Xbal. The Xbal 
fragment, which contained the complete antisense CAT ORF and the 3’ BUN S UTR, was 
then gel purified, prior to ligation into the Bal 31 digested/ Xbal vector fragment. The 
products of this ligation were used to transform competent DH5a cells, and small scale 
plasmid preparations were made from ampicillin resistant clones. Clones which were found 
to be positive by digestion with EcoRl were then sequenced through their T7 promoter 
region, and into the CAT ORF, to confirm the extent of the Bal 31 deletions within the 
BUNS 5’ UTR.
Out of a range of positive clones generated in this way, five were selected for initial testing 
on the basis that the deleted sequences covered the regions of interest, namely, the A-C rich 
motif (nucleotides 73 to 88), and the site of the predicted mRNA terminus (nucleotides 100 
to 112). Additionally, the selected clones contained sequential deletions, thus providing a 
range of mutants for this study. The clones that were chosen were denoted pBUNSCAT(7ta/ 
31), clones -(75), -(2), -(7), -(15), and -(10).
pBUNSCAT(2ML 31) clone (75) has a deletion of 29 nucleotides upstream of the Nsil site, 
clone (2), 57 nucleotides upstream, clone (7), 71 nucleotides upstream, clone (15), 93 
nucleotides upstream, and clone (10), 156 nucleotides upstream. The deleted regions within 
these clones is highlighted in Figure 8.5.
A higher than expected number of the deletion clones (which were not selected for further 
study) were found to have deletions which mapped to the GU rich region. It is possible that 
the GU rich sequence may have caused the Bal 31 exonuclease to pause, resulting in a 
number of clones with the same deletion (Berger and Kimnel, 1987).
8.2 Testing the pBUNSCAT Bal 31 clones in the reporter system.
It was important that an equal number of transcripts from each clone were transfected into the 
reporter system. Therefore, the amount of transfected RNA was adjusted to take into account
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4324bp
3675bp
2323bp
1929bp
1371 bp 
1264bp
702bp
Lane
Figure 8.3 Bal 31 digestion of N sil linearised pBUNSCAT DNA.
Approximately 10 jig Nsil linearised pBUNSCAT DNA was digested with Bal 31 at 0.1 
units/pg, at 30°C, for varying times as follows: lane (2) 30 sec.; lane (3) 1 minutes 30 sec.; 
lane (4) 3 minutes; lane (5) 4 minutes 30 sec.; lane (6) 6 minutes. Reactions were stopped by 
the addition of EDTA and run on a 1% TAE gel. DNA bands were excised and purified by 
Geneclean, prior to incubation with T4 DNA polymerase at 11°C for 30 minutes, to repair 
the ends. Reactions were then digested with Xbal before purifying the vector band. Lanes 1
and 7 on the gel shown above contain lpg of X BstEll markers. A reduction in the size of
Nsil linearised pBUNSCAT can be seen as the incubation time of Bal 31 digestion is 
increased.
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the size difference in the deletion mutants. Thus, an equimolar amount of each transcript was 
transfected (Table 8.1).
Clone Number transcript length 
nucleotides
% in length 
of BUNSCAT
amount of RNA 
transfected
pBUNSCAT wt 919 100% 2.50|ig
pBUNSCAT(2ta/31)75 890 96.8% 2.44pg
pBUNSCAT(2ta/ 31)2 862 93.4% 2.34pg
pBUNSCAT(2ta/ 31)7 848 92.7% 2.32pg
pBUNSCAT(£ar/31)15 826 89.9% 2.25pg
pBUNSCATCM 31)10 763 83.0% 2.08|ig
Table 8.1 Transfection of BUNCAT Bal 31 clone transcripts.
The above table demonstrates the adjustments made to the amount of RNA transfected when 
taking the length of the transcript into consideration, ensuring an equimolar amount of each 
transcript was transfected.
The results of the CAT assay using the Bal 31 deletion mutants are shown in Figure 8.4, and 
summarised in Figure 8.5. These results show that a construct containing an internal deletion 
of 29 nucleotides in the 5’ UTR (clone 75), resulted a level of CAT activity in the reporter 
assay that was comparable to that obtained with full length BUNSCAT. Similarly, in the 
constructs where the deleted sequence was extended to 57 nucleotides (clone 2), 71 
nucleotides (clone 7), and 93 nucleotides (clone 15), all of which resulted in the gradual 
removal of the U-G rich and the A-C rich motifs, the level of CAT activity obtained was still 
comparable to full length BUNSCAT. In fact, the only deletion mutant which showed any 
deviation from wild type BUNSCAT behaviour was clone 10 with a CAT expression level 
<1% that of wild type; this construct had a deletion of 156 nucleotides, leaving only eleven 
nucleotides at its 5’ terminus.
8.3 Discussion.
As demonstrated in Figure 8.5, reporter construct RNAs in which the A-C and G-U rich 
motifs were deleted gave rise to a level of CAT activity indistinguishable from wild type 
BUNSCAT RNA, when transfected into the reporter assay. It was expected that deletion of 
the motifs might have caused a reduction in the CAT activity, thereby explaining the 
sequence conservation in this region.
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RNA RNA RNA RNA RNA RNA
Figure 8.4 CAT expression from Bal 31 deletion pBUNSCAT clones.
CV-1 cells expressing BUN S and L segment proteins were transfected with equimolar 
amounts of each RNA transcript (Table 8.1). The cells were incubated at 37°C for 3 hours 
before the addition of growth medium, after which the incubation was continued overnight. 
At 24 hours post infection the cells were harvested and the cell extracts assayed for protein 
concentration. The volume of cell extracts which were assayed was adjusted, so that the 
amount of protein tested was equivalent to that in the BUNSCAT extract. CAT activity 
comparable to BUNSCAT wild type was detected in extracts from cells transfected with 
BUNSCAT (Bal 31)-clones 75, 2, 7 and 15. The deleted sequences in these clones ranged 
from 28 to 93 nucleotides, and encompassed the G-U rich motif. CAT activity less that 1% 
that of wild type BUNSCAT was detected for clone 10: this construct has a deletion of 156 
nucleotides. Therefore, sequences important for CAT expression, within the reporter 
system, lie between nucleotides 11 and 74 in the BUN S 5’ UTR.
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Figure 8.5 Schematic showing the extent of the 5’ UTR internal Bal 31 
deletions.
The above diagram shows a series of pBUNSCAT clones with deletions within the 5’ UTR. 
The deleted regions range from 28 to 156 nucleotides. The purine rich motif within the 5’ 
UTR at position 100-112 is marked by a hatched box, and the predicted mRNA termini is 
marked by a striped box at position 73-88. Also shown on the diagram is the CAT activity 
obtained from transfection of transcripts from each of the mutants into the reporter assay. 
The CAT activity is noted as a % of that obtained from transfection of “wild type” 
BUNSCAT transcripts. It can be seen that deletions of between 28 and 93 nucleotides result 
in no detectable drop in the CAT signal obtained compared to “wild type” BUNSCAT. 
Deletion of 156 nucleotides, however, results in a drastic reduction in CAT activity to less 
than 1 % wild type.
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It was observed from transfection of clone 10 that a deletion of 156 nucleotides completely 
abolished all detectable CAT activity, thus demonstrating that the sequence between 
nucleotides 11 and 74 is essential for transcription of BUNSCAT RNA. To determine the 
exact nucleotide at which CAT activity is lost, further deletion analysis of the region between 
nucleotides 11 and 74 of pBUNSCAT would be required.
The lack of detectable CAT activity in clone 10 may have been the result of removing 
sequence that is conserved between all the Bunyavirus S segments. Although clone 10 still 
retained eleven terminal nucleotides common to all three BUN segments, the four preceding 
nucleotides, CCAC (Figure 1.3), which are common to all S segments of the Bunyavirus 
genus, were not present in this clone. These four nucleotides may form part of a signal, or 
more likely, may be required to stabilise the formation of a panhandle structure in which the 
first eleven nucleotides of the BUN S segment are involved.
The purine rich region has previously been characterised as the 3 * termini of mRNA. If the 
signal for termination of mRNA transcription was located in the G-U rich region, then when 
this region is removed, as it is in clones (7) and (15), the resulting CAT activity may be 
produced by translation of a pseudo-mRNA transcript. There are two possible scenarios by 
which this could occur: either the BUN L polymerase could terminate transcription at a 
pseudo-termination site or, more likely, the resulting transcript, which would consist of a 5’ 
capped leader sequence and an intact anti genomic 3 ’ BUN S termini (with the potential to 
form a panhandle), could act as a mRNA within this reporter system.
It is possible that the capped leader sequence stops or interferes with the encapsidation of the 
transcript by the nucleocapsid protein. Alternatively, as the polymerase would be primed to 
transcribe a mRNA transcript, it might not be able to orchestrate the encapsidation of the 
transcript, or to recognise the 5’ termini due to the presence of the cap leader sequence. 
Analysis of the 3’ ends of the message sense chimeric CAT RNA would help determine what 
effect the various Bal 31 deletions have on mRNA transcription.
Similar work has been performed previously by a group working on influenza B virus 
(Barclay and Palese, 1995). In these experiments, a full length cDNA of the influenza B 
virus HA (MdHAX) segment was engineered, carrying a silent mutation encoding an Xbal 
site to differentiate this segment from wild type RNA. A CAT reporter construct based on the 
same HA segment termed HABCAT was also engineered. A series of deletion mutants were 
then generated from both the MdHAX and the HABCAT constructs. The deleted regions 
were in the 5’ UTR of both the MdHAX and the HABCAT constructs, and were of 10, 33
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and 67 nucleotides in length; between the termination codon and the poly-U stretch which is 
thought to act as a polyadenylation signal.
It was found that transcripts from all the HABCAT mutants produced a comparable CAT 
signal to undeleted HABCAT transcripts in a reporter assay. They also found that these 
transcripts could be rescued for one passage. However, with the MdHAX segment, it was 
found that it was only possible to rescue viruses which had deletions of 10 and 33 
nucleotides. No viruses could be rescued containing the MdHAX segment with 67 deleted 
nucleotides. This implies that a deletion of 67 nucleotides in the 5’ UTR of the MdHAX 
segment is lethal to the virus, despite the lack of effect of this deletion on the similar reporter 
construct, HABCAT.
This result is important as it highlights the fact that although the CAT reporter assay can 
provide insight into many aspects of the replicative processes of bunyavirus, it may not be 
comprehensively informative, and will be unable to measure certain effects of mutations on 
the in vivo events occurring during virus infection.
8.4 Future Work.
The results from the BUNSCAT Bal 31 deletion mutants showed that mutation of the A-C 
and G-U rich motifs resulted in constructs which displayed a level of CAT activity in the 
reporter assay that was indistinguishable from wild type BUNSCAT RNA. It is possible that 
the inability to characterise a possible BUN S mRNA termination signal or site was made 
difficult due to vaccinia virus encoded proteins modifying the resulting transcripts, possibly 
by polyadenylation of the resulting transcripts, thus masking any detectable drop in CAT 
activity brought about by the BUN S 5’ UTR deletion. An alternative explanation might be 
that mRNA was not transcribed in the reporter system, only antigenomic RNA, which may 
not have become encapsidated.
An alternative way to isolate a possible mRNA termination signal would be to insert regions 
of the 5’ UTR after the CAT ORF, but before the 3’ UTR (Figure 8.6). Thus if a specific 
inserted region caused a drop in CAT activity, this would signify that the insertion of the 
sequence had caused a premature termination of the transcript, resulting in a drop in CAT 
activity. Active CAT genes would be verified as before, by transfecting the construct DNA 
into vTF7-3 infected cells.
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Chapter 9.
9.0 Mutagenesis of the terminal regions of the 3’ and 5’ BUNS 
UTRs.
9.0 Introduction.
As was discussed in Chapter 3, transcripts derived from a pBUNSCAT clone, 
pBUNSCATmut-12, which contained a single point mutation in the BUNS 5’ terminus (C to 
G, at position 12), produced a level of CAT activity in the reporter assay that was 
significantly lower than that obtained from “wild type” BUNSCAT transcripts. That a single 
point mutation could exert such an effect on the functioning of the reporter RNA, suggested 
that conservation of the sequence and/or the structure of the BUN segment UTRs might be 
of great importance.
Electron microscopy studies performed on both influenza virus and bunyavirus RNPs have 
led to the suggestion that the 5’ and 3’ UTRs of a genome segment might interact, possibly 
through base-pairing of the complementary sequences in the termini, to form a “pan-handle” 
structure (Raju and Kolakofsky, 1989; Kolakofsky and Hacker, 1991). In the pan-handle 
model, the “handle” is formed by the interacting 5’ and 3’ termini, and the “pan” is formed 
by the coding sequence of the segment, tightly bound up with N protein. Although there is 
no direct evidence, it is thought that the polymerase is also associated with the RNP and may 
be bound between the termini of the UTRs: this suggestion is based purely on the premise 
that the polymerase would probably be excluded from binding to the coding sequence of the 
segments due to their tight association with N protein.
It is not known if the mutation in clone pBUNSCATmut-12 which disrupted the functioning 
of the RNA transcript did so because it interfered with a recognition or transcription signal 
present in the 5’ UTR, or because it affected the structural stability of the putative panhandle.
Therefore, in an effort to address this, a series of mutations were made to the 5’ and 3’ 
UTRs of the BUNSCAT reporter RNA, to investigate both the effect of changing the 
sequence content of the termini, and also to question whether disruption of the hypothetical 
panhandle structure would result in loss of CAT activity from the reporter RNA. These 
experiments involved the construction of a large range of mutants which contained individual
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nucleotide substitutions for each of the terminal 15 nucleotides of either the 5’ or 3’ UTR. 
This series of constructs was designed to investigate the effect of changing the sequence 
content of the termini. Further to this, a second series of mutants was constructed which 
contained individual substitutions to nucleotides of the 5’ terminus with additional, 
corresponding mutations in the 3’ terminus, so that the base pairing potential between the 
termini was maintained. It was hoped that analysis of these mutants using the reporter assay 
would resolve whether it was more important to maintain sequence specificity in the termini 
or whether base pairing potential was sufficient.
Whilst in the process of this work, a new model was proposed for influenza A virus genome 
segments. This model was based on secondary structure predictions from results of a 
mutagenesis study of the 3’ and 5’ termini, and described the possible interaction between 
the 3’ and 5’ ends (Flick et al., 1996). The model, termed the “corkscrew” model (Chapter
1.7.4), differs from previous models as it predicts both intra-strand base-pairing within each 
of the 3’ and 5’ termini, resulting in a tetra stem-loop structure, as well as base-pairing 
between the termini.
From examination of the 3’ and 5’ termini of BUN S it was noticed that a similar 
hypothetical structure could be drawn, where base-pairing within the 3’ and 5’ termini 
formed stem-1 oops, as well as base pairing between the termini. Three possible tri-stem-loop 
structures, each with increasing “stem” length are shown in figure 9.6.
Therefore, to test these models a series of complementary intra-strand mutations were made 
at base-paired regions shown in each of the three proposed models for the BUN S 5’ and 3’ 
termini (Figure 9.6).
9.1 Construction of the single 5’ and 3’ terminal substitution mutants.
This first series of BUNSCAT mutants contained single, individual nucleotide substitutions 
in either the 5’ or the 3’ termini. Construction of these mutants was achieved by random 
nucleotide substitution mutagenesis PCR, using spiked oligonucleotides as primers with the 
pBUNSCAT reporter construct as a template
By synthesising each oligonucleotide in two stages, on two separate oligonucleotide 
synthesising machines, it was possible to produce a primer that contain a spiked region for 
the mutagenesis of the 3’ and 5’ termini, and an un-spiked region to encode the T7 promoter, 
Bbsl site and restriction sites for cloning (Xbal and Sad)  (Figure 9.1).
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702bp
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Figure 9.1 Construction of 5’ and 3’ term inal m utants.
(A ) Spiked oligonucleotides ED.30 (5 ’ ATTCGAGC7GTAATACGACTCACTATAAGTAGTGTG  
C T C C A C C TA A A A C TTA A A A ) and ED.31 (5’ AGAC7C7AGAAGACGCAGTAGTGTACTCC  
A C A C T A C A A A C T T G C ) were synthesised as primers. The spiked region, i.e. the region 
which contained the BUNS terminal sequences (shown in bold), was synthesised using a 
nucleotide ratio of 97% specific and 3% others (i.e. 1% of each), while the un-spiked 
region, i.e. the region encoding the T7 promoter, Bbsl site (underlined) and the restriction 
sites for cloning, Sacl and Xbal (shown in italics) were synthesised using 100% specific 
nucleotides. (B) PCR reactions were set up with pBUNSCAT as the template, with either the 
spiked primer ED.30 (BUNS 5' UTR) and an un-spiked version of ED.31 as the distal 
primer (Lane 2) or the spiked primer ED.31 (BUNS 3' UTR) and an un-spiked version of 
ED.30 as the distal primer (Lane 3). Lane 4 represents a control PCR reaction with the two 
spiked oligonucleotides but with no template. The resulting PCR fragments were purified 
from a 1% TAE gel by silica matrix absorption, and subsequently digested with restriction 
enzymes Xbal and Sad . The digested PCR fragments were then ligated into similarly 
digested pUC118. Clones which were positive for the BUNSCAT insert were then 
sequenced in both orientations to determine the possible mutations to the 3' and 5' UTRs 
(Figure 9.2).
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The spiked region of the oligonucleotide was synthesised with a nucleotide ratio of 97% 
specific and 3% others, as described by Blacklow and Knowles (1991). This protocol 
results in the spiked region of the oligonucleotide having a 3% probability of an incorrect 
base at any particular position. After synthesis of the spiked region, the oligonucleotide 
columns were transferred to another machine to continue synthesis with un-spiked 
nucleotides (100% specific). Thus the resulting oligonucleotides ED.30 (to mutate the 
BUNSCAT 3’ termini) and ED.31 (to mutate the BUNSCAT 5’ termini), shown in Figure 
9.1, were composed of a 3’ spiked region and a 5’ un-spiked region. The oligonucleotides 
were then used as primers in conjunction with an un-spiked version of the opposite primer 
(i.e. ED.30 was paired with an un-spiked version of ED.31), to amplify the BUNSCAT 
reporter from pBUNSCAT (Figure 9.1). The resulting PCR fragments were digested with 
Xbal/SacI and ligated into similarly digested pUC118, those clones positive for insertion 
were sequenced to determine if they carried a mutation to the 3’ or 5’ termini (Figure 9.2).
Of 200 clones screened, only 20% encoded a single point mutation to the 3’ or 5’ termini of 
the BUNSCAT. This was lower than expected and may have been caused by inaccurate 
spiking of the nucleotides to synthesis the oligonucleotides, or it is possible that the 
annealing temperature during PCR affected the outcome. Due to the expense of synthesising 
spiked oligonucleotides of this nature, no attempts were made to increase the ratio of spike/ 
nucleotide during synthesis.
9.2 Construction of complementary base-paired mutations.
To determine if base pairing potential between the terminal sequences was important, a series 
of complementary double mutations were made within the panhandle region that maintained 
base-pairing. Initially, where possible, this was done by pairing specific 3’ and 5’ single 
point mutants. This was achieved by subcloning the 5’ termini mutant (utilising the unique 
Sacl site upstream of the T7 promoter and the unique Nsil site within the CAT gene) into the 
similarly digested 3’ termini mutant. Where this was not possible, oligonucleotides based on 
ED.30 and ED.31 were synthesised carrying specific mutations for PCR (Figure 9.1).
9.3 Construction of complementary intra-strand double nucleotide 
substitution mutants.
Complementary double mutations to the possible stem-loop structures (Figure 9.6), were 
achieved by synthesising oligonucleotides as mutating primers similar to ED.30 and ED.31, 
but carrying specific nucleotide changes (the position of these nucleotide changes are shown 
in Figure 9.6). PCR mutagenesis was performed on the pBUNSCAT template with a
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specific mutating primer and the distal wt sequence primer (i.e. ED.30 or ED.31, Figure 
9.1).
In the 5’ stem-loop, primers ED.5’db3 and ED.5’db4 mutated the nucleotides at positions 3 
and 9 from U-G to C-A, and at positions 4 and 8 from a A-U to a G-C base-pair 
respectively. In the 3’ stem-loop, primers ED.3’db3 and ED.3’db4 mutated the nucleotides 
at positions 3 and 9 from a A-U to a G-C base-pair, and at positions 4 and 8 from a U-A to a 
C-G base-pair respectively. The consequence of these changes are also shown in figure 9.6. 
The resulting mutants were named after the mutating oligonucleotide, e.g. pBUNSCAT 
(3’db3).
9.4 Analysis of the single 5’ and 3’ terminal substitution mutants and 
complementary double mutants using the reporter assay.
DNA from each of the single 5’ and 3’ terminal substitution mutants and complementary 
base-pair mutants were each linearised by digestion with Bbsl and used as a template for in 
vitro transcription. After DNasel treatment, the resulting RNA transcripts were purified from 
the transcription reaction using the RNeasy Mini Spin column (QIAGEN) clean-up protocol 
(methods 2.4.4), and resuspended in RNase-free water. The transcribed mutant BUNSCAT 
RNAs were applied to the reporter system using the same protocol as described earlier 
(Section 3.1). CV-1 cells, transiently expressing the BUN viral proteins of the BUN S and L 
segments, were transfected with equimolar amounts of each transcript. The cells were 
harvested 20 hours post transfection and the extracts collected as described previously 
(Section 3.1). The quantity of cell extract assayed was adjusted for protein concentration 
before assaying for CAT activity and quantification. The results of these experiments are 
summarised in Figures 9.3 and 9.4.
9.5 Results.
The effect of single point mutations and complementary double mutations within the 5’ and 
3’ termini of BUNSCAT RNA on the resulting CAT activity are summarised in Figures 9.3 
and 9.4 respectively.
From Figure 9.3 it can be seen that a large number of the single point mutations to the 5’ and 
3’ termini resulted in a marked reduction in CAT activity (<4%). This is in keeping with the 
observation discussed earlier, that a spurious mutation (C->G nucleotide 12) in the 5’ termini 
of construct pBUNSCATmut-12 resulted in resulted in a drastic loss of CAT activity. In the 
terminal 14 nucleotides of the putative panhandle, only the single nucleotide changes at
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Figure 9 .3  The effect o f  single point mutations in the BUN S 5 ’ and 3 ’ 
termini.
The above figure describes a series of single point mutations to the 5’ and 3 ’ termini of the 
BUNSCAT RNA. The effect of each mutation, as assayed in the reporter system, is 
expressed as a % activity of wild type BUNSCAT reporter RNA. Each point mutation is 
indicated by an arrow and the specific nucleotide change. Also shown beside each mutation 
is the resulting CAT activity, for example, the nucleotide at position 1 of the 5’ UTR is 
changed from A to G, and the CAT activity from this mutant is 40% that of wt- The mutants 
which produced a level of CAT activity less than 20% are shown in red, those which gave a 
signal between 20% and 49% are shown in green, and those equal to or greater than 50% are 
shown in black. Nucleotides 12 to 15, shown as the boxed yellow region, represents those 
nucleotides that are conserved between bunyavirus S segments.
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F igu re  9 .4  The e ffec t o f  com plem entary base-paired  m utations in the BUN S 
5 ’ and 3 ’ te rm in i.
The above figure describes a series of complementary base-paired mutations to the 5 ’ and 3 ’ 
termini of the BUNSCAT RNA. The effect of each mutation, as assayed in the reporter 
system, is expressed as a % activity of wild type BUNSCAT reporter RNA. Each mutation 
is indicated by an arrow and the specific base-pair changes. Also shown beside each 
mutation is the resulting CAT activity, for example, the base-pair at position 1 of paired 
termini is changed from A-U to G-C, and the CAT activity from this mutant is 23% that of 
wt. The mutants which produced a level of CAT activity less than 20% are shown in red, 
those which gave a signal between 20% and 49% are shown in green, and those equal to or 
greater than 50% are shown in black. Nucleotides 12 to 15, shown as the boxed yellow 
region, represents those nucleotides that are conserved between bunyavirus S segments.
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Figure 9.5 Proposed secondary structures for influenza A virus 3’ and 5 ’ 
ends.
(A) The influenza A virus proposed panhandle secondary structure based on the consensus 
sequence. (B) and (C), secondary structures as proposed by patterns of single substitutions, 
and supported by complementary double substitutions, (B) the fork model (Fodor et al., 
1994), and (C) the corkscrew model (Flick et al., 1996). Watson and Crick base pairs are 
indicated by vertical lines. Figures (A) and (C) adapted from Flick et al. (1996), and Figure
(B) is adapted from Fodor et al. (1994).
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Figure 9.6 Hypothetical secondary structures formed between the 5’ and 3 ’ 
term ini of the BUN S segment.
The above figure represents three hypothetical secondary structures formed between the 5’ 
and 3’ termini of the BUN S segment: these are based on the “corkscrew” model proposed 
for influenza A virus (Flick et al., 1996), shown in Figure 9.5. Each model predicts a tri­
stem loop structure formed by varying lengths of intra-strand base-pairing as well as base- 
pairing between the termini. Shown in the diagram are the positions of four complementary 
base-pair changes, each designed to maintain the possible intra-strand base-pairing in all 
three models. The notation is such that (3’db4) BUNSCAT contains the mutation U-A to C- 
G.
Lane 1 2 3 4 5 6 7 8 9 10
RNA BUNSCAT BUNSCAT BUNSCAT BUNSCAT BUNSCAT
template wt. 5’db3 5’db4 3’db3 3’db4
Figure 9.7 The effect of intra-strand complementary base-pair m utations 
within the BUN S 5’ and 3’ termini.
CV-1 cells transiently expressing BUN viral proteins were transfected in duplicate with equal 
quantities of the BUNSCAT RNA containing the intra-strand complementary base-pair 
mutations. Wild type BUNSCAT RNA was included as a control (Lanes 1 & 2). Lanes 3 & 
4, 5 & 6, 7 & 8, and 9 & 10, show the CAT results obtained from the BUNSCAT mutants 
5’db3, 5’db4, 3’db3, and 3’db4, respectively. All mutations resulted in CAT activities <2% 
wildtype level.
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positions 1, 4 and 8 of the 5’ termini and position 1 of the 3’ termini did not result in a 
drastic reduction in CAT activity (40%, 39%, 103% and 28% respectively). Single 
nucleotide changes within positions 15-18 in the 5’ termini and 3’ termini did not markedly 
reduce the CAT signal. This may reflect a greater necessity for base pairing between the 
terminal 14 nucleotides of the UTRs or of nucleotide specificity.
Figure 9.4 summarises the CAT activities from reporter BUNSCAT RNAs containing the 
complementary double mutations to the terminal 15 nucleotides of the 5’ and 3’ termini. It 
can be seen that, as in the case of single point mutations within this region, the majority of 
changes resulted in a drastic loss in CAT activity (<4%). Only at positions 1 and 4 was a 
moderate level of CAT activity detected at 23% and 31% respectively, while complementary 
double mutations at positions 13 to 15 of the panhandle produced relatively high levels of 
CAT activity, at 86%, 57% and 100% respectively.
Figure 9.7 shows the resulting CAT activities from a series of complementary intra-strand 
double mutations based on the structure in Figure 9.6. These results show that all intra­
strand complementary double nucleotide changes resulted in a CAT activity less than 4% of 
the BUNSCAT wt level.
9.6 Discussion.
Figure 9.3 shows the CAT activities from the series of mutant BUNSCAT reporter RNAs 
containing single point changes in the 5’ and 3’ termini. This series of mutants was 
constructed in an attempt to determine if base-pairing potential between the termini was 
important for function of the reporter RNA. Since most of the changes to the terminal 14 
nucleotides of either the 5’ or the 3’ UTRs drastically reduced CAT activity, the initial 
conclusion from this experiment was that the base pairing potential between the termini might 
be important for activity. However, Figure 9.4 summarises the CAT results from a series of 
pBUNSCAT mutants containing complementary double exchanges in the 3’ and 5’ termini. 
These mutants were designed to address the requirement for sequence specificity while 
maintaining base-pairing within the proposed panhandle structure. From Figure 9.4 it can be 
seen that only nucleotide “pairs” at position 1 and 4 in the first 12 nucleotides can be varied 
without abolishing CAT activity, demonstrating the importance not only of base pairing 
potential but also of sequence specificity within the termini. Whether these features of the 
termini are necessary for the processes of transcription and/or encapsidation is not clear.
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The complementary mutations at positions 13, 14 and 15 result in CAT activity between 57% 
and 100% that of wild type (Figure 9.4). However, a number of the point mutations which 
disrupt base-pairing in this region abolish CAT activity (Figure 9.3). Although a limited 
number of complementary mutations were made within nucleotides 12 to 15 of the 3’ and 5’ 
termini, the suggestion from the results so far is that the maintenance of base-pairing within 
this region might be more important than specificity of sequence. Interestingly, these 
nucleotides correspond to the region of sequence shared between bunyavirus S segments but 
not between the bunyavirus M and L genome segments (Figure 1.3), and so it might be 
predicted that base-pairing in this region will also be essential for transcription from the L 
and M BUN segments.
Mutational studies of the influenza A virus 3’ and 5’ termini has predicted two models, “the 
fork “ and the “corkscrew” models. In both models a region of base-pairing between the 
termini was predicted (Fodor et al., 1994, 1995: Flick et al., 1996; Kim et al., 1997). The 
first three base-pairs formed by nucleotides 11 to 13 at the 5’ end and nucleotides 10 to 12 at 
the 3’ end, are strictly conserved among different vRNA segments of all influenza A viruses. 
In addition, the panhandle base-pairing may be extended by nonconserved nucleotides at the 
3’ and 5’ ends. Thus nucleotides 14 to 16 at the 5’ end are generally complementary to 
nucleotides 13 to 15 at the 3’ end. These nucleotide positions, although nonconserved 
among the different vRNA segments, are in most instances highly conserved for the same 
segment of different influenza virus strains (Desselberger etal., 1980).
In the mutational studies that predict the two models, the authors suggest that within the 
base-paired region, secondary structure is more important than the actual sequence of the 
residues (Fodor et al., 1994, 1995; Flick et al., 1996)) Within the “corkscrew” model (Flick 
et al., 1996) intra-strand base-pairing was predicted within the 3’ and 5’ ends.
From examination of the BUN S termini sequence, it was thought that similar secondary 
structures might be formed, and therefore the effect of complementary intra-strand mutations 
was tested on these theoretical models. Unfortunately, each the four complementary intra­
strand 3’ and 5’ mutations abolished CAT activity, a result which might indicate that the 
termini do not form such structures. However, it is still possible that intra-strand pairing 
does occur and that the lack of CAT activity from the mutants might simply be the result of 
changing the sequence specificity.
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9.7 Future Work.
Future work would be to continue the single point mutagenesis of the 3’ and 5’ BUN S 
termini to predict those nucleotides essential for transcription and possibly predict a 
secondary structure complex formed between the 3’ and 5’ termini.
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Chapter 10.
10.0 The effect of modifications to the untranslated regions of 
BUNSCAT RNA.
10.0 Introduction.
The S segments from viruses in the Bunyamwera serogroup whose genomes have been 
sequenced so far vary in length from 945 to 992 nucleotides. This variation is not attributed 
to a size difference in the open reading frames of these segments as they are identical, 
encoding a protein of 233 amino acids. Rather, the difference in length of the S segments is 
directly due to variations in the length of the untranslated regions (UTRs). Both the 
individual 5’ and 3’ UTRs of the S-segments vary in size: the 5' UTR ranges from 26 to 87 
nucleotides and the 3' UTR from 169 to 226 nucleotides in length. It is the UTRs which are 
thought to contain the c/s-acting signals for the initiation of transcription and replication, for 
nucleocapsid assembly, and for packaging into virions. As each of the S-segment UTRs is 
expected to encode the equivalent signals, the variation in length of the UTRs may represent 
a different spacing of these important signals.
To determine the minimum length of the 5' and 3' UTRs needed for the expression of CAT 
activity, a series of BUNSCAT mini-reporter constructs was engineered: these constructs 
featured an antisense CAT gene flanked by varying lengths of the BUN S termini.
10.1 Construction of pBUNS-13CAT, pBUNS-20CAT, and pBUNS-32CAT 
mini-reporter constructs.
The possible base-pairing between the 3' and 5' termini of the BUN S segment is shown in 
Figure 10.1. It was on the basis of these predicted base pairings that specific regions of the 
5’ and 3’ UTRs were selected for investigation.
Importantly, the figure highlights the possibility of base pairing of the first 11 nucleotides of 
the 5’ UTR, with the last 11 nucleotides of the 3’ UTR. These are conserved between the S 
segment termini of all bunyavirus segments sequenced thus far, which suggests that this 
region must be highly important if not essential. Therefore, in designing the mini-reporter 
constructs, it was thought crucial that this conserved region be maintained in the flanking 
sequences.
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Figure 10.1 Possible complementary base-pairing between the 3’ and 5 ’ 
termini of the Bunyamwera S segment.
Figure 10.1 also depicts the observed high degree of complementary between termini, which 
is maintained for approximately the first 31 nucleotides of the 5' and 3' UTRs of the BUN S 
segment. Specifically, for the BUN S segment, there are 31 nucleotides at the 5' terminus 
which may possibly form a structure with a high degree of base-pairing with 33 nucleotides 
of the 3' terminus.
Therefore, two mini-reporter constructs were built initially, one contained a CAT ORF 
flanked by the terminal 11 nucleotides, and another contained a CAT ORF flanked by the 
first 31 nucleotides of the BUNS 5' UTR and the last 33 nucleotides of the 3' BUNS 
termini: these sequences encompassed the regions of high complementary between the 
termini. Details of the construction of the mini-reporters are shown in Figure 10.2 and 10.3; 
however, to achieve the final constructs it was necessary to use purpose-built cloning 
cassettes. These cassettes contained a restriction site (Smal), placed to allow insertion of a 
reporter gene, so that the reporter gene would be flanked by varying lengths of the 5' and 3' 
BUNS termini (Figure 10.2 and 10.3). Consequently, due to the use of the Smal restriction 
site to introduce the CAT ORF into the cloning cassettes, the number of flanking BUN S 
specific nucleotides in the first construct increased from 11 to 13 nucleotides (in both 
termini), and the number of flanking nucleotides in the second construct increased from 31 to 
32 nucleotides (of the 5' termini). The constructs were denoted pBUNS-13CAT and 
pBUNS-32CAT (Figure 10.2 and 10.3).
Another mini-reporter construct was built which contained the antisense CAT gene flanked 
by 20 nucleotides of the 5’ and 3’ BUN S termini. Twenty nucleotides of the BUN S termini 
were chosen as it served as an intermediate between the pBUNS-13CAT and pBUNS- 
32CAT mini-reporters. This mini-reporter was denoted pBUNS-20CAT, and details of the 
construction are shown in Figure 10.4.
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Figure 10.2 Prim er design and construction of pBUNS-13CAT.
Complementary oligonucleotides ED.5 and ED.6 (A), were annealed by the following 
method: 0.5|Lfg of each oligonucleotide were diluted to a final volume of 49jLll in lx T4 kinase 
buffer and heated for 5 minutes at 94°C, then slowly cooled to room temperature. The 
resulting annealed oligonucleotides were treated with T4 DNA kinase before being ligated 
into EcoRUXbal cut pUCl 18 (B), resulting in the construct pT7BUNS5’(13)-3’(13)CAT. A 
full length CAT ORF, as described in Figure 3.11, was ligated into Smal digested 
pT7BUNS5’(13)-3’(13). Resulting clones were screened by restriction digestion to confirm 
the presence and orientation of the CAT gene, and then sequenced to check the fidelity of 
sequence of the flanking regions. The final construct, shown in (C), contained an antisense 
CAT gene flanked by 13 nucleotides of the BUN S 5’ and 3’ termini, and was denoted 
pT7BUNS-13CAT.
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Figure 10.3 Construction of p T7BUNS-32CAT.
Generation of the cloning cassette shown in (C), was achieved by a two-step procedure. 
Two sets of complementary oligonucleotides, ED.9 & ED .10, and ED .11 & ED.12, were 
annealed as described earlier (Figure 10.1), and subsequently digested with EcoRl/Smal, 
and SmaUXbal, respectively. The resulting fragments were then purified by silica matrix 
absorption, and ligated into similarly digested pUC118, to produce the constructs 
pT7BUNS-5’(32) and pBUNS-3’(33), as shown in (B). The Small Xbal fragment from 
pBUNS-3’(33) was removed and ligated into pT7BUNS-5’(32), to result in 
pT7BUNS5’(32)-3’(33), as shown in (C). The CAT ORF was then cloned into the Smal 
site of pT7BUNS5’(32)-3’(33). Resulting clones were digested and sequenced to confirm 
the presence and orientation of the CAT gene, and the fidelity of sequence of the flanking 
regions. The resulting construct (D), which contained a full length CAT ORF, flanked by 32 
nucleotides of the BUNS 5’ UTR and 33 nucleotides of the BUNS 3’ UTR, was denoted 
pT7BUNS-32CAT.
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Figure 10.4 Construction of pT7BUNS-20CAT.
Two oligonucleotides were designed as primers to amplify and flank a CAT ORF with 
BUNS termini sequence by PCR. (A). Oligonucleotide T7BUN.20 (5' GGGGAGCTCTAATA 
CGACTCACTATA AGT AGTGTGCTCC ACCT A A ATTA C G C C C C G C C C C T G C C A )  encoded, in 
the 5' to 3' direction, a Sacl site for cloning, a T7 promoter (underlined), the first 20 
nucleotides of the BUNS 5' UTR and then the complement of the last 19 nucleotides of the 
CAT ORF (bold, stop codon underlined). Oligonucleotide BbsBUN.22 (GGGTCTAGAAGAC 
GC AGTAGTGT ACTCC AC ACT AC A A A T G G A G A A A A A A A T C A C T G G A ) encoded, in the 5' to 
3' direction, a Xbal site for cloning, Bbsl site, the terminal 22 nucleotides of the BUNS 3' 
UTR followed immediately by the first 21 nucleotides of the CAT ORF (bold, start codon 
underlined). The resulting PCR fragment was digested with Sacll X bal, and cloned into 
similarly digested pUC118 (B). Positive clones were sequenced to confirm fidelity of 
sequence of the CAT gene and the flanking regions. The resulting construct contained a full 
length ar.tisense CAT ORF flanked by 20 and 22 nucleotides of the BUNS 5’ and 3’ termini, 
and was denoted pBUNS-20CAT.
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10.2 Production of run-off transcripts from the mini-reporter constructs.
As in the case of pBUNSCAT, transcription of RNA from the mini-reporter constructs 
initiated from a truncated T7 promoter at the 5’ A residue of the BUN S 5’ terminus and 
terminated at the authentic 3' U residue due to the engineered Bbsl downstream of the 3’ 
terminus.
RNA transcripts derived from the pBUNS-13CAT plasmid, therefore, possessed the 
authentic ends of the BUN S segment RNA, and contained, in the 5’ to 3’ order, the 13 
nucleotides of the 5’ UTR of the BUN S segment, the entire CAT gene in a negative-sense 
polarity, and 13 nucleotides of the BUN S segment 3’ UTR. Similarly transcripts derived 
from the BUNS-20CAT plasmid contained, in the 5’ to 3’ order, 20 nucleotides of the 5’ 
UTR of the BUN S segment, the entire CAT gene in a negative-sense polarity, and 20 
nucleotides of the BUN S segment 3’ UTR, and transcripts from the pBUNS-32CAT 
plasmid contained, in the 5’ to 3’ order, the 32 nucleotides of the 5’ UTR of the BUN S 
segment, the entire CAT gene in a negative-sense polarity, and 33 nucleotides of the BUN S 
segment 3 ’ UTR.
In-vitro synthesis of run-off RNA transcripts from each the mini-reporters was achieved as 
described previously. After DNasel treatment, the resulting RNA transcripts were purified 
from the transcription reaction using the RNeasy Mini Spin column (QIAGEN) clean-up 
protocol (Methods 2.4.4), and resuspended in RNase-free water. The RNA concentration 
for each of the transcripts was determined by spectrophotometery as described previously. 
Figure 10.5 shows RNA transcripts derived from pBUNS-13CAT, pBUNS-32CAT and 
pBUNS-20CAT, shown alongside RNA derived from pBUNSCAT for comparison.
10.3 CAT activity detected from BUNS-13CAT, BUNS-20CAT and BUNS- 
32CAT mini-reporter RNA transcripts in the reporter assay.
It was important that an equal number of transcripts from each clone were transfected into the 
reporter system, and therefore the amount of transfected RNA was adjusted to take into 
account the size difference of the transcripts. Thus, an equimolar amount of each transcript 
was transfected (Table 10.1).
121
Results and Discussion: Chapter 10
m
1264 bp 
702 bp
Lane 1 2  3 4 5
Figure 10.5 M inireporter run-off transcripts.
The run-off transcripts from Bbsl linearised pBUNS-13CAT (Lane 5), pBUNS-20CAT 
(Lane 4) and pBUNS-32CAT (Lane 3) were compared with pBUNSCAT RNA transcripts
(Lane 2). X BstEll markers (0.5 JL X g ) are shown in lane 1.
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BUNS-CAT clone
transcript length 
in nucleotides
% in length 
of BUNSCAT
amount of RNA 
transfected
pBUNSCAT 919 100% 2.50pg
pBUNS-32CAT 728 79.2% 1 98jng
pBUNS-20CAT 702 76.4% 1.91pg
pBUNS-13CAT 688 74.9% 1.87pg
Table 10.1 Transfection of BUNSCAT mini-reporter RNAs.
This table describes the adjustments made to the amount of RNA transfected when the length 
of the transcript is taken into consideration. This ensured that equimolar amounts of each 
transcript were transfected onto cell expressing the BUN viral proteins.
The RNAs transcribed from the pBUNS-13CAT and pBUNS-32CAT, and pBUNS-20CAT 
mini-reporter clones were used in the reporter system along with BUNSCAT RNA as a 
control.
A comparison of the level of reporter gene expression obtained from BUNS-13CAT, 
BUNS-32CAT, and BUNS-20CAT mini-reporter RNA transcripts in the reporter assay is 
shown in Figure 10.6. Extracts from cells transfected with BUNSCAT RNA are shown in 
lanes 1, 2, and 3, extracts from cells transfected with BUNS-32CAT are shown in lanes 4, 
5, and 6, extracts from cells transfected with BUNS-20CAT are shown in lanes 7, 8, and 9, 
and extracts from cells transfected with BUNS-13CAT are shown in lanes 10, 11, and 12,
From this experiment it was apparent after quantification, that the highest level of CAT 
activity was obtained from BUNSCAT RNA; this was taken as 100%. Transfection of 
BUNS-32CAT RNA by comparison, was calculated to be between 63% and 70% of “wild 
type” i.e. BUNSCAT CAT activity. Both BUNS-20CAT and BUNS-13CAT produced 
levels of CAT activity that were extremely low (< 5%), and since sequencing confirmed that 
the CAT gene of these constructs was intact and without errors, it was concluded that this 
result indicated a drastic loss of function in these RNA transcripts.
10.4 Discussion.
It was discussed earlier in this chapter that there may be possible base-pairing between the 3' 
and 5' termini of the BUN S, M and L-segments. Additionally, the first 11 nucleotides of the
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BUNSCAT BUNS-32CAT BUNS-20CAT BUNS-13CAT
Figure 10.6 Comparison of reporter gene expression from BU N S-CA T, 
BUN-32CAT, BUN-20CAT and BUNS-13CAT RNA transfections.
CV-1 cells transiently expressing BUN viral proteins were transfected with equal quantities 
of BUNSCAT (Lanes 1, 2 and 3), BUNS-32CAT (Lanes 4, 5 and 6) BUNS-20CAT (Lanes 
7, 8 and 9) and BUNS-13CAT (Lanes 10, 11 and 12) RNA transcripts. This was achieved 
by adjusting the amount of transfected RNA to account for the length of each transcript 
(BUNSCAT (919 nucleotides), BUNS-32CAT (728 nucleotides) BUNS-20CAT (702 
nucleotides) and BUNS-13CAT (688 nucleotides)) so that a equivalent number of molecules 
for each transcript was transfected. The ratio of transfected BUNSCAT: BUNS-32CAT: 
BUNS-20CAT: BUNS-13CAT, in Jig, was 1: 0.792: 0.764: 0.749 respectively. Cells 
were harvested 20 hours post transfection and the cell extracts assayed for protein 
concentration before equivalent amounts of cell protein in each cell extract were assayed for 
CAT activity.
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Figure 10.7 Comparison of the termini from the BUNSCAT mini reporter 
constructs.
The portions of the BUNS UTR flanking the CAT gene of the mini reporter constructs are 
shown schematically above. The diagram also depicts the possible complementary base 
pairing of the BUNS 5’ and 3’ termini flanking the CAT gene. Non-BUNS UTR sequences 
are shown in bold italics, and the CAT initiation stop codons are underlined.
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segment 5’ UTR, and the last 11 nucleotides of the 3’ UTR are conserved between the 
termini of all bunyaviruses sequenced thus far, which suggests that this region must be 
highly important, if not essential.
On the basis of the predicted base pairings, and the observation that the terminal 11 
nucleotides of the S segment are conserved, it was decided that these regions should be 
investigated. Therefore, three mini-reporter constructs were built, pBUNS-13CAT, pBUN- 
20CAT and pBUNS-32CAT, which contained the antisense CAT gene flanked by various 
lengths of the BUNS termini. Figure 10.7 depicts a diagram which highlights the differences 
in length, and the possible complementary base pairing of the termini of the minireporter 
RNAs.
When the RNA transcripts from the mini-reporter constructs were used in the reporter assay, 
it was found that transfection of RNA transcripts from pBUNS-13CAT and pBUNS-20CAT 
resulted in no significant CAT activity. This finding indicated that flanking sequences of 
either 13 or 20 nucleotides of the 5’ and 3’ termini, were insufficient to allow transcription of 
the reporter gene.
CAT activity which was between 63 and 71% of “wild type”, i.e. the BUNSCAT signal, 
was detected from transfection of the BUNS-32CAT RNA. This suggested that 32 
nucleotides of the 5’ BUN S UTR and 33 nucleotides of the 3’ BUN S UTR were sufficient 
for the recognition and subsequent transcription of the reporter RNA by BUN viral proteins. 
However, given that this reporter RNA gave a signal which was not wild type level, it is 
suggested that sequences outwith this region may also be important for full transcriptional 
activity from the reporter. It can also be concluded from this experiment that the minimum 
requirement of nucleotides of the 5’ and 3’ BUN S UTRs necessary for recognition and 
transcription, is more than 20, and may be less than 32.
A paper from this laboratory (Bridgen and Elliott, 1996), published subsequently to this 
study, demonstrated the rescue of a recombinant Bunyamwera virus from three full length 
cDNA clones. This important paper is discussed in more depth in Chapter 1 section 1.8.5. 
However, in this study, on the basis of the results obtained with the pBUNS-32CAT 
minireporter, this construct was utilised to build similar construct termed 
pT7riboBUNSGFP(-). This minireporter contained an antisense GFP (Green Fluorescent 
Protein) ORF in place on the CAT gene, and was used essentially to optimise the transfection 
protocols in the rescue procedures used in these experiments. RNA transcripts transcribed 
in-vivo from pT7riboBUNSGFP contained, in the 5’ to 3’ direction, two G residues derived 
from the cloning site, 32 nucleotides of the BUNS 5’ UTR, the antisense GFP ORF, and the 
33 nucleotides of the BUNS 3’ UTR.
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Transfection of pT7riboBUNSGFP(-) into cells expressing the proteins from the BUNL, M, 
and S-segments, resulted in the expression and subsequent detection of GFP. This was in 
agreement with the pBUNS-32 CAT results, and demonstrated that an antisense reporter 
ORF flanked by 32 nucleotides of the BUNS 5’ and 33 nucleotides of the 3’ UTRs, could be 
recognised and transcribed by the recombinant BUN viral proteins to result in expression of 
the reporter protein.
It was also demonstrated in this study that when extracts prepared from these cells were 
subsequently overlaid onto cells expressing BUN viral proteins (either by BUN virus 
infection or by transient expression), some of the new cells were observed to express GFP. 
No GFP was detected in cells which were not expressing BUN viral proteins. From this 
result, it was suggested that the BUNSGFP RNA transcripts had been packaged into BUN 
virus-like particles that were capable of infecting new cells.
This result would suggest therefore, that the terminal 32 nucleotides and 33 nucleotides of 
the BUNS 5’ and 3’ UTRs are sufficient, and contain the appropriate cis acting signals, not 
only for transcription and replication of the reporter RNA, but also for packaging of the 
transcript into virus-like particles.
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C hapter 11.
11.0 Investigation of the untranslated regions in the BUN 
genomic segments.
11.0 Introduction.
Throughout the course of a bunyavirus infection, viral mRNA transcripts of the L, M and S 
segments can be detected at different levels in molar terms within the cell. The S mRNA 
species is more abundant than the M mRNA species, which in turn is more abundant than the 
L mRNA species; it has been estimated that the ratios are 40: 10: 1 respectively (Vezza et al., 
1979; Rossier et al., 1988). The exact reasons for these differences are unknown, but it is 
thought that cis-acting signals encoded within the untranslated regions of each of the three 
genomic segments may control or influence transcription and replication events.
Alignment and comparison of the BUN genomic full length UTRs, shown in Figure 11.1, 
highlights that other than the terminal 11 conserved nucleotides, there are few residues in the 
remaining regions of the 5’ and 3’ UTRs that are conserved between the BUN segments. 
There are no other obvious sequence motifs common to all three segments to which ex­
acting functions, related to transcription and replication, could be attributed.
To investigate the possibility that control of transcription and replication is mediated by 
signals in the untranslated regions CAT reporter constructs, containing the BUN L and M 
segment UTRs were constructed. Since measurement of CAT activity is essentially an 
indication of the amount of CAT protein translated from mRNA transcripts, it was hoped that 
use of these constructs in the reporter system would determine the influence of the BUN L 
and M UTRs on the level of CAT mRNA transcript.
11.1 Construction of pBUNLCAT and pBUNMCAT reporter constructs.
The pBUNLCAT and pBUNMCAT reporter constructs were built using a PCR approach 
similar to that used in the construction of pBUNSCAT, (Chapter 3.1). Again, as in the case 
of pBUNSCAT, transcription of RNA from pBUNLCAT and pBUNMCAT initiated from a 
truncated T7 promoter at the 5’ A residue of the BUN L and M genome, and terminated at 
the exact 3’ residue of the BUN genomes, due to linearisation of the plasmids by the
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Figure 11.1 Conserved nucleotides in the 3' and 5' UTRs of the BUN virus 
genomic segments.
Alignments of the BUN L, M and S segment UTRs were generated using the PILEUP 
program of the GCG Wisconsin Package™ (version 9). Sequences were aligned in the 
genomic RNA sense in a 5' to 3' manner. Capital letters highlight residues conserved in two 
or more segments and the consensus sequence, while those residues conserved in all three 
segments are marked with an asterisk. Figure (A) shows the alignment of the 5' UTRs, 
while (B) shows the alignment of the 3’ UTRs. The figure demonstrates that besides the 
terminal eleven nucleotides (conserved in all bunyaviruses), few residues are conserved 
between all three BUN segments.
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restriction enzyme Bbsl. Thus T7 transcripts derived from pBUNLCAT and pBUNMCAT 
contained the authentic termini of the genome segments, with a CAT ORF of negative 
polarity, flanked by the 5’ UTR (108 nucleotides) and 3’ UTR (50 nucleotides) of the BUN 
L genome or alternatively, flanked by the 5’ UTR (103 nucleotides) and 3’ UTR (56 
nucleotides) of the BUN M genome segment.
11.2 The design of primers to construct pBUNLCAT and pBUNMCAT.
The oligonucleotides L-START and L-STOP were designed as primers to amplify the CAT 
open reading frame from pTZCAT(-) and tail it with short regions of the Bunyamwera virus 
L segment UTR which would normally flank the L protein coding region. The 
oligonucleotides T7-L and Bbsl-L were designed as primers to amplify the 5’ and 3’ UTRs 
respectively. T7-L placed a T7 promoter upstream of the 5’ UTR such that transcription 
initiated at +1 of the BUN L 5’ UTR. The primer Bbsl-L positioned a Bbsl restriction site 
down stream of the 3’ UTR so that T7-directed run-off transcription terminated at the exact 
nucleotide of the 3’ UTR (Figure 11.2A).
Oligonucleotides were designed in a similar manner to act as primers in the construction of 
pBUNMCAT: these were denoted M-START, M-STOP, T7-M and Bbsl-M (Figure 11.3).
11.3 Generation of BUN L and M 5’ and 3’ UTRs containing cDNA 
restriction fragments.
cDNA templates containing the complete untranslated regions of the BUN M and BUN L 
segments were obtained as follows: pT7-BUNM-Ribo(-) (Bridgen and Elliott, unpublished 
work) was digested with Clal and Xbal to produce a fragment containing the complete BUN 
M 3’ UTR and plasmid pT7-BUNM-Ribo(+) (Bridgen and Elliott, 1996) was digested with 
BamHl to obtain a fragment containing the complete BUN M 5’ UTR. To obtain cDNA 
fragments containing the complete BUN L 3’ and 5’ UTRs, pT7-BUNL(M7)-Ribo(+) 
(Bridgen and Elliott, 1996) was either digested with EcoRl, to obtain the BUN L 3’ UTR 
fragment, or Xbal to obtain the BUN L 5’ UTR fragment. Digestion reactions were run on a 
1% agarose TAE gel, the desired cDNA fragments were removed and purified by silica 
matrix absorption.
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BUN L 5
pTZ-CAT(-)
—  BUNLcDNA
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BUNLCAT
Figure 11.2 (A) Construction of pBUNLCAT.
The sequence of the primers were as follows:
L-STOP: 5 ’ AACCAATGAAGATATGTTTC ACGCCCCGCCCTGCC ACTC. The
underlined sequence shown above, corresponds to BUN L segment cDNA nucleotides 
6785-6768, which immediately follow the L protein reading frame. The remainder of the 
sequence is the complement of the last 21 nucleotides of the CAT reading frame starting with 
the complement of the stop codon (bold).
L-START: 5’ AATATAACCAGTAGGAGTATGGAGAAAAAAATCACTGGA.
The underlined sequence corresponds to BUN L segment cDNA nucleotides 33-50 which 
immediately precede the L protein reading frame. The remainder of the sequence is the first 
21 nucleotides of the CAT reading frame starting with the initiation codon (bold).
T7L(-):5’ ATTCGAGCTCTAATACGACTCACTATAAGTAGTGTGCTCCTACATA 
AG AAA ATT. The underlined sequence corresponds to the complement of the last 27 
nucleotides of the Bunyamwera virus L segment cDNA. This is immediately preceded by a 
truncated T7 promoter (17 nucleotides ending TATA (bold)) and an Sac\ restriction site for 
cloning.
B bsl-L (-): 5’ AG ACT CT AG A AG ACGC AGT AGTGT ACTCCT AC AT AT AG AAA ATT. 
The underlined sequence corresponds to the first 28 nucleotides of the Bunyamwera virus L 
segment cDNA. The remainder of the sequence codes for a Xbal restriction site for cloning 
and an inverted Bbsl site to allow cleavage at the viral cDNA terminus for run-off 
transcription.
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Figure 11.2 (B) Construction of pBUNMCAT.
The sequence of the primers are as follows:
M -STO P: 5’ ATAACCGTCTAATTTTCACGCCCCGCCCTGCCACTC. The underlined 
sequence shown above, corresponds to BUN M segment cDNA nucleotides 4359-4373 
which immediately follow the M segment reading frame. The remainder of the sequence is 
the complement of the last 23 nucleotides of the CAT reading frame starting with the 
complement of the stop codon (shown in bold).
M -START: 5’ CACATCTTTATTTCCAAGATGGAGAAAAAAATCACTGGA. The
underlined sequence corresponds to BUN M segment cDNA nucleotides 39-56, which 
immediately precede the M segment reading frame. The remainder of the sequence is the first 
20 nucleotides of the CAT reading frame starting with the initiation codon (bold).
T7-M(-): 5’ ATTCGAGCTCTAATACGACTCACTATAAGTAGTGTGCTACCGAT 
AACAAAACAG. The underlined sequence corresponds to the complement of the last 27 
nucleotides of the Bunyamwera virus M segment cDNA. This is immediately preceded by a 
truncated T7 promoter (17 nucleotides ending TATA (bold)) and an Sacl restriction site for 
cloning.
B b sl-M (-): 5’ AG ACT CT AG A AG ACGC AGT AGTGT ACT ACCG AT AC ATC AC AA AC. 
The underlined sequence corresponds to the first 28 nucleotides of the Bunyamwera virus M 
segment cDNA. The remainder of the sequence codes for a Xha\ restriction site for cloning 
and an inverted Bbsl site to allow cleavage at the viral cDNA terminus for run-off 
transcription.
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Figure 11.3 Schematic protocol for the construction of pBUNLCAT.
The same protocol was used to construct pBUNMCAT, but with M segment cDNAs and the 
oligonucleotides described in figure 11.2B.
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Figure 11.4 Amplification of the CAT open reading fram e from pTZCAT(-).
A DNA fragment flanked by short sequences from the BUN M or the BUN L segments was 
generated by PCR from pTZCAT(-) (lOOng), using the primer pairs M-START and M- 
STOP (Lanes 2 and 3), and L-START and L-STOP (Lanes 5 and 6). Lanes 4 and 7 shows a 
control PCR reaction in which all four primers were included, but no template. Lanes 1 and 
8 contain X RstEII size markers (0.5 pig). The PCR generated cDNA fragments in lanes 3 
and 6 (position marked by arrow) were cut from the gel and purified by silica matrix 
adsorption (methods 2.3.7), then used as templates in further PCR reactions (see figure 11.2 
(B)).
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11.4 Generation of pBUNLCAT and pBUNMCAT.
The strategy used in the construction of pBUNLCAT is shown schematically in Figure 11.3. 
Note that pBUNLCAT and pBUNMCAT were constructed in a similar manner. In the first 
step, a CAT open reading frame was amplified by PCR using oligonucleotides L-START 
and L-STOP, which were designed to tail the CAT sequence with short regions identical to 
those flanking the BUN L or BUN M open reading frames: The resulting PCR products of 
approximately 696 base-pairs are shown in Figure 11.4, Lanes 2, 3 and 5, 6 respectively.
For the next step (Figure 11.3, step 2a), in a “three way” PCR reaction, two BUN L 
segment termini cDNA fragments were recombined with the BUN-tailed CAT gene. Initially 
this reaction (Figure 11.3 step 2b) produced two overlapping fragments which both 
contained the CAT coding sequence recombined by PCR with the 3’ or 5’ untranslated L 
segment sequences, together with the relevant terminal modifications (Figure 11.3, step 2b). 
These fragments were then combined and amplified with the terminal primers to produce the 
final full length expression cassette, to result PCR products of approximately 825 base-pairs 
as shown in Figure 11.5 (Lanes 4 and 7), (Figure 11.3, step 3). This final fragment was 
digested with restriction enzymes Sacl and Xbal and then ligated into Sad  and Xbal digested 
pUC119. Sequencing of each clone into the CAT open reading frame confirmed the 
sequences of the T7 promoter, Bbsl site and the BUN termini and that no spurious mutations 
had occurred during PCR. Two clones for each construct were selected, and were denoted 
pBUNMCAT (2) and (3) and pBUNLCAT (22) and (23).
11.5 Production of run-off RNA transcripts from pBUNMCAT and 
pBUNLCAT clones.
DNA from each of the clones pBUNMCAT (2) and (3) and pBUNLCAT (22) and (23) was 
linearised by digestion with Bbsl to act as a template for in vitro transcription (Figure 11.6). 
After DNasel treatment, the resulting RNA transcripts were purified from the transcription 
reaction using the RNeasy Mini Spin column (QIAGEN) clean-up protocol (Methods 2.4.4), 
and resuspended in RNase-free water.
The RNA concentration for each of the transcripts was determined by spectrophotometery as 
described previously (Methods 2.4.4). It was important that an equal number of transcripts 
from each clone were transfected into the reporter system, therefore, the amount of 
transfected RNA was adjusted to take into account the size difference of the transcripts. 
Thus, an equimolar amount of each transcript was transfected (Table 11.1).
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Figure 11.5 Recombinant PCR of the M and L tailed CAT gene with BUNM 
and BUNL segment term ini.
A 1% TAE agarose gel was loaded with the products of PCR reactions set up with the 
following template and primer combinations:- Lane 2 contained two templates, the M-CAT 
tailed fragment and the M 3’ UTR(C/tfI, Xbal) fragment. Primers in this reaction were M- 
STOP and Bbsl-M. Lane 3 contained two templates, the M-CAT tailed fragment and M 5’ 
UTR(5araHI) fragment. Primers in this reaction were M-START and T7-M. Lane 4 
contained three templates, the M-CAT tailed fragment, M 3’ UTR(C7aI, Xbal) fragment and 
the M 5’ UTR(ZtamHI) fragment. The primers in this reaction were M-STOP. M-START , 
Bbsl-M and T7-M. Lane 5 contained two templates, the L-CAT tailed fragment and the L 3’ 
UTR(£'coRI) fragment. Primers in this reaction were L-STOP and Bbsl-L. Lane 6 contained 
two templates, the L-CAT tailed fragment and L 5’ UTR(Xfral) fragment. Primers in this 
reaction were L-START and T7-L. Lane 7 contained three templates, the L-CAT tailed 
fragment, L 3’ UTR(£cc>RI) fragment and the L 5’ UTR(XM) fragment. The primers in this 
reaction were L-STOP, L-START, Bbsl-L and T7-L. Lanes 2 and 5, and lanes 3 and 6 
represent the intermediate PCR fragments generated by the addition of the 3’ and 5’ UTRs 
onto the M and L tailed CAT genes. These PCR reactions served as controls to ensure 
intermediate fragments of the correct size would be generated in the three way PCR reactions 
(Lanes 4 and 7). Lanes 4 and 7 contain the final full length PCR products marked of 
approximately 850 basepairs, BUNMCAT(circle) and BUNLCAT(diamond) respectively. 
The cDNA fragments in lanes 4(circle) and 5(diamond) were removed from the gel, purified 
and digested with Sac I and Xbal before being ligated into Sacl, Xbal cut pUCl 19 vector.
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RNA
transcripts
Lane 1 2 3 4 5 6 7
Figure 11.6 In vitro transcription from B bsl linerised tem plates.
A 1% TBE agarose gel was loaded with a 4 pi aliquot from each 100 pi run-off transcription 
reaction, before the addition of RQ1 DNase. Lanes 2 and 3 contain RNA transcripts from 
Bbsl cut pBUNSCAT. Lanes 4 and 5 contain RNA transcribed from Bbsl cut pBUNMCAT. 
Lanes 6 and 7 contain RNA transcribed from Bbsl linearised pBUNLCAT. Lane 1 contains 
X 5sfEII size markers (0.5 pg).
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BUN-CAT clone transcript length 
nucleotides
% in length amount of RNA 
transfected
pBUNSCAT 919 100% 2.50 pg
pBUNMCAT 819 89.12% 2.23 pg
pBUNLCAT 818 89.01% 2.23 pg
Table 11.1 Transfection of genomic BUNCAT transcripts.
The above table demonstrates the adjustments made to the amount of RNA transfected when 
taking the length of the transcript into consideration, ensuring an equimolar amount of each 
transcript was transfected.
11.6 Comparison of CAT activity from (genomic CAT constructs) 
BUNLCAT, BUNMCAT and BUNSCAT RNA in the reporter assay.
The RNAs transcribed from the pBUNLCAT, pBUNMCAT and pBUNSCAT clones 
(Figure 11.6) were applied to the reporter system using the same protocol as described 
earlier (Section 3.1). The quantity of cell extract assayed was adjusted for protein 
concentration before assaying for CAT activity and phosphorimager quantification.
A comparison of the level of reporter gene expression obtained from transfecting 
BUNSCAT, BUNMCAT and BUNLCAT RNA in the reporter assay is shown in Figure
11.7. From this experiment it was apparent that the highest level of CAT activity was 
obtained from transfection of BUNLCAT RNA, and the lowest level from transfection of 
BUNSCAT RNA. If the level of CAT expression from transfection of BUNLCAT was 
taken as 100%, then the CAT activity from BUNMCAT RNA was between 60 and 70%, 
and from BUNS-CAT, between 3 and 10%. Given that equimolar amounts of RNA of each 
construct were transfected into the reporter system, the efficiency of expression of the 
reporter gene in the context of each of the BUN segments is in the order of 
BUNLCAT»BUNMCAT»BUNSCAT.
It was not known whether the different levels of CAT expression from each of the three 
genomic CAT constructs was a result of differences in efficiency of transcription or 
replication by the BUN viral proteins, or even possibly the efficiency of translation of the 
mRNA transcripts by host cell proteins (although this last factor was not initially considered 
to be of issue here). Therefore, in an effort to establish if control of expression of the 
reporter occurred at the transcriptional level, Northern blot analysis was used to probe total 
RNA extracts from cells transfected with genomic BUN-CAT transcripts in the reporter 
assay. Probing was performed as described in Chapter 3.1. However, as was found
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11.7. Com parison of reporter gene expression from BUNS-CAT, BU N M ­
CAT and BUNL-CAT RNA transfections.
CV-1 cells transiently expressing BUN viral proteins were transfected with equal quantities 
of BUNSCAT (Lanes 1 and 2), BUNMCAT (Lanes 3 and 4) and BUNLCAT (Lanes 5 and 
6) RNA transcripts. This was achieved by adjusting the amount of transfected RNA to 
account for the length of each transcript i.e., (BUNSCAT (100%), BUNMCAT (89.1%) 
and BUNLCAT (89%)) so that an equivalent number of molecules for each transcript was 
transfected. The amount of transfected BUNSCAT, BUNMCAT, BUNLCAT RNA in pg, 
was 2.50, 2.23 and 2.23 pg respectively. Cells were harvested 20 hours post transfection 
and the cell extracts assayed for protein concentration before equivalent amounts of cell 
protein in each cell extract were assayed for CAT activity.
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previously, Northern Blot analysis was unsuccessful in detecting the presence of positive 
sense transcripts.
11.7 The effect on translational efficiency by changing the sequence context 
of the AUG initiation codon.
It has been shown previously, that the sequence context of the initiation codon is important 
for translational efficiency (Kozak, 1986; Kozak, 1996). Since Northern blot analysis was 
unsuccessful, it was not clear if the observed differences in expression of the CAT reporter 
gene from each of the genomic BUN-CAT constructs were due to transcriptional control, 
and thus the possibility arose that translational control might also be responsible for the 
differing levels of CAT activity obtained from the BUN-CAT constructs. Therefore, it was 
decided to examine the sequences around the AUG initiation codon in each of the three BUN 
anti genomic segments for Kozak consensus similarity.
Figure 11.8 (A) shows a comparison of the sequences surrounding the AUG of each of the 
antigenomic BUN segment RNAs. These are compared against the optimal translation 
initiation signal consensus, Kozak, (1986). Figure 11.8 (B) shows the same comparison of 
the antigenomic BUN-CAT RNAs, where the sequence context of the AUG is slightly 
different due to the presence of the reporter gene in place of the segment ORFs. Again, this 
is compared against the Kozak sequence. It has been shown previously that the strongest 
determinant for efficient translation initiation is the presence of a purine (R) at position -3, 
followed by a G at position +4 {i.e. RNNATGG1 with respect to the initiation codon 
(Kozak, 1986). It can be seen in Figure 11.8 (A) that the context of the AUG in the BUN L 
segment antigenomic RNA has the highest Kozak similarity, with an A residue at position - 
3, and a G residue at position +4. By comparison, the BUN M segment antigenomic RNA 
has an A at position -3, but no G at position +4, and the BUN S segment antigenomic RNA 
has neither of these important residues.
However in Figure 11.8 (B), which shows the context of the AUG in the BUN-CAT 
constructs, it can be seen that each of the BUN-CAT sequences now have a G at position 
+4. This increases the Kozak similarity of the context of the BUNMCAT initiation codon, to 
that of the BUNLCAT AUG. Since the BUNMCAT antigenomic RNA also possesses minor 
Kozak determinants at positions -4 and -5, it might be expected that this transcript would be 
translated most efficiently to result in the highest CAT signal.
Since the BUNLCAT and BUNMCAT antigenomic RNAs exhibited more similarity to the 
Kozak consensus than the BUNSCAT antigenomic RNA, it was possible that these
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Figure 11.8 Comparison o f BUN sequences upstream and 
downstream o f the AUG initiation codon.
The above diagram shows a comparison of BUN sequences upstream and downstream of 
the initiation codon, specifically, from nucleotides at position -9 to +1, with respect to the 
AUG initiation codon. This is shown both for each BUN virus antigenome segment (A), and 
each BUN-CAT antigenome transcript (B). Both of these are shown compared with the 
optimum eukaryotic translation initiation signal ‘KOZAK’ (Kozak, 1996). Nucleotides 
which are conserved between the BUN segments and the Kozak sequence are highlighted.
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sequences accounted for the observed differences in expression of the CAT gene from each 
of these constructs. This seemed possible considering that BUNLCAT and BUNMCAT 
gave much higher expression than BUNSCAT (10 and 7 fold, respectively). To investigate 
this, it was decided to mutate nucleotides at position -3, with respect to the initiation codon, 
in the BUNLCAT and BUNSCAT transcripts, to attempt to increase and decrease, 
respectively, their similarity to the Kozak sequence. Therefore the U residue at position -3 in 
the BUNSCAT transcript was mutated to an A, and the A at the same position in the 
BUNLCAT transcript was changed to a U.
11.8 Construction of BUN-CAT “Kozak” mutants.
Mutation of position -3 residues in the pBUNSCAT and pBUNLCAT reporter constructs 
was achieved using the Quik Change™ mutagenesis kit by Stratagene. This method was 
chosen as it offered a low spurious error rate. The protocol entailed designing two sets of 
complementary oligonucleotides (CAT.6 and CAT. 7, CAT.8 and CAT.9) encoding the 
desired nucleotide change at position -3. These are shown in Figure 11.9. All other 
methodology was performed exactly according to instructions supplied by the manufacturers 
of this kit (Methods 2.3.12).
Positive colonies generated using this system were selected and sequenced to confirm the 
presence of the desired mutations. The resulting constructs were denoted 
pBUNSCATkozak, which contained a U-->A change at position -3, and pBUNLCATkozak, 
which encodes a A—>U change at position -3, with respect to their CAT ORF initiation 
codon. Figure 11.9 shows samples of sequence from clones positive for the desired 
mutants.
11.9 Transfection of BUNSCATkozak and BUNLCATkozak RNA in the 
reporter assay.
Run-off RNA transcripts were obtained from Bbsl linerised pBUNSCATkozak and 
pBUNLCATkozak by the same methods described previously.
As described previously, it was important that equivalent amounts of each transcript were 
transfected to allow comparison of the resulting CAT expressions from the transcripts. 
Therefore, adjustments were made to take transcript length into account. These adjustments 
were essentially the same as those made for transcripts from the parental constructs (Table 
11 . 1) .
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Figure 11.9 Construction of Kozak consensus mutants pBUNSCATkozak 
and pBUNLCATkozak.
To construct the BUNSCAT and BUNLCAT Kozak consensus mutants the Quik Change ™ 
site-directed mutagenesis kit (Stratagene) was used (Methods 2.3.12). The oligonucleotides 
used as primers to construct the BUNSCAT Kozak mutant, were CAT.6 (5’CTCCATTATA 
GAGCCTTT AATG) and CAT.7 (5’CATTAAAGGCTCTATAATGGAG), and 
oligonucleotides CAT.8 (5’CTCCATACACCTACTGGTTA) and CAT.9 (5’TAACCAGTA 
GGTGTATGGAG) were used to construct the BUNLCAT Kozak mutant. The resulting 
constructs were termed pBUNSCATkozak and pBUNLCATkozak.
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Lane 1 2 3 4 5 6 7 8
pBUNSCAT pBUNSCAT pBUNLCAT pBUNLCAT
kozak kozak
Figure 11.10 R eporter gene expression from m utants pBUNSCATkozak and 
pBU N LC A Tkozak.
CV-1 cells transiently expressing BUN viral proteins were transfected in duplicate with equal 
quantities of RNA transcripts from the mutants BUNSCATkozak and BUNLCATkozak as 
indicated above (Lanes 3 and 4, and 7 and 8), and the BUNSCAT and BUNLCAT 
transcripts as controls (Lanes 1 and 2, 5 and 6). Cells were harvested 20 hours post 
transfection and the cell extracts assayed for protein concentration before equivalent amounts 
of cell protein in each cell extract were assayed for CAT activity.
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Transcripts of the Kozak mutants pBUNSCATkozak and pBUNLCATkozak were 
transfected into the reporter system by methods described previously. Transcripts from the 
parental constructs, pBUNSCAT and pBUNLCAT, were also transfected into the reporter 
system as controls. Cell extracts were harvested and assayed for protein concentration, 
before CAT activity was measured and quantified by methods described previously.
The results of this experiment are shown in Figure 11.10, where it can be seen that mutation 
of the U residue at position -3 to an A residue in the BUNSCAT antigenomic RNA (i.e. as in 
the pBUNSCATkozak mutant) resulted in no significant change in the expression of the 
CAT gene when compared to the parental control (i.e. as in the pBUNSCAT). After 
quantitation, the CAT activity obtained from the BUNSCAT RNA was taken to be 100%, 
and by comparison, the activity from the BUNSCATkozak mutant was 104%.
Similarly, mutation of the A residue at position -3 to a U residue in the BUNLCAT 
antigenomic RNA (i.e. as in the pBUNLCATkozak mutant), also produced no significant 
change in the CAT activity detected, as compared to the parental control construct (i.e. as in 
pBUNLCAT “wild type”). If, after quantitation, the CAT activity from BUNLCAT was 
taken to be 100%, then the resulting CAT activity from BUNLCATkozak mutant was also 
found to be 100%.
Therefore, mutation of the nucleotide at position -3 in pBUNSCATkozak from an A to a U, 
a mutation which would have made the context of the initiation codon of the CAT gene more 
Kozak-like, did not result in a significant rise in CAT activity, as may have been expected. 
Furthermore, a mutation at the -3 position in pBUNLCATkozak from a U to an A, a 
mutation which would have made the context of the initiation codon of the CAT gene less 
Kozak-like, did not result in a significant reduction in CAT activity, as may have been 
expected.
Taken together, these results indicated that the sequence at the -3 position with respect to the 
initiation codon of the CAT ORF does not influence the level of CAT expression from BUN- 
CAT mRNA transcripts in this reporter system. This experiment does not rule out the 
possibility that translation efficiency may be affected by other sequences outwith nucleotides 
-9 to +1, in the context of the initiation codon. However, the data collected here lends 
support to the initial premise that CAT activity is an indication of CAT protein production, 
which is in turn an indication of CAT mRNA transcript levels, and furthermore, that the 
marked difference in the level of CAT activity detected between BUNLCAT and BUNSCAT 
is not due to differences in translational efficiency.
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11.10 Construction of chimeric BUN-CAT reporter constructs.
Northern blot analysis was unsuccessful in determining whether the differences in CAT 
activity from each of the BUN-CAT reporter constructs was due to replicational or 
transcriptional control. Therefore, it was decided to make a series of chimeric BUN segment 
CAT reporter constructs, designed to determine the reason for the elevated CAT activity of 
BUNLCAT. The rationale behind this was that by separating the BUN L UTRs, i.e. by 
making chimeras with the CAT reporter gene flanked by either the 3' or the 5' UTR of the L 
segment (with the opposite termini from another segment), it would be possible to determine 
which of the BUN L UTRs was responsible for the elevated expression CAT from the 
BUNLCAT transcript. Essentially, it was hoped that this experiment would also allow the 
isolated study of the replication and the transcription promoters of the BUN L segment (i.e. 
5' UTR for anti genome replication (anti-vRNA) and mRNA transcription, the 3' UTR for 
genome replication (vRNA)). In addition, the generation of chimera with termini from the 
other segments would also allow investigation into how pairing of heterologous termini 
affects CAT expression from these constructs. In pairing the different combinations of 
termini of the BUN L, M and S segments, it was expected that a pattern in the levels of CAT 
expression would suggest which of the termini, 3’ or 5’, and therefore which promoter, was 
responsible for the characteristic level of CAT activity observed for each chimeric construct. 
As each terminus must contain the proper signals i.e. the authentic viral signals, potentially 
required for recognition by the BUN viral proteins and expression during a viral infection, it 
was presumed that the termini from each segment would be able to co-operate, at least to 
some extent, with other heterologous termini.
11.11 Generation of chimeric BUN CAT constructs.
The chimeric UTR BUN-CAT constructs were engineered by taking advantage of the unique 
Ncol restriction sites within the CAT gene of the reporter constructs and the Xbal site 
downstream of the Bbsl site, downstream in the vector sequence (Figure 11.11 A).
Therefore, ligation of the different XballNcol fragments containing each of the BUN 
segment 3’ UTRs into the different XballNcol BUN segment 5’ UTR vector fragments 
resulted in a series of constructs covering all possible combinations of the three segments 
UTRs. All positive clones were sequenced to confirm that no mutations had been introduced 
during cloning.
The resulting chimeric BUN termini-CAT constructs were termed pBUNS/M-CAT, 
pBUNS/L-CAT, pBUNM/S-CAT, pBUNM/L-CAT, pBUNL/S-CAT and pBUNL/M-CAT.
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Figure 11.11 Construction of chimeric UTR BUN-CAT constructs.
(A) Each of the genomic CAT reporter plasmids were digested with Xbal and Ncol and the 
resulting fragments purified from a 1% TAE gel by silica matrix adsorption. The three 
different XballNcol fragments containing the 3’ UTRs were ligated into the three different 
XballNcol 5’ UTR vector fragments, resulting in a series of constructs covering all possible 
combinations of the three segments non-coding regions. The resulting chimeric BUN termini 
CAT constructs were termed pBUNS/M-CAT, pBUNS/L-CAT, pBUNM/S-CAT, 
pBUNM/L-CAT, pBUNL/S-CAT and pBUNL/M-CAT. (B) For example, pBUNL/M-CAT 
contains an antisense CAT gene flanked by the BUNL 5’ UTR and the BUNM 3’ UTR. All 
positive clones were sequenced to confirm the non-coding regions and to eliminate the 
possibility of any changes to sequence at the cloning sites.
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The clones were given names according to a system which referred first to the origin of the 
5’ UTR, then the 3’ UTR. For example, pBUNL/M-CAT contained an antisense CAT gene 
flanked by the BUNL 5’ UTR and the BUNM 3’ UTR. This chimeric BUN termini 
construct described diagrammatically in Figure 11.11 B.
11.12 CAT expression from chimeric BUN termini-CAT RNA transcripts.
The run-off transcripts from each of the six chimeric BUN termini-CAT constructs were 
transfected into cells transiently expressing the products of the S and L segments. The 
BUNL-, M- and S-CAT constructs were also transfected to serve as comparative controls. 
For clarity, the BUNL-, M- and S-CAT constructs will be referred to forthwith in this 
chapter as the genomic BUN-CAT constructs. The transfection protocol was as described 
previously.
As demonstrated in Figure 11.12, CAT activity was detected in the cell lysates from cells 
transfected individually with the genomic BUN-CAT transcripts as described previously, but 
surprisingly no CAT activity was detectable in the lysates from cells transfected with any of 
the six chimeric BUN-CAT transcripts. All chimeric constructs, pBUNS/M-CAT, 
pBUNS/L-CAT, pBUNM/S-CAT, pBUNM/L-CAT, pBUNL/S-CAT and pBUNL/M-CAT, 
were completely negative for CAT activity.
That every chimeric construct would be negative for CAT activity in the reporter assay was 
unexpected. Therefore, to check that the CAT ORF was active in each of the chimeric 
reporter constructs, the chimeric DNAs were transfected into vaccinia (vTF7-3)-infected cells 
(Figure 11.13). As described previously transfection of BUN-CAT DNA into cells infected 
with vTF7-3 results in expression of the CAT gene, mediated by vaccinia associated 
proteins. This observation inadvertently gave rise to a convenient means by which the CAT 
ORF could be checked (section 3.1).
Of the constructs tested, it was found that those which contained a BUNM 3' UTR were all 
found to be negative for CAT activity while all others were positive for CAT activity (Figure 
11.13). However, the CAT gene of pBUNMCAT had previously been shown to be active, 
as demonstrated by the results shown in Figure 11.7, where the transfection of BUNMCAT 
RNA gave rise to CAT activity. This result was also surprising, and it was not clear why 
CAT activity was not generated by transfection of the chimeric DNA.
One explanation of this is that it is possible that a vaccinia virus pseudo transcription 
termination signal is encoded within the BUNM 3' UTR sequence. Only one such
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Figure 11.12 Transfection of chimeric BUN-CAT RNA transcrip ts.
Run-off RNA transcripts from Bbsl linearised templates from each of the chimeric CAT 
constructs and the three BUN segment CAT constructs were transfected into CV-1 cells 
transiently expressing BUN viral proteins. An equal quantity of each transcript was 
transfected in duplicate.
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LANE
Figure 11.13 Expression of CAT from chimeric pBUN-CAT DNAs.
CV-1 cells infected with vTF7-3 at 5 pfu/cell were transfected with 2 pg of plasmid DNA to 
confirm that the CAT gene was active in each. Lanes 1 to 6 show extracts from cells which 
had been transfected with chimeric constructs pBUNM/L-CAT (Lane 1), pBUNS/M-CAT 
(Lane 2), pBUNS/L-CAT (Lane 3), pBUNM/S-CAT (Lane 4), pBUNL/S-CAT (Lane 5) 
and pBUNL/M-CAT (Lane 6). Lane 7 shows extract of cells transfected with pBUNMCAT 
and lane 8 with pBUNLCAT as control positives.
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transcription termination mechanism has been described for vaccinia virus early genes 
(Rohrmann et al., 1986), and in this case, the appearance of a UUU IIU N II sequence 
terminated transcription of the nascent RNA transcript (Shuman et al., 1988). No such signal 
exists within the BUNM 3' UTR, however, there is a pyrimidine-rich stretch, UUUAUUU 
(at nucleotides 4408 to 4414 of the BUN M segment 3’ UTR). It is possible that this 
sequence has enough similarity to a vaccinia virus termination sequence so as to terminate 
transcription from the plasmid template, resulting in no mRNA and thus no background CAT 
activity.
11.13 Comparison of the predicted base-pairing of the termini.
The possible secondary structure of the termini of both the BUN genomic segments and the 
chimeric constructs were predicted by the FoldRNA (Zuker et a l., 1991) program of the 
GCG Wisconsin Package. The terminal 40 nucleotides of the 5' and 3' termini were paired 
together in a 5' to 3' manner, and their putative secondary structures predicted
The results of the predictions are shown in Figure 11.14 (A and B). In the diagram shown in 
this figure, the sequences to the left of the dotted line comprise the 11 conserved terminal 
nucleotides in the BUN genomic termini. It can be seen that the nucleotides to the right of the 
dotted line, i.e. to the right of the 11 conserved terminal nucleotides in the BUN genomic 
termini, base-pair up to nucleotide 15 (5' termini) in the S segment (S/S), nucleotide 18 (5' 
termini) in the M segment (M/M) and nucleotide 19 (5* termini) of the L segment (L/L).
However, it can also be seen from Figure 11.14 (A and B), that in the predicted folding for 
the termini of all of the chimeras, some mismatches occur in the paired regions. A consistent 
feature is disruption of base-pairing at the segment specific regions from nucleotides 12 to 14 
or 15 which are conserved on a segment specific basis in all the available sequenced 
bunyavirus RNA segments. These are highlighted in Figures 11.14 (A) and (B).
11.14 Mutagenesis of the BUN L 5’ UTR of the pBUNL/M-CAT construct.
From the results of transfecting the chimera into the reporter assay it was found that the 
termini of heterologous segments were unable to co-operate. It was possible that there was a 
requirement for base pairing of nucleotides proceeding the 11 terminal conserved 
nucleotides, specifically those nucleotides conserved within segments, between 
bunyaviruses, i.e., the terminal nucleotides 12-14 of the M-segment 5’ and 3’ UTRs and the 
terminal nucleotides 12 to 15 of the S and L segment 5’ and 3’ UTRs.
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Figure 11.14 (A) and (B) Possible base-paired structures between the 5 ' 
and 3' termini of the BUN genomic segments and the chimera RNA 
tra n sc rip ts .
The terminal 40 nucleotides of the 5' and 3' termini from each of the Bunyamwera virus 
genome segments and the chimera constructs were paired together in a 5' to 3' manner in the 
genomic sense. The putative base pairing and secondary structure of these sequences were 
predicted by the FoldRNA (Zuker et a l 1991) program in the GCG Wisconsin Package 
(Version 9)™. The dotted line marks the boundary of the 11 terminal nucleotides which are 
conserved in all genomic segments. The shaded regions highlight the nucleotides which are 
conserved on a segment specific basis in all available sequenced bunyavirus RNA segments.
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Figure 11.14 (B) continued.
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To test this possibility, mutagenesis was performed on the BUNL/M-CAT sequence, so that 
the 5' UTR (L 5' UTR) was mutated to the sequence of the BUN M 5' terminal sequence. It 
was decided to initially perform mutagenesis on pBUNL/M-CAT construct as the BUN L 
and M 5' UTRs are of a similar length
A series of mutations were made to the BUNL 5' UTR of pBUNL/M-CAT, with the aim of 
increasing the amount of possible complementary base pairing between the 5’ and 3’ termini. 
This was achieved by mutating sequences within the L 5' UTR termini sequence to those of 
BUNM 5' UTR termini sequence, thereby increasing the complementarity between the 3’ 
and 5’ termini (Figure 11.15).
To mutate the BUN L 5’ UTR of pBUNL/M-CAT, five oligonucleotides were designed and 
synthesised as primers (mutations shown in italics, bold, underlined), Primer L(IA-12M) 
inserted a <4 residue between nucleotides 11 and 12, Primer L(12-14M) mutated nucleotides 
12-14 to the corresponding M UTR sequence (CTT to A CC  ), Primer L(12-16M) mutated 
nucleotides 12-16 to the corresponding M UTR sequence (CTT AC to A C  CCA) Primer 
L(12-18M) mutated nucleotides 12-18 to the corresponding M UTR sequence (CTT AC AT to 
A CCGA UA). and Primer L(12-21M) mutated nucleotides 12-21 to the corresponding M 
UTR sequence (CTTACATAAG to A CCGA IIA A C  A )
The sequence of the primers were:
+1
L (I-12M): 5’GGGGAGCTCTAATACGACTCACTATAAGTAGTGTGCL4 CCTACATAAGAAAATT 
Lf 12-14M f 5’GGGGAGCTCTA AT ACGACTCACT AT A AGTAGTGTGCT4 C CACATAAGAAAATT 
L( 12- 16M): 5 ’ GGGG AGCTCTA AT ACGACTCACT AT A AGT AGTGTGCT/t C C G A  ATAAGAAAATT 
L(12-18M1:5’GGGGAGCTCTAATACGACTCACTATAAGTAGTGTGCL4 C C G A  UAAAGAAAATTG  
I n  2-2 ITVn: 5 ’ GGGG AGCTCT A AT A CG ACTC ACT AT A AGTAGTGTGCT4 C C G A  U A A  C AAAAATYG
PCR reactions were set up with the mutating primers and the UNIversal primer (which 
anneals to the vector sequence) as the distal primer, and pBUNL/M-CAT was the DNA 
template. For the construction of L(12-18M) and L(12-21M) mutants, pBUNL/M-CAT (12- 
16M) was used as the template for PCR.
Initially, Pfu polymerase was utilised in the PCR reactions, however, no visible products 
were generated with this enzyme. This problem was solved by generating the PCR products 
with Taq polymerase. However, to limit the risk of spurious mutations resulting from Taq 
errors, the PCR products were digested with SacI and Seal to release a small 200 base-pair 
fragment which was then subcloned into SacI, Seal digested pBUNL/M-CAT (The
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The above figure demonstrates schematically the FoldRNA secondary structure predictions 
for a series of BUNL 5' UTR mutants in the pBUNL/M-CAT reporter construct. The aim of 
the mutations was to increase the complementarity between the 3' and 5' termini by mutating 
terminal regions of the L UTR sequence to that of M UTR sequence. The conserved terminal 
nucleotides to the left of the dotted line are shown in black, as is the M-segment sequences. 
The BUN L-segment sequences are shown in green. The insertion mutation of L/M(IA-12) 
is shown bold red (italic and underlined), while the mutations in L/M(12-14M), L/M(12- 
16M), L/M(12-18M) and L/M(12-21M) are shown in bold (italics and underlined).
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positioning of these restriction sites in the chimeric BUN-CAT constructs can be seen in 
Figure 11.11 (B) ). Clones positive for insertion were sequenced to confirm the desired 
mutations of the L 5' UTR and to check that no spurious mutations occurred during Taq 
driven PCR and subcloning. Clones representing each mutation were selected and denoted 
pBUNL/M-CAT (1-12), pBUNL/M-CAT (12-14M), pBUNL/M-CAT (12-16M), 
pBUNL/M-CAT (12-18M), pBUNL/M-CAT (12-21M).
11.15 Transfection of the pBUNL/M-CAT (BUNL 5’ UTR) mutants into the 
reporter assay.
Run-off transcripts from each of the Bbsl linearised mutants were tested in the reporter 
system by methods described previously, and the results shown in Figure 11.16.
From quantitation of the CAT signals shown in Figure 11.16, it was found that the insertion 
of an A residue between positions 11 and 12 of the BUN L 5' UTR, as in mutant 
pBUNL/M-CAT (IA-12M), failed to restore CAT activity. Furthermore, when nucleotides 
12-14 of the L 5' UTR were mutated to that of the M 5' UTR, as in mutant pBUNL/M-CAT 
(12-14M), still no CAT activity was detected. CAT activity was detected when nucleotides 
12 -16 of the L 5' UTR were mutated to those of the M 5' UTR (as in mutant pBUNL/M- 
CAT (12-16M)), although this activity was calculated to be only 6% of the BUNMCAT 
“wildtype” level. However, when the mutated region was extended to 12-18 nucleotides of 
the M 5' UTR, as in mutant pBUNL/M-CAT (12-18M), or to 12-21 nucleotides of the M 5’ 
UTR, as in mutant pBUNL/M-CAT (12-21), then CAT activity was observed to increase 
dramatically, to 71% and 65% respectively.
The results from this experiment indicated therefore that to achieve CAT activity from the 
reporter construct, base pairing was required, not only between the conserved 11 terminal 
nucleotides at the 5’ and 3’ termini, but between the terminal 18 nucleotides of the 5’ and 3’ 
termini, at least in the BUNM segment.
However, since the CAT activity detected by mutating nucleotides 12-21 of the L 5' UTR in 
pBUNL/M-CAT was still approximately 30% lower than that detected from pBUNMCAT, 
this indicates that further mutagenesis may need to be performed to increase CAT activity to 
wild type (i.e. pBUNMCAT) levels.
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Figure 11.16 Reporter gene expression from the pBUNL/M-CAT BUNL 5 ’ 
UTR m utants.
CV-1 cells transiently expressing BUN viral proteins were transfected in duplicate with equal 
quantities of RNA transcripts from the BUNL/M-CAT mutants as indicated above (Lanes 3 
to 10, and 13 to 18), BUNMCAT and BUNL/M-CAT as controls (Lanes 1 to 4, 11 and 12). 
Cells were harvested 20 hours post transfection and the cell extracts assayed for protein 
concentration before equivalent amounts of cell protein in each cell extract were assayed for 
CAT activity.
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Figure 11.17 CAT activity obtained from transfection of cells expressing  
bunyavirus proteins with pBUNMCAT-R-T<J) DNA.
Cells were infected with vTF7-3 at 5 pfu/cell, and then transfected with 1 pg pTFBUNS 
(Lane 2), 5 pg pTFBUNL (Lane 4), or both plasmids (Lane 3), as indicated, then 
subsequently transfected with 1 pg pBUNMCAT-R-T(J) DNA. Cell extracts were harvested 
24 hours post infection and assayed for CAT activity by thin layer chromatography (TLC). 
CAT activity was detected when the proteins from both recombinant plasmids were supplied 
(Lane 3), but not individually (Lanes 2 and 4). No CAT activity was detected from vaccinia
infected cells when transfected with pBUNMCAT-R-T<F DNA.
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11.16 Construction of pBUNMCAT-Ribo-TO.
A fragment encoding the BUNMCAT reporter construct was amplified by PCR from the 
pBUNMCAT plasmid, using BUNM specific terminal primers, and ligated into Stul/Smal 
sites of the ribozyme construct, pT7-Ribo-T<t>. The resulting construct, pBUNMCAT-Ribo- 
To, was sequenced to determine the orientation of the insert and to check that no spurious 
mutations had occurred during PCR and cloning.
RNA transcripts derived from pT7-Ribo-To have two extra nucleotides (GG) at the 5' end. 
Another feature of this vector is that it contains a hepatitis delta virus ribozyme sequence. 
Thus, RNA transcripts derived from pBUNMCAT-Ribo-TO contained, in the 5’ to 3’ order, 
two G residues followed by BUNMCAT, a hepatitis delta virus ribozyme sequence, then a 
portion of the T7 terminator sequence (To). Autolytic cleavage by the ribozyme releases 
itself, to generate the authentic 3' BUNM termini.
When DNA from this construct was transfected into cells pre-infected with vTF7-3, no CAT 
activity could be detected, but when transfected into cells transiently expressing the L and S 
segment proteins, CAT activity was detected (Figure 11.17).
As there is no problem of background CAT activity from transfection of the DNA from this 
construct, and since transfection of DNA into eukaryotic cells is a much simpler procedure 
than transfection of in vitro transcribed RNA, pBUNMCAT-Ribo-TO could be used as a 
template for construction of mutants designed to investigate the effects of mutations to the 5’ 
terminus of the M segment: the plasmid DNA of these constructs could be transfected 
directly into cells, obviating the need for transfection of in vitro transcribed RNA.
11.17 Discussion.
As was discussed earlier in this chapter, upon infection with bunyavirus, viral mRNA 
transcripts of the L, M and S segments, can be detected at different levels within the cell, 
with the S mRNA species, the M mRNA species and the L mRNA species in a molar ratio of 
40: 10: 1. Reasons why this occurs are not clear, but it was suggested that sequences 
encoded within the UTRs of each segment may influence or control the transcription of that 
segment. To investigate this possibility, reporter constructs based on the BUN L and M 
segments which contained the CAT gene flanked by either the BUN L or M UTRs were 
constructed. It was intended that use of RNA transcripts derived from these plasmids in the
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reporter system would determine the effect of the BUN L and M UTRs on the level of CAT 
expression.
The CAT signal obtained from the reporter assay is a direct measurement of the amount of 
CAT protein translated from CAT mRNA transcripts. Therefore, for the purpose of this 
experiment, CAT activity was initially presumed to be an indirect measurement of actual level 
of CAT mRNA transcripts. However, the results from this experiment showed that the 
highest level of CAT activity was obtained from transfection of BUNLCAT RNA, and the 
lowest level, from transfection of BUNSCAT RNA. The efficiency of expression of the 
reporter gene in the context of each of the BUN segments, was in the order of BUNLCAT 
(taken as 100%) > BUNMCAT (6 0 -70% )»  BUNSCAT (3-10%), a complete inversion of 
the ratios of mRNA transcripts found in infected cells.
The obvious disparity between the observed ratio of L, M, and S segment transcripts found 
in the cell throughout infection with bunyavirus, and the ratio of expression from each of the 
BUN-CAT reporters was surprising, and suggested that other factors must influence the 
transcript levels in the context of the infected cell.
During an infection, there are a number of other factors which may influence the gene 
expression of viral proteins which cannot be addressed with the reporter system. It is 
possible that the length of each genomic segment may influence the resulting levels of 
transcription and gene expression from that segment. Since each of the BUN genomic 
segments differ in length, it might be predicted that the S segment (961 nucleotides) for 
example, which is approximately seven times shorter than the L segment (6875 nucleotides), 
would be replicated, transcribed and encapsidated by viral proteins at a more efficient rate.
Another factor which also must be considered in the context of the viral infection is the 
involvement of the coding sequences of the BUN segments in the control of expression of 
their gene products. In work that was published subsequently to this study, Zheng et al.
(1996), engineered two influenza A (WSN) virus NA-RNA segments, in which the UTRs 
were substituted by the corresponding UTRs of the PB1- and NS-RNA segments. Using 
these constructs, it was demonstrated via RNP transfection of these RNAs, that transfectant 
viruses NA/PB1 and NA/NS could be rescued from the experiment. However, transfectant 
viruses containing an NA-RNA segment with PB1- or NS-specific UTRs showed a 
reduction in NA-specific vRNA levels of about 10 and 50 times, respectively, both in the 
released virus population and in infected cells while the levels of both the PB1 and NS 
segments were unaffected. This work suggests that RNA synthesis is influenced by both the 
coding region and noncoding regions of the viral RNA, and that the UTRs of influenza virus 
have evolved in such a way that each RNA segment contains a UTR which matches its
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corresponding coding region in a manner that ensures optimal replication and transcription of 
that segments gene product(s). Furthermore, the discovery that sequences within a coding 
region can influence their own gene expression is not unique to influenza virus. The 
nucleotide sequences of the Hepatitis C virus capsid protein ORF, for example, has been 
shown to be involved and essential for IRES activity (translation initiation) (Honda et al.y 
1996).
Therefore it is highly possible that the coding sequence of the BUN segments play a role in 
the control of replication and transcription of its specific segment {i.e. the N ORF of the S 
segment may increase expression of itself).
Another feature of replication and transcription of the BUN segments that cannot be 
measured by the CAT reporter system is the possibility that each segment exerts an effect on 
the others, by competing for interaction with the viral replication proteins during a viral 
infection. Analysis of transcription and replication signals in the UTRs of one segment in 
isolation may not illuminate the effects of competition from other segments, in what is 
essentially a series of enzymic reactions. It is possible, for example, that the S segment has a 
selective advantage over the L and M segments, in the context of a viral infection, that 
accounts for, or contributes to, the high levels of this transcript found in infected cells.
Therefore, it must be considered that various aspects of viral replication are not measurable 
in this system, and that possibly, one or more of these factors may influence or regulate the 
levels of segment replication, transcription and gene expression during bunyavirus infection, 
to result in the observed ratio of segment mRNA transcripts.
However, the fact that these other factors cannot be measured by the reporter assay, could be 
used to the advantage of this study, to allow the isolated investigation of the signals which 
reside in the BUN segment UTRs. Since each of the BUNCAT reporter constructs encoded 
the same reporter gene, the potential influence of length of the coding region, and potential 
involvement of the coding region in reporter gene expression, were eliminated from the 
assay.
The results obtained here indicated that when the involvement of other factors was removed, 
the ratio of gene expression from the BUN L, M and S segments in the reporter assay was 
completely inverted, with respect to mRNA transcript levels found in BUN infected cells. It 
was perhaps even more striking that the BUN segment UTRs possessed signals which 
strictly and specifically regulated reporter gene expression, albeit with a different pattern than 
might have been expected. At this point therefore, an exact explanation was not apparent of 
how the BUN segment UTRs mediated this regulation of CAT gene expression, whether via
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replicational or transcriptional control, or if level of CAT protein expression could be 
influenced by translational efficiency.
In an attempt to determine if expression of the CAT gene from the BUN-CAT constructs was 
under transcriptional control, Northern blot analysis of the BUN-CAT RNA transcripts 
formed in the reporter assay was attempted. Again, as in the experiments presented in 
Chapter 3, I was unsuccessful in detecting the presence of positive sense transcripts. 
Possible reasons for the failure of this technique are discussed elsewhere in this thesis.
Since Northern blot analysis of the RNAs transcribed from each reporter construct within the 
reporter system was unsuccessful, alternative routes were chosen to determine the reason for 
the observed ratio of CAT activity from the BUNCAT constructs. To investigate the 
possibility that expression from the CAT gene in the BUN-CAT constructs was influenced 
by translational control, the sequences around the AUG initiation codon in each of the three 
BUN antigenomic segments were examined for Kozak-similarity. It was found that the 
sequence context of the initiation codon in the L, M, and S segment antigenomic RNAs 
showed some degree of Kozak similarity (Figure 11.8), the L segment exhibiting the 
highest, and the S segment showing the lowest degree of similarity. The sequence context of 
the initiation codon in the BUN-CAT constructs sequence was slightly different due to the 
replacement of the coding sequence with the CAT gene, and the Kozak similarity of the 
BUNMCAT and the BUNSCAT was increased slightly due to the insertion of one of the 
major Kozak determinants {i.e. a G residue at position -4). However, the BUNLCAT 
construct still exhibited a higher Kozak similarity compared to BUNSCAT.
Mutagenesis was performed on the BUNLCAT to produce a lower degree of Kozak 
similarity, resembling that found in the BUNSCAT construct. Similarly, the BUNSCAT 
construct was mutated to possess a higher degree of Kozak sequence similarity, thus 
resembling the BUNLCAT construct. Study of these mutants in the reporter assay however, 
revealed no major change in expression of the CAT gene as a result of the changes in Kozak 
similarity, and it was concluded that differences in the level of CAT activity between the 
BUNLCAT and BUNSCAT constructs was not due to the extent of Kozak consensus 
similarity within the sequences surrounding the initiation codon.
To determine if either the replication or transcription promoters of each of the BUN segments 
{i.e. 5' UTR for anti genome replication (anti-vRNA) and mRNA transcription, the 3' UTR 
for genome replication (vRNA)), influenced the level of CAT activity produced from each of 
the BUN-CAT constructs, a series of chimeric BUN segment CAT reporter constructs were 
engineered where the CAT reporter gene was flanked by either the 3' or the 5' UTR of one 
particular segment, with the opposite termini from another segment. It was presumed that the
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termini from each segment would be able to co-operate, at least to some extent, with other 
heterologous termini. However, the results of the chimeric BUN UTR constructs 
demonstrate that the 3’ and 5’ termini of the three BUN segments cannot co-operate, 
possibly either in forming the correct secondary structure, or in supplying the proper 
recognition or transcription signals. This was surprising, as the termini from each of 
chimeric transcripts must contain the correct BUN virus promoter sequences for 
transcription. These results do suggest however, that the 3’ and 5’ termini of each BUN 
segment have co-evolved so that the correct secondary structure between the 3’ and 5’ 
termini is maintained to present the cis acting signals encoded in the correct conformation.
The finding that the termini of the three BUN segments were not able to co-operate, either to 
form the correct secondary structure, or to supply the proper recognition or transcription 
signals, is also surprising in light of recent work by Odagiri and Tashiro (1997) on influenza 
A virus, which provided evidence, not only for reporter gene expression, but for the efficient 
viral rescue of chimeric UTR CAT RNA transcripts. In this study the CAT gene was flanked 
either by the PA segment 3’ UTR and the PB2 5’ UTR (3’ PA/ 5’ PB2) or the PB2 3’ UTR 
and the PA 5’ UTR (3’ PB2/ 5’ PA). Therefore, this work demonstrated that, in the case of 
influenza A virus at least, chimeric RNA segments which possessed a 3’ UTR and a 5’ UTR 
each derived from different segments were capable of being expressed and packaged into 
viral particles.
Upon comparison of the possible secondary structures formed between each of the 3’ and 5’ 
termini of the genomic transcripts and the chimera transcripts, it was found, not 
unsurprisingly, that there was a greater degree of complementarity maintained between the 
termini of the genomic segments compared to the termini of the chimera segments (Figure 
11.14).
To investigate whether the reduced complementarity between the termini of the chimera 
transcripts was responsible for the lack of CAT activity, a series of mutants was constructed, 
which increased gradually the degree of complementarity between the 3’ and 5’ termini. The 
L/M-CAT chimera was chosen for further investigation as the L and M segments have UTRs 
of a similar length. The complementarity between the termini was increased gradually by 
mutating the L 5’ UTR terminal sequence to that of the M segment 5’ UTR sequence. As 
was shown in Figure 11.16, CAT activity was not detected until the terminal 16 nucleotides 
were complementary. Furthermore, when the restored complementarity between the 5’ and 
3’ termini was increased to 18 and 21 nucleotides, the CAT signal increased to 
approximately 70% the level of BUNMCAT CAT activity.
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These results indicate that complementarity between the 5’ and 3’ termini, greater than the 
terminal 11 nucleotides, may be critical for creating the correct secondary structure at the 
termini to allow transcription and subsequent expression of the CAT reporter construct.
It has been proposed previously by several bunyavirus groups (Elliott, 1990; Kolakofsky 
and Hacker, 1991), that the sequences conserved between the termini of the 3 genomic 
segments {i.e. the first 11 nucleotides in the case of bunyaviruses), are important for viral 
protein recognition and encode the viral promoters necessary for transcription and replication 
(Chapter 1.4.1). Furthermore, it is thought that these conserved sequences may form a 
panhandle structure. However, it is possible that the nonconserved nucleotides flanking 
these regions (i.e. nucleotides 12-18 of the BUN M termini) may be involved in stabilising 
the panhandle structure, possibly by extending the complementarity and base-pairing 
between the termini (Figure 1.3).
These results also imply that further mutation of the L 5’ UTR within pBUNL/M-CAT to 
that of M 5’ UTR would presumably restore CAT activity equivalent to BUNMCAT levels.
It is also possible that the non-conserved nucleotides may be involved in the formation of 
more complex RNA structures, such as pseudoknots, which might be required for 
interaction with cellular factors during RNA replication. Alternatively, nucleotides close to 
this structure may enhance or inhibit the formation of the panhandle structure, either by 
directly interacting with the conserved nucleotides or by interacting with internal sequences.
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Conclusions
I have described the establishment and characterisation of a convenient in vivo transient 
expression reporter system to investigate Bunyamwera viral RNA synthesis and the proteins 
involved by reverse genetics. The reporter system initially utilised a chimeric BUN virus-like 
S segment RNA transcript carrying an antisense CAT reporter gene. Transfection of this 
reporter RNA into cells expressing recombinant BUN virus proteins resulted in the detection 
of CAT activity. This indicated that the negative sense BUNSCAT RNA transcript, which 
could not have acted as a template for translation, was recognised by, and had interacted with 
the recombinant BUN virus proteins to form a functional bunyavirus ribonucleoprotein 
(RNP)-like complex. Formation of this complex allowed the subsequent transcription of a 
positive sense RNA from the transfected BUNSCAT reporter RNA transcript. It was also 
shown that detection of CAT activity from the reporter transcript was dependent upon 
expression of proteins from both the BUN L and S segments. These proteins could be 
supplied by transient expression, either from recombinant vaccinia viruses, or from 
transfected plasmids using the vaccinia virus-T7 RNA polymerase system.
Further analysis of the S segment proteins determined that the N protein and the BUN L 
protein are sufficient for the transcription of BUNSCAT RNA in the reporter assay. This 
suggests that only the L and N proteins are required, in conjunction with an appropriate 
RNA molecule, to reconstitute a transcriptionally active RNP structure. The function of the 
BUN S segment NSs protein still remains unclear.
It was also demonstrated that BUN L protein was able to transcribe BUNSCAT RNA in 
concert with certain heterologous bunyavirus S segment proteins. The heterologous S 
segments that produced significant levels of CAT activity were those in which the N protein 
was most closely related to BUN N protein at the amino acid level.
Analysis of BUN viral-like RNA transcripts produced within the reporter system by 
Northern blotting, was unsuccessful in determining whether the BUNSCAT transcript was 
being replicated. However, the use of a BUNSCAT(+) RNA in the reporter system which 
gave an elevated CAT level above background when the BUN L and S segment proteins 
were supplied, indicated that BUNSCAT(+) RNA was replicated to BUNSCAT (negative 
sense) which subsequently acted as a template for mRNA transcription. This suggests that 
the reporter system does indeed support replication of BUN S-like transcripts.
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When the effect of adding or removing nucleotides from the extreme ends of the BUNSCAT 
RNA termini was tested, it was found that the addition of nucleotides at either the end of the 
5’ or the 3’ termini of BUNSCAT reporter RNA resulted in a transcript which gave 
detectable CAT activity in the reporter assay. This suggests that the viral polymerase can 
probably recognise and interact, at least to some extent, with specific sequences which are 
present in the 5’ and 3’ termini, whether these signals are presented at the extreme termini, or 
whether they are internal to other sequence. Deletion of any number of nucleotides from the 
BUNSCAT 5’ UTR was not tolerated, indicating that the terminal conserved nucleotides of 
the 5’ UTR are absolutely essential for interaction with the polymerase. Deletion of one 
nucleotide from the 3’ terminus were better tolerated, resulting in CAT activity that was 
equivalent to “wild type” BUNSCAT RNA. However, a deletion of 2 nucleotides drastically 
reduced CAT activity. This maybe explained if we consider that the 3’ UTR would be acting 
as the template for transcription initiation while the 5’ UTR maybe important for in 
polymerase recognition or positioning of the template RNA.
Garcin et al. (1995), proposed a mechanism for the synthesis of viral mRNA termed the 
“prime-and-realign” model. This model could account for the observation that a deletion of 1 
nucleotide from the 3’ UTR was tolerated, as a deletion of 1 nucleotide would still allow the 
capped-primer to anneal at the C at position 2, and to initiate with a G in the usual manner, 
and that the prime-and-realign mechanism could proceed without disruption. The reiteration 
of sequence at the 3’ terminus, in conjunction with the “prime-and-realign” mechanism, 
would mean that genome segments which lack a nucleotide at the 3’ end are still active for 
transcription and could feasibly be repaired during replication, as shown in Figure 7.11 B.
In an attempt to determine the function of two conserved sequence motifs which are present 
within the 5’ UTR of all sequenced bunyavirus S segments, a series of deletions were made 
within the BUNSCAT 5’ UTR. When the RNA transcripts from these mutants were tested in 
the reporter system only those with an internal deletion of 156 nucleotides, leaving only 11 
terminal nucleotides were inactive in the assay. It was thought that the drop in CAT activity 
was not due to the removal of conserved sequenced motifs in the RNA, but rather of 
nucleotides 12-15 which are conserved between all bunyavirus S segments.
To determine the importance and function of the conserved sequences found at the BUN 3’ 
and 5’ termini a series of mutations was made. In the first series of BUNSCAT mutants, the 
results of single nucleotide substitutions in either the 5’ or the 3’ terminus suggested that 
sequence specificity and/or base-pairing between the termini was essential. To investigate the 
importance of base-pairing between the termini a series of complementary base-paired 
mutations were tested; these mutations also demonstrated that the majority of changes to the 
terminal 12 nucleotides were detrimental. Only changes to nucleotides 13-15 were tolerated
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suggesting that the maintenance of base-pairing in this region is more important than 
specificity of sequence. Interestingly, mutations to the very terminal nucleotides were 
moderately tolerated which again suggests a role for the “prime-and-realign” model to 
overcome changes in a terminal nucleotide.
Mini-BUNSCAT reporters were constructed to determine the minimum lengths of the BUN 
S 3’ and 5’ UTRs required for the expression of CAT activity. It was shown that the termini 
had to be more than 20 terminal nucleotides in length for functional activity. Termini which 
were 13 nucleotides in length and therefore contained the conserved terminal 11 nucleotides, 
were insufficient in length to allow transcription of the reporter gene. Furthermore, termini 
which were 20 nucleotides in length and therefore contained both the conserved terminal 
sequence and those sequences conserved between bunyavirus S segments were similarly 
insufficient for functional activity. However, a mini reporter with 32 5’ and 33 3’ terminal 
nucleotides elicited CAT activity, which suggests that a length of between 20 and 33 terminal 
nucleotides is sufficient for the formation of an active RNP structure.
Comparison of the level of CAT activity within the reporter system from all three BUN 
genomic CAT reporters found that the BUNLCAT reporter was greater than the BUNMCAT 
which in turn was greater than BUNSCAT. To determine which UTR, 3’ or 5’, was 
responsible for controlling CAT levels a series of chimeric BUN UTR CAT reporter was 
constructed. The results from these chimeric RNAs demonstrated that the 3’ and 5’ termini 
of different BUN segments cannot co-operate, possibly either in forming the correct 
secondary structure, or in supplying the proper recognition or transcription signals. This was 
surprising, as the termini from each of the chimeric transcripts must each contain the correct 
BUN virus promoter sequences for transcription of its segment, and suggests that 
complementarity greater than the terminal 11 nucleotides may be critical for creating the 
correct secondary structure at the termini to allow transcription and subsequent expression of 
the CAT reporter construct.
Further to this, it was shown that when nucleotides 12-18 of the L 5’ UTR in the chimeric 
reporter pBUNL/M-CAT were mutated to M 5’ UTR sequence, thereby increasing 
complementarity between the termini of the chimeric RNA, a significant level of CAT activity 
was restored. This suggests that not only is complementarity required between the terminal 
11 nucleotides of the termini, but also between the terminal 18 nucleotides of the 3’ and 5’ 
termini, at least in the case of the BUN M segment. These nonconserved nucleotides that 
flank the conserved terminal 11 nucleotides in genomic segments {i.e. nucleotides 12-18 of 
the BUN M termini) may be involved in stabilising the panhandle structure, possibly by 
extending the complementarity and base-pairing between the termini (Figure 1.3).
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The BUN-CAT reporter system as it stands is a very useful reliable and convenient tool for 
investigating BUN RNA synthesis and specifically the proteins involved in the replication 
and transcription events. However, one potential problem with the reporter system which 
was not experimentally addressed in this study was the effect of vaccinia virus (vTF7-3) 
encoded proteins on the transfected RNAs and the resulting BUN viral-like transcripts 
produced within the system. It is possible that vaccinia virus encoded proteins might cap and 
polyadenylate BUN viral-like transcripts: if this were so then the degree of polyadenylation 
may have made it difficult to detect individual BUN transcripts as discrete bands by Northern 
blotting.
Recently Agapov et al. (1998) described a series of noncytopathic Sindbis virus vectors 
capable of generating cell lines for the long term expression of foreign genes. One such 
vector, SINrepl9/T7pol which expresses the T7 RNA polymerase, could act as an 
alternative to vaccinia virus vTF7-3 in the BUN reporter system for in vivo T7-expression.
Employment of a different T7-expression system could greatly enhance the usefulness of the 
BUN reporter system, by allowing the detection and further characterisation of RNA 
transcripts produced within the assay. Such characterisation might provide further insight 
into specific aspects of BUN replication and transcription such as CAP snatching, 
transcription initiation and mRNA termination.
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